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Abstract
The mammalian middle ear is composed of three bony ossicles, the malleus, incus, and stapes 
that function to conduct  sound from the external to the inner ear. Normal development  of middle 
ear structures is integral for transduction of sound, defects resulting in conductive deafness. 
Mice are reliant  on both embryonic and postnatal developmental events to acquire hearing, and 
Eya1 mutant  mice present  with middle ear defects during both these developmental periods. 
Therefore, the aim of this project  was to investigate the role of Eya1 in middle ear development 
and disease. 
Eya1 mutant  mice on several backgrounds have previously been characterised with middle ear 
ossicle defects, however the role of Eya1  in regulating ossicle development has not  been 
investigated. In this project, I characterise novel ossicle joint  patterning defects of Eya1 mice of 
the C57BL/6 background, and show Eya1 to be expressed in the middle ear ossicles during 
embryonic development. I also investigate genetic regulators of joint  development and show 
Gdf5 misexpression in the Eya1 +/- middle ear. I suggest Eya1 indirectly regulates middle ear 
joint patterning through a more general role in cartilage development. During postnatal 
development, Eya1 may further be required for the maintenance of joints.
Transformation of Meckel’s cartilage results in separation of the jaw and middle ear, and is a 
characteristic feature of modern mammaliaforms. The Eya1 +/- mouse exhibits a delay in 
postnatal Meckel’s cartilage development, suggesting Eya1 as a regulator of this process. I 
investigate mechanisms associated with transformation of Meckel’s cartilage, and suggest Eya1 
regulates this process indirectly through recruitment of TRAP positive cells.
During adult  stages of postnatal development, Eya1  +/- mice are predisposed to developing 
middle ear infections. With the use of microscopy and histological techniques, I characterise the 
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1   Introduction 
1.1  Why study middle ear development?
Most vertebrates can sense their environment through some form of hearing. Middle ear 
function specifically ranges from basic bone conduction through the reptilian jaw to a 
fully  specialised mammalian middle ear apparatus (Kirikae., 1957; Goodrich., 1914). 
Hearing plays an integral role in response, survival and communication, and is 
additionally important for human speech development from birth (Stelmachowicz et al., 
2004). During these informative stages of life, delays in speech development may in 
turn impact learning, and result in diminished educational outcomes (Bluestone and 
Klein., 2007). As hearing has greatly  influenced our evolution as social animals, 
deafness can be a profoundly isolating condition. In the UK alone 9 million people are 
estimated to suffer from hearing impairments (www.nhs.uk). These largely fall into two 
categories, sensorineural hearing loss caused by a functional defect in the inner ear, or 
conductive hearing loss associated with the middle and external ear.
Middle ear defects are often a by product of severe craniofacial syndromes that affect 
formation of the bones of the skull, including the temporal bone which encases the 
middle ear. Middle ear defects can manifest in a variety of structural anomalies, 
including malformation of the bony  structures such as the ossicles and middle ear 
cavity. Fusions of the ossicles for example is one of two main causes of conductive 
deafness observed in syndromes of developmental abnormalities (Gorlin et al., 1995). 
The second cause concerns the formation of an air filled middle ear cavity. During 
human and murine embryonic development, the middle ear cavity is filled with 
mesenchyme, which embeds the ossicles and prevents their movement (Jaskoll and 
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Maderson.,1978). This mesenchyme is gradually cleared from the middle ear cavity  in 
the last trimester in humans, and within the first two postnatal weeks in mice 
(Guggenheim et al., 1956). Without effective clearance the middle ear ossicles remain 
fixed in the mesenchyme and are unable to vibrate and transduce sound. Abrogated 
mesenchymal clearance is a further complication in several syndromes of conductive 
deafness (Jaisinghani et al., 1999). 
In addition to developmental abrogations, disease of the middle ear can also result in 
conductive deafness. For example, inflammation of the middle ear cavity (otitis media) 
is a common cause for a visit to the paediatrician, and is a leading cause for acquired 
hearing impairment in children (WHO., 2004). Cholesteatoma, another inflammatory 
disease of the ear, can arise in association or independently of otitis media (Holt et al., 
2003), and otosclerosis is amongst the most common causes for deafness in the adult 
population (Altman et al., 1967). Disease of the middle ear can develop as a result of 
syndromic middle ear malformations, and inflammatory disorders of the ear may arise 
as secondary consequences of structural middle ear defects. Residual mesenchyme into 
childhood, for example, is thought to increase the chance of developing otitis media 
(Paparella et al., 1980). As structural malformations of the middle ear can be causative 
of later disease development, investigation of embryonic and postnatal middle ear 
development is of great clinical value.
 
The structure of the mammalian middle ear has been accurately  documented since the 
early anatomists of the 17th century (Graboyes et al., 2011), and with the emergence of 
the field of developmental biology, the embryonic origin and morphogenesis of these 
structures have largely  been elucidated. With the advancement of genetic tools, such as 
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transgenic mice and genetic screening, the complex nature of the genetics and 
mechanisms that govern development of the mouse and human middle ear are gradually 
being unveiled. Studies investigating the genetics of middle ear development and 
disease will improve our understanding of the developmental events that lead to a 
functional middle ear, and in turn the mechanisms that cause pathology. The long term 
goal is therefore to use information derived from these studies to aid identification of 
syndromic deafness, and develop  therapeutics which ameliorate the quality  of life of 
sufferers of these syndromes.
1.2  The ear has functionally discrete regions
The human ear is composed of three specialised regions for sound transduction, the 
external, middle, and inner ears. The pinna of the external ear, a flexible funnel shaped 
cartilaginous structure, channels air pressure changes from the environment, through the 
external auditory canal and onto the tympanic membrane (ear drum). Movement of the 
tympanic membrane due to air pressure changes transduces sound energy into 
mechanical vibrations. Vibrations are subsequently transferred into the middle ear 
cavity by three closely associated middle ear bones (ossicles), the malleus, incus and 
stapes. The manubrium of the malleus rests on the inner tympanic membrane and 
directly  transmits vibrational energy to the incus, which is in turn transferred to the 
stapes. The footplate of the stapes inserts into the oval window of the inner ear cochlea, 
and in turn transmits these vibrations into the fluid filled cochlea. It is here where 
mechano-sound transduction finally  occurs, and mechanical energy  is transduced into 
electrical impulses, which are transmitted to the brain through the vestibulocochlear 
nerve (Moller., 2006). The middle ear therefore plays an integral role in sound 
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conduction, mediated by the ossicular chain, which transfers vibrations from the 
external to the inner ear.
1.3 Structure of the middle ear
The middle ear is a highly  specialised and conserved component  of the hearing 
apparatus found in mammals and non mammalian vertebrates. In humans it is functional 
from birth, and two weeks postnatally in mice (Guggenheim et al., 1956). The fully 
developed middle ear and inner ear are encased together within a bony capsule (the 
auditory bulla), which is formed partially from the temporal bone of the skull.
1.3.1   The middle ear cavity
The mature middle ear cavity  can be divided into three sub regions; the epitympanum, 
mesotympanum and hypotympanum. The epitympanum (attic) harbours the articular 
surfaces of the malleus and incus. The mesotympanum is the region of the cavity in 
plane with the external auditory  cavity, and surrounds the bulk of the ossicles. The 
hypotympanum is the region inferior to the ossicles and below the plane of the external 
ear (Hoeffner and Mukherji., 2008). 
1.3.2    The ossicles and bony structures of the middle ear
The middle ear is composed of three small ossicles that reside in the middle ear cavity; 
the malleus, incus, and stapes, and an eardrum formed by the tympanic ring and 
membrane. The middle ear ossicles are structurally complex and exhibit  specialised 
surfaces that  facilitate sound conduction. For example, the malleal manubrium is a thin 
extension of bone, which inserts into the medial surface of the tympanic membrane. 
This direct  connection between the first ossicle of the middle ear and the tympanic 
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membrane, enables efficient detection and transference of vibrations into the middle ear 
ossicle chain. The malleus and incus possess corresponding articular surfaces, with the 
groove of the malleus accommodating the notch of the incus. The incudo-malleal 
articular surfaces enable close apposition of both bones, ensuring vibrations are passed 
from one to another directly. This incudo-malleal joint is synovial. The incus in turn 
exhibits a long process that stretches posteriorly to meet the neck of the stapes through a 
small circular lenticular process. These processes of the incus and stapes articulate 
through the incudo-stapedial joint, which is also a synovial joint. The stapes is the final 
ossicle in the chain that communicates directly with the inner ear, through a footplate 
which sits in the oval window of the inner ear cochlea. The annular ligament completely 
fills the stapedio-vestibular joint, resulting in a syndesmosis joint (Buytaert et al., 2011). 
Through this articulation sound vibrations are passed from the middle ear to the inner 
ear oval window membrane (Fig.1.1). Articular surface specialisations are therefore 
critical for efficient sound transduction. Mice additionally possess the gonium, which 
alongside the tympanic ring connects the middle ear ossicles to the skull (Gaupp.,1911). 
The size, shape, and ossicle number further influence the frequency range in which 
animals can hear (Mason., 2012).  
1.3.3   Middle ear muscles and ligaments
The ossicles are held in place by delicate muscles, the tensor tympani inserting into the 
manubrium of the malleus and the stapedius into the neck of the  stapes. This gives the 
ossicles flexibility to conduct air pressure vibrations and also offers mechanical 
impedance control (Mallo., 1998).
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Similarly, middle ear ligaments connect the ossicles to the surrounding walls of the 
tympanic cavity, and influence ossicle movement and sound conduction through the 
middle ear. Four suspensory ligaments hold the ossicles in place. The superior and 
anterior malleal ligaments insert into the head of the malleus and the roof and anterior 
wall of the middle ear cavity respectively. The superior incudal ligament inserts into the 
head of the incus and the roof of the middle ear cavity, and the posterior incudal 
ligament inserts into the short  process of the incus and the fossa incudis of the posterior 
wall of the middle ear cavity. These ligaments suspend the ossicles in the aerated middle 
ear cavity. Lateral ligaments also support the malleus and incus, and an incudo-malleal 
ligament holds the malleus and incus loosely together around the developed incudo-
malleal joint (Lemmerling et al., 1997). The stapes footplate is similarly held in place in 
the oval window by the annular ligament (Whyte et al., 2002).
1.3.4   The eustachian tube
The eustachian tube is a predominantly  fibrocartilaginous structure that stretches from 
the nasopharynx to the anterior region of the middle ear cavity. In approach to the 
middle ear cavity it  is composed of a funnel shaped bony osseus portion, which is 
continuous with the anterior region of the middle ear cavity. The eustachian tube enters 
the middle ear through a bony ostium, and opens into the mesotympanum of the middle 
ear cavity. The narrowest region of the eustachian tube, the isthmus, is positioned just 
inferior to the entrance into the middle ear cavity. This constriction functions to prevent 
pathogens from the nasopharynx entering the middle ear cavity. At the nasopharyngeal 
end, the eustachian tube enters as a cartilaginous tube at the torus tubarius. The 
eustachian tube lining is composed of a pseudostratified ciliated epithelia, which 
facilitates its function to channel debris and middle ear effusions from the cavity into 
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the nasopharynx. At rest  the cartilaginous portion remains flattened, but opens due to 
swallowing or reflexes such as yawning and sneezing. Function of the tube is dependent 
in part  on the surrounding muscles that help to push material from one end to another. 
The muscles which are thought critical to this function are the tensor veli palatini and 
the levator veli palatini. The eustachian tube is additionally important for aeration of the 
middle ear cavity and consequentially is also an entrance for pathogens into the middle 
ear cavity (Bluestone., 2005). 
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Fig 1.1    Structure of the middle ear.  The middle ear ossicles form a chain linking the tympanic 
membrane to the inner ear oval window membrane. The manubrium of the malleus inserts directly into 
the tympanic membrane. The footplate of the stapes inserts into the oval window membrane. The incudo-
malleal joint is formed by the articular surfaces of the ossicles, which are held together by ligaments to 
form a joint capsule. This joint is a synovial joint. The incudo-stapedial joint is also a synovial joint and is 
also held together by a joint capsule. The stapedio-vestibular joint is a syndesmosis joint, and the 
footplate of the stapes is attached to the oval window through the annular ligament. Ligaments hold the 
malleus and incus in place. The anterior malleolar ligament inserts into the neck of the malleus and is 
continuous with the sphenomandibular ligament (not shown). The superior mallolar and superior incudal 
ligaments suspend the ossicles in the cavity.  The posterior incudal ligament attaches the incus to the 
posterior wall of the cavity. The tensor tympani inserts into the manubrium of the malleus and the 
stapedius muscle attaches to the neck of the stapes and the wall of the cavity. The eustachian tube 
connects to the middle ear cavity, and provides drainage and aeration. tm, tympanic membrane, M, 
malleus, I,  incus, S,  stapes, mb, manubrium, pb,  processus brevis, owm, oval window membrane, IMJ, 
incudo-malleal joint, ISJ, incudo-stapedial joint, SVJ, stapedio-vestibular joint, aml, anterior malleolar 
ligament, sml, superior malleolar ligament, sil,  superior incudal ligament, pil, posterior incudal ligament, 
al, annular ligament, tt, tensor tympani, sm, stapedius muscle, ET, eustachian tube.
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1.4   Development of the middle ear
The ear is a developmentally  diverse organ, composed of three succinct functional 
entities, the external ear, the middle ear and the inner ear. Whilst the external ear derives 
from ectoderm of the first branchial cleft, the middle ear forms from endoderm of the 
branchial arch and neural crest derived mesenchyme, and the inner ear forms from 
surface ectoderm of the otic placode (Van De Water et al., 1988). In order to achieve 
functional integration, a degree of developmental co-ordination is therefore required. 
Here the major events of embryonic and postnatal middle ear development will be 
described.
1.4.1   Embryonic middle ear development
1.4.1.1   The neural crest contribution to the middle ear
The neural crest is a cell population of great developmental potential, which 
delaminates from the dorsal neural tube during closure and migrates to fill the arches of 
the branchial apparatus (Lumsden et al., 1991). Here they  form the mesenchyme of the 
branchial arches. Due to their multipotency, neural crest  cells are often considered a 
fourth germ layer (Hall., 1998), and from the branchial arches they contribute to various 
developing structures of the embryo. 
For example neural crest of the first branchial arch gives rise to Meckel’s cartilage, the 
neck and manubrium of the malleus and the incus, whilst the stapes and processus 
brevis of the malleus form from neural crest  of the second branchial arch (Carlson.,
1994; O’Gormon.,2005). The neural crest migrates into the branchial arches in a 
sequential stage dependent manner, with the cells that form the articular surfaces of the 
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ossicles, specifically the head of the malleus, incus, and footplate of stapes migrating 
first, followed by neural crest that forms the tympanic ring, manubrium, and neck of the 
stapes, and then the neural crest that fills in the remaining bodies of the ossicles (Mallo 
et al., 1997). Interactions between the overlying branchial arch epithelium and 
mesenchyme most likely induce the development of these skeletal structures (Le 
Dourain et al., 1982), although specification of the neural crest prior to migration has 
not been completely  ruled out (Mallo et al.,1997). Cell tracing studies performed using 
chick and quail chimeras have shown neural crest of the branchial arches to be of multi 
rhombomere origin, which may reflect a degree of pre-migratory  specification. Based 
on their avian homologues, the malleus is suggested to develop from neural crest 
originating from the midbrain and the first  and second rhombomeres of the hindbrain, 
the incus may  develop from the first and second rhombomeres, and the stapes would 
form exclusively from neural crest  of the fourth rhombomere (Kontages and Lumsden.,
1996) (Mallo.,1998). Therefore despite developing from branchial arch derived neural 
crest, mesenchyme which forms the ossicles may be heterogenous, even prior to overt 
ossicle development.
The structures that compose the middle ear form predominantly during embryonic 
development (Mallo et al.,1998), and during these stages mesenchyme of the first and 
second branchial arches become differentially specified to give rise to various structures 
of the middle ear. The first branchial arch elongates to form the tubotympanic recess, 
and during later embryonic development, the medial region elongates and the lateral 
region balloons, to form the eustachian tube and middle ear cavity respectively. As the 
middle ear cavity forms a break must occur, in order to incorporate the developing 
middle ear structures (Park and Lim., 1992). Together the endoderm of the branchial 
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pouch and neural crest mesenchyme form the epithelia of the middle ear cavity 
(Thompson and Tucker., 2013). Within the developing middle ear cavity, neural crest of 
the first and second branchial arches condense and differentiate to give rise to the 
cartilaginous anlages of the middle ear ossicles. The ossicles remain cartilaginous 
during embryonic development but undergo endochondral ossification during postnatal 
stages. The articular surfaces of the malleus, incus, and stapes however remain 
cartilaginous (Mallo.,1998). The remaining neural crest continues to surround the 
middle ear ossicles throughout embryonic and early postnatal middle ear development, 
and likely functions as an important cellular and signalling source during these 
developmental stages.
1.4.1.2   Incudo-malleal joint formation
As a result  of their common origin, the malleus and the incus develop as a combined 
cartilaginous complex (Miyake et al., 1996). Therefore, in order to acquire independent 
movement, this incudo-malleal complex must be separated into two individual ossicles. 
This is achieved through the process of joint formation, which gives rise to an 
independent malleus and incus. The process of ossicle joint  formation is regulated by an 
interplay  of genetics and mechanisms, which likely position the joint and direct its 
formation (Amin and Tucker., 2006; Amin et al., 2007).
1.4.1.3   Stapes and stapedio-vestibular joint development
Although derived largely from neural crest of the second branchial arch, recent studies 
have shown the footplate of the stapes to form from a dual origin. The base of the 
footplate develops from the middle ear neural crest along with the head and crus of the 
stapes, and the outermost rim forms from mesoderm of the inner ear. Formation of both 
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regions of the footplate are interdependent, and loss of the neural crest  derived 
footplate, results in absence of the mesoderm derived base. Whilst the stapes is not 
thought to be required for induction of the oval window, it  may influence the correct 
development of this structure (Mallo et al., 1997; Thompson et al., 2012). In support, an 
absence of the stapes is often associated with malformed oval windows in humans and 
transgenic mice (Zeifer et al., 2000; Kanzler., et al., 2000; Gendron-Maguire et al.,
1993). Signals from the developing oval window may also influence development of the 
stapes (Zou et al., 2012). Therefore a degree of developmental interdependence is 
implicated between the developing stapes and oval window. Whilst positioning of the 
stapes and oval window may occur independently, the derivation of the outer footplate 
from inner ear mesoderm enables close structural correlation between the two. The dual 
origin of the stapes footplate further requires separation of the mesoderm derived 
footplate from the inner ear cartilage, in order to give rise to a freely mobile stapes. This 
occurs through development of the stapedio-vestibular joint, which separates the stapes 
from the inner ear cartilage. The annular ligament forms around the stapes and cushions 
the movement of the stapes against  the oval window membrane. The formation of the 
stapedio-vestibular joint and annular ligament are therefore important for function of the 
stapes (Nandapalan et al., 2000). The stapedial artery courses through the middle ear 
cavity during embryonic stages, and forms the foramen of the stapes. As a result, during 
embryonic stages this vessel can be seen to traverse the stapedial formamen. The 
stapedial artery is an embryonic structure however, and degenerates prior to postnatal 
stages of development (Padjet et al., 1948). 
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1.4.1.4   Development of the tympanic ring and membrane
Whilst development of the middle ear ossicles are taking place, other structures of the 
middle ear synchronously develop. The tympanic ring, which later becomes 
incorporated into the developing auditory bulla (Novacek., 1993), is a first branchial 
arch derivative that  forms through the process of intramembraneous ossification. The 
development of the tympanic ring and its membrane occurs through integrated 
development of both external and middle ear tissues. Signals from the branchial arch 
epithelium induce condensation of the first branchial arch mesenchyme to form the 
tympanic ring. Formation of the tympanic ring in turn induces the invagination of the 
branchial ectoderm, which grows towards the tympanic ring and forms the external 
auditory meatus (EAM). The EAM  will eventually form the external auditory  cavity. 
This invagination in turn induces development of the malleal manubrium (Mallo and 
Grindley., 1996). The growth and correct positioning of the manubrium in the vicinity 
of the developing tympanic membrane may be regulated by opposing cartilage inductive 
and inhibitory signals (Mallo et al., 2000), which ensure the manubrium is incorporated 
into the developing tympanic membrane. The external ear epithelium follows the 
growing tympanic ring, eventually forming a flat layer of epithelium, and forms the 
external layer of the developing tympanic membrane. As this occurs, endoderm of the 
middle ear cavity  opposes the ectoderm derived membrane, in the process incorporating 
neural crest mesenchyme and the manubrium of the malleus between the two layers. As 
a result, the tympanic membrane is composed of a three layered striated membrane, the 
lateral most region derived from ectoderm of the external ear, the middle layer 
composed of neural crest derived mesenchyme of the middle ear, and the medial most 
layer composed of endoderm of the middle ear cavity. Formation of the external ear, 
tympanic ring, and membrane therefore appear to be interdependent processes, which 
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align and integrate the ossicles of the middle ear with the tympanic membrane, and in 
turn the external ear. Due to this co-ordinated development, defects in the formation of 
the external auditory  canal often correlates with defects in the tympanic ring (Mallo and 
Grindley., 1996). 
1.4.1.5   Muscles and Ligaments
Soft tissue structures of the middle ear are also formed during embryonic stages of 
development, although embryological studies investigating their development are 
lacking. The middle ear muscles, namely the tensor tympani and stapedius, are 
presumed to develop from the paraxial mesoderm, much like other muscles of the head 
(Mallo et al., 1998). However, the regions of immediate insertion into the malleus and 
stapes respectively  are of neural crest origin (Kontages and Lumsden., 1996). 
Developmental studies of the ligaments of the middle ear are equally lacking, although 
their structurally  close association with the ossicles may suggest they  also derive from 
the neural crest mesenchyme of the middle ear cavity. They  form from loose lamina that 
forms closely to the wall of the cavity, which eventually  condense and appear 
continuous with the perichondrium of the ossicles. As the articular surfaces of the 
ossicles and the joint interzone develop, the incudo-malleal ligaments become stretched, 
forming a capsule encompassing the joint region of the ossicles (Gimeno et al., 2009). 
By the final stages of embryonic development, the morphology of the three ear regions 
appear distinct. The middle ear ossicular chain forms in an integrated manner with the 
external ear, and is in position to transfer external ear vibrations through the ossicular 
chain. Similarly  the footplate of the stapes is situated opposite the oval window, in order 
to transfer sound vibrations directly to the inner ear. The integrated development of 
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these structures therefore ensures correct alignment and in turn integration of these three 
functional ear regions. 
1.4.2   Postnatal middle ear development
However, even after the co-ordinated development of the middle ear and the process of 
ossicle joint formation, the middle ear has still not by these stages attained function. 
This is for two reasons; firstly the maintenance of the continuity between the malleus 
and Meckel’s cartilage functions as a structural link between the malleus and the jaw, 
thus preventing movement of the malleus. Secondly the middle ear ossicles continue to 
be surrounded by neural crest mesenchyme, which embed the ossicles and prevent their 
movement. It  is for these developmental reasons that the mouse is born deaf. Function 
of the middle ear in the mouse is therefore dependent on postnatal developmental 
events, namely  the postnatal transformation of Meckel’s cartilage and removal of 
mesenchyme from the middle ear cavity. In humans, these events occur during 
embryonic development, giving rise to functional middle ears and hearing by birth.
1.4.2.1   Transformation of Meckel’s cartilage
The continuity between Meckel’s cartilage and the malleus is therefore retained into 
postnatal stages in the mouse. During these stages the mid region of Meckel’s cartilage 
is eventually  lost, separating the malleus from the remainder of Meckel’s cartilage, and 
removing the link between the jaw and the middle ear. This gives rise to a freely mobile 
malleus. The postnatal loss of Meckel’s cartilage is a result of a complex interplay  of 
cellular remodelling and cell fate changes, and will hereafter be referred to as the 
transformation of Meckel’s cartilage (Anthwal et al., 2012).
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1.4.2.2   Cavitation
Following transformation of Meckel’s cartilage, the removal of mesenchyme that 
restricts the movement of the middle ear ossicles, is the final step in acquiring adult 
middle ear function. As removal of mesenchyme from the middle ear in effect forms the 
cavity of the middle ear, this developmental event is referred to as cavitation.
Several mechanisms have been proposed to influence middle ear cavitation, and 
removal of middle ear mesenchyme is likely  influenced by several developmental 
processes. Some studies have suggested mesenchyme of the middle ear to degenerate, 
followed by resorption of these cells by phagocytes that are brought to the middle ear 
through the vascular system (Palva and Ramsay., 2002). In support, apoptosis has been 
observed in the postnatal middle ear cavity  of the mouse. However as only a small 
population of cells are observed to undergo apoptosis, they cannot account for removal 
of the entire middle ear mesenchyme (Roberts and Miller., 1998). In addition, cell death 
is not observed in the chick middle ear cavity  (Jaskoll and Maderson.,1978; Roberts and 
Miller., 1998) and some studies do not observe vascularisation of the middle ear cavity, 
suggesting resorption of degenerate cells through phagocytic activity  may not be a 
contributory mechanism. Therefore, whilst cell death may contribute to removal of 
mesenchyme in the mouse middle ear, it does not appear to be the primary  mechanism 
of cavitation. Other studies have suggested the middle ear mesenchyme to simply 
redistribute around the edges of the growing middle ear cavity, giving the illusion that 
the middle ear mesenchyme has been lost (Piza et al., 1998). Although the middle ear 
epithelium is traditionally considered to be of endodermal origin, recent studies have 
shown the middle ear epithelium to be partly composed of neural crest (Thompson and 
Tucker., 2013). Therefore it could be speculated that  mesenchyme of the middle ear 
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cavity regresses and forms this region of the middle ear epithelium. In humans, retained 
mesenchyme correlates with hypoplastic middle ear cavities, which has often been 
observed in association with congenital abnormalities (Kasemsuwah et al., 1996). In 
addition, cavitation defects in transgenic mice have been associated defects in auditory 
bulla growth (Richter et al., 2010), further implicating growth of the middle ear cavity 
to play a role in cavitation. Retention of mesenchyme in the middle ear has been 
suggested to predispose the middle ear to infections (Guggenheim et al.,1956), and in 
humans a strong correlation has been observed between retention of mesenchyme in the 
middle ear cavity and otitis media (Jaisinghani et al., 1999). Genetics have been 
proposed to influence the process of middle ear cavitation, which differs slightly in time 
scale between individuals (Palva and Ramsay.,2002). The process of cavitation is 
therefore important for not only middle ear function and conductive hearing, but also is 
a factor in the susceptibility to middle ear infections.
Whilst these developmental events occur, the middle ear gradually becomes 
encapsulated into the developing auditory bulla, which forms from the fusion of several 
intramembraneous bones, namely the tympanic ring, petrosal bone, and retrotympanic 
process (Hanken and Hall.,1993). In the mouse the final morphology of the auditory 
bulla is complete by nine days following birth (Richter et al., 2010).    
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1.5   Evolutionary considerations of the middle ear
The mammalian middle ear evolved from a primitive jaw joint  in reptiles that formed 
between the quadrate bone of the palatoquadrate and most proximal region of Meckel's 
cartilage, the articular (Fig.1.2). This single craniomandibular joint was bi-functional, 
forming part of the hearing and feeding apparatus, which is retained in modern non 
mammalian vertebrates such as the chick.
Further evolutionary development gave rise to a second jaw joint structured by the 
squamosal portion of the temporal bone and the condylar process of the mandible, to 
create a juxtaposing temporomandibular joint (TMJ) (Hopson., 1966). The evolutionary 
enlargement of the neo- cortex subsequently pulled the articulo-quadrate joint  (CMJ) 
away from and medially to the TMJ, to create a more distal medial joint with exclusive 
hearing function. In consequence, the articular and quadrate, now accessory bones of 
the jaw, assumed the function of the malleus and incus respectively (Rich et al., 2005). 
Although at this stage the new middle ear joint remained connected to the TMJ, spatial 
separation prevented movements of the jaw joint transferring directly to the middle ear 
apparatus. Interestingly  this evolutionary  change is thought to have occurred primarily 
as a modification of the feeding apparatus, with improved middle ear function as a 
secondary consequence (Rowe., 1996).
Meckel's cartilage of more ancestral mammals remained during development and 
formed a permanent adult  structure. This resulted in an ossified connection between the 
mandible and middle ear ossicles. Modern day  mammaliaforms lost this connection 
through transformation of Meckel's cartilage during embryonic development, giving rise 
to a detached middle ear (Luo., 2007). The detached middle ear is a fundamental feature 
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that identifies living mammals from non-mammalian vertebrates, and is often termed 
the definitive mammalian middle ear (DMME). A fossil of Maotherium asiaticus 
however, an ancestral mammal within the trechnotherian clade, possessed an ossified 
Meckel's cartilage despite existing after the reported evolution of the DMME. This 
implies an evolutionary lability of Meckel's cartilage, suggesting the transformation of 
Meckel's cartilage to have evolved at least twice. This example of paedomorphism is 























































































































































































































































































































































































































































































































































































































1.6   Syndromes of the Neural Crest: Clinical Manifestations
The neural crest is a population of cells which delaminate from the dorsal midline of the 
neural tube during closure. These cells migrate throughout the embryo, and through 
their ability to differentiate into a variety of cell types, contribute to various developing 
structures. For example, neural crest that  arises from the forebrain and midbrain regions 
of the neural tube, migrate to the frontonasal process, the palate, and form the 
mesenchyme of the first branchial arch. Neural crest derived from the hindbrain of the 
neural tube gives rise to mesenchyme of the second branchial arch (Fraser et al., 1994). 
Neural crest derived mesenchyme of both the first and second branchial arches give rise 
to the middle ear ossicles (Carlson., 1994). Due to the extensive multipotency of the 
neural crest, this population of cells  is often considered a fourth germ layer (Hall., 
1998). Defects in the neural crest cell population result in a group of syndromes termed 
neurocristopathies (Bolande.,1974), and account for a third of all congenital 
abnormalities, reflecting their developmental importance (Jones and Trainor., 2004). As 
the cranial neural crest gives rise to most of the cartilage, bone, and connective tissue of 
the head (Platt., 1893; Le Douarin et al., 1982), syndromes of craniofacial development 
are often a result of defects in the neural crest. In addition, due to their neural crest 
origin, middle ear defects are often an associated feature of syndromes of craniofacial 
development. One such syndrome that has been a particular focus of this thesis is 
Branchio-Oto-Renal syndrome (BOR), and will be described here in some detail.
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1.6.1   Branchio-Oto-Renal syndrome (BOR)
BOR is a syndrome of autosomal dominant inheritance, with an incidence of one in 
fourty thousand (Fraser et al., 1980), and is typified by  defects in branchial arch 
derivatives; the ear regions and the kidney. Primary  diagnostic features of this syndrome 
are therefore hearing loss accompanied by early onset renal disease. Typical 
malformations of the kidney include renal hypoplasia, with characteristics such as 
malformed glomeruli, disarrangement of collecting tubules, polycystic kidney disease, 
or complete agenesis of the kidneys. In particularly severe cases, duplication of the 
urinary  duct system (Heimler and Lieber., 1986) and tissue dysplasia in the kidney have 
also been reported (Melnick et  al., 1976). Malformation of the cranial skeleton is 
evidenced as micrognathia, hemifacial microsomia (Johnston et al., 2011), and cleft 
palate (Chen et al., 1995). Cyst formation has been reported in the the neck, the 
thyroglossal duct (Melnick et al., 1978), the middle ear (cholesteatoma) (Johnston et al., 
2011), and a benign tumour in the intracranial region (Weber and Kousseff., 1999). 
Stenosis of the lacrimal gland duct may also present, and can lead to episodes of 
conjunctivitis. Lung hypoplasia has been observed in a case with neonatal lethality 
(Legius et al., 1990), and mild malformations of the limbs have also been reported, 
evidenced as clinodactyly of the hands and feet (Melnick et al., 1978; Weber et al., 
1999). Other atypical features include osteosclerosis, hypodontia, gustatory lacrimation, 
imperforate anus, and incomplete fixation of the colon (Weber and Kousseff ., 1999).   
Of the ear regions, stenosis or complete atresia of the external ear can occur. In addition, 
malformed pinnae with surrounding pre auricular pits and tags can be present. Along 
with branchial fistulae, auricular pits and tags are considered remnants of embryonic 
structures. Middle ear defects can be unilateral or bilateral, and include a variety of 
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ossicular malformations, which may  be accompanied by a reduction in volume of the 
middle ear cavity (Millman et al., 1995; Melnick et al., 1976). Dilation of the eustachian 
tube has also been evidenced (Johnston et al., 2011), and individuals may  experience 
recurrent episodes of otitis media (Legius et al., 1990; Weber and Kousseff., 1999; 
Johnston et al.,2011). Defects of the inner ear may manifest as hypoplastic and 
malformed cochlea, and defects in the the vestibular apparatus may also be apparent 
(Melncik et al., 1978). The facial nerve is often observed to exhibit a deviated path 
(Johnston et al., 2011). 
As a result of these various ear anomalies, fifty percent of sufferers of BOR experience 
hearing loss, which can be either conductive, sensorineural or a combination of both, 
with BOR syndrome alone accounting for 2% of profound deafness in children world 
wide (Fraser et al., 1980). BOR syndrome therefore manifests with varying expressivity, 
with individuals possessing differing combinations of the phenotypes described above. 
Due to this variation, absolute diagnosis requires hereditary analysis of the syndrome 
within multiple family generations (Melnick., 1976; Konig et al., 1994). BOR syndrome 
diagnosis overlaps with a small cohort of seemingly related syndromes, including 
branchio-oto syndrome (BO), branchio-oto-uretal syndrome (BOU), and branchio-oto-
facial syndrome (BOF). Whilst BOF syndrome is thought to be separate, arising from a 
distinct genetic etiology (Carter et al., 2004), the phenotypes of BOR, BO, and BOU 
closely overlap, and much debate has arisen from whether they are distinct syndromes 
or variations of BOR syndrome  (Melnick et al., 1978; Konig et al., 1994). Part of the 
underlying genetics of BOR syndrome has been identified, with mutations in the EYA1 
gene accounting for 40% of cases, and the SIX1 and SIX5 gene together accounting for 
under 5% of cases (Abdelhak et al., 1997; Ruf et al., 2004; Hoskins et al., 2007), 
36
however the majority of incidences of BOR are of unknown genetic etiology. The 
multiple genetic causes of BOR may explain the large variability of phenotypes in 
individuals with this syndrome. Elucidation of the genetics that underly BOR, BO, and 
BOU, may  reveal underlying genetics and pathways, and determine whether they  are 
variations of the same disease, or separate syndromes.
1.6.2   Middle ear defects in syndromes of craniofacial development
Due to their neural crest origin, middle ear defects are often observed in syndromes of 
craniofacial development, which can result in conductive deafness. The nature of 
middle ear defects of some of these syndromes will be described.
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Incudo-malleal fusion, stapes fixation, 
thickened stapes footplate, absence of 
stapes, ectopic bone in the middle ear 
cavity, ossicle hypoplasia and hyperplasia, 
calcification of oval window, fusions of 
ossicles to wall of middle ear cavity, 
cholesteatoma, otitis media and patulous 
eustachian tube (Ceruti et al., 2002; 
Worley  et al.1999; Motta et al., 1996; 






Incudo-malleal fusion, hypoplasia of 
malleus and incus, absence of stapes and 
oval window, fixation of stapes, small 
middle ear cavity, otitis media. (Phelps et 






Ossicular fusions and malformations 
(Otani and Schuknecht.,1984). Otitis 
media  (Ganbo et al., 1999).
Teunissen-Cremers 
syndrome NOG
Hypoplastic incus, fixation of the incus 
short process to the wall of middle ear 




Stapes fixation (Cremers et al., 1985; Ueda 
et al., 2012)
Cleidocranial dysplasia RUNX2
Ossicle hypoplasia, malformed, clustered 
ossicles, incudo-malleal fusion, shortened 
long process of the incus, stapes fixation, 




Ankylosis of malleus to wall of the 
auditory bulla, incus fixation, stapes 
fixation, small middle ear cavity, otitis 
media (Bluestone et al, 1983; Orvidas et 
al., 1999)
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1.7   Disease of the middle ear 
1.7.1   Otitis  media
1.7.1.1   Why investigate middle ear inflammation?
Otitis media (OM) is a result of inflammation of the middle ear cavity. With increased 
prevalence during childhood, approximately  two hundred thousand children suffer from 
repeated middle ear infections each year in the UK alone (NICE report, 2008), with 
costs to the NHS of approximately  £2- 300 million yearly (Williamson et al., 2006). 
Episodes of acute OM, in addition to pain and discomfort, can cause a temporary 
conductive hearing loss of up  to 40 decibels (db). Chronic infections can additionally 
cause longterm and permanent hearing loss, as result of inflammatory  damage to middle 
ear structures. This includes erosion of the ossicles, which results in a further 
conductive hearing loss up to 60 db (Deka., 1998). Hearing is essential for speech 
development during infancy, and OM  contributes to language and learning difficulties in 
children predisposed to middle ear infections (Chan et al., 1967; Holm and Kunze.,
1969). Current treatments rely on antibiotics and in more severe instances 
tympanostomies, both of which have short term effects and do not prevent reoccurring 
episodes of OM (Ramakrishnan et al., 2007). There is therefore great clinical 
motivation for understanding the mechanisms and genetics of OM, with the aim of 
designing prophylactic and more effective treatments for the future.
1.7.1.2   Pathology and diagnosis of OM
OM  is the result of an exacerbated inflammatory  reaction. The onset of OM typically 
occurs after a bacterial or viral infection. Development of OM often coincides with 
upper respiratory tract infections and rhinitis, implicating the common cold as a 
sufficient pathological trigger (Massa et al., 2009). The mechanisms and order of 
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disease progression of OM are poorly understood, however several inflammatory 
processes are implicated. These include the innate and adaptive immune responses 
(Emonts et al., 2007; Freijd et al., 1984), angiogenesis (Lim and Birck 1971), and a 
compensatory increase of middle ear secretions to remove pathogens and debris from 
the cavity (Lin et al., 2012). If clearance is impaired due to eustachian tube defects or 
obstruction, these responses may additionally encourage a build up of fluid (effusions) 
in the middle ear, further predisposing the middle ear to infection (Takahashi et al., 
1989). 
 
The severity of OM can vary greatly and for diagnostic purposes OM is subdivided into 
several inter-related categories. Whilst there is general consensus of OM subtypes, 
uniform clinical classifications of OM are lacking and may be based on differing 
aspects of the disease. This may  be partly due to a limited understanding of the disease 
mechanisms and progression of otitis media. A classification system based on duration 
of inflammation and effusion type has been used to compare various mouse models of 
OM  (Rye et al., 2007). In this system, OM may  present as an acute infection or a 
chronic infection. Acute OM (AOM) is characterised by a sudden onset and short 
duration. It is often accompanied by otalgia and fever. AOM  may also be recurrent 
(rAOM), which is defined as a minimum of three episodes of AOM in six months or 
more than four in a year (Rye et al., 2011). Chronic OM  (COM) is of a longer and more 
persistent duration. Both acute and chronic forms of OM occur with or without 
effusions. Effusions vary and can be serous (watery), mucoid (mucus), and purulent 
(pus like). Chronic suppurative OM (CSOM), OM with purulent effusions, may result in 
otorrhea due to perforations of the tympanic membrane. Therefore repetitive or chronic 
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incidences of OM  can cause considerable pain and hearing loss, and may additionally 
result in permanent damage to the middle ear structures.
1.7.1.3   Development and disease
Several syndromes of craniofacial development are associated with a prevalence to 
developing middle ear disease. In these cases, development of OM is most likely  due to 
defects of structures that facilitate middle ear function. Syndromes that  present with 
cleft palate, for example, are often associated with OM (Paradise et al., 1969). In these 
cases, OM develops due to abnormalities of ET structure, the positioning of the ET, and 
also abnormal insertions of muscles that control ET and soft palate function (Huang et 
al.,1997; Shibahara and Sando., 1988). Another craniofacial malformation associated 
with OM is hypoplasia of the middle ear cavity  (Trojanowska et al., 2012). Natural non 
syndromic craniofacial variabilities also predispose certain individuals to OM, including 
the length of the cranial base and size of the hard palate (Francesco et al., 2008). The 
auditory bullae, which house both the middle and inner ears, form from part of the 
temporal bone of the cranial base. Therefore it is possible differences in size and 
morphology  of the cranial base directly affect the size and shape of the middle ear 
cavity, and position of the ET. Craniofacial morphology  is therefore of great importance 
to mature middle ear function. 
 
As discussed earlier, middle ear cavity  size may correlate with the process of cavitation, 
smaller cavities resulting in retained mesenchyme (Richter et al., 2010). In addition, 
retention of mesenchyme is also associated with OM (Jaisinghani et al., 1999). 
Therefore cavitation defects may result in a predisposition to OM. Retained 
mesenchyme may  obstruct clearance of middle ear secretions, causing the build up  of 
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effusions and in turn OM. Excess tissue in the middle ear cavity may also encourage 
infections. Several studies have found middle ears with OM  to also possess retained 
mesenchyme, although whether tissue retention is a cause or consequence of OM is 
unclear (Kasemsuwan et al., 1996). Therefore hypoplastic middle ear cavities may be 
predisposed to developing OM, either directly  due to smaller cavity size and relation to 
ET position, or indirectly due to cavitation defects.
Middle ear defects in syndromes of craniofacial development often result in permanent 
conductive deafness. In these cases, hearing amelioration is dependent on hearing aids. 
As many of these individuals experience additional hearing loss due to otitis media, 
hearing aid adjustments must be frequently undertaken (Hagr., 2007). Therefore 
investigation of otitis media in relation to development of the middle ear is of great 
clinical value for the management and treatment of otitis media, in particular for 
sufferers of syndromic OM.
1.7.2   Cholesteatoma
Cholesteatoma is a cyst formed from squamous epithelium and connective tissues, 
which are filled with layers of keratin. Cholesteatomas typically form in the middle ear 
cavity, and in rarer instances the external ear (Persaud et al., 2006) and intracranial 
regions (Granato et al., 2012). Cholesteatomas can fall into two categories; congenital 
cholesteatoma and acquired cholesteatoma. Congenital cholesteatomas are extremely 
rare, and form during embryonic stages of middle ear development. Acquired 
cholesteatomas however form in the mature middle ear cavity after birth, and is likely a 
result of insult  to the tympanic membrane, such as otitis media or even surgery. How 
cholesteatomas form is still contentious, and several theories have been proposed. 
42
1.7.2.1   Congenital Cholesteatoma
Congenital cholesteatomas have been suggested to form through migration of epithelia 
of the external ear canal into the developing middle ear cavity, prior to formation of the 
tympanic membrane (Aimi., 1983). Another theory  postulates that cells from the 
amniotic fluid enter from the eustachian tube and implant into the middle ear cavity 
(Northrop et al., 1986). However the most plausible theory involves the formation of 
epidermoids (squamous cell clusters), which may  arise from ectodermal tissue of the 
invaginating ectodermal branchial cleft  during early stages of development. These cells 
remain in the forming middle ear cavity and function as precursors for the development 
of cholesteatomas during developmental stages (Michaels et al., 1986).    
1.7.2.2   Acquired Cholesteatoma
Several theories have also been suggested for the formation of acquired cholesteatoma. 
The retraction pocket theory  is based on the pocketing (retraction) of the tympanic 
membrane due to the accumulation of a negative air pressure in the middle ear cavity. 
This most likely  occurs as a result of eustachian tube obstruction, so that the middle ear 
cavity is no longer adequately aerated (Youngs et al., 1998). Middle ear cell debris and 
keratinising cells in the vicinity may then accumulate in the retraction pocket, 
eventually resulting in the formation of a cyst (Portman et al., 1982). Another theory, 
the migration theory, suggests cells of the external ear epithelium to migrate through 
perforations of the tympanic membrane, into the middle ear cavity (Benzold.,1891). In 
this theory, otitis media is a proposed trigger for medial migration and proliferation of 
the tympanic membrane. This also appears to be a plausible explanation for how cysts 
of squamous epithelium form in the middle ear cavity, as squamous cells are not innate 
to the middle ear region. (Karmody and Northrop., 2011). Cholesteatoma has also been 
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proposed to form from metaplasia of cuboidal middle ear epithelia into squamous 
epithelia of the cholesteatoma (Sade et al., 1983). However this theory is largely 
disregarded due to consensus of cholesteatoma formation from epithelia of the tympanic 
membrane (Persaud et al., 2007). Hyperplasia of the basal epithelium of the tympanic 
membrane into the middle ear cavity is also another theory for the formation of 
cholesteatoma (Masaki et al., 1989). Several growth factors and receptors have been 
shown to be upregulated in cholesteatoma tissue (Liu et al., 2013; Guzinska- 
Ustymowicz et al., 2013), supporting proliferation as a mechanism underlying 
pathology.
Interestingly, for all four theories of acquired cholesteatoma, inflammation of the 
middle ear is closely associated with cyst  formation. However whether otitis media is a 
cause or consequence of cholesteatoma formation is unclear. It has further been argued 
that if cholesteatoma formed as a result of otitis media, it  would be observed more 
commonly than currently reported (Persaud et al., 2007). 
Cholesteatomas are not cancerous, but they  can cause considerable damage through 
physical obstruction and local invasion of the middle ear cavity. Complications from 
cholesteatoma include facial nerve paralysis, tinnitus, and in more severe cases 
meningitis and brain abcess formation. In addition, cholesteatoma may induce infection 
of the middle ear cavity, causing ottorhea and considerable ossicular errosion. Damage 
to the middle ear will inevitably  result in progressive conductive deafness. Although ear 
drops and antibiotics may clear secondary  infections caused my cholesteatoma, the only 
method to remove the cholesteatoma permanently is surgery (Holt et al., 2003). 
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Understanding the pathological mechanisms that underly formation of these cysts may 
therefore enable alternative treatment options in the future.  
1.7.3   Otosclerosis
Otosclerosis is a disease of the temporal bone, which results in the deposition of ectopic 
bone in the middle and inner ear structures. Ectopic bone foci that disrupt hearing, are 
termed clinical otosclerosis. Ectopic bone foci that do not affect hearing are termed 
histological otosclerosis, although these can develop into clinical otosclerosis. Ectopic 
foci of bone that deposit on the middle ear ossicles can cause ossicular fusions and 
ankylosis, which result in conductive hearing loss. Although all ossicles can exhibit 
signs of otosclerosis, the stapes is most commonly affected ossicle (Stankovic et al., 
2006). Ectopic bone in the vicinity of the stapes footplate can result in fixation of the 
stapes to inner ear oval window (Bachor et al., 2005). These lesions are often observed 
after birth, typically between teenage years and mid-forties (Uppal et al., 2009). 
Therefore progressive hearing loss during these stages is a diagnostic feature of 
otosclerosis. The primary method for resolution of ectopic bone is surgery, although 
results may not be permanent due to regrowth of ectopic bone (Bachor., 2005). As the 
middle ear is completely formed by these stages, bone remodelling of the already 
formed ossicles is the implicated mechanism of otosclerosis. This is especially 
intriguing as the temporal bone has an extremely  low rate of bone remodelling in 
comparison to other bones of the body, and once postnatal development is complete, 
this region does not alter its bone composition (Frisch et al., 2000). Several factors have 
been implicated in the etiology of otosclerosis, and genetics is thought to underly most 
cases (Stankovic et al., 2006). Autosomal dominant patterns of inheritance have been 
identified through family linkage analysis (Albrecht et  al., 1922), albeit with a low and 
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variable penetrance (Larsson., 1960). Spontaneous incidences of otosclerosis are also 
thought to be caused by  several low penetrance genetic mutations (Ealy and Smith., 
2010).
When considering genetic related otosclerosis, a key factor is the distinction between 
congenital ankylosis due to developmental defects and fixation due to otosclerosis, as 
they  may present as very similar malformations.  A general guide is followed where 
fixation of the ossicles before the age of six years is considered congenital, whilst after 
six years of age is considered otosclerotic (Bachor et al., 2005). Several genetic loci 
associated with otosclerosis have been identified (Stankovic et al., 2006), and gene 
expression studies have shown several genes to be altered in otosclerotic ears (Ealy et 
al., 2008). Polymorphisms in the COL1A1 gene have been identified in individuals with 
otosclerosis (Mckenna et al., 1998). In addition, genes that regulate bone remodelling 
such as Opg and RankL have also been suggested in the pathology  of otosclerosis, 
although to date mutations in these genes have not been identified in humans. For 
example, Opg mutant mice exhibit otosclerotic type foci throughout the ossicular chain, 
suggesting Opg may function to inhibit bone formation in the ear regions (Zehnder et 
al., 2006). Indeed Opg expression levels are found to be higher in normal otic capsules, 
suggesting this gene underlies the low bone turnover in the ear (Zehnder et al.,2005). 
Studies of the LP/J mouse, which have mutations in the endothelin receptor type B 
gene, also show otosclerotic type lesions in the middle ear during later life. However, 
the histology of lesions in mouse models and humans with otosclerosis may differ, and 
is an important consideration when using mouse models to study the human pathology 
of otosclerosis (Steel et al ., 1987).  
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In addition to hereditary predisposition, other factors such as immunity  (Bujia et al., 
1994), the measles virus (Niedermayer and Arnold.,1995), and endocrine hormones 
(Grayeli et al., 1999) have been implicated. Therefore the etiology of otosclerosis is 
likely to be multifactorial. Otosclerosis is amongst the leading causes of conductive 
deafness in the adult population (Altman et al., 1967), therefore studies investigating the 
genetics and mechanisms that  may  contribute to this pathology is of current clinical 
interest and a growing focus of research in related fields.
1.8   Mouse models of conductive deafness
Mouse models have been useful tools for understanding the genetics that underly human 
conditions such as deafness. Studies using mouse models have adopted one of two 
approaches; a forwards genetic phenotype driven approach, or a reverse genetics 
genotype driven approach. Forwards genetic investigations are based on the induction 
of random genetic mutations through exposure to a mutagenic agent. Through this 
technique novel phenotypes of interest can be identified, and followed up by screening 
to identify genetic etiology. This approach may result in the identification of previously 
unknown genetic regulators of a particular process. In addition, with the discovery  of 
causative genes in human syndromes, reverse genetics approaches have also been 
harnessed in attempts to phenocopy human disease traits. This provides a tractable 
model system to investigate the genetics and mechanisms that may underly a particular 
syndrome of interest. Through both approaches several mouse models have been 
created, which have proved useful for the investigation of the genetics of middle ear 
congenital malformations and disease. To summarise findings acquired through these 
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methods, mouse models of congenital ossicle defects and otitis media are briefly 
reviewed.
Table 1.2 Mouse models of middle ear ossicle defects
Gene mutated in 
mouse model Ossicle defects
Eya1
(BALB/c and 129/Sv backgrounds) Eya1 +/-, fusion of 
malleus, incus, and ectopic ossicle into one complex, 
loss of ossicle shape definition due to presence of 
ectopic bone. Fusion of malleus to wall of middle ear 
cavity and stapes displacement. Eya1 -/-, variable 
phenotype, fused ossicles, malformed incus, processus 
brevis of malleus and stapes absent (Xu et al., 1999).
Six1
Six1 +/-, small lumen of stapes, mild ossicle 
malformations. Six1 -/- mice hypoplastic incus, incudo-
malleal fusion, short process of malleus and stapes 
absent, shortened manubrium of malleus (Zheng et al., 
2003).
Tshz1
Tshz1 -/- shortened, thicker tympanic ring, hypoplastic 
gonium, narrow malleus body, which lacks the 
processus brevis and manubrium (Core et al., 2007). 
Tcof1
Hypoplastic tympanic ring. Hypoplastic and malformed 
ossicles (Dixon et al., 2000).
Emx2
Emx2 +/- (Pardon mice). Hypoplasia of articular 
surfaces of all three ossicles. The long process and 
lenticular process of the incus is absent (Rhodes et al., 
2003). 
Bapx1 Bapx1 -/- narrow body of malleus, hypoplastic tympanic ring absent gonium (Tucker et al., 2004).
Msx1
Msx1-/-, absence of malleal processus brevis (Zhang et 
al., 2003).
Tbx1
Tbx1 -/-, hypoplastic malleus, shortened and thickened 
tympanic ring, absence of the body  of incus, with only 
articular surface remaining. Complete absence of stapes 
(Moraes et al., 2005).
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Gene mutated in 
mouse model Ossicle defects
Prx1
Prx1 -/-, hyperplastic body of malleus, truncated 
manubrium and displaced processus brevis. Fusion of 
incus to quadrate cartilage of middle ear cavity, 
resulting in loss of articulation between the incus and 
stapes though the incudo-stapedial joint. Columella like 
stapes, which fuses to Reichert’s cartilage. Loss of 
stapes foramen due to fusion of the stapedial crus 
(Martin et al., 1995).
Dlx1
Dlx1 -/-, defects of the stapes only, which has an absent 
suprastructure, and as a result lacks the foramen (Qui et 
al., 1997).
Dlx2
Dlx2 -/-, misshapen incus, that  is fused to the 
pterygoquadrate cartilage, resulting in loss of 
articulation with the stapes through the incudo-stapedial 
joint. Small stapes, which lacks a foramen (Qui et al., 
1995).
Dlx5 Dlx -/-, hypoplastic, shortened tympanic ring, absence of stapes (Depew et al., 1999; Acampora et al., 1995).
Gsc Gsc -/- absence of processus brevis of malleus, shortened manubrium (Yamada et al., 1995).
Hoxa1 Absence of all three middle ear ossicles (Chisaka et al., 1992).
Hoxa2 Absence of stapes and duplication of malleus and incus (Gendron-Maguire et al.,1993).
Bcl2
Bcl2 -/-, variable defects in the stapes, including 
suprastructure fixation, unilateral absence of stapes crus 
(Carpinelli et al., 2012).  
Gdf6
Gdf6 -/-, hypoplasia of articular surfaces of the malleus, 
incus, neck of stapes and stapes footplate (Settle et al., 
2003).
Noggin
Noggin +/-, stapes suprastructure fixation. Noggin -/-, 
fusions of the three ossicles into one complex, marked 
by ossicle hyperplasia, resulting in loss of individual 
ossicle identity (Hwang and Wu., 2008).
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Gene mutated in 
mouse model Ossicle defects
Fgfr1
Conditional Fgfr1 hypomorphs (Fgfr1n7/n7), absence or 
extreme hypoplasia of the ossicles (Trokovik et al., 
2003). Fgfr1 hushpuppy +/-, variable stapes defects, with 
hypoplastic, monocrural stapes suprastructure and 
variable hypoplasia of the incus (Pau et al., 2005).
Ap-2! (Tcfap2a)
Dor/+, Narrow body of malleus, hypoplasia of incudo-
malleal articular surfaces, malformed lenticular process 
of incus that resembles tendinous tissue rather than 
bone, and slightly misshapen stapes (Ahituv et al., 
2004).
Table 1.3. Mouse models of otitis media
Gene Otitis media phenotype Implicated Disease Etiology
Eya4 Early onset otitis media from two 
weeks of age
Smaller middle ear cavity, narrow 
and abnormally positioned 
eustachian tube (Depreux et al., 
2008).
Fbxo11    
(Jeff 
mouse)
Chronic otitis media with 
effusion, fully penetrant
Narrow eustachian tube, smaller 
middle ear cavity (Hardisty et al., 
2003; Hardisty et al., 2006).
Chd7 early onset, chronic otitis media Increased eustachian tube angle, 





Chronic otitis media with 
effusion, onset at three weeks.
Dilated eustachian tube (Noben-
Trauth and Latoche.,2011). 
Sh3pxd2b Early onset otitis media from 
eleven days.
Horizontal positioning of 
eustachian tube (Yang et al., 2011)
Ts65Dn Variable otitis media with effusion Possible influence of craniofacial 
abnormalities and repressed 
immunity (Han et al., 2009).
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Spontaneous, bilateral, chronic 
suppurative otitis media with 
otorrhea. Fully penetrant 
phenotype by weaning.
Absence of craniofacial defects 
and adaptive immune system 
compromisation. Modest bacterial 
contribution, potential regulation 
of the innate immune response 
through mucin production. 




Variable, low penetrance otitis 
media with effusion
Suggested regulation of secretions 






High penetrance, otitis media with 
effusion
Increased proliferation of the 
middle ear mucosa, goblet cell 
metaplasia, ciliary development 
(Han et al., 2012).
Chibby 
(Cby)
Chronic otitis media Reduced and immotile cilia 
(Voronina et al., 2009)
Mdnah5 Acute and chronic otitis media Immotile cilia (Ibanez-Tallon et 
al., 2002).
Dnah11 Low penetrance, unilateral otitis 
media
Immotile respiratory cilia (Lucas 
et al., 2012)
Myd88 Induced otitis media Delayed resolution of otitis media 
due to a delayed innate immune 
response mediated recruitment of 
neutrophils and macrophages. 
Function of macrophages is also 
compromised (Hernandez et al., 
2008).
Tlr9 Induced otitis media Innate immune system; delayed 
resolution of otitis media and 
delayed bacterial clearance 
(Leichtle et al., 2012).
TLR2 Induced otitis media Innate immune system; reduced 
levels of cytokines, which may 





Chronic otitis media Innate immune system; 
susceptibility to bacterial 
infections, due to an inability to 
respond to the the LPS pamp 
(Macarthur et al., 2008)
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Gene Otitis media phenotype Implicated Disease Etiology
Fas Induced otitis media Delayed resolution of otitis media 
likely due to an inability for cells 
of the thickened mucosa to 
undergo cell death (Rivkin et al., 
2008).
P73 Purulent otitis media Suggested reduced or 
inappropriate middle ear 
epithelium responses to infection, 
such as mucin production (Yang et 
al., 2000).
Tgif Tgif -/- Chronic otitis media with 
effusion
Craniofacial defects (smaller head 
size), and abrogations in Tgfb 
signalling (Tateossian et al., 2013).
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1.9   Signalling in Development
1.9.1   The RDGN
1.9.1.1   The Eya genes are highly conserved developmental regulators 
Initially discovered in the fly, eya functions in a network of genes termed the RDGN 
(retinal determination gene network) to induce and pattern the eye. These genes which 
include ey (the orthologue of mammalian Pax genes), eya, so, and dachshund are highly 
conserved from invertebrates to vertebrates, their importance reflected in their 
evolutionary  duplication. In humans and mice four orthologues of the eya gene have 
been identified, EYA1, EYA2, EYA3 and EYA 4 (Eya1, Eya2, Eya3 and Eya4 in the 
mouse) (Abdelhak et al., 1997; Xu et al., 1997; Zimmerman et al., 1997; Borsani et al., 
1999). Similarly there are six Six genes (Six1-Six6) and two Dach genes (Dach1 and 
Dach2), paralogues of so and dachshund respectively (Kawakami et al., 1996; Kozmic 
et al., 1999; Davis et al., 2001). Genes of the RDGN encode transcription co-factors and 
function to regulate gene expression. This network of transcription factors has since 
been observed to pattern several organ systems in vertebrates, often functioning in 
conserved epistatic hierarchies traditionally with Eya upstream of Six and Dach 
respectively. 
eya is most renowned for its integral role in eye development. In the fly, loss of eya 
results in loss of compound eye formation, whilst ectopic expression results in the 
formation of ectopic eyes (Bonini et al., 1993). Therefore eya is a key regulator of eye 
induction and development. Roles in eye development are conserved across several 
phyla including the jelly  fish, fish, and frog (Graziussi et al.,2012; Soker T. et al., 2008; 
Kriebel M.,2007). Several eya paralogues are expressed in the developing eye regions 
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of mice suggesting these genes evolved as back ups of the eya gene’s critical role in eye 
development (Xu et al.,1997). In support, severe eye defects are not observed in mice or 
humans with mutations in a single Eya gene alone, suggesting functional redundancy  of 
the mammalian Eya genes (Xu et al., 1999; Abdelhak et al., 1997). Rare instances of 
ocular defects and congenital cataracts however are associated with mutations in the 
EYA1 gene, implicating conserved roles of eya in mammalian eye development (Azuma 
et al., 2000). Strikingly, mouse Eya1, Eya2, and Eya3 genes are able to rescue the 
eyeless phenotype in Drosophila, exhibiting remarkable functional homology from 
invertebrates to mammals in eye development (Bonini et al.,1997; Bui et al., 2000). 
However, whilst the Eya genes are co-expressed in several regions in the mouse 
inferring redundant functions, expression patterns also suggest individual Eya genes 
have acquired independent functions in the patterning of higher vertebrates (Xu et al., 
2002). Since discovery in the fly, Eya genes have been implicated in the development of 
several organ systems in vertebrates. Eya genes are therefore highly  conserved 
regulators of organogenesis, and suggests a common signalling system may underly the 
development of several organ systems from invertebrates to vertebrates. 
This project investigates the role of Eya1 in murine middle ear development, therefore 
further discussion will focus on developmental roles of Eya1 in mice.
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1.9.1.2   The role of Eya1 in murine development
The mouse is a widely used model system for investigating the genetics of mammalian 
organogenesis. Studies using Eya1 mutant mice have revealed wide spread roles of 
Eya1 in skeletogenesis and in the development of several organ systems including the 
ear and kidney, organs affected in BOR syndrome. 
Eya1 is integral for auditory  system development, mutations resulting in defects of the 
inner, middle, and external ear structures in mice. Eya1 is haplosufficient for the 
development of the inner ear, with Eya1 +/- mice exhibiting well formed cochleae. A 
minority of Eya1 +/- mice however did exhibit atrophy of the spiral ganglion and 
vestibulocochlear nerve, and malformations of the membraneous labyrinth of the 
vestibular system.  Whilst the inner ear is induced to form in Eya1 -/- mice, the cochlea 
remains arrested at  the otic vesicle stage and the endolymphatic duct of the vestibular 
apparatus are malformed or absent (Xu et al.,1999; Zou et al., 2006). Eya1 is also 
required for the differentiation of specialised cell types during inner ear development, 
such as mechanosensory hair cells of the cochlea (Zou et al., 2008; Ahmed et al.,
2012a). Middle ear defects, in contrast, appear dose dependent with Eya1 +/- mice 
exhibiting milder defects than Eya1 -/- mice. Eya1 +/- mice exhibit ossicular 
synostoses, malformed ear drums, and secondary  inflammation of the middle ear cavity. 
Eya1 -/- mice further exhibit ossicular malformations, and missing ossicles or ossicle 
regions, namely  the stapes and processus brevis of the malleus. In these mice the middle 
ear cavity itself fails to form, resulting in a blind ending of the developing external 
auditory canal. Atresia of the external ear canal, malformed pinnae, and pre-auricular 
pits are also observed in the external ears of Eya1 -/- mice (Xu et al., 1999). Therefore 
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Eya1 influences the development of the three ear regions during mouse embryonic 
development.
Neural structures of the middle ear are also affected, marked by an abnormal passage of 
the facial nerve between the stapes and oval window, which prevents transference of 
vibrations to the inner ear of Eya1 +/- mice. Eya1 -/- mice have complete absence of the 
facial and vestibulo-cochlear nerves and lack the petrosal ganglia (Xu et al.,1999). 
Therefore Eya1 is important for neurogenesis during ear development. 
In addition to defects of the bony ear structures, Eya1 -/- mice possess defects of the 
skull and skeleton. Craniofacial defects include reduced skull size accompanied by 
hypoplasia of the mandible, pre-maxilla, maxilla, and reduced ossification of cranial 
structures. Hypoplasia and fusions of the cervical vertebrae, ribs, and hip  bone are also 
present, implicating a widespread role for Eya1 in skeletal patterning and development 
(Xu et al., 1999). 
Eya1 is also required from the earliest stages of kidney development for induction of the 
metanephric blastema and ureteric bud outgrowth. Later in development Eya1 is a 
additionally required for kidney branching morphogenesis (Sajithlal et al.,2005). 
Therefore Eya1 regulates kidney organogenesis at several stages of development. 
Whilst Eya1 +/- mice exhibit renal hypoplasia and unilateral agenesis with low 
penetrance, Eya1 -/- mice completely lack kidneys and ureters, implicating Eya1 as a 
critical genetic factor for kidney development in the mouse (Xu et al., 1999). Therefore 
defects observed in the ear, kidney, and the cranial bones of Eya1 mutant  mice 
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phenocopy  several aspects of BOR syndrome, suggesting Eya1 to play  similar 
developmental roles in the mouse and human. 
Eya1 mutant mice exhibit additional defects that are not observed in BOR syndrome. 
For example Eya1 -/- mice die shortly after birth due to respiratory distress. This is 
attributed to reduced branching of the lung which results in hypoplasia. Haemorrhage of 
the pulmonary vessels also occurs due to smooth muscle defects. Therefore Eya1 is a 
critical regulator of embryonic lung development in mice (El-Hashash et al., 2011). 
Eya1 -/- mice also lack the thymus and parathyroid glands, whilst Eya1 is required for 
formation of a mature thyroid gland (Xu et al., 2002). These phenotypes therefore 
implicate Eya1 as an important factor for the development of third pharyngeal pouch 
derivatives. In addition to defects observed in Eya1 mouse mutants, gene expression 
analysis infers roles for Eya1 in the brain, PNS, cranial placodes, tooth, hair, gut, 
tendon, muscle, tongue and heart development (Xu et al., 1997a; Xu et al.,1997b; 
Grifone et al., 2007; Xu et al., 2002). Therefore reverse genetic approaches and gene 
expression analysis highlight the widespread developmental roles of Eya1 during 
murine embryogenesis.
1.9.1.3   Mechanisms of Eya1 function in development
Eya1 functions in a cell autonomous fashion to regulate key cellular mechanisms that 
drive organogenesis. Failure of the inner ear to mature and acquire adult structures in 
Eya1-/- mice is associated with marked cell death in the otic vesicle. Similarly excess 
apoptosis in the metanephric mesenchyme results in lack of kidneys and ureters (Xu et 
al.,1999). Absence of the vestibular cochlear nerve in Eya1 -/- mice is also attributed to 
increased cell death in neuronal precursors during early embryonic development (Zou et 
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al., 2004). Therefore Eya1 is a critical regulator of cell survival in these organs, and 
functions to maintain cell populations in which it is expressed. Ectopic cell death 
however, is not always associated with organ malformations observed in Eya1 -/- mice 
(Xu et al., 2002; El- Hashash et al., 2011).
Increased cell death often coincides with decreases in proliferation, which together give 
rise to the resulting organ malformation. Increased apoptosis and decreased proliferation 
are observed in the secondary heart  field of Eya1-/-Six1-/- double mutant mice, and 
contributes to cardiac malformations observed (Guo et al., 2011). Decreased 
proliferation alone is noted in lung epithelial progenitor cells of Eya1 -/- mice, resulting 
in lung hypoplasia. Decreased proliferation of these cells correlates with an increase in 
specified pulmonary cell types, suggesting progenitor cells erroneously enter terminal 
differentiation pathways at the expense of the progenitor population (El- Hashash et al., 
2011a). Therefore in the lung Eya1 maintains lung progenitor populations, loss resulting 
in premature differentiation. This maintenance occurs through Eya1 regulation of cell 
polarity and asymmetric cell divisions (El- Hashash et al., 2011b). 
Therefore Eya1 is additionally  a regulator of cell fate. Whilst  high levels of Eya1 
maintain a proliferative state of inner ear progenitor cells, low levels promote neuronal 
differentiation, implicating level dependent roles for Eya1 (Schlosser et al., 2008). 
However this does not implicate a permissive or indirect mechanism of cell fate 
regulation, and Eya1 is required for the direct induction of downstream gene targets for 
the specification of several cell types (Xu et al., 1999; Zou et al., 2004; Zou et al., 2006; 
Grifone et al., 2007; Guo et al., 2011). Therefore cell survival, proliferation, cell 
polarity, and cell fate regulation are often interdependent processes, defects in one 
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causing alterations for the others. For example, lack of appropriate cellular specification 
in the absence of Eya1 is the suggested cause of apoptosis in those cell populations, 
resulting in loss of the organ primordia (Xu et al., 1999; Xu et al., 2002; Zou et al., 
2004; Zou et al., 2006; Sajithlal et al., 2005; Guo et al., 2011). Therefore Eya1 regulates 
mechanisms of cell survival, proliferation, cell polarity, and cell fate, most likely  in an 
interdependent manner to direct the development of several organ systems.
1.9.1.4   The RDGN and Eya1 signalling
The Eya genes consist  of two functional domains: the eya domain 1 (ED1), a conserved 
271 amino acid C terminal region that functions to mediate protein-protein interactions, 
and the eya domain 2 (ED2), a weakly conserved region of 30 amino acids in an 
otherwise divergent N terminal domain. The ED2 is the region associated with gene 
transactivation function (Zimmerman et al., 1997). Eya proteins are regulators of gene 
expression but are unable to bind DNA directly. For this interactions with members of 
the Six gene family are required. Together the Six-Eya protein complex functions as a 
bipartite transcription factor, the Six protein providing a DNA binding domain and the 
Eya protein providing transcriptional function (Silver., 2003). This interaction between 
Six and Eya proteins is direct and occurs through the ED1 (Ikeda et al., 2002) (Fig.1.3). 
More recently Eya1 has also been identified as a protein phosphatase. This enzymatic 
function has been linked to the ability of Eya1 to induce transcriptional activation (Li et 
al., 2003).
  
Eya proteins are therefore reliant on Six binding to exert their developmental functions. 
In vitro studies reveal Eya proteins have potential to bind many of the Six proteins, 
creating several combinations of bipartite complexes (Ohto et al., 1999). Although not 
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all combinations may be relevant in vivo. Mutations associated with BOR syndrome 
have been observed in the SIX1 and SIX5 genes to date, suggesting these proteins may 
function with EYA1 in human kidney and ear development (Ruf et al., 2004; Hoskins et 
al., 2007).   
 
During murine development, Six1 is strongly associated with Eya1 function. Eya1 and 
Six1 mutant mice exhibit similar malformations in the inner ear, middle ear, and heart 
suggesting these genes function in the same genetic pathway to pattern these organs (Xu 
et al., 1999; Zheng et al., 2003; Guo et al., 2011). Eya1 and Six1 are additionally 
required for hair cell specification in the inner ear, inner ear neurogenesis, and kidney 
development (Ahmed et al., 2012a; Ahmed et al., 2012b; Gong et al., 2007). Eya1-Six2 
complexes are also implicated in development of the kidney and extensor limb tendons 
(Gong et al., 2007; Oliver et al., 1995; Xu et al., 1997; Grifone et al., 2007). Eya1 and 
Six2 are co-expressed in the craniofacial tissues, the nasal placode and the gut which 
may suggest Eya1-Six2 as functional pairs for the development of these structures (Xu 
et al.,1997). Six5 and Eya1 have overlapping expression in muscles of the human limb 
bud and dental mesenchyme suggesting Eya1 and Six5 may functionally pair during 
muscle and tooth development (Fougerousse et al., 2002; Xu et al., 1997; Nonomura et 




Fig.1.3   The basic structure of Eya and Six proteins. The Eya protein has two functional domains: the 
Eya Domain 1 (ED1) that binds to Six proteins and the Eya Domain 2 (ED2) that is required for 
transcription function. The Six protein binds to Eya proteins through the Six Domain (SD) and to DNA 
through their Homeobox Domain (HD). Together the Eya and Six proteins form a bipartite transcription 
factor complex.The dotted line marks regions of interaction.
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1.9.1.5   Eya1 signal transduction
Eya1 transcriptional output is regulated by highly conserved interactions between the 
Eya, Six, and Dach proteins. A molecular mechanism has been suggested in which Dach 
proteins repress Six proteins and therefore downstream gene targets in the absence of 
Eya, most likely  through recruitment of a repressor complex. In turn Eya functions to 
relieve this repression by binding to both Dach and Six, and recruiting transcription co-
factors (Li et al., 2003). Eya1 can bind only  to Dach1 indirectly through the Creb 
Binding Protein (CBP), a known transcriptional regulator, and may indirectly  recruit 
RNA polymerase 2 in this way switching Six1 from a repressed to activated state (Li et 
al., 2003; Ikeda et al., 2002). In Drosophila, groucho, a transcriptional repressor can 
interact with so in the absence of eya (Silver et al., 2003). Therefore Six proteins can 
function both as a repressor and activator of gene expression depending on which 
cofactors are present. Eya proteins can be regarded as transcription co-activators and 
Dach proteins as co-repressors, each recruiting with them further co-factors to inhibit or 
activate Six1 (Li et al., 2003) (Fig.1.4). 
Eya1 interacts with several transcription factors directly  to modulate gene expression. 
These include members of the RDGN such as Six and Pax genes. Expression of Six 
genes are lost in Eya1-/- mice, suggesting Eya1 to function upstream of Six binding 
partners (Xu et al., 1999). Interestingly expression of several Pax genes are also lost in 
Eya1 -/- mice suggesting hierarchies of the RDGN are not  always conserved in 
mammalian development (Xu et al., 2002).
Downstream of RDGN interactions, Eya1 affects several signalling pathways that are 
integral for development. These include the bone morphogenetic protein (Bmp), 
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fibroblast growth factor (Fgf), Wnt, and Notch signalling pathways. Bmp4 is lost in the 
inner ear otic vesicle in Eya1 -/- mice (Zou et al., 2006). Similarly  Fgf3 expression is 
lost in the otic vesicle in Eya1 -/- mice, while Fgf10 is reduced in the otic vesicle and in 
the lung, and Fgf8 in the heart and third pharyngeal pouch (Xu et al.,1999; Zou et al., 
2006; El-Hashash et al., 2011a; Guo et al., 2011; Zou et al.,2006). Wnt5b expression is 
lost completely in the third pharyngeal pouch of Eya1 -/- mice, and Eya1 regulates cell 
polarity in the lung through modulation of the Notch signalling pathway (Zou et al., 
2006; El- Hashash et al., 2011b). Therefore Eya1 exerts developmental influences 
through the regulation of integral growth factor pathways. However further 
investigations will be required to determine whether this is through direct  interactions or 
indirect effects due to loss of the relevant structures, or specification of that region.
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Fig.1.4    Model of  Eya, Six, and Dach interactions (based on the experiments of Li et al., 2003).  A) In 
the absence of Eya, Six target gene expression is repressed.  This is due to interactions with Dach, which 
recruits a repressor complex. B) In the presence of Eya, Eya binds to Six and inhibits Dach mediated 
repression. This is acheived through the recruitment of further co-activator proteins that promote gene 
transcription.
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1.9.2   Bone Morphogenetic Proteins (Bmps)
Bone morphogenetic proteins (Bmps) are a family  of secreted growth factors that form a 
subgroup  within the Tgfb superfamily. Their name derives from the first discovery  of 
these proteins as potent inducers of bone formation (Urist., 1965), however since then 
they  have been shown to regulate various developmental events from embryonic to 
postnatal stages of development. For example, Bmps are integral for dorso-ventral 
patterning of the body axis in both invertebrates and vertebrates during early embryonic 
development (Little and Mullins., 2006). Therefore much like the RDGN, Bmps are 
highly  conserved developmental regulators. In addition, roles for Bmps are implicated in 
the development of several organs such as the nervous system (Hattori et al., 1999), 
lung (Weaver et al., 1999), pancreas (Ahnfelt-Ronne et al., 2010) and bony structures 
such as the tooth (Tucker et al., 1998), cranial skeleton (Hu et al., 2008) and limb bones 
(Pizette et al., 2001). As a reflection of their integral developmental roles, Bmp 
signalling is also implicated in various pathologies such as cancer (Le Page et al., 
2009), osteosclerosis (Ando et al., 2005), and middle ear inflammatory  disease 
(Schmidt et al., 2002). The Bmp family therefore plays extensive roles in development. 
Mouse models of Bmps have further revealed roles for the Bmp family in cartilage and 
bone development. For example the short  ear mouse, which has a mutation in the Bmp5 
gene (Kingsley  et al., 1994), exhibits reduction in the size and width of several 
vertebrae, loss of ribs, and the scaphal portion of the external ear, hence named short ear 
(Green., 1946). Similarly, Bmp7 -/- mice possess skeletal defects, exhibiting misaligned, 
hypoplastic and fused ribs, malformed bones of the skull, and polydactyly  (Luo et al., 
1995). 
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Bmps are key  genetic regulators in the process of endochondral ossification (Yu et al., 
2012), and are therefore integral for both cartilage and bone development. Bmps can 
influence cartilage and bone development at several stages of the process, including 
induction, growth, and patterning of skeletal structures. For example, Bmps are 
implicated in the regulation of early  chondrogenic events. In the limb, Bmpr1 
expression precedes collagen 2 expression in the prechondrogenic mesenchyme, and 
exogenous application of Bmps in vitro upregulate several Sox genes including Sox9 
(Monroy  et al., 2003). Therefore Bmps are implicated in the early differentiation of 
prechondrogenic mesenchymal condensations of the limb. 
Once precursors are formed, Bmps are implicated in the growth of cartilage. For 
example, over expression of Bmps result in hypertrophic cartilage anlages of the digits, 
which is suggested to occur due to increased recruitment of chondrocytes into the 
developing anlages (Duprez et al., 1996). Bmps are also implicated in cartilage 
regeneration. For example, Bmp2 promotes cartilage growth following distal digit tip 
amputation in the mouse. This is achieved through induction of new endochondral 
ossification centres, which then use existing positional information from the digits to 
pattern appropriate growth (Yu et al., 2012). Once cartilage has formed, Bmps are also 
implicated in the patterning of these skeletal elements. For example, several Bmp 
mutant mice possess skeletal patterning defects, usually marked by  the absence of inter-
cartilaginous joints. Bmpr1 mutant mice for example, possess limb defects, and exhibit 
loss of the proximal interphalangeal joints (Yi et al., 2000). Bmps are therefore 
implicated in limb digit patterning. 
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1.9.2.1   Growth differentiation factors (Gdfs)
The role of growth differentiation factors (Gdfs), a small divergent group within the 
Bmp family, have been a particular focus for investigating the role of Bmps in cartilage 
joint patterning. Fifteen members of the Gdf family have been identified to date, and 
within this group several members, namely  Gdf5 (Bmp14), Gdf6 (Bmp13), Gdf7 
(Bmp12) and Gdf11(Bmp11) are implicated in cartilage development and patterning. 
For example, Gdf5 is implicated in several stages of limb development, from the 
recruitment of chondrocytes into the developing digit anlage, to subsequent growth and 
patterning of the inter-phalangeal joints (Francis-west et al., 1999). Mutations in Gdf5 
are responsible for the limb defects in the brachypodism mouse (Storm et al., 1994), 
which exhibit shortened digits that lack interphalangeal joints (Landauer., 1952; 
Gruneberg.,1973). Loss of joint phenotypes have additionally been observed in the 
wrists and ankles of these mice (Settle et al.,2003). Gdf5 is inferred to play  a direct role 
in the process of joint formation across several structures, and Gdf5 is expressed in the 
prospective joint regions of the limb, jaw and middle ear (Wilson and Tucker., 2003; 
Tucker et al., 2004; Settle Jr. et al., 2003). Gdf6 and Gdf7 are also expressed in 
prospective joint regions of the limb, in overlapping but smaller subsets of joints to 
Gdf5. Gdf6 mutants exhibit fusions in regions corresponding to expression domains in 
the wrist and ankle, and Gdf7 expression is restricted to the proximal interphalangeal 
joints only (Settle et al., 2003). In the skull, Gdf6 mutant mice exhibit craniosynostosis, 
due to a failure to maintain the suture joint between the frontal and parietal bones 
(Clendenning and Mortlock., 2012). In the middle ear, Gdf6 is required for ossicle 
cartilage growth, and Gdf6 null mice exhibit  hypoplasia of the middle ear ossicles 
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(Settle et al., 2003). Therefore Gdf5, Gdf6, and Gdf7 appear to play  widespread roles in 
cartilage growth, joint patterning, and development. Interestingly, Gdf5, Gdf6, and Gdf7 
form a subgroup within the Gdf family due to close structural homology. In particular, 
these members display approximately 85% homology in their mature C terminal 
signalling domains, which may underly  their similarity in function (Storm et al., 1994). 
In addition, Gdf11-/- mice exhibit  anterio-posterior skeletal patterning defects, 
implicating a role for Gdf11 in vertebral identity specification (Mcpherron et al., 1999). 
Roles in skeletal patterning appear to be conserved from the mouse to human. For 
example, mutations in the Gdf5 gene in humans (CDMP1) accounts for a subset of 
syndromes with limb defects, such as brachydactyly and symphalangia. Similarly, Gdf6 
mutations underly Klippel-Feil syndrome, which amongst several anomalies is 
characterised by  fusions of the cervical vertebrae, and carpal and tarsal fusions of the 
wrist and ankle respectively (Tassabehji et al., 2008). Therefore several members of the 
Gdf subset of the Bmp family  are highly implicated in cartilage patterning and joint 
formation. 
1.9.2.2   Extracellular antagonism of Bmp signalling; Noggin
Bmp signalling is negatively regulated at multiple levels of the pathway. In the 
extracellular environment, Bmp signalling is modulated by  secreted growth factor 
antagonists, which bind to the Bmps directly to obscure their receptor binding sites 
(Groppe et al., 2003; Winkler et al., 2003). Multiple extracellular antagonists have been 
identified (Rider and Malloy.,2010), and Bmps can also play tissue specific or level 
specific roles as both agonists and antagonists(Daluiski et al., 2001). Negative 
68
regulation of Bmp signalling is equally critical to Bmp activating proteins, loss of 
antagonism resulting in maldevelopment and disease. 
One such antagonist is the Noggin protein, which was first discovered for its role in 
dorso-ventral patterning in Xenopus, through inhibition of the Bmp4 (Zimmerman and 
Harland.,1996). Noggin is also implicated in cartilage development, and Noggin null 
mice exhibit  widespread skeletal defects of the ribs and vertebrae. In addition Noggin 
null mice exhibit limb defects, characterised by shortened, broadened limb bones, and 
an absence of interphalangeal joints. The increased size of developing limb bones is 
suggested to be a result  of unregulated Bmp activity, which increase recruitment of cells 
into the developing anlages. Interestingly, Gdf5 expression is lost in the prospective 
interphalangeal regions in Noggin null limbs, suggesting Noggin influences joint 
patterning through direct or indirect regulation of Gdf5 (Brunet et al., 1998). Similar 
phenotypes are observed in the middle ears of Noggin mutant mice. For example, 
Noggin +/- mice exhibit ectopic bone formation between the stapes and styloid process, 
resulting in stapes fixation. This phenotype is more pronounced in Noggin null mice, 
where the ossicles are fused into one combined cartilaginous lump, resulting in loss of 
ossicle shape definition and articular joints (Hwang and Wu., 2008). It therefore appears 
a delicate balance of Bmps and their inhibitors is required for cartilage development and 
patterning, loss of inhibition resulting in developmental malformations similar to loss of 
Bmps.
When considering the development of cartilage, bone, and skeletal patterning, Bmps and 
their antagonists are therefore molecules of particular interest.
69
1.9.2.3   Bmp signalling and transduction
Bmps are translated as large protein precursors, with an N terminal signal peptide 
domain, a latency domain, and a mature domain. The latency domain masks the 
functional mature domain, and as a result Bmps remain inactive when secreted (Thies et 
al., 2001). In order to be activated, cleavage of the N terminal latency domain is 
required, providing a mechanism for fine regulation of Bmp signalling (Cui et al., 
1998). 
Once activated, Bmp ligands form dimers and bind to Bmp receptors. Bmp receptors are 
single pass transmembrane proteins with an intracellular serine/threonine enzymatic 
domain, and a ligand binding extracellular domain. Several Tgfb receptors have been 
identified, and these fall into two classes; the type one Tgfb receptors and type two Tgfb 
receptors. Structurally both classes are very  similar, and within these classes various 
combinations of type one and type two receptors can complex together in order to 
transduce Bmp signalling. Bmp proteins can bind to several receptor complexes, and 
through this redundacy differentially regulate signalling (Rider and Malloy., 2010). Bmp 
signalling initiates with binding to either type one or type two receptors, triggering 
homodimerisation of the receptor type, followed by heterodimerisation with a 
corresponding class receptor homodimer. This results in a tetramer receptor complex 
with an associated Bmp dimer ligand. Ligand receptor binding initiates cross 
phosphorylation of the intracellular domains of both receptors, and the activated 
receptor complex recruits cytoplasmic intracellular signal mediator proteins called 
Smads (Wrana et al., 2000). Smad proteins fall into three categories based on function; 
receptor smads (R-Smads), common Smads (co- Smads) and inhibitor Smads (I-Smads). 
Specific R- smads mediate different  signalling pathways, for example whilst  R-Smads 
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1,5 and 8 mediate Bmp signalling, R- Smads 2 and 3 mediate Tgfb signalling 
(Miyazawa.,1999). Bmp signalling can also be mediated through the non canonical P38 
Mitogen activated protein kinase pathway (MAPK) (Zuzarte-Luis et al., 2004). Once the 
R- smads have recruited to the receptor complex, they are in turn phosphorylated at  their 
carboxyl termini and activated. Activated Smad complexes dissociate from the receptor 
and bind to the co-Smad, Smad 4. Together the Smad complex translocates into the 
nucleus, where they  modulate gene transcription through recruitment of co-repressors 
and co-activators, in this way regulating target gene expression. Several levels of Bmp 
signalling modulation occur in order to fine tune Bmp levels. In addition to extracellular 
antagonism as described above, Bmp signalling can be negatively regulated in the 
cytoplasm through inhibitor Smads (I-Smads), which bind to the receptor complex and 
as a result  prevent binding of the R-Smads. They can also bind to R-Smads directly and 
prevent them from binding to the receptor complex. The Smurf family  of proteins 
(Smad ubiquitin regulatory factors), which are E3 ubiquitin ligase proteins, can also 
inhibit Bmp signalling by targeting Smad complexes for degradation (Wrana., 2000) 
(Fig.4). In addition to regulation at multiple levels of the pathway, cross talk between 
other signalling pathways will also influence the overall signalling output 






































































































































































































































































































1.10   Summary and Aims of thesis
This introduction aims to emphasise the importance of middle ear development in the 
formation of a functional middle ear. Hearing impairments that cause conductive 
deafness can occur as result of developmental defects and middle ear pathology. The 
latter may be a secondary consequence of congenital malformations in middle ear and 
associated structures.
From a developmental perspective, the middle ear is a fascinating organ system, derived 
from various embryonic tissue sources and influenced by a myriad of genetic factors. As 
described, formation of a functional middle ear is reliant on multiple embryonic and 
postnatal developmental events, and defects in any  one of these events alone may cause 
conductive deafness. Several of these developmental events have been characterised in 
detail, and transgenic mouse mutants have implicated many genetic influences in the 
formation of middle ear structures. However how these genes integrate and function to 
drive middle ear morphogenesis is of limited understanding, and therefore forms a focus 
of work undertaken in this project.
In this project I have taken advantage of the Eya1 mouse model, in order to investigate 
the influence of this gene in middle ear development, and in turn disease. Investigation 
of embryonic and postnatal middle ear development in these mice have identified three 
main areas of interest;
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1. Embryonic joint formation in the middle ear 
Defects in ossicle joint patterning are observed in Eya1 mutant  mice. The influence of 
Eya1 on the genetics and mechanisms of incudo-malleal and stapedio-vestibular joint 
patterning are therefore investigated.
2. Postnatal development of Meckel’s cartilage
The disconnection of the middle ear and mandible is a process influenced by postnatal 
development of Meckel’s cartilage. However little is known of the genetics that control 
the mechanisms of this process. A potential role for Eya1 in this developmental event is 
investigated.
3. Disease of the middle ear; otitis media
Middle ear disease can develop as a result of syndromic genetic abrogations, and 
disease development may further highlight additional roles of a particular gene. A 




2.1   Animals
2.1.1   Eya1/BL6 Mice
Eya1 heterozygous mice on a Black 6 (BL/6) background were kindly provided by Dr. 
Richard Maas from the Division of Genetics, Department of Medicine, Brigham and 
Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA. 
Generation of these mice were all carried out at Harvard Medical School and is 
described in Xu et al.,1999. A targeted Eya1 mutation was introduced by replacing 
exons 10-13, which encodes 153 residues of the 271 amino acid functional Eya domain 
1 (ED1), with a neomycin cassette. This results in a translated Eya1 protein with a non 
functional ED1 domain. Mutant Eya1 proteins are therefore unable to bind to Six 
proteins to form a bi-partite transcription factor complex (Xu et al., 1999). The ED2 
domain remains unaffected, however studies to date suggest that modulation of gene 
transactivation through the ED2 domain is dependent on Eya1-Six1 binding through the 
ED1 domain (Silver et al., 2003).  Therefore abrogation of the ED1 domain may  result 
in a functionally null Eya1 protein, although the ability  of other domains within the 
Eya1 protein to independently affect gene transactivation function cannot be ruled out. 
For example, Eya1 proteins are able to form homodimers through their N terminal 
domains, although the functional significance of this is unknown (Silver et al., 2003). 
However, it is clear from the phenotype of Eya1 mutant mice that loss of function of the 
ED1 domain impacts development of several structures in these mice (Xu et al., 1999). 
2.1.2   Mouse Husbandry
Up to three female mice were housed together to encourage the Whitten effect upon 
introduction to a male. Sexually  mature male and female mice were set up in evenings 
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for overnight matings. Females were checked for vaginal plugs the following mornings, 
by insertion of a plugging stick into the vaginal canal. Plugs were taken as an indication 
of fertilisation. Plugs found in the morning were attributed as 0.5 days into the gestation 
period, and females were then housed independently from the male.  Eya1 +/- mice 
were mated with BL/6 mice (Eya1 +/+) in order to obtain Eya1 +/+ and Eya1 +/- 
progeny. Matings between Eya +/- males and Eya1 +/- females were undertaken to 
obtain Eya1 -/- embryonic samples. Eya1 -/- mice die at birth, therefore postnatal Eya1 
-/- samples could not be obtained. The line was propagated and maintained in the 
Biological Services Unit  in New Hunts House, Guy’s Campus, King’s College London, 
UK.
2.1.3   Culling of adult mice
Adult mice were culled using the method of cervical dislocation according to Schedule 
1A of the Animals Scientific Procedures Act 1986.
2.1.4   Collection of embryos
Once the pregnant female was culled (see above), skin and hair over the abdomen was 
pulled back and a small incision made over the uterus using sterilised scissors. The 
string of embryos were extracted using forceps (Dunmount Tweezers No.5, World 
Precision Instruments) and scissors, placed in ice cold Dulbecco Modified Eagle 
Medium, nutrient mix F-12, GLBCO, (DMEM/F12) containing 1% penicillin-
streptomycin (Gibco) and 1% glutamaxTM (Invitrogen) and left on ice for culture work. 
Embryos were dissected out  of their amniotic sacs and decapitated immediately 
according to Schedule 1B of the Animals Scientific Procedures Act 1986.
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2.2   Cultures
2.2.1   Dissection of tissue explants
All dissections were undertaken in a 9cm disposable Petri dish (Sterilin, Fisher 
Scientific). Dissections were performed under a light dissecting microscope (2.10.3). To 
avoid infection, surfaces were cleaned with 70% ethanol (EtOH) and the germinator 
500TM used to heat sterilise forceps and blades. 
E16.5 embryonic middle ears were dissected from heads using the following method; 
heads were orientated with the nose region positioned uppermost. A transverse cut was 
made with a surgical blade (Swann- Morton®) to divide the mandible and maxilla, and 
the upper maxilla half discarded. In this plane, the lower half revealed the tongue, which 
lay  between the lower mandible halves, and Meckel’s cartilage was often visible medial 
to the mandible on both sides. Using a pair of forceps (Dunmount Tweezers No.5, 
World Precision Instruments) the regions around Meckel’s cartilage were carefully 
dissected away, gradually  progressing more proximally to meet the developing auditory 
bulla, which encases the inner and middle ear structures. Once this region had been 
finely dissected, a cut was made with a blade to carefully separate the middle ear from 
the inner ear (Fig.2.1). Dissected middle ears were placed in a 3.5mm cell culture dish 
(Cellstar®, greinerbio-one) in DMEM/F12 and stored on ice, until ready for mounting.
2.2.2   Mounting of explants
Once all dissections were performed, cultures were mounted in culture dishes. For 
embryonic middle ears a Trowell culture method was chosen, as this was sufficient for 
the growth of small tissue explants. Trowell organ culture dishes (BD center-well 
FalconTM) were used. These dishes contain an inner and outer well. Cultures were 
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mounted on 0.4um filter membranes (Becton Dickinson Labware) supported by 
sterilised metal grids, suspended over the inner well. The inner well of the culture dish 
was filled with DMEM/F12 media (supplemented with 1% penicillin- streptomycin and 
1% Glutamax), until just reaching the bottom of the culture. This creates an air-liquid 
interface, where the tissue is oxygenated from above and perfused by media below. Care 
was taken so that  cultures were not submerged in media as the above conditions support 
optimum culture development. 1mL of sterile distilled water (dH2O) was added to the 
outer well of the dish. Cultures were incubated at 37ºC, 5% CO2 (NuaireTM DH 
Autoflow) and supplemented with fresh media daily. Cultures were photographed using 
a light microscope (2.10.3). Explants were typically cultured for 7 days and then fixed 
in 95% EtOH for skeletal preparation (2.4).
2.2.3   Culture manipulation with Noggin recombinant protein
Recombinant mouse Noggin protein (rmNoggin R&D Systems®) was reconstituted at 
100ug/mL in sterile phosphate buffered saline PBS with 0.1% Bovine Serum Albumin 
BSA (Sigma). Affi-gel® blue beads (Bio-Rad) were the vector of choice. 100ul of beads 
were pipetted into sterile PBS, washed in another change of sterile PBS, and separated 
in a 9cm Petri dish according to size using a forcep sharpened for ease of bead 
manipulation. The largest beads were chosen, and as much of the PBS removed using a 
20ul pipette (eppendorf Research). Beads were dried fully under a light source (Leica 
CLS 150 XE lamp), and once fully  dehydrated (indicated by a shriveled appearance), 
were placed in 10ul of 100ug/mL Noggin. For controls, Affi-gel® beads of the same size 
were washed in PBS as above and placed in 10ul of 100ug/mL of (BSA). Beads were 
incubated at 37ºC for 30 minutes to promote protein uptake, and stored at 4ºC until use.
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Fig 2.1. Schematic to show dissection of the middle ear at embryonic stages. 1. The 
head of the embryo is cut in a transverse plane, to separate the upper and lower jaws. 2. 
The middle ear and Meckel’s cartilage  is visible either side of the tongue in the lower 
jaw portion. 3.  The middle ear and Meckel’s cartilage is finely  dissected from the 
surrounding tissues. 4. The inner ear tissues are removed to reveal the middle ear 
ossicles. AB, auditory bulla, C, cranial fossa, T, tongue, MC, Meckel’s cartilage, M, 
malleus, I, Incus.
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2.3   Middle ear bacteria culture
2.3.1   Preparation of FAA plates
Fastidious Anaerobe Agar (FAA) plates were a kind gift from Steven Gilbert, 
department of microbiology, King’s College London. Plates were prepared as follows; 
23g of Fastidious Anaerobe Agar (Lab M  Ltd) were dissolved in 500mL of distilled 
H2O, mixed well and autoclaved. The agar was allowed to cool and 25mL of sterile 
defibrinated horse blood (Oxoid) was preheated to 37ºC and added. The resulting agar 
mixture was poured into 9cm pertri dishes (approximately 25mL/plate), and allowed to 
set at RT for at least 2 hours. Plates were stored at 4ºC until use.
2.3.2   Adult middle ear swabbing
Dissection and swabbing was undertaken in a laminar flow hood to ensure sterile 
conditions. Auditory  bullae were dissected from adult heads and placed in a 9cm Petri 
dish. A pair of forceps (Dunmount Tweezers No.5, World Precision Instruments) were 
cleaned in 70% EtOH and heat  sterilised using the germinator 500TM. Using these 
forceps, a perforation in the tympanic membrane was made, and the membrane 
carefully  peeled back, to reveal the middle ear cavity. A fine dissecting needle was 
sterilised as above, and inserted into the middle ear cavity. Contact with all surfaces of 
the middle ear cavity walls, and any material in the middle ear cavity, was made with 
the needle. An FAA plate was opened at a 45ºC angle and the needle was swabbed 
gently onto the surface of the FAA agar. The lid of the Petri dish was replaced, and 
dishes were incubated overnight at  37ºC. Following culture, dishes were removed from 




Alcian Blue and Alizarin Red for the staining of non- mineralised cartilage and bone 
respectively. Taken from (Mcleod, 1980) and modified by  (Depew et al., 1999). 
Embryos were harvested according to Home Office schedule 1 regulations as described 
previously  (2.1.5). To facilitate penetration heads were halved, eviscerated, and skinned. 
Heads were then fixed in 95% ethanol (EtOH) (AnalaR) for 3 days at RT. 
Samples were subsequently placed in acetone (Scientific Laboratory Supplies) for 2 
days, the heads air dried at RT, and placed in newly  made staining solution (1 volume 
0.3% Alician Blue 8GX (Ingrain Blue 1, Harleco) in 70% (EtOH); 1 volume 0.1% 
Alizarin Red S (BDH Gurr Certistain®) in 95% EtOH; 1 volume Glacial Acetic Acid; 17 
volumes 70% EtOH) for 3 days with agitation. Heads were then cleared in 0.5 % 
Potassium Hydroxide (KOH) (Sigma®) until soft  tissue maceration was complete and 
underlying bones and cartilages were visible. Following this, samples were processed 
through a series of 0.5 % Potassium Hydroxide (KOH) in Glycerol (AnalaR Normapur) 
for at least two weeks, commencing with 1 volume Glycerol to four volumes of KOH 
(1:4), one volume Glycerol to one volume KOH (1:1) and four volumes Glycerol to one 
volume KOH (4:1). Samples were photographed with a Leica light dissecting 
microscope (2.10.3), and then stored indefinitely in 100% glycerol at RT.
2.5   Tissue processing
2.5.1   Fixation and dehydration
Tissue was fixed in 4% Paraformaldehyde (PFA) (Alfa Aesar) at 4ºC over night. The 
following day samples were washed in PBS and dehydrated through a graded methanol 
(MeOH) (Sigma®) series from PBS, 30% MeOH, 50% MeOH, 70% MeOH, 85% 
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MeOH, 90% MeOH, 95% MeOH and into 100% MeOH. Samples were then washed 
twice in isopropanol (Acr!s Organics) and the fat dissolved in 1,2,3,4- 
tetrahydronapthalene (Sigma Aldrich), until samples appeared transparent. Samples 
were subsequently washed in polyisobutylene histological wax (Ultraplast, Solmedia) at 
65ºC, the wax being changed every  30 minutes. The time of all washes depended on the 
sample size (Table 2.1.)
Tissue stage Time per wash
E.13.5 - E14.5 45 mins
E16.5 - E17.5 1hr 30 mins
E18.5 2 hrs
P0 - P1 3 hrs
P2 - P4 1/2 a day
P5 - P7 1 day
P8 - P14  2 days
P21 3 days
>P21 3 days
Table 2.1. Processing of tissue samples through a graded series of alcohol. Time per 
wash for histological processing of tissue samples through a graded alcohol series. Time 
is based on half head samples. This guide can be used for tissue samples of equivalent 
sizes to half heads at each stage.
2.5.2   Sample Embedding
Once the sample was fully permeated with wax, it was embedded into a metal mould 
using a wax embedding station (Leica EG 1150H). A metal mould was filled with wax 
and rested on a cold plate. The sample was orientated accordingly and held in place 
until the surrounding wax solidified. A plastic embedding cassette (VWR International) 
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was firmly placed on the mould whilst  the remaining wax was still molten. The sample 
was left to solidify  completely in a cold stage for at least 30 minutes. Once solidified, 
the sample was removed from mould and trimmed down to the area of interest using a 
surgical blade (Swann-Morton®). 
2.5.3   Sectioning and mounting
Tissues were sectioned to a width of 8um with a conventional microtome (Leica 
RM2245). Sections were floated in a 42ºC water bath (Electrothermal, paraffin section 
mounting bath) and mounted on glass slides (Superfrost Plus TM VWR international). 
Slides were left to dry on a hot block (Thermo Scientific slide drying bench) at  42ºC 
overnight or at 65ºC for 2 hours.
2.5.4   Decalcification
Samples from E18.5 onwards were decalcified due to the presence of bone. Tissue was 
fixed in 4% PFA overnight, and then placed in a solution of 12.5% 0.5M 
ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich) and 1% PFA in PBS. The 
length of time and number of solution changes in decalcification solution depended on 
the size of the tissue sample (Table 2.2). Samples were then washed in PBS, dehydrated 
and processed as above.
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Stage Time of incubation 
E18.5 7 days
P0 - P1 10 days
P2 - P7 2 weeks
P7 - P14 3 weeks
P21 1 month
> P21 1 month - 1 month, 2 
weeks
Table 2.2. Times for tissue incubation in EDTA for decalcification. Time of 
incubation is according to one solution change per day. This guide can be used for tissue 
samples of equivalent sizes to half heads at each stage.
2.6   Histology staining
2.6.1   Trichrome Staining
Trichrome staining was undertaken for the histological visualisation of cartilage and 
bone. Alcian blue stains mucopolysaccharides which are present in cartilage matrix, 
Picrosirius red for the staining of calcified tissues and Haemotoxylin for the staining of 
nuclei (Bancroft., 2008). Trichrome staining was undertaken on 8um paraffin sections. 
Slides were deparaffinised in HistoclearTMII (NationalDiagnostics) in 3 changes of 10 
minutes each, and rehydrated in decreasing concentrations of industrial methylated 
spirit (IMS) (Solmedia®) for 2 minutes each, commencing with 100% IMS, 90% IMS, 
70% IMS, 50% IMS and then rinsed in deionised water. To stain cartilage, slides were 
then incubated in 1% Alcian Blue 8GX (Sigma) in 3% acetic acid, pH 2.5 for 10 
minutes. Slides were washed in running water for 10 minutes, rinsed in deionised water, 
and immersed in Ehrlich’s Haemotoxylin (Solmedia®) for two minutes, to stain nuclei. 
Once stained, slides were again washed in running water for 10 minutes, rinsed in 
deionised water and differentiated in 2.5% Phosphomolybdic Acid (Fluka Biochemica) 
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for 10 minutes. Slides were again rinsed in deionised water and left in 0.5% Sirius Red 
(BDH Gurr Certistain®) in saturated Picric Acid for at least one hour, to stain bone. 
Once sufficiently stained, slides were rinsed twice in 0.5 % acetic acid (AnalaR®), to 
remove excess unspecific staining of sirius red, blotted dry after each rinse, and 
dehydrated in 3 changes of 100% IMS for two minutes each. Slides were left to air dry 
for a minimum of 10 minutes and mounted with 25 X 60 mm glass coverslips (Menzel-
Glasër) and DPX mounting medium (Lamb RA).
2.6.2   Eosin Counterstain
Slides were washed in PBS and dehydrated through increasing concentrations of EtOH: 
commencing with 30% EtOH, 50% EtOH, 70% EtOH, 85% EtOH and 90% EtOH, for 2 
minutes each. Once in 90% EtOH, slides were stained with 0.5 % Eosin in 90% EtOH 
(Sigma Diagnostics) for 1 minute. Once stained, dehydration was continued into 95% 
and finally  100% EtOH, for 2 minutes each. Slides were air dried and coverslips 
mounted with DPX mounting medium.
2.7   Molecular Biology
2.7.1   Electrophoresis
Agarose gel electrophoresis was used to verify the presence of DNA or RNA. 1% 
Agarose (Sigma®) was dissolved in Tris-acetate-EDTA buffer (TAE buffer) by  heating 
in a glass beaker in the microwave. The molten gel was cooled by placing the beaker 
under cold running water, and ethidium bromide (Fisher Scientific) added to the agarose 
gel (1ul of ethidium bromide in 50mL of gel), just before solidification, for the 
visualisation of DNA and RNA. The agarose was poured into a mould, and a comb 
inserted to create wells. The gel was allowed to set at  RT for approximately 20 minutes. 
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Once set, the gel was placed in an electrophoresis tank (Scie-Plas HU6 Mini) containing 
1 X TAE buffer, so that the gel was completely submerged. A mixture of 1ul of nucleic 
acid to be visualised, in 4ul of dH2O with 1ul of loading dye (Promega) was pipetted 
into a well. An equivalent mixture containing 1ul of DNA ladder (Thermo Scientific, 
GeneRuler) was pipetted into the adjacent well, as an indication of nucleic acid sample 
size. The gel was run at 80 volts for approximately  20 minutes. Nucleic acid bands were 
observed and photographed with a UV transilluminator (BioDoc-ItTM Imaging System) 
and printer (Mitsubishi p91).
2.7.2   Plasmid DNA Extraction
DNA was extracted from filter paper by immersing in 50ul of Tris- EDTA (TE) buffer; 
10mmM  Tris- HCl pH8 and 1mM  EDTA (Fisher Chemical), for a minimum of two 
hours at RT. DNA was then stored at -20ºC.
2.7.3   Plasmid Preparation: DNA transformation and growth 
Lysogeny broth medium (LB medium) and agar (LB agar) were prepared in advance; 
LB medium contained 1% NaCl, 1% Bacto-trypton (Oxoid) and 0.5% bacto-yeast 
extract (Oxoid). For LB agar, 2% Agar bacteriological No.1 (Oxoid) was added to LB 
medium and the solution heated until the agar had dissolved. Both solutions were 
autoclaved prior to use.
For LB agar plates, LB agar was liquified in the microwave and 2mg/mL of Ampicillin 
(Sigma) was added to cooled LB agar. 20mL of this mixture were poured into each 9cm 
disposable Petri dish and left to set at RT. For storage, plates were sealed with 
paraffinTM (Fluka Biochemica) and stored at 4ºC until use.
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For sterility, bench work for cell transformation and growth was undertaken near a 
bunsen burner flame. An aliquot of competent cells (Subcloning EfficiencyTM, 
DH5alphaTM, Chemically  Competent Cells) (InvitrogenTM) was thawed on ice. Once 
thawed, 10ng of plasmid DNA was added to 50ul of competent cells and incubated on 
ice for 30 minutes. A control transformation was also prepared, substituting plasmid 
DNA with an equal volume of dH2O. Cells were heat shocked in a 42ºC water bath for 
45 seconds, to enable transformation of cells with the plasmid DNA, and cooled on ice 
for 2 minutes. For bacterial growth, 950ul of LB medium without Ampicillin was added 
to the cells and DNA, tubes were incubated in a shaking incubator at  37ºC for 1 hour, 
200 rpm. Following incubation, 100ul of transformed cells in LB medium were pipetted 
onto an Ampicillin resistant LB agar plate and spread with a sterile spreader (greiner 
labortechnik). Inoculated plates were left to dry for 5 minutes at RT, then turned upside 
down and incubated in a 37ºC oven overnight, for up to 16 hours. Prolonged incubation 
was avoided to prevent merging of colonies.
The following day, plates were removed from the incubator and verified for colony 
growth. Under sterile conditions, control plates without plasmids should lack growth 
and remain clear. Plates were stored at 4ºC until the end of the day. Individual colonies 
were then picked (4 colonies, 1 per Eppendorf (Star Lab)), using a 10ul sterile pipette 
tip  (Star Lab) and the entire tip placed in a 15mL falcon tube containing 5mL LB 
medium with 2mg/mL Ampicillin. For control conditions, a sterile pipette tip  was used 
in place of a bacteria innoculated tip. Tubes were incubated overnight in a shaking 
incubator at 37ºC, 200 rpm, for a maximum of 16 hours to enable Ampicillin selective 
growth.
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Following incubation, the cultures were checked for bacterial growth, evidenced by 
cloudy  medium. Control cultures did not exhibit bacterial growth and remained clear 
under sterile conditions. Cells were harvested by centrifugation. 1 mL of culture was 
pipetted into an Eppendorf, centrifuged and the supernatant removed. This step was 
repeated once more to obtain a sufficient amount of plasmid DNA containing cells. 
DNA was purified using a QIAprepR Spin miniprep  kit, according to the manufacturers 
instructions. All centrifugation steps were performed at 13,000 rpm.
In detail, pelleted bacterial cells were resuspended in 250ul of Tris-HCl/EDTA pH8 
buffer (Buffer p1) and vortexed to mix. This buffer is supplemented with RNase A to 
prevent RNA contamination. 250ul of an alkaline lysis buffer (Buffer P2) of NaOH/SDS 
was added to lyse the bacterial cells. 350ul of a high salt  buffer (Buffer N3) was added 
to the lysate and centrifuged for 10 minutes at 13,000 rpm. This buffer neutralises the 
lysate and precipitates denatured proteins, chromosomal DNA and cellular debris whilst 
leaving the plasmid DNA in solution.
The supernatant containing the plasmid DNA was applied to a QIAprep column silica 
membrane to adsorb the DNA, and centrifuged for 60 seconds. The column was 
subsequently  washed with 500ul of guanidine-HCl and ethanol (buffer PB), centrifuged 
for another 60 seconds and the flow through discarded, in order to remove 
endonucleases. 750ul of TE buffer and ethanol (Buffer PE) were then added to the 
column and centrifuged for 60 seconds, in order to remove any remaining salts. The 
flow through was discarded, and the column centrifuged for another 60 seconds, to 
ensure the removal of all remaining buffer. The QIAprep column was then placed in a 
clean 1.5 mL eppendorf and 50ul of a 10mM Tris-HCl, pH 8.5 elution buffer (Buffer 
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EB) added. The column was left to stand for 1 minute and then centrifuged for 60 
seconds. The flow through with eluted plasmid DNA was collected in the eppendorf and 
stored at  -20ºC. 1% Agarose electrophoresis was undertaken to verify  successful 
extraction of DNA,  and the DNA concentration measured (2.7.1).
2.7.4   Measurement of DNA concentration 
A spectrophotometer (Eppendorf Biophotometer) was used for measurement of DNA 
concentration, at a wavelength of 260nm. 100ul of dH2O was pipetted into a cuvette to 
calibrate the spectrophotometer. 1 ul of DNA sample in 99ul of dH2O was then pipetted 
into a cuvette and placed into the spectrophotometer for measurement.
2.7.5   DNA Linearisation
For plasmid DNA linearisation, a plasmid map of the DNA of interest was consulted, to 
identify restriction sites. 1ug of DNA was incubated with up to 12% of appropriate 
restriction endonuclease enzyme (Promega) and a 1 X concentration of the enzyme’s 
corresponding buffer (10 X stock) (Promega) in dH2O. The reaction mixture was 
incubated for a minimum of 2 hours or left  overnight at 37ºC. Linearisation was verified 
by 1% Agarose electrophoresis (2.7.1) of 1ul of the linearised plasmid and 1ul of 
unrestricted control plasmid for comparison.
2.7.6   Purification of Plasmid DNA
Linearised plasmid DNA was purified using the QIAquickR PCR purification kit 
(QIAGEN).  All centrifugation steps took place at 13,000 rpm. 5 volumes of buffer PB, 
containing guanidine hydrochloride and isopropanol, were added to 1 volume of DNA. 
This solution was pipetted into a QIAquick spin column, which was placed in a 2mL 
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collection tube, and centrifuged for 60 seconds. This enabled the DNA to bind to the 
silica membrane of the spin column. The flow through was discarded and 750ul of TE 
buffer and ethanol (buffer PE) were pipetted into the column and again centrifuged for 
60 seconds to clean the DNA. The flow through was discarded and the column 
centrifuged for a further 60 seconds, to ensure all the buffer had been removed. The 
column was placed in a clean 1.5mL micro centrifuge tube, and the DNA eluted by 
pipetting 30ul of a 10mM Tris-HCl, pH 8.5 elution buffer (buffer EB) directly  onto the 
filter column membrane, leaving the column to stand for 1 minute, and then centrifuged 
for 1 minute. The presence of DNA was verified by 1% Agarose gel electrophoresis 
(2.7.1), and the DNA was stored at -20ºC thereafter.
2.7.7   Digoxygenin (dig)- labelled RNA transcription (RNA probe synthesis)
For RNA synthesis, 1ug of linearised DNA was incubated with 5 X transcription buffer 
(200mM Tris- HCl, 30mM  MgCl2, 50mM NaCl,10mM  spermidine, 10 X stock), 20 mM 
DTT (0.1 M stock), 1 X dig-RNA labelling mix (10 X stock), 4 U/ul of Rnase inhibitor 
(40U/ul stock) and 0.5 U/ul of appropriate polymerase enzyme (10,000U/mL stock). 
The final volume of the reaction mixture was adjusted with DEPC treated H2O. All 
reagents were supplied by Promega, excepting the dig-RNA labelling mix which was 
supplied by Roche. The reaction mixture was incubated for 2 hours at 37ºC, 
supplemented with another 0.5U/ul of polymerase enzyme following 1 hour. 
Transcription was verified with 1% agarose electrophoresis of 1ul of transcribed RNA 
against 1ul of untranscribed DNA template for comparison. Following transcription, the 
DNA template was degraded with 2ul (2 units) of RNAse-free DNAseI (RQ1, 
promega), at 37ºC for 15 minutes. RNA was precipitated from the reaction mixture by 
adding 1mL of a 75% EtOH and 100mm LiCL in DEPC treated H2O solution. Probes 
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were stored in this solution at -80ºC until required. On the day  of use, the probe was 
centrifuged at 13,000 rpm for 15 mins at  4ºC, to form an RNA pellet. The supernatant 
was removed, the RNA pellet washed by adding 500ul of 70% EtOH in DEPC treated 
H2O and centrifuged for 5 mins at 13,000 rpm. The EtOH was removed and the pellet 
resuspended in hybridisation mixture (2.7.8) to the desired volume (typically 100ul/
slide). Remaining probe in hybridisation mix could be stored at -20ºC for later use.
2.7.8   Digoxygenin-labelled RNA in situ hybridisation on slides
8um thick wax sections were mounted on glass slides for RNA in situ hybridisations 
(2.5.3). Glassware was cleaned thoroughly with Rnase Away (Molecular Bioproducts, 
MBP), to protect against ribonuclease contamination. For the same purpose, solutions 
used prior to RNA hybridisation were diluted in diethylpyrocarbonate (DEPC) treated 
H2O (Sigma), to ensure solutions were ribonuclease free. Slides were placed in a 50mL 
coplin jar and deparaffinised in 3 washes of 10 minutes each in HistoclearTMII. Slides 
were then rehydrated in a graded MeOH in DEPC H2O series; Starting from 100% 
MeOH, 90% MeOH, 70% MeOH and into DEPC treated H2O. Slides were fixed in 4% 
PFA for 10 minutes to protect tissue integrity, and washed twice in 1 X PBS in DEPC 
treated H2O (DEPC PBS) for 5 minutes each. Slides were permeabilised with 10ug/ml 
of Proteinase K enzyme (Sigma- Aldrich) in DEPC PBS for 10 minutes, rinsed in PBS, 
and post fixed in 4% PFA again for 5 minutes. PFA was washed away by rinsing in one 
change of DEPC PBS and then washing in DEPC PBS for 5 minutes. For the 
minimisation of non specific RNA probe binding, a 0.1M triethanolamine (TEA) 
(AnalaR®) in DEPC H2O solution was prepared, and the pH adjusted to 7.5 with the 
addition of 37% HCl (AnalaR®). Slides were placed in the solution, 875ul of acetic 
anhydride (AnalaR Normapur) added, and the coplin jar placed on a rocker for 10 
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minutes. Slides were then washed 3 times in PBS for 5 minutes each, and left to 
prehybridise for a minimum of 1 hour at  65ºC in a solution of 50% formamide 
(BioUltra for molecular biology) (Sigma®), 10% dextran sulphate (50% stock) (Severn 
Biotech ltd.), 1 X Denhardt’s (50 X stock) (Sigma), 0.25mg/mL yeast RNA (Sigma), 
0.3M NaCl (Aldrich), 20mM  Tris-HCl, pH8 (Sigma®), 5mM EDTA, 1% N- 
Lauroylsarcosine sodium salt solution,(20%) (Sigma) in DEPC treated H2O. Following 
prehybridisation, slides were laid flat in a humidified chamber, 100ul of digoxygenin-
labelled riboprobe was pipetted onto each slide and covered with 25mm x 60mm  glass 
coverslip. The slides were left to hybridise with the RNA probe overnight at 65ºC.
The following day, coverslips were carefully  removed by immersing the slides in 
prewarmed 5 x SSC (containing sodium chloride and sodium citrate) (Sigma). The 
following washes were undertaken to minimise background by removing excess 
unbound probes and non specifically  bound probes. Firstly slides were washed for 30 
minutes at  65ºC in a high stringency wash of 2 X SSC, 50% formamide (purum ! 98%) 
(Fluka Analytical®) in dH2O). Slides were washed 3 times for 10 minutes each at 37ºC 
in a RNAse buffer consisting of 0.5M NaCl, 10 mM  Tris-HCl pH 7.5, 5mM  EDTA, pH 
8 in dH2O. These washes optimised conditions for an enzymatic step to minimise 
background. This is done with the ribonuclease A enzyme (Rnase A) (Sigma), which 
degrades of single stranded or non specifically bound RNA. 20ug/mL of RNAse A 
enzyme was added to Rnase buffer, and the slides incubated in this solution at 37ºC for 
30 minutes. Following this, the Rnase enzyme was removed in a 15 minute wash at 
37ºC in RNAse buffer, and then washed in a high stringency wash (as above) twice for 
20 minutes each. Slides were also washed in lower stringency  washes at  37ºC for 15 
minutes each, once in 2 x SSC and once in 0.1 X SSC. Slides were washed once in 
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PBT (PBS with 0.1%Tween® 20 (BDH)) for 15 minutes at RT and left in a blocking 
solution of 10% goat serum (Goat serum donor herd) (Sigma) in PBT for a minimum of 
1 hour, to minimise non specific binding of the digoxigenin antibody.
Slides were laid out in a humidified chamber and 320ul of an anti-digoxigenin, alkaline 
phosphatase (AP) conjugate antibody (1:2000 dilution) (Roche) in 10% goat serum was 
pipetted onto each slide and covered with a Parafilm coverslipTM. Slides were left in the 
humidified chamber at 4ºC overnight, to allow the antibody to bind.
The following day, coverslips were removed and slides washed in four changes of PBT 
for 15 minutes each at RT, to remove excess unbound anti-digoxigenin antibody. Slides 
were optimised for colour development by washing twice for 10 minutes each in 
NTMT buffer (0.1M NaCl, 0.1M Tris-HCl pH 9.5, 0.05M MgCl2 (Sigma®), 0.1% 
Tween-20 in dH2O). For colour development, slides were placed in a 10% solution of 
polyvinyl alcohol (PVA) (MW 98,000, fully  hydrolysed) (Sigma®) in dH2O and the 
NBT (Roche) and BCIP (Roche) substrates added at a concentration of 2.6ul/mL and 
2ul/mL respectively. These substrates are sensitive to light, therefore the coplin jar was 
covered with tin foil and for quicker development, incubated at 37ºC. Colour 
development was checked by observing slides under a light dissecting microscope 
(Leica). Once optimum development was achieved, slides were washed in PBT until the 
PVA had washed off completely, and dehydrated through an EtOH series, 
counterstained with Eosin and cover slipped (2.6.2). Regions of published gene 
expression were used as controls for novel gene expression observed in a different 
region for the same gene. Negative controls used were slides of equivalent sections 
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hybridised to sense probes in order to assess non specific staining. Slides were 
photographed with a Nikon microscope (2.10.1).
2.7.9   Polymerase chain reaction (PCR) for sample genotyping
Polymerase chain reaction was routinely  used to identify  the genotype of Eya1 mice. 
Tissue clippings from each mouse were taken and digested in buffer. Tail clippings were 
placed in a 1.5 mL microcentrifuge tube with 200ul of direct PCR tail reagent (Peqlab) 
and 1mg/mL Proteinase K enzyme. Ear clippings were placed in a 1.5 mL 
microcentrifugetube with 100ul of direct PCR reagent (Peqlab) in 1.5mg Proteinase K 
enzyme. Tissue samples in lysis reagents were heated on a hot block at 55ºC for 3-6 
hours or overnight, and subsequently  incubated for a further 45 minutes at  85ºC. 
Digested samples were stored at -20ºC. CD1 tail clippings were used as negative 
controls for the Eya1 mutant allele, whilst previously correctly genotyped Eya1 +/- tail 
samples were used as positive controls for the mutant Eya1 allele.
For PCR, 1ul of each tissue sample was placed in a 0.5mL microcentrifuge tube (Star 
Labs) containing the reaction mixture; 0.625ul of the Eya wild type sense primer, 
0.625ul of the Eya wild type antisense primer, 0.625ul of Eya mutant antisense primer, 
6.25ul of Kappa polymerase hotstart enzyme (Promega) and 3.875ul of dH2O. All 
primers were ordered from Integrated DNA Technologies. Forward common wild type 
primer sequence (5-CAGATTTTCTGTCTGGCTCC-3), reverse wild type primer 
sequence (5–GTCGTCTGATGAAACATCATCTAT–3), and reverse mutant primer 
sequence (5–AAGGGCCAGCTCATTCCTCCCACT–3) (Xu et al., 1999). Reactions 
were set up on ice. Eppendorfs were placed in a PCR machine (G- Storm), which was 
set to a kappa2g robust program; The samples are pre-heated to 95ºC for 3 minutes. 
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Following this the samples undergo 35 cycles of incubation at 95ºC for 15 seconds 
(DNA denaturation), incubation at 60ºC for 15 seconds (primer annealing) and 72ºC for 
15 seconds (DNA extension). Once the PCR was complete, samples were placed on ice 
and sample genotyping was verified using 1% agarose gel electrophoresis (2.7.1). 
2.8   Immunohistochemistry
All immuno-histochemistry  was performed on 8um paraffin sections, mounted on glass 
slides (2.5.3). The following immunohistochemistry was performed with flourescent 
secondary  antibodies and counterstained with a flourescent nuclear dye. In detail, for 
counterstaining, slides were laid out in a humidified chamber and incubated for 10 
minutes at RT with a nuclear counterstain that binds to double stranded DNA, Hoescht 
Stain Solution (Sigma®). 200ul of flourescent stain was applied per slide, and covered 
with ParafilmTM coverslips. Slides were then washed in 4 changes of PBS for 10 
minutes each and coverslips mounted with an aqueous mounting medium 
(Mowiol®4-88) (Aldrich®). Slides were protected from light and stored at 4ºC. 
Flourescent immunohistochemistry  was visualised as described in (2.10.2). Regions of 
known expression of each protein were used as positive controls. Negative controls 
were used to identify  non specific staining. These slides were taken through the same 
immunohistochemistry procedure but without addition of the primary antibody.
2.8.1   Phospho-Histone H3 (PHH3)
PHH3 immunohistochemistry was undertaken for the detection of proliferating cells. 
Residues of histone 3 in chromatin are only  phosphorylated during the phases of 
mitosis. Therefore, an antibody which binds phosphorylated H3 is a method of detecting 
proliferating cells (Chadee et al., 1999).
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Slides were placed in a 50mL coplin jar and deparaffinised in 3 changes of 
HistoclearTMII, for 10 minutes each. Slides were rehydrated though a graded EtOH 
series (diluted in dH2O) for 10 minutes in each concentration; from 100% EtOH, 90% 
EtOH, 70% EtOH into 50% EtOH. Slides were then washed twice in PBS for 10 
minutes each, removed from the coplin jar, and submerged in a pressure cooker filled 
with 10mM sodium citrate, pH6. Slides were heated in a microwave for 20 minutes for 
antigen retrieval. The solution was allowed to cool at RT for 10 minutes and slides were 
then placed back into the coplin jar and washed for 5 minutes in PBS. Sections were 
blocked in 10% goat serum in PBS for 1 hour at RT, to minimise non specific binding of 
the primary antibody. Slides were then laid out in a humidified chamber and sections 
outlined with a wax pen (ImmedgeTM Pen, Vector) to retain the solution on the slide and 
prevent the slides from drying. The primary antibody, rabbit anti- PHH3, (Upstate Cell 
Signalling Solutions) was diluted in 10% goat serum (Sigma®) in a 1:200 dilution and 
applied to each slide, 250ul/slide. The sections were covered with a ParafilmTM 
coverslip and incubated at 4ºC overnight.
The following day, coverslips were removed, slides were placed back in the coplin jar 
and washed in 3 changes of PBS for 15 minutes each, to remove unbound primary 
antibody. Slides were laid out in a humidified chamber and 250ul of the secondary 
antibody, a goat anti-rabbit fluorophore, Alexa Fluor 568, (Invitrogen), was applied to 
each slide in a 1:400 diliution in 10% goat serum in PBS. Slides were incubated in the 
dark for 1 hour at RT and then returned to the coplin jar and washed in one change of 
PBS for 15 minutes. Slides were counterstained and mounted as detailed above (2.6.2).
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2.8.2   Sox 9
Slides were placed in a 50 mL glass coplin jar and sections deparaffinised in 3, 10 
minute washes of HistoclearTMII. Sections were rehydrated through a graded MeOH 
series (diluted in dH2O) for 2 minutes in each concentration; from 100% MeOH, 95% 
MeOH, 90% MeOH, 80% MeOH, 60% MeOH, into 30% MeOH. Slides were washed 
twice for 2 minutes each in dH2O and then incubated for 5 minutes in 50 mM Tris-HCl 
pH 7.5. Slides were permeabilised for 10 minutes in a fresh change of 50 mM Tris-HCl 
pH 7.5, containing 10ug/mL of proteinase K enzyme. Following permeabilisation, slides 
were washed in 2 changes of dH2O, for 2 minutes and then 5 minutes respectively. 
Slides were then placed in a blocking solution of 10% goat serum in PBS for a 
minimum of 1 hour, to block non specific binding of the primary antibody. Sections 
were outlined with a wax pen. Slides were laid out one by one in a humidified chamber 
and the primary antibody, Sox9 anti-rabbit, diluted in 10% goat serum in a 1:200 
dilution (Millipore), was pipetted onto each slide (250ul/slide). ParafilmTM coverslips 
were applied to each slide and the chamber sealed and incubated at 4ºC overnight.
The following day coverslips were removed and the slides washed in 3 changes of PBS 
for 15 minutes each, to remove unbound primary antibody. The secondary antibody, a 
goat anti-rabbit fluorophore, Alexa Fluor® 568 (invitrogen), was diluted in 10% goat 
serum in a 1:200 dilution. Slides were placed horizontally in the humidified chamber 
and 250ul pipetted onto each slide. Slides were covered with Parafilm coverslipsTM, and 
the chamber wrapped in foil to prevent light exposure. Slides were incubated in the dark 
at RT for 1 hour, to enable the secondary antibody to bind. After 1 hour, slides were 
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washed in 3 changes of PBS for 5 minutes each, to wash off unbound secondary 
antibody. Slides were counterstained and mounted as detailed above (2.6.2).
2.8.3   Psmad 158
The immunohistochemistry for pSmad158 and Evi1 was undertaken with a common 
protocol, incorporating the use of a Tyramide signal amplification kit (TSA kit) (Perkin 
ElmerTM), in order to produce a stronger signal. Details of primary antibodies, 
secondary antibodies, and dilutions, are listed in the table below.
Slides were deparaffinised in 2 changes of HistoclearTMII, for 15 minutes each and 
rehydrated through a graded EtOH series in dH2O; from 100% EtOH, 95% EtOH, 90% 
EtOH, 80% EtOH, 60% EtOH and into 30% EtOH, for 2 minutes each wash. Slides 
were then washed in 2 changes of dH2O for 2 minutes each, and incubated in a 0.05M 
Tris-HCl pH 7.5 for 5 minutes. Slides were permeabilised in fresh 0.05M  Tris-HCl with 
10ug/mL proteinase K enzyme for 10 minutes, and then washed in dH2O twice for 2 
minutes and 5 minutes respectively. Slides were placed in 3% H2O2 diluted in 100% 
MeOH for 30 minutes, to block endogenous peroxidases. Slides were washed in dH2O 
for 2 minutes, sections outlined with a wax pen and laid out  in a humidified chamber. 
250ul of TNB buffer; 0.1M  Tris-HCl, pH 7.5, 0.15M  NaCl and 250mg block 
(component of TSA kit) in PBS, was pipetted onto each slide, covered with a 
ParafilmTM coverslip, and left at RT for 30 minutes. The slides were drained and 200ul 
of the primary antibody diluted in TNB buffer in a 1:100 dilution was applied per slide. 
Slides were covered with a ParafilmTM coverslip and left to hybridise overnight at 4ºC.
The following day, coverslips were removed and the slides washed in 3 changes of 
TNT buffer (0.1M Tris-HCl pH 7.5, 0.15M  NaCl and 0.05% Tween-20) for 5 minutes 
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each. Slides were laid out in a humidified chamber and a secondary biotinylated 
antibody (Dako) diluted in TNB buffer in a 1:100 dilution. 200ul of the secondary 
antibody was then pipetted onto each slide. Slides were covered with a ParafilmTM 
coverslip, and incubated for 1 hour at RT. Coverslips were removed and slides washed 
in 3 changes of TNT buffer for 5 minutes each, and again laid out in a humidified 
chamber. A Streptavidin- HRP conjugate was diluted in TNB buffer (1:100) (component 
of TSA kit) and 200ul pipetted onto each slide. Slides were again covered with parafilm 
coverslips and incubated for 30 minutes at RT. Slides were then washed in 3 changes of 
TNT buffer for 5 minutes each and laid out in a humidified chamber. A Tyramide 
flourophore was diluted in amplification diluent (component of kit), and 200ul pipetted 
onto each slide. The slides were covered with ParafilmTM coverslips, protected from 
light exposure, and left to incubate at RT for 10 minutes. Slides were then washed in 3 
changes of TNT buffer and counterstained as above (2.6.2). Slides were photographed 
using confocal microscopy (2.10.2).
Table 2.3 Primary and secondary antibodies
Primary Antibody Secondary antibody
PHH3 Rabbit host antibodies.Rabbit anti- PHH3
Goat anti- rabbit 
fluorophore conjugate 
(Alexa Fluor 568) 
Sox9 Rabbit host antibodies.Rabbit anti- Sox9





Rabbit anti- pSmad 
1,5,8.
Goat anti- rabbit 
biotinylated conjugate   
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2.8.4  TUNEL Assay
TUNEL assay’s were performed using the ApoptagR Peroxidase In Situ Apoptosis 
Detection Kit (Millipore), in order to detect cells which were undergoing programmed 
cell death (apoptosis). The principle of this protocol centers around DNA fragmentation, 
a key feature of apoptosis. DNA fragmentation results in increased DNA 3’OH termini. 
These ‘free’ ends can be marked with dig-labelled nucleotides, which are catalysed to 
bind 3‘OH termini by the terminal deoxynucleotidyl transferase (TdT) enzyme. An anti-
digoxygenin peroxidase conjugate followed by addition of a peroxidase substrate are 
then used to create a colour reaction, in order to visualise where these apoptotic cells 
reside. 
Slides were deparaffinised in 3 changes of HistoclearIITM for 5 minutes each and 
rehydrated through a graded EtOH series in dH2O; 2 changes of 100% EtOH for 5 
minutes each, 95% EtOH for 3 minutes, and into 70% EtOH for 3 minutes. The slides 
were then washed once in PBS for 5 minutes and permeabilised with 20ug/mL of 
proteinase K enzyme in fresh PBS for 15 minutes. The slides were washed twice for 2 
minutes each in distilled H2O and then incubated in a blocking solution of 3% H2O2 in 
PBS for 5 minutes. Slides were again washed twice in distilled H2O for 5 minutes each 
time, and then slides were laid out in a humidified chamber. 75 ul of equilibration buffer 
(component of kit) were pipetted onto each slide. Slides were covered with a ParafilmTM 
coverslip and incubated for a minimum of 10 seconds. Equilibration buffer was drained 
off and 55ul of working strength tdt enzyme (33ul of tdt enzyme, millipore 90418, in 
77ul of reaction buffer, millipore 90417, for two slides) was applied to each slide. 
ParafilmTM coverslips were applied and the slides incubated in a humidified chamber at 
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37ºC for 1 hour. Following this the slides were placed in a coplin jar containing working 
strength stop buffer (millipore 90419 (1.47mL stop wash buffer in 50mL PBS), agitated 
for 15 seconds and incubated for a further 10 minutes at RT. Slides were then washed in 
3 changes of PBS for 1 minute each and again laid out in a humidified chamber. 65ul of 
anti-digoxygenin antibody (millipore 90420) was applied to each slide. Slides were then 
cover slipped and incubated at RT for 30 minutes. Following this, slides were washed in 
4 changes of PBS for 2 minutes each, and laid out in a humidified chamber. Colour 
development was performed using a 3, 3‘- Diaminobenzidine (DAB) substrate kit 
(Vector laboratories). A working solution was prepared by adding 2 drops of Buffer 
stock solution, 4 drops of the DAB stock solution, 2 drops of the H2O2 solution and 2 
drops of Nikel solution (for a black stain) to 5 mL distilled H2O. The staining solution 
was mixing thoroughly between each addition, and the resulting solution was protected 
form light. Slides were laid out in a humidified chamber and 250ul of the DAB 
substrate applied to each slide. Coverslips were not applied to avoid contact with DAB, 
but the humidified chamber was closed and covered in foil to minimise light exposure. 
Slides were left to develop for 5-10 minutes. Slides were occasionally observed under a 
light dissecting microscope (Leica). Apoptosis in the developing external ear canal was 
used as a positive control for apoptosis. Negative control slides were taken through the 
same protocol series but  without addition of the tdt enzyme. Following development, 
the slides were washed in 4 changes of PBS for 5 minutes each, dehydrated and 
counterstained with Alcian blue pH 3.1. Alcian blue pH 3.1 was used for a non specific 
counterstain, which facilitated visualisation of scarce apoptotic cells under a light 
microscope. Slides were dehydrated in an increasing series of EtOH, starting with 30% 
EtOH, 50% EtOH, 70% EtOH, 85% EtOH, 90% EtOH, and stained with Alcian blue 
8GX pH 3.1 (Sigma) in 0.5 % acetic acid, for 1 minute. Dehydration was continued into 
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95% EtOH and 100% EtOH. Slides were left to air dry and then mounted with DPX 
mounting medium.
2.9   Tartrate resistant acid phosphatase staining (TRAP)
TRAP staining was performed for the detection of osteoclasts and based on the protocol 
of Burstone et al., 1979. 60mL of acetate buffer, consisting of 0.2M glacial acetic acid 
(AnalaR) and 0.2M of sodium acetate (Sigma- Aldrich®) was prepared. 60mg of 
Napthol-AS-TR phosphate (Sigma) was dissolved in 300ul of N-N-Dimethylformamide 
(Sigma- Aldrich), and added to the acetate buffer. Following this 1.38g of Sodium 
tartrate (100mM final concentration) (Alfa Aesar®) and 60mg of Fast Red TR Salt 
(Sigma) was added to the acetate buffer and mixed thoroughly. The resulting solution 
was of pH 5.2.
Slides were deparaffinised in 3 changes of HistoclearIITM for 10 minutes each wash and 
rehydrated through a graded MeOH series; from 100%, 90%, 70%, 50%, 30% MeOH 
and into PBS, for 2 minutes at  each concentration. Slides were then placed in staining 
solution and incubated for 30 minutes at 37ºC. TRAP staining in bone of the mandible 
was used as a general positive control. Following colour development, slides were 
rinsed twice in dH2O, counterstained with 1% Malachite green (Sigma) for 1 minute 
and cover slipped with an aqueous mounting medium, Mowbiol (Sigma). 
2.10   Imaging
2.10.1   Slides, brightfield microscopy
Slides were routinely viewed and photographed using a Nikon Eclipse 80i microscope 
and a Nikon Digital Sight camera, under bright field.
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2.10. 2   Slides, flourescent microscopy
For flourescence, slides were routinely  viewed using a Zeiss Axioskop 2 plus and 
photographed using Axiovision software.
For higher resolution images, confocal laser scanning microscopy  (Leica TCS SP5) was 
also employed. Hoeschst was excited by the UV laser set at 10%, Alexa Flour 568 was 
excited with the DPSS 561 laser, set at 40%, and Alexa Flour 488 excited with Argon 
488 set at 40%. The region of interest was positioned in the center of field and the smart 
gain, off set, pin hole, and Z stack position values adjusted for optimum imaging. 
Objectives used included X 20 dry and X 40 oil. Images were captured using LAS AF 
acquisition software.
2.10.3   Cultures and skeletal preparations
Cultures were dissected and visualised under a Leica MZFLIII dissecting microscope 
under bright field, and photographed with a Leica DFC300 FX camera.
2.10.4   Micro Computed Tomography (Micro- CT)
Mouse heads were prepared by fixation in PFA over night at 4°C. The following day 
they were washed in PBS and scanned.
Specimens for micro- CT were scanned using a GE Locus SP micro CT scanner (GE 
Pre-clinical Imaging, London, Ontario, Canada). The specimens were immobilised 
using cotton gauze and a short scan protocol was used to produce 14um voxel size 
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volumes. The X-ray source was filtered through aluminium in order to reduce beam-
hardening artefacts. The specimens were characterised further by making three-
dimensional isosurfaces using Microview software (GE).
2.11   Quantification
2.11.1   Cell counting
Cell counting was performed using Image J software. The image to be analysed was 
opened in image J and converted to a black and white image (16- bit). The freehand tool 
was used to select the area of interest, and regions outside the area of interest were 
deleted. The image threshold was adjusted so that  cells in the area of interest were 
selected and could be distinguished as individual cells. If cells appeared merged the 
erode tool was also used, to redefine cellular boundaries. Particles were then analysed 
and the cell count  recorded. This gave a value of the total number of cells in the area. 
Due to the small number, PHH3 positive cells were counted manually. This process was 
repeated for 5 consecutive sections of the same region per sample. From these values a 
mitotic index, i.e the percentage of proliferating cells in the region, was calculated per 
section. An average mitotic index for the 5 sections was calculated per sample, and then 
an average of the mitotic index across all Eya1 +/+ and Eya1+/- samples was 
calculated. Differences between Eya1 +/+ and Eya1 +/- samples were evaluated using a 
two- tailed student’s T- test. The standard error of the mean was calculated for error 
bars. 
2.11.2   Measurement of auditory bullae size
Auditory bullae were dissected from the heads of Eya1 +/+ and Eya1 +/- mice and 
positioned on a 10mm scale micrometer ruler under a light dissecting microscope 
(Leica). Measurements for the width and length were recorded. Statistical analysis to 
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compare Eya1 +/+ and Eya1 +/- auditory bullae measurements was performed using a 
two tailed student’s T- test.
2.12  
Table 2.4  Summary Table of Eya1 +/+, Eya1 +/-, and Eya1 -/- phenotypes and 
         sample numbers
Fig. Chapter 3
numbers of ears 
with phenotype/ n
3.4, 3.6
Eya1 +/+ middle ears at stages E17.5 and older with 
a supernumerary ossicle/s 0/21
Eya1 +/- middle ears at stages E17.5 and older with a 
supernumerary ossicle/s 30/33
3.6
Eya1 +/- middle ears at stages E17.5 and older with 
an incompletely formed supernumerary ossicle/s 3/33
3.5
Eya1 +/+ malleus with articular surface hypoplasia 0/5
Eya1 +/- malleus with articular surface hypoplasia 2/7
3.9
Hypoplasia of E14.5 Eya1 +/+ malleus and incus 
articular surfaces 0/4
Mild hypoplasia of E14.5 Eya1 +/- malleus and incus 
articular surfaces 4/4
Hypoplasia of E14.5 Eya1 -/- malleus and incus 
articular surfaces 2/2
3.17
E16.5 Eya1 +/+ middle ear cultures that develop 
supernumerary ossicles in vitro 0/5
E16.5 Eya1 +/- middle ear cultures that develop 
supernumerary ossicles in vitro 3/7
3.18
E16.5 CD1 middle ears cultures with BSA soaked 
beads that develop ectopic joints or cartilage 0/5
E16.5 CD1 middle ears cultures with Noggin soaked 
beads that develop ectopic joints 1/7
E16.5 CD1 middle ears cultures with Noggin soaked 
beads that develop ectopic cartilage 2/7
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Fig. Chapter 3
numbers of ears 
with phenotype/ n
3.19
E17.5 Eya1 +/- middle ears that exhibit apoptosis in 
the ectopic joint region 0/3
3.20
E16.5 Eya1 +/- middle ears that exhibit an altered 
mitotic index from Eya1 +/+ middle ears 0/7
Fig. Chapter 4
numbers of ears 
with phenotype/ n
4.5
Normal morphology of anterior annular ligament at 
E18.5 in Eya1 +/+ middle ears 6/6
Normal morphology of anterior annular ligament at 
E18.5 in Eya1 +/- middle ears 3/3
Break in the anterior annular ligament at P0 in Eya1 
+/+ middle ears 0/4
Break in the anterior annular ligament at P0 in Eya1 
+/- middle ears 3/3
4.6
Maintenance of a break in the anterior annular 
ligament of adult (P21 or older) Eya1 +/- middle ears 10/10
Ossification of the posterior annular ligament in adult 
(P21 or older) Eya1 +/- middle ears 6/10
4.9
Apoptosis in the anterior annular ligament region in 
the E18.5 Eya1 +/- middle ear 0/3
Fig. Chapter 5




Delay in transformation of Eya1 +/+ Meckel’s 
cartilages 0/5








Otitis media in Eya1 +/+ middle ears 1/12
Otitis media in Eya1 +/- middle ears 9/14
6.6
Mesenchyme present in the adult Eya1 +/+ middle ear 
with otitis media 0/1
Mesenchyme present in the adult Eya1 +/- middle ear 
with otitis media 9/9
6.7
Mesenchyme present in the Eya1 +/+ middle ear at 
P14 0/1
Mesenchyme present in the Eya1 +/- middle ear at 
P14 1/1
6.8, 6.9
Eya1 +/+ auditory bullae measured 13
Eya1 +/- auditory bullae measured 18
6.10
Bacteria present in the Eya1 +/+ middle ear 0/4
Bacteria present in the Eya1 +/- middle ear 4/4
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3.  Joint formation in the Eya1 +/- and Eya1 -/- middle ear: The incudo-
malleal joint
3.1  Introduction
Joints can form in several ways. For example, the temporomandibular joint is formed 
through the rapid growth of the condylar process of the mandible towards the temporal 
bone, closing the distance between them to form a joint (Cate., 2008). In the limb, the 
digit anlage is separated into phalangeal segments through the formation of the 
interphalangeal joints. These joints function to enable movements of the digits (Lamb., 
2003). Similarly  in the jaw, the quadrate and articular bones are separated through the 
process of joint formation. This gives rise to the non-mammalian jaw joint, which is 
required for jaw movements (Wilson and Tucker., 2004). In the middle ear, the first two 
ossicles derive from a common cartilaginous precursor at the distal most region of 
Meckel’s cartilage (Miyake et al., 1996). Due to this common origin, these ossicles 
initially develop together as part of a combined cartilaginous complex, giving the 
appearance of a single united structure. The process of joint formation is therefore 
required to divide this complex into two individual ossicles, the malleus and the incus. 
This separation enables the malleus and incus to move independently  of each other, 
which in turn enables them to transmit sound vibrations through the ossicular chain and 
into the inner ear. Therefore, the general principle of joint formation in the limb and 
middle ear is the separation of a continuous cartilaginous tissue anlage into several 
independent structures (Fig.3.1). Joint abrogations result  in a variety  of defects 
generally  termed synostoses syndromes. The failure of joint  formation between the 
malleus and incus results in the maintenance of a fused incudo-malleal complex, 
preventing movement of the malleus and incus, and ultimately  resulting in conductive 
108
deafness (Amin and Tucker., 2006). Cartilage joint patterning is therefore integral for 
middle ear function and hearing, and ossicular synostoses are often observed in 
syndromes of craniofacial development.
One such disorder is Branchio-oto-renal syndrome (BOR), which presents with renal 
disease and deafness. In this syndrome deafness can be conductive, sensorineural, or a 
combination of both, the severity varying considerably  between individuals (Kochhar et 
al., 2007). There is therefore a spectrum of middle ear ossicle defects in individuals 
with BOR, which include ossicular hypoplasias, malformations, complete absence of 
the ossicles and hyperplasias (Ceruti et al., 2002). The latter is evidenced in several 
forms: fusions of the ossicles to the wall of the middle ear cavity, stapes fixation to the 
oval window, calcification of the oval window membrane, and the presence of ectopic 
bone that  obstructs the middle ear cavity. Fusions between the malleus and incus are 
also present, resulting in an absence of the incudo-malleal joint. The severity  of middle 
ear defects is often similar in both ears, resulting in bilateral conductive deafness (Smith 
et al., 1984; Motta et al., 1996; Worley et al., 1999; Ceruti et al., 2002). Ossicular 
malformations and synostoses are therefore causes of conductive deafness in BOR 
syndrome and most likely contribute to the overall deafness phenotype. Whilst middle 
ear operative treatment is an option for those with BOR related ossicular defects, the 
variability and complexity of malformations often results in unsuccessful outcomes 
(Motta et al., 1996). 
The process of joint formation is therefore of great clinical interest. Joint formation has 
been divided into two principle phases; the patterning of the joint regions through 
genetic specification, and the formation or cavitation of the joint region itself (Lamb et 
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al., 2003). There is a great body of research investigating joint patterning in the limb, 
which has provided a foundation for the investigation of joint formation throughout the 
body. Through these investigations, partial conservation of the genetics of joint 
formation across several structures has been revealed (Wilson and Tucker., 2004; Amin 
and Tucker., 2006; Settle Jr. et al., 2003). Studies in the mouse have revealed several 
genes that influence ossicle development (Mallo., 1998). In particular, Bmps appear to 
play  a central role for cartilage development and joint patterning (Macias et al., 1997; 
Brunet et al., 1998; Francis-west  et al., 1999), and has therefore formed a focus of this 
investigation. 
Growth differentiation factors (Gdf) form a divergent subgroup of the bone 
morphogenetic family (BMP), which have several implicated roles in cartilage and bone 
development (Storm et al., 1994). In vertebrates, this group is composed of Gdf5 
(Bmp14), Gdf6 (Bmp13), and Gdf7 (Bmp12) (Storm et al., 1994). To date, orthologues 
of Gdfs have not been identified in invertebrates, suggesting this subgroup may have 
evolved specifically  to pattern the increasingly complicated structure of the vertebrate 
skeleton (Ducy and Karsenty., 2000). Gdf5 mutations are the identified cause of the 
brachypodism mouse phenotype (bp), a mouse model for brachydactyly, characterised 
by shortened bones of the limbs (Landauer et al., 1952; Gruneberg and Lee., 1973). 
Therefore, Gdf5 has implicated roles in development of the appendicular limb 
structures. In pursuance of these early studies, Gdf5 mutations have since been 
identified as the cause of subtypes A1 and C of brachydactyly  in humans (Byrnes et al., 
2010; Polinkovsky et al., 1997), in addition to proximal symphalangia, and mutliple 
synostoses syndrome, in which limb defects are characterised by fusion of the 
interphalangeal joints (Seemann et al., 2005; Dawson et al., 2006). Genetic studies have 
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further implicated Gdf5 as a regulator of joint patterning, with expression observed in 
joints of the jaw, middle ear, and several joints of the limbs (Wilson and Tucker., 2003; 
Amin and Tucker., 2006; Settle Jr. et al., 2003). Interestingly joint defects or 
malformations of the middle ear ossicles have not been reported in the bp mouse. This 
has been accounted for by potential redundancy between the Gdf5 and Gdf6 genes, 
which are both expressed in the middle ear joints (Storm et al., 1999). Gdf5 therefore 
appears strongly affiliated with the process of joint formation across several species 
including the chick, mouse, and human, and implicates a general mechanism of joint 
formation to be conserved between various structures, with Gdf5 playing a role in joint 
specification.
 
Reverse genetic approaches with the use of mouse models has been a favourable tool 
for identifying genetic regulators of ossicle development and joint formation. Mouse 
models of the BMP family have further implicated the importance of these genes in 
middle ear development. Gdf6 null mice for example, exhibit ossicular hypoplasia, with 
malformations specifically of the articular surfaces where the ossicles connect. These 
mice however do not exhibit middle ear joint synostoses, although they do exhibit joint 
loss in the limbs (Settle et al., 2003). The Noggin gene is classically regarded as an 
inhibitor of Bmp activity  (Zimmermann et al., 1996), and for this reason may also 
influence ossicle development and joint formation. In support, Noggin heterozygous 
mice exhibit ossicular synostoses, with specific fusions between the stapes and styloid 
process. Loss of joints and fusions between all three ossicles additionally occur in the 
Noggin homozygous mice, where the ossicles appear enlarged and of abnormal 
morphology  (Hwang and Wu., 2008). It therefore appears likely  a balance of BMPs and 
their inhibitors are important for maintaining ossicle size, shape, and joint patterning.
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The underlying genetics of BOR syndrome varies, with mutations in the EYA1 gene 
present in 40% of individuals, and mutations in the closely associated RDGN members 
SIX1 and SIX5, together accounting for under 5% of cases (Abdelhak et al., 1997; Ruf 
et al., 2004; Hoskins et al., 2007). Therefore, a large proportion of cases are of 
unknown genetic etiology, suggesting there are several as yet unidentified genetic loci 
associated with BOR syndrome. Mouse models of the RDGN have implicated several 
roles for this genetic network in middle ear development. Haploinsufficient Eya1 mice 
on 129/Sv and BALB/c backgrounds exhibit severe malformations of the ossicular 
chain due to ectopic bone formation and incudo-malleal joint fusion (Xu et al., 1999). 
Six1 homozygous mice exhibit  middle ear defects, including ossicular synostoses with 
an absence of the incudo-malleal joint (Zheng et al., 2003). The Six2 null mouse has 
much milder defects, restricted to the manubrium and processus brevis of the malleus 
(He et al., 2010). In addition, absence of Eya4 causes defects of the middle ear cavity 
and the structurally associated eustachian tube (Depreux et al., 2004). Therefore, these 
studies implicate conservation of the RDGN in mammalian middle ear development, 
and suggest abrogations of other members of this genetic network may account for BOR 
syndrome. Eya1 has been previously reported to be expressed in mesenchyme of the 
middle ear and surrounding the incudo-malleal complex (Kalatzis et al.,1998; Tucker et 
al., 2004). However, how this expression correlates with a role in middle ear patterning 
has not been investigated. Similarly, whilst it appears members of the RDGN influence 
middle ear development, spatial expression analysis of other genes such as Six1 and 
Dach1, which are suggested to work closely with Eya1, is lacking. Investigations of this 
nature will elucidate potential interactions between these members, which may be 
important in ossicle development. 
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Investigation of the mechanism of joint formation has proved more elusive than joint 
formation in the limb, and it has become apparent that mechanisms are not conserved 
between the limb and middle ear (Amin et al., 2007). This suggests conserved genes of 
joint formation may function differently in both systems to create a joint. Further 
integrative studies which examine both the genetics of joint formation, and their 
contribution to the mechanisms of joint formation are therefore required. Eya1 
expression is observed in two newly formed interphalangeal joints of the limb (Xu et 
al., 1997), suggesting Eya1 may play a role in joint development. In addition, Eya1 has 
been identified as a potent regulator of cell survival, proliferation, and cell fate (Zou et 
al., 2004; Zou et al., 2006; Schlosser et al., 2008; El-Hashash et al., 2011a; El-Hashash 
et al., 2011b). It will therefore be interesting to identify the function that Eya1 may 
regulate during ossicle development and joint patterning.
Developmental studies with the use of mouse models therefore implicates the 
importance of several genes for middle ear patterning, however an integrated 
knowledge of how these signals function together is lacking. Studies investigating 
signalling pathways involved in middle ear joint formation are therefore advantageous 
for improving our knowledge of the genetics behind these syndromes. Many mouse 
models to date exhibit severe middle ear defects, making it difficult to separate primary 
and secondary consequences of the gene mutation. This study aims to use a 
haploinsufficient Eya1 mouse model of a BL6 background to elucidate the genetics of 
middle ear joint patterning. Favourably, this model exhibits a novel phenotype with 
isolated defects specifically of the middle ear joints, enabling direct identification of 
genetic regulators of the process of joint formation in the middle ear. Further elucidation 
of critical genetic networks in middle ear development is of clinical value as it can 
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reveal common genetic etiology of syndromes with a spectrum of sometimes unrelated 
phenotypes. In turn these studies may widen screens for genetic candidates of 
syndromes of conductive deafness.
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Figure 3.1. Joint formation divides cartilaginous precursors of the limb and 
middle ear. (A) The digit anlage consists of a continuous rod of cartilage. During 
development joints form to separate the anlage into phalangeal segments (arrows). (B) 
The malleus and incus form from the distal region of Meckel’s cartilage as a united 
cartilaginous complex. During development a joint forms between the complex (arrow) to 
give rise to two independent ossicles, the malleus and incus.
3.2   Results
3.2.1 Eya1 is expressed in the middle ear ossicles during embryonic development
A role for Eya1 in middle ear development has been inferred by the previously 
published phenotype of Eya1 mutant mice. These mice exhibit severe middle ear defects 
including ossicular fusions in the middle ear on various genetic backgrounds. For 
example, Eya1 +/- mice on BALB/c and 129/Sv backgrounds exhibit a supernumerary 
ossicle which sits between the malleus and incus, and fuses the two ossicles together 
into a single bony complex. Therefore on these backgrounds ossicle synostoses is 
observed (Xu et al.,1999). Gene expression analysis was therefore undertaken to 
observe the temporal and spatial expression patterns of Eya1 in the middle ear, in order 
to understand how Eya1 may function to affect ossicle development. Eya1 has 
previously  been reported to be expressed in the mesenchyme surrounding the ossicles, 
with concentrated expression adjacent to the external auditory  meatus. In this previous 
study, Eya1 expression was not observed in the ossicles during early or late embryonic 
development, suggesting an indirect role for Eya1 in ossicle development (Kalatzis et 
al., 1998). In accordance with previous studies, Eya1 expression is observed in the 
middle ear mesenchyme from E13.5 onwards, encompassing the condensing malleus 
and incus (3.2A). Mesenchymal expression is maintained at subsequent stages (E14.5 
and E16.5) and is particularly prominent in the region between the malleus and 
developing external auditory  meatus (EAM), which correlates with the vicinity  of the 
developing manubrium (3.2C and F). In contrast, Eya1 expression is also observed from 
E13.5 in the condensing mesenchyme which incorporates into the most lateral edges of 
the malleus and incus in relation to the joint region (3.2A and B). Expression is 
observed in the head of the developing malleus at E14.5 (3.2C and D), and is 
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maintained in the lateral edges furthest from the articular surfaces at E16.5 (3.2E). 
Therefore, Eya1 expression is observed in the chondrocytes of the ossicles, suggesting a 
more direct role in ossicle development. Interestingly, Eya1 expression is not observed 
in the prospective joint region at E13.5, and although diffuse expression is observed in 
the newly formed incudo-malleal joint at E14.5, this appears an indirect consequence of 
mesenchymal Eya1 expression, which surrounds the three ossicles. Expression of Eya1 
therefore does not suggest a direct role in joint development, although a direct role in 
ossicle development is inferred.
3.2.2   Members of the RDGN are expressed in the middle ear
Eya proteins are transcription factors with a primary role in gene regulation, which is 
achieved through complex interactions with other members of the RDGN (Li et al., 
2003). As a result of studies undertaken in Drosophila, a model has been proposed in 
which Eya proteins function as co-activators, and Dach proteins as co repressors, each 
protein recruiting further transcriptional activators and repressors with them 
respectively. Both proteins are unable to bind DNA directly, and are reliant on 
interactions with Six proteins that provide DNA binding function through their highly 
conserved Six domains (Li et al., 2003). It therefore seems likely a balance of Eya, Six, 
and Dach proteins function closely  together to modulate overall gene expression output. 
In the middle ear, Six1 homozygous mice exhibit classic incudo-malleal joint fusions, 
suggesting a role for Six1 in middle ear development and joint patterning (Zheng et al., 
2003). The resemblance of ossicle phenotypes in Eya1 and Six1 mutant mice may 
suggest these genes function together to regulate ossicle development and joint 
patterning. Therefore, gene expression analysis for Six1 and Dach1 in the middle ear 
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was undertaken, to investigate potential conservation of the Eya1-Six1-Dach1 network 
in ossicle development. Six1 expression is observed strongly in the newly formed 
incudo-malleal joint at E14.5, specifically in the region where the malleus and incus 
separate (3.3A). Dach1 is also expressed between the malleus and incus at E14.5, 
although is not restricted to region of incudo-malleal joint formation (3.3B). Therefore, 
Six1 and Dach1 expression overlap between the malleus and incus at E14.5 once joint 
formation has occurred, suggesting these members of the RDGN may function together 
in the joint region, in a role secondary to initial joint formation. Interestingly, Eya1 
expression does not overlap with either Six1 or Dach1, suggesting Eya1 functions 
independently of these RDGN members.
3.2.3   C57BL/6 Eya1 +/- mice exhibit middle ear ossicle defects
Eya1 +/- mice of 129/Sv and BALB/c backgrounds exhibit malformations of the 
ossicular chain that result in deafness. This includes the presence of a supernumerary 
ossicle, which in some cases fuses with the malleus and incus to create a compound 
ossicle structure. Therefore, ossicular synostoses likely contributes to the deafness 
phenotype of these mice (Xu et al.,1999). This project  analyses Eya1 +/- mice of a 
C57BL/6 background, henceforth referred to simply as Eya1 +/- mice, which have not 
been previously investigated. 
To determine the structure of the middle ear ossicles in Eya1 +/+ and Eya1 +/- middle 
ears, micro computed tomography (micro-CT) analysis was employed. By adult stages 
the malleus and incus in the Eya1 +/+ middle ear were separated by the incudo-malleal 
joint (arrow). Both ossicles had corresponding ‘V’shaped articular surfaces, which 
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formed either side of the joint (3.4C and D). These articular surfaces are important for 
ossicle function, as they enable the malleus and incus to interconnect and transfer 
vibrations to the inner ear. In contrast, the Eya1 +/- middle ear had supernumerary 
ossicle like structures, which resided in the incudo-malleal joint region, resulting in loss 
of a clear ‘V’shaped articular surface of the incus (3.4E and F).
To further analyse these supernumerary structures, ossicles from Eya1 +/+ and Eya1 +/- 
middle ears were dissected. Whilst three ossicles, the malleus, incus, and stapes, were 
identified in the Eya1 +/+ middle ear, four ossicle like structures were extracted from 
the Eya1 +/- middle ear (3.5A and B). A supernumerary structure was positioned 
between the malleus and incus, of a shape that corresponds to the groove of the malleal 
articular surface (3.5C). Closer inspection revealed the malleus and incus to have mildly 
misshapen and hypoplastic articular surfaces. This included the lenticular process of the 
incus, which articulates with the stapes (3.5D), and the articular surface of the malleus 
(3.5F). Strikingly, the incus of the Eya1 +/- middle ear completely  lacked the superior 
articular surface, which forms one arm of the corresponding ‘V’shaped articulatory 
surface (3.5D). Whilst these mice show evidence of a supernumerary  ossicle, they  do 
not exhibit incudo-malleal fusions. Instead, these mice exhibit hypoplasias, specifically 
in the articular regions of the ossicles, differing from the phenotype previously 
described in Eya1 +/- mice on the 129/Sv and BALB/c  backgrounds.
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Figure 3.2. Expression of Eya1 in the middle ear during embryonic development.  
RNA in situ hybridisation of sagittal middle ear sections, Eya1 positive regions are stained 
purple.  (A) At E13.5, Eya1 is expressed in the middle ear mesenchyme and the lateral edges 
of the developing malleus and incus, but not in the prospective incudo-malleal joint region 
(arrow). (B) Corresponding trichrome histology reveals a conjoined incudo-malleal complex 
(arrow). (C) At E14.5 Eya1 expression incorporates into the developing head of the malleus, 
and is expressed in the mesenchyme surrounding the ossicles. (D) Trichrome histology 
reveals the malleus and incus to be separated by a joint (arrow). (E and F) Eya1 expression 
in the ossicles and surrounding middle ear mesenchyme is maintained at E16.5, and is 
strongest in the region between the manubrium and external auditory meatus. (E) Plane of 
section to show the articular regions of the malleus and incus. Eya1 is expressed in the most 
lateral chondrocytes of both ossicles (arrows). (F) A more medial section to show expression 
in the head of the malleus (arrow) and strong expression adjacent to the developed 
manubrium (arrow). (M), Malleus,  (I) incus , (EAM) external auditory meatus,  (mb) 























































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.5. Eya1 +/- middle ear ossicles exhibit hypoplastic articular surfaces. (A-B) 
Dissected ossicles from the middle ear cavity of P21 Eya1 +/+ and Eya1 +/- mice. (A) The Eya1+/+ 
middle ear cavity contains three middle ear ossicles,  the malleus, the incus and the stapes. (B) The 
Eya1 +/- middle ear cavity contains an extra fourth ossicle. (C) The fourth extra ossicle is positioned 
between the malleus and incus in the middle ear cavity. (D) The Eya1 +/- incus lacks the superior 
articular surface. (E) The WT malleus exhibits a prominent ‘V’  shaped articular surface (n = 5/5 
ears). (F) The Eya1 +/- malleus exhibits hypoplastic malformed articular surfaces (n = 2/7 ears). 
(Scale bars, A and B = 200um, C- F = 100um) M, Malleus, I, Incus, S, stapes, o, extra ossicle.
3.2.4   The supernumerary ossicles form during embryonic development and derive from 
the articular surfaces of the incus.
The supernumerary ossicles are therefore present by adulthood in Eya1 +/- middle ears. 
However, to identify the stage at which these additional structures initially form, 
skeletal preparation analysis was undertaken, which enables visualisation of the initially 
cartilaginous ossicles prior to ossification. E14.5 is a critical stage during embryonic 
middle ear development, due to the formation of the incudo-malleal joint (Miyake et al., 
1996; Amin and Tucker., 2005). Therefore, the morphology of the Eya1 +/- middle ear 
was examined at  this stage, in order to investigate initiation of the incudo-malleal joint. 
At this stage however, the malleus and incus of the Eya1 +/- middle ear appeared 
indistinguishable from the malleus and incus of an Eya1 +/+ middle ear (3.6A and B). 
In addition, a clear joint region was visible between the two ossicles, indicating normal 
formation of the incudo-malleal joint (3.6B). The first evidence of abnormal 
development occurred during later stages of embryonic development at E17.5. At this 
stage a supernumerary  ossicle was observed between the malleus and incus (3.6D). 
Closer comparison of Eya1 +/+ and Eya1 +/- incudes, revealed the presence of an 
ectopic joint, which separated the supernumerary structure from the body of the incus 
(3.6F). A small proportion of middle ears exhibited only a partial joint between the 
incus and supernumerary  ossicle (3.6G). These latter instances provided evidence to 
suggest the additional ossicles were fragments of the incus itself, which corresponded to 
the articular surfaces (3.6E). Investigation of further Eya1 +/- middle ears revealed 
these structures to form from both the superior (3.7D and G), and in rarer instances, the 
inferior articular surfaces (3.7 D, E, and H), confirming these ossicles derived from the 
incus. All Eya1 +/- mice exhibited one ectopic ossicle or partially formed ossicle, 
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derived from the superior articular surface of the incus. Some individuals in addition 
possessed another extra ossicle derived from the inferior articular surface of the incus. 
As the supernumerary ossicles formed from the articular surfaces of the incus, they 
were held in position by the incuo-malleal joint capsule (3.7G and H). By  P7, ectopic 
articular cartilage developed between the body of the incus and the supernumerary 
ossicles, suggesting these fragments developed articulatory surfaces (3.8B and D). 
3.2.5 Eya1 -/- middle ears exhibit joint defects, ossicular hypoplasias, synostoses and 
ectopic cartilage
Investigation of ossicle morphology in Eya1 -/- middle ears was subsequently 
undertaken; to identify further developmental abrogations associated with loss of Eya1 
function. As Eya1 -/- mice are postnatally non-viable, analysis was restricted to 
embryonic stages. Skeletal preparation analysis revealed ossicle hypoplasia at E14.5 in 
the Eya1 -/- middle ear, specifically of the articular surfaces of the malleus and incus 
(3.9C). This hypoplasia did not recover by E18.5, identifying this defect as a permanent 
abrogation, rather than a developmental delay. By E18.5 the ‘V’shaped articular surface 
of the malleus remained absent, and the articular surfaces of the incus were 
indistinguishable (3.9H and I). The body  of the incus was fused with the developing 
wall of the middle ear cavity, and ectopic cartilage spanned the cavity of the middle ear. 
The processus brevis of the malleus was malformed, and composed of an excess of 
cartilage. Whilst inner ear structures appeared grossly normal in Eya1 +/- mice, the 
Eya1 -/- inner ear appeared immature and smaller in size, resembling a much earlier 
stage of otic vesicle development (3.9F). Therefore, the phenotype of Eya1 -/- middle 
ears are more severe, marked by ossicular hypoplasia, fusions, and the presence of
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Figure 3.6. The Eya1 +/- supernumerary ossicle forms during embryonic 
development at E17.5. Skeletal preparations of embryonic middle ear ossicles. (A) An 
E14.5 Eya1 +/+ malleus and incus exhibiting normal morphology (n = 8/8 ears). (B) 
The Eya1 +/- malleus and incus resemble the morphology of the Eya1 +/+ ossicles at 
E14.5 (n= 5/5 ears) (C) The Eya1 +/+ malleus and incus at E17.5 exhibiting normal 
morphology (n = 11/11 ears) (D) An extra joint is visible at E17.5 in the Eya1 +/- 
middle ears (n = 19/19 ears). An ectopic joint separates the extra ossicle from the body 
of the incus (Arrow). (E-F) Higher magnifications of incudes of Eya1 +/+ and Eya1 +/- 
middle ears. (E) The superior articular surface of the Eya1 +/+ incus remains attached 
to the body of the incus (arrow) (n = 11/11 incudes). (F) An ectopic joint is observed 
between the superior articular surface and the body of the incus,  giving rise to an 
independent ossicle (arrow) (n = 16/19 incudes). (G) The extra ossicle in this Eya1 +/- 
middle ear has not separated completely from the body of the incus (arrow) (n= 3/19 
incudes). (Scale bars, A and B, 200um, C - G,  100um) M,  malleus,  I,  incus, MC, 
Meckel’s cartilage, o, extra ossicle. 
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Figure 3.7. Extra ossicle like structures of the Eya1 +/- derive from the incus. (A-E) 
Skeletal preparations of the middle ear ossicles at E17.5. (A) The Eya1 +/+ malleus and incus. 
Arrow points to the superior articular surface of the incus (B) An Eya1 +/- incus exhibits an extra 
ossicle like structure,  in the process of separating from the incus.  In this middle ear, the extra ossicle 
does not appear as an independent structure and remains attached to the incus (arrow). (C) An Eya1 
+/+ incus with attached superior and inferior articular surfaces (arrows). (D) An Eya1 +/- incus with 
an extra ossicle formed from the inferior articular surface (arrow) (n = 2/19 incudes) . (E) An Eya1 
+/- incus with an incompletely separated extra ossicle from the inferior articular surface (n = 1/19 
incudes). (F-H) Trichrome histology of  P21 sagittal middle ear sections. (F) The malleus and incus 
of an Eya1 +/+ middle ear.  Arrows point to superior and inferior articular surfaces. (G) An extra 
ossicle formed from the superior articular surface of an Eya1 +/- incus. The extra ossicle is held in 
place by the ligament capsule (arrowheads) (H) An extra ossicle formed from the inferior articular 
surface of an Eya1 +/- incus. The extra ossicle is held in place by the ligament capsule (arrowheads) 
(Scale bars) 200!m. MC, Meckel’s cartilage, M,  malleus,  I, incus, o, extra ossicle, ss, superior 
articular surface, is, inferior articular surface.
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Figure 3.8. The Eya1 +/- extra ossicle develops an articular surface by adult 
stages.  (A-B) Skeletal preparations and (C-D) trichrome histology of Eya1 +/+ and 
Eya1 +/- P7 incudes. (A and C) The Eya1+/+ incus has cartilaginous articular surfaces 
(arrow). (B and D) The Eya1 +/- extra ossicle develops ectopic articular cartilage, 
which gives rise to an articular surface between the body and superior articular surface 
of the incus (arrow). Scale bars (A-B) 100!m, (C-D) 200!m.
ectopic cartilage. Interestingly, despite this increased severity  of abrogation, the Eya1 -/- 
middle ear exhibited a supernumerary ossicle and ectopic joint, which resembled the 
phenotype of Eya1 +/- middle ears (3.9F). However, due to the diverse phenotype, and 
postnatal inviability of Eya1 -/- mice, further analysis of middle ear development 
focused on Eya1 +/- mice. The milder, isolated joint, and articular surface phenotypes, 
made Eya1 +/- mice a preferable model system for the investigation of middle ear joint 
development. In addition, haploinsufficiency of the Eya1 gene underlies BOR 
syndrome.
3.2.6   Gdf5 is misexpressed in the prospective ectopic joint region
The supernumerary  ossicles observed in the Eya1 +/- middle ears morphologically 
appeared as products of ectopic joint formation. Therefore, to determine whether the 
supernumerary ossicle formed through a process genetically  resembling joint formation, 
gene expression analysis was undertaken. Gdf5 is a regulator of joint formation in the 
middle ear, which is expressed in chondrocytes of the prospective incudo-malleal joint 
region at E13.5, and in turn in the newly formed joint (Amin and Tucker., 2006; Tucker 
et al., 2004). Gdf5 expression therefore delineates the region where the future incudo-
malleal joint will form. To determine whether the supernumerary  ossicles form as a 
result of an ectopic mechanism of joint formation, in situ hybridisation of Gdf5 was 
undertaken at E16.5, the stage which precedes formation of the supernumerary ossicles. 
In the Eya1 +/+ middle ear, Gdf5 was expressed in one stripe between the malleus and 
incus, in the formed incudo-malleal joint (3.10A). In the Eya1 +/- middle ear however, 
two stripes of Gdf5 expression were observed, one which corresponded to the incudo-
malleal joint and another stripe expressed between the superior articular surface and the 
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body of the incus (3.10B). More medial regions of the middle ear revealed two stripes 
of ectopic Gdf5 expression, which separated the body of the incus from the superior and 
inferior articular surfaces respectively (3.10D). These additional stripes of Gdf5 
expression corresponded with the regions of ectopic joint formation. Gdf5 continued to 
be expressed in the newly formed ectopic joints at E17.5 (3.11B and D). 
Following incudo-malleal joint formation, cells in the joint region no longer express 
genes associated with cartilage such as Sox9, and alter from a rounded cartilaginous 
appearance to cells of mesenchymal histology (Amin and Tucker., 2006). To verify that 
Gdf5 expression occurs in the prospective ectopic joint region, Sox9 immuno-
histochemistry  was undertaken. At E16.5, Sox9 was expressed in all chondrocytes of the 
incus, including the region that corresponded to ectopic Gdf5 expression (3.12B), 
resembling Sox9 expression in the Eya1 +/+ middle ear (3.12A). Following ectopic joint 
formation, this region no longer expressed Sox9, indicating these cells were no longer 
cartilaginous (3.12D). At this stage, the incus of the Eya1 +/+ middle ear uniformly 
expressed Sox9 (3.12C). Therefore, Sox9 expression at E16.5 in the Eya1 +/- incus 
confirms Gdf5 expression in the prospective ectopic joint region, which at that  stage is 
composed of chondrocytes. This ectopic expression corresponds to the region of the 
incus where the ectopic joint will form at the next developmental stage.
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Figure 3.9. Eya1 -/- middle ear ossicles appear hypoplastic during early development 
but exhibit ectopic cartilage by later embryonic stages. Skeletal preparations of Eya1 +/
+, Eya1 +/- and Eya1 -/- middle ears. (A) An Eya1 +/+ malleus and incus exhibiting normal 
morphology of articular surfaces at E14.5 (arrows) (n = 4/4 ears). (B) The Eya1 +/- malleus 
and incus is of normal morphology at E14.5, although articular surfaces appear mildly 
hypoplastic (n = 4/4 ears) (arrows).  (C) The Eya1 -/- malleus and incus have hypoplastic 
articular surfaces at E14.5 (arrows). The body of the incus also appears hypoplastic (n = 2/2 
ears). (D) An E18.5 Eya1 +/+ malleus, incus and inner ear of normal morphology. Arrow 
points to the processus brevis of the malleus (n = 6/6) (E) The Eya1 +/- middle ear exhibits 
an extra ossicle at E18.5.  The inner ear morphology resembles the Eya1 +/+ (n = 4/4 ears). 
(F) The Eya1 -/- incus exhibits an ectopic joint, and the malleus exhibits hypoplastic 
articular surfaces. The body of the incus is fused with the developing auditory bulla. Ectopic 
cartilage obstructs the middle ear cavity and the inner ear is developmentally immature (n = 
2/2 ears). (G) An Eya1 +/+ malleus to show normal morphology of the malleal processus 
brevis (arrow). (H) The Eya1 -/- malleus exhibits a malformed processus brevis (arrow). (I) 
The Eya1 -/- incus exhibits hypoplastic articular surfaces (arrow) and is fused to cartilage of 
the auditory bulla. (Scale bars 200!m). Meckel’s cartilage MC,  M, malleus, I, incus,  S, 
stapes, o, extra ossicle,  eb, ectopic bone, pb,  processus brevis, OV, otic vesicle, AB, 
auditory bulla.           
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Figure 3.10. Gdf5 is misexpressed in the prospective ectopic joint region at 
E16.5. Gdf5 RNA in situ hybridisation on sagittal middle ear sections at E16.5. Regions 
of gene expression stain purple. (A and B) Planes of sections to show articulation of the 
malleus and incus.  (C and D) More medial sections to show the superior and inferior 
articular surfaces of the incus. (A and C) In Eya1 +/+ middle ears, Gdf5 is expressed in 
one stripe between the malleus and incus in the incudo-malleal joint. (B and D) Gdf5 is 
ectopically expressed in the prospective ectopic joint regions, between the articular 
surfaces and the body of the incus (arrows). The dotted line in (C) demarcates the 
equivalent region in the Eya1 +/+ (Scale bars 100!m). M,  malleus, I,  incus, ss,  superior 
articular surface, is, inferior articular surface. 
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Figure 3. 11. Gdf5 remains misexpressed in the newly formed ectopic joint at 
E17.5 in  Eya1 +/- middle ears. Gdf5 RNA in situ hybridisation of E17.5 sagittal middle 
ear sections. Regions of gene expression stain purple. (A and B) Planes of sections to show 
articulation of the malleus and incus. (C and D) More medial sections to show the superior 
and inferior articular surfaces of the incus. (A and C) In the Eya1 +/+, Gdf5 remains 
expressed in one stripe at E17.5 in the incudo-malleal joint between the malleus and incus. 
(B and D). Gdf5 remains misexpressed in the newly formed ectopic joint. By E17.5 joints 
have formed between the superior and inferior articular surfaces and the body of the incus 
(arrows). The dotted line in (C) demarcates the equivalent region in the Eya1 +/+ (Scale 
bars 100!m). M, malleus, I, incus,  ss,  superior articular surfaces, is, inferior articular 
surface.
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Figure 3.12.  The prospective ectopic joint region remains cartilaginous at 
E16.5 in Eya1 +/- middle ears. Sox9 immunohistochemistry on sagittal middle ear 
sections. Sox9 positive regions appear pink. (A) The Eya1 +/+ incus at E16.5 is formed 
of Sox9 positive chondrocytes. (B) At E16.5 all chondrocytes of the incus including 
the prospective ectopic joint region, remain Sox9 positive in Eya1 +/- middle ears, an 
indication that this region is cartilaginous. (C) At E17.5 the Eya1 +/+ incus is 
composed entirely of Sox9 positive chondrocytes. (D) At E17.5, the ectopic joint in the 
Eya1 +/- middle ear has formed, indicated by loss of Sox9 positive chondrocytes in 
this region (arrow).(Scale bars). M, malleus, I, incus, o, ectopic ossicle.   
To further understand the genetics of supernumerary ossicle formation, other genes 
associated with middle ear joint development were then investigated. As observed at 
E14.5, Six1 is expressed in the newly  formed incudo-malleal joint. Similarly, Gdf6 is 
expressed in the middle ear joints once formed, loss resulting in hypoplastic articular 
surfaces of the ossicles (Settle et  al., 2003). Therefore, to determine if ectopic joint 
formation mirrors subsequent stages of incudo-malleal joint development, in situ 
hybridisation for Six1 and Gdf6 expression was undertaken. At E17.5, Six1 and Gdf6 
expression was observed in the formed incudo-malleal joint in Eya1 +/+ middle ears 
(3.13A and C). In Eya1 +/- middle ears however, Six1 and Gdf6 expression was 
additionally observed in the newly formed ectopic joint (3.13B and D). It therefore 
appears the supernumerary  ossicles in Eya1 +/- middle ears form due to an ectopic 
recapitulated process of joint formation in the incus, genetically mirroring incudo-
malleal joint formation. 
3.2.7   Bmps and Noggin are expressed in the articular surfaces of the ossicles
The expression patterns of Gdf5 and Gdf6 during middle ear development implicate 
direct roles for these divergent members of the Bmp family  in joint formation and 
maintenance. Other Bmps are also known to be expressed in the middle ear (Amin and 
Tucker., 2006; Hwang and Wu., 2008), and Bmps have integral roles in cartilage 
development and joint formation (Reddi et al. 2003; Francis-West  et al., 1999). 
Therefore In order to investigate general Bmp activity during embryonic development, 
immunohistochemistry  for phosphorylated Smads 1,5 and 8 (pSmads1,5,8), downstream 
effector molecules for Bmp signalling, was undertaken. At E16.5 pSmads1,5,8 were 
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expressed in the ossicles, specifically in the articular surfaces of the incus and malleus. 
Interestingly, pSmads1,5,8 were completely  absent from the joint regions, and 
expression pattern differences between Eya1 +/+ and Eya1 +/- ossicles were not 
observed (3.14A and B). However, pSmad 1,5,8 expression suggests a role for the Bmps 
in ossicle articular surface development.   
Bmp inhibitors, such as Noggin, are integral for negative regulation of Bmp signalling 
(Rosen et al., 2006). Loss of Noggin causes ectopic cartilage development and ossicular 
synostoses in the middle ear (Hwang and Wu., 2008). Therefore, a balance of Bmps and 
Bmp inhibitors likely play a role in middle ear joint and articular surface development. 
To investigate the expression of Noggin in the middle ear ossicles, RNA in situ 
hybridisation was undertaken. At E16.5 Noggin was expressed in the chondrocytes of 
the ossicles, particularly in the articular surfaces of the malleus and incus (3.15A). 
Expression differences of Noggin were not observed in the Eya1 +/- middle ear (3.15B). 
The expression pattern of Noggin resembled that of pSmad1,5,8, implicating Bmp 




Figure 3.13. Six1 and Gdf6 are expressed in the newly formed ectopic joints at 
E17.5 in Eya1 +/- middle ears.  Six1 and Gdf6 RNA in situ hybridisation on E17.5 
sagittal middle ear sections. Regions of gene expression stain purple (A) Six1 is 
expressed in one stripe in the incudo-malleal joint between the malleus and the incus. 
(B) Six1 is expressed in the newly formed ectopic joint in Eya1 +/- middle ears at E17.5 
(arrow). (C) Gdf6 is expressed in one stripe in the incudo-malleal joint between the 
malleus and the incus. (D) Gdf6 is expressed in the newly formed ectopic joint in Eya1 
+/- middle ears at E17.5 (arrow). The dotted line in (C) demarcates the equivalent 



































































































































































































































































































































































































































































































3.2.8  Gdf5 and Noggin expression are not lost in Eya1 -/- middle ears
To investigate potential genetic epistasis between Eya1, Gdf5, and Noggin, in situ 
hybridisation for these genes was undertaken in Eya1 -/- mice. In the Eya1 +/+ middle 
ear, a defined stripe of Gdf5 expression was observed in the incudo-malleal joint 
(3.16D). Whilst Gdf5 expression was not lost in Eya1 +/-  or Eya1 -/- middle ears at 
E14.5, expression gradually  appeared more diffuse. In Eya1 +/- middle ears, expression 
was largely confined to the incudo-malleal joint  region (3.16E), however expression in 
Eya1 -/- middle ears was less restricted and spanned the joint region and articular 
surface of the incus (3.16F). A gradual loss of ‘V’shaped articular surface definition of 
the malleus and incus can also be seen in Eya1 +/- and Eya1 -/- middle ears 
respectively, in comparison to the Eya1 +/+ malleus and incus (3.16G, H, and I). This 
gradual loss of articular surface definition may correspond with the gradual loss of Gdf5 
restriction to the joint. 
Noggin is expressed in the chondrocytes of the malleus and incus at E14.5 in Eya1 +/+ 
middle ears, but is devoid from the incudo-malleal joint regions (3.16J and M). 
However, differences of Noggin expression are not observed in Eya1 +/- or Eya1 -/- 
middle ears (3.16 K,N,L and O). These results suggest that whilst Eya1 may regulate 
the spatial expression pattern of Gdf5, Eya1 is not required for induction of Gdf5 or 
Noggin expression.
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3.2.9   Eya1 +/- incudes develop extra ossicles in vitro but exhibit variability
An in vitro culture approach was subsequently  employed, with the aim of investigating 
gene function in middle ear development, through rescue of the Eya1 +/- phenotype 
with exogenous protein manipulations. The first  objective was therefore to devise a 
culture system that supported growth of the Eya1 +/- middle ear. Ossicles were cultured 
from E16.5 middle ears for seven days, and skeletal preparation analysis undertaken to 
visualise incus morphology. Following culture, all Eya1 +/+ cultures developed normal 
superior and inferior articular surfaces of the incus. In contrast, 43% of Eya1 +/- 
incudes developed supernumerary ossicles (3.17C and D). Whilst this culture system 
supported development of these extra ossicles, the majority (57%) of Eya1 +/- incus 
cultures developed normally, and resembled Eya1 +/+ incudes. In vivo, all Eya1 +/- 
middle ears analysed possessed at least one supernumerary ossicle, therefore in vitro 
development of all Eya1 +/- incudes did not resemble in vivo development consistently.
3.2.10   Exogenous Noggin induces loss of cartilage and gain of ectopic cartilage in 
 CD1 wild type middle ears 
Due to the variability of in vitro development of Eya1 +/- middle ear cultures, an 
alternative approach was adopted. Instead, wild type CD1 middle ears were cultured in 
the presence of an exogenous source of 100ug/mL of Noggin protein. This experiment 
was based on the hypothesis that if loss of Noggin causes a loss of joints in vivo (Brunet 
et al., 1998; Hwang et al.,2008), an exogenous source of Noggin in vitro might cause 
the formation of ectopic joints. Middle ears were cultured for seven days with either 
100ug/mL of BSA control beads or 100ug/mL Noggin beads, placed in the vicinity  of 
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the developing incus. Middle ears in the presence of BSA developed normally  (3.18B 
and C), however cultures exposed to a source of Noggin exhibited both loss and gain of 
cartilage. Specifically a large region of cartilage was missing from the body  of the 
malleus (3.18E and F), which may be considered an ectopic joint. Additionally, ectopic 
cartilage also developed in the region of the malleus and incus, fusing these ossicles 
with the wall of the developing middle ear cavity (3.18H and I). A large majority of 
cultures however developed normally, and resembled BSA treated control cultures. 
Therefore, whilst Noggin is able to induce joint like structures and the formation of 
ectopic cartilage in vitro, middle ears of a CD1 background also exhibit high variability 
to treatment with the Noggin protein.
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Figure 3.16. Gdf5 and Noggin expression is not lost in Eya1 -/- middle ears. 
(A-C) Skeletal preparations of E14.5 Eya1 +/+, Eya1 +/- and Eya1 -/- middle ears, as 
described in figure 9. (D- I) RNA in situ hybridisation of Gdf5 on E14.5 sagittal 
middle ear sections. Regions of gene expression appear purple. (D and G) Gdf5 is 
expressed in the joint between the malleus and incus at E14.5 in the Eya1 +/+ middle 
ear.  (E) Gdf5 is expressed in the incudo-malleal joint at E14.5 although appears 
diffuse in the Eya1 +/- middle ear (H) The ‘V’ shaped articular surfaces between the 
malleus and incus appear less prominent (arrow). (F) Gdf5 expression is diffuse and 
is not restricted to the incudo-malleal joint region in the Eya1 -/- middle ear. (I) The 
malleus and incus lack the ‘V’ shaped articular surface (arrow). (J-O) RNA in situ 
hybridisation of Noggin on E14.5 sagittal middle ear sections. (J and M) Noggin is 
expressed in the chondrocytes of the ossicles. Strong Noggin expression is observed 
in the medial borders of the ossicles adjacent to the incudo-malleal joint. (K and N) 
The expression of Noggin in the Eya1 +/- middle ear resembles expression in Eya1 
+/+ middle ears and is expressed in the chondrocytes of the ossicles. (L and M) 
Noggin expression is unaltered in Eya1 -/- middle ears and is also observed in the 
chondrocytes of the ossicles, with strong expression in the borders adjacent to the 
incudo-malleal joint. (Scale bars = 100!m). MC,  Meckel’s cartilage, M, malleus, I, 
incus, s, stapes, pb, processus brevis.
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Figure 3.17. E16.5 Eya1 +/- middle ear cultures develop extra ossicles 
in vitro.  E16.5 incudes cultured for 7 days, followed with skeletal preparation 
treatment for visualisation.  (A) Parasagittal view of an Eya1 +/+ incus, to show 
the superior and inferior articular surfaces. (B) A sagittal view of an Eya1 +/+ 
incus to show the superior articular surface.  (C) An Eya1 +/- culture that 
developed an extra ossicle and joint, formed from the inferior articular surface. 
(D) An Eya1 +/- culture with an ectopic ossicle in the process of separating 
from the body of the incus. (E) A graph to show the percentage of Eya1 +/+ and 
Eya1 +/- cultures which developed an extra ossicle in vitro. Total Eya1 +/+ ears 
n= 5, total Eya1 +/-  ears n = 7. (Scale bars 200!m). ss, superior articular 
surface, is, inferior articular surface.  
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Figure 3.18. An exogenous source of Noggin protein induces ectopic loss and 
gain of cartilage in CD1 WT middle ears. E16.5 CD1 middle ears cultured for 7 days 
in the presence of exogenous BSA or Noggin (100ug/mL). (C,F and I) Skeletal 
preparation of cultures for visualisation. (A,B and C) CD1 middle ears cultured with 
BSA, developed normally in vitro (n = 5/5 ears). (D, E and F) CD1 middle ear cultured 
with exogenous Noggin protein developed a loss of cartilage/joint in the body of the 
malleus (n = 1/7 ears).  (G,H and I) A CD1 middle ear cultured with Noggin developed 
ectopic cartilage in the middle ear cavity (n = 2/7 ears). Scale bar (200!m).MC, 
Meckel’s cartilage, M, malleus, I, incus.
3.2.11   Apoptosis is not observed in the region of ectopic joint formation
A discrete population of cells undergo apoptosis in the incudo-malleal joint at E13.75, 
and after the joint has formed at E15.5. However, as inhibition of apoptosis in vitro and 
in vivo does not affect formation of the incudo-malleal joint, the exact contribution of 
this process to joint development remains elusive (Amin et al., 2007). To investigate 
whether ectopic joint formation in the Eya1 +/- middle ear recapitulates this feature of 
cell death, TUNEL analysis following joint formation at E17.5 was undertaken. A few 
TUNEL positive cells were observed in the ectopic joint region (3.19B), suggesting cell 
death may contribute to the process of joint formation. Increased cell death in the Eya1 
+/- middle ear mesenchyme in comparison to Eya1 +/+ middle ears was also observed.
 
3.2.12    Proliferation is not altered in Eya1 +/- incudes
Eya1 has been previously associated with roles in proliferation (Schloss et al., 2008; El- 
Hashash et al., 2012). To investigate a potential difference in proliferation of the 
incudes of Eya1 +/+ and Eya1 +/- middle ears, phospho histone H3 (PHH3) 
immunohistochemistry  was undertaken. Histone H3 (HH3) is a core histone protein 
which is phosphorylated only during the stages of mitosis, therefore immuno detection 
of PHH3 is indicative of active proliferation (Chadee et al., 1999). Using this method, 
proliferation was detected in both Eya1 +/+ and Eya1 +/- incudes, although a significant 
difference in the mitotic indices between Eya1 +/+ and Eya1 +/-  was not found. In 
addition, proliferation was not observed in the ectopic joint region (3.20A and B). 
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Figure 3.19. A few cells undergo apoptosis in the ectopic joint region. TUNEL assay for cell 
death on E17.5 sagittal middle ear sections. TUNEL positive regions appear black. (A) Apoptosis does 
not occur in the articular region of the incus in Eya1 +/+ middle ear (red box) (n = 3). (C) Magnified 
view of the red box in (A). (B) A few cells undergo apoptosis in the newly formed ectopic joint at 
E17.5 in the Eya1 +/- middle ear (red box). Increased cell death can also be observed in the 
mesenchyme (arrows), (n = 3 ears)(Scale bars 100!m). (D) Magnified view of the red box in (B). A 





















Figure 3.20. Eya1 +/- incudes do not possess significant proliferation differences from 
Eya1 +/+ incudes. PHH3 positive cells appear red (A-B) PHH3  immunohistochemistry on 
E16.5 sagittal middle ear sections. PHH3 positive cells (red) are observed in the chondrocytes 
of the Eya1  +/+ (A) and Eya1 +/- incudes (B).  (C) Graph to show the mitotic indices of Eya1 
+/+ and Eya1  +/- incudes. significant differences between Eya1 +/+ and Eya1 +/- incudes 
were not  found. Eya1 +/+ incudes n= 5, Eya1 +/- incudes n=7. (Scale bar 100!m). M, 
malleus, I, incus.
3.3   Discussion
3.3.1   The Eya1 +/- mouse model; a tool for understanding joint formation in the 
middle ear
Whilst several mouse models exhibit joint fusions and ossicular synostoses, the C57BL/
6 Eya1 +/-  mouse is the first model to date that instead exhibits ectopic joints in the 
middle ear. In this model, supernumerary ossicles form from the articular surfaces of the 
incus due to an ectopic process of joint development, implicating a role for Eya1 in 
middle ear joint patterning. Interestingly, Eya1+/- mice of BALB/c and 129/Sv 
backgrounds also possess a supernumerary  ossicle, which lies between the malleus and 
incus. Inferred from this project, it  is likely this ossicle also corresponds to the superior 
articular surface of the incus. In contrast however, in Eya1+/- mice of these 
backgrounds, the supernumerary ossicle appears fused with the malleus and incus in a 
large ossicular complex. The malleus is additionally fused to the wall of the middle ear 
cavity, and loss of ossicle definition further suggests the presence of ectopic bone (Xu et 
al., 1999). The phenotypic differences between Eya1 mice of different strains reveal the 
importance of genetic background for the expressivity of the Eya1 mutation. For 
example, loss of Eya1 on the BALB/c and 129/Sv backgrounds result in fusions of the 
malleus and incus, which appear to be a result of ectopic cartilage development. In 
contrast, on the BL/6 background loss of Eya1 results in ectopic joint formation 
between the body of the incus and articular surfaces. In the BL/6 Eya1 +/- mice ectopic 
cartilage formation and joint synostosis are absent and the incudo-malleal and incudo-
stapedial joints appear of normal morphology. This novel phenotype therefore indicates 
the BL/6 Eya1 +/- mice as the preferential background to investigate joint formation in 
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the middle ear. Indeed, there is a spectrum of middle ear defects in individuals with 
BOR syndrome, most likely  due to genetic heterogeneity. Further, the presence of joint 
fusions and formation of ectopic joints could be viewed as abrogations of the same 
developmental mechanism; a loss or gain of joints which arise due to abrogated 
cartilage development. Interestingly, the supernumerary ossicles develop their own 
corresponding articular surface, suggesting joint and articular surface development are 
consequences of a common developmental program. In support of this, Eya1 +/- and 
Eya1 -/- middle ear ossicles additionally exhibit hypoplastic articular surfaces. The 
isolated joint and articular surface phenotypes make the C57BL/6 Eya1 +/- mouse an 
ideal tool to investigate the genes and mechanisms which influence joint  development 
in the middle ear.
3.3.2   Genes of middle ear joint development
3.3.2.1   The RDGN: Eya1, Six1, and Dach1
In agreement with previous studies (Kalatzis et al., 1998; Tucker et al., 2004), Eya1 
expression is observed in the middle ear mesenchyme and the mesenchyme surrounding 
the ossicles, implicating a role in middle ear development. However, as Eya1 encodes a 
transcription factor, expression of Eya1 in the mesenchyme alone suggests an indirect 
role in ossicle morphogenesis. In this study, expression of Eya1 is additionally observed 
in chondrocytes of both the malleus and incus, implicating a direct role for Eya1 in 
ossicle development. Interestingly, whilst Eya1 is expressed in the lateral edges of the 
developing malleus and incus, Eya1 is not expressed in the prospective or newly formed 
incudo-malleal joint  region, suggesting a more indirect role in joint formation. 
Nevertheless, loss of Eya1 results in ossicular fusions in individuals with BOR 
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syndrome, suggesting Eya1 influences ossicle joint patterning (Worley et al., 1999; 
Ceruti et al., 2002). It has often been assumed that incudo-malleal fusions form as a 
result of failed incudo-malleal joint initiation during early stages of embryonic 
development. Interestingly the Eya1 +/- and  Eya1 -/- middle ears, exhibit normally 
formed incudo-malleal joints at E14.5, despite ossicular hypoplasias, suggesting ossicle 
fusions observed in BOR syndrome are consequences of later developmental defects, as 
opposed to a failure of incudo-malleal joint initiation. This is additionally supported by 
the later fusions and ectopic cartilage observed at E18.5 in Eya1 -/- middle ears. 
Interestingly  the Six1 and Noggin mutant mice, which also exhibit incudo-malleal 
fusions, have only been examined at stages following incudo-malleal joint formation 
(Zheng et al., 2003; Hwang and Wu., 2008). Therefore joint initiation in these mouse 
models is yet to be investigated. The diversity of the ectopic joint, cartilage, and fusion 
phenotypes caused by Eya1 mutations across the C57BL/6, 129/Sv, and BALB/c 
backgrounds, and the ectopic joint and cartilage phenotypes observed in the Eya1 -/- 
mice of the C57BL/6 background, suggest Eya1 may play a more general role in 
regulating cartilage development, rather than a role in joint formation per se. 
Abrogations of cartilage development in Eya1 +/- mice may therefore result  in ossicle 
joint patterning defects as a secondary consequence. Eya1 expression in both 
mesenchymal and cartilaginous components of the middle ear, would further suggest 
multiple roles for Eya1 during these dynamic stages of middle ear development. Stage 
specific roles may be further inferred from the large variability of phenotypes observed 
following culture of the Eya1 +/- middle ears in vitro.
Expression of Six1 in the incudo-malleal joint region, in addition to the joint fusions 
observed in the Six1-/- mice (Zheng et al., 2003), suggest a role for Six1 in joint 
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development. In addition, the expression of Dach1 in the formed incudo-malleal joint 
shows conservation of the RDGN in middle ear development. Whilst diffuse expression 
of Eya1 is observed in mesenchyme of the joint  region, this seems an indirect effect of 
mesenchymal Eya1 expression, and strong expression resembling Six1 and Dach1 in the 
joint regions is not observed. Therefore, whilst members of the RDGN appear to be 
conserved in embryonic middle ear development, Eya1 may  function independent of 
classical Eya1- Dach1- Six1 interactions in joint development.
3.3.2.2   Gdf5 
It has long been established that bp mice exhibit shortened, hypoplastic phalanges, 
accompanied by the absence or fusion of interphalangeal joints (Landauer., 1952; 
Gruneberg and Lee., 1973). In addition, indirect loss of Gdf5 expression in the chick 
jaw corresponds with fusions of the jaw joint, implicating a conserved role of Gdf5 in 
jaw joint development (Wilson and Tucker., 2004). These studies therefore suggest 
direct roles for Gdf5 in joint development. Consequently, it  could be hypothesised that if 
loss of Gdf5 function results in an absence of joints, ectopic expression will result in the 
formation of ectopic joints. However, investigations of Gdf5 function during limb 
development, have yielded conflicting results. For example, increase of Gdf5 expression 
by application of an exogenous source in vitro, instead results in the formation of 
ectopic cartilage, and the fusion of interphalangeal joints in mouse and chick limb 
cultures (Merino et al., 1999; Storm et al., 1999; Tsumaki et al., 1999; Francis-West et 
al., 1999). Therefore, whilst these results support a role for Gdf5 in cartilage 
development, the nature of a role for Gdf5 in joint patterning and development remains 
unclear.
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Additionally  in humans, Gdf5 mutations result in several syndromes, depending on 
whether the mutation causes a gain or loss of Gdf5 function. Gdf5 gain of function 
mutations result in multiple synostoses syndrome, characterised by loss, or fusions of 
the interphalangeal joints (Dawson et al., 2006). Therefore, in vivo gain of function 
mutations also do not result in ectopic limb joints in humans. In addition, mutations that 
cause loss of Gdf5 function, result in brachydacyly  types A1 and C, characterised by 
shortened digits of the hand without alterations of the interphalangeal joints (Byrnes et 
al., 2010; Polinkovsky et al., 1997). Therefore, it would appear whilst gain of function 
mutations result in a loss of joints, loss of Gdf5 function does not affect joint formation. 
These results may therefore suggest that Gdf5 does not function in the process of limb 
joint formation directly, but  rather functions to regulate cartilage development. In 
support, Gdf5 has been proposed to promote chondrogenesis in a paracrine fashion, 
signalling to adjacent cartilage from the interphalangeal joints (Francis-West et al., 
1999). Abrogations in Gdf5 signalling may therefore result in limb joint fusions as a 
secondary consequence of dysregulated cartilage development.
Interestingly, whilst  Gdf5 mutant mice exhibit limb joint defects, they do not exhibit 
middle ear joint  defects (Settle Jr et al., 2003). Therefore although Gdf5 is expressed in 
the prospective and newly formed incudo-malleal joint region (Amin and Tucker., 2006; 
Tucker et al., 2004), a direct role for Gdf5 in the process of joint formation has not been 
established. In addition, other genes such as Emx2 and Bapx1 are also expressed in 
prospective middle ear joint regions (Amin and Tucker., 2006), and could potentially 
regulate the process of middle ear joint  development. Therefore whilst previous studies 
have revealed genetic candidates for the process of middle ear joint patterning, 
understanding of the function of these genes is lacking. The Eya1 +/- mouse model 
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exhibits an ectopic middle ear joint at a stage much later during embryonic 
development, once initial incudo-malleal joint  formation and early ossicle development 
has taken place. Using this model it  is therefore possible to distinguish genes required 
for early ossicle development, and the process of joint formation itself, dissecting the 
genetics of these events during middle ear development. 
Here it  is shown that ectopic joints of the Eya1 +/- middle ear form through a process 
which mirrors incudo-malleal joint formation, with ectopic Gdf5 expressed in regions 
delineating future ectopic joints. Therefore the Eya1 +/- mouse model represents the 
first in vivo evidence to correlate ectopic Gdf5 expression with the formation of ectopic 
joints, implicating a direct function for Gdf5 in the regulation of middle ear joint 
formation. This also suggests Gdf5 may play different roles in the limb and middle ear, 
with perhaps a more direct role in middle ear joint formation. Upstream regulators for 
middle ear joint  patterning are currently unknown, and it  has been suggested that the 
Hox genes, which are integral developmental patterners, may function upstream of Gdf5 
to regulate joint patterning (Brunet et al., 1998). The ectopic joint phenotype in Eya1 
+/- middle ears reveals a novel link between Eya1 (a homeodomain containing protein) 
and Gdf5. Inferred from expression domains, it is unlikely Eya1 plays a direct role in 
joint formation. However Eya1 may play an indirect role in joint patterning through the 
regulation of Gdf5. It could therefore be hypothesised that Eya1 is expressed in 
chondrocytes of the ossicles, in order to promote cartilage development. This could be 
directly  through induction of cartilage genes such as Sox9, and indirectly through 
inhibition of joint inducers such as Gdf5. Interestingly  Gdf5 expression is not lost  in 
Eya1 -/- middle ears, suggesting Eya1 is not required for Gdf5 expression. However loss 
of Eya1 results in loss of Gdf5 restriction, which diffuses into regions adjacent to the 
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joint, such as the articular surfaces of the ossicles. The increased hypoplasia of Eya1 -/- 
middle ear ossicles, marked by diffuse expression of Gdf5 in the articular surface 
regions, appears to support this theory. In addition, whilst the superior articular surface 
is evidenced as the supernumerary ossicle at E18.5 in Eya1 -/- middle ears, the 
remaining articular surfaces of the incus and malleus remain hypoplastic and absent. 
Therefore loss of Gdf5 restriction, may  result in the formation of a widened joint region, 
at the expense of articular surface cartilage development. Intriguingly, the ectopic joint 
phenotypes of both the Eya1 +/- and Eya1 -/- middle ears, suggest ossicles remain 
responsive to joint signals after initial joint formation at  E14.5, and throughout 
embryonic development. This would also infer joint development as a default state, 
inhibition of joint development required for ossicle cartilage development and 
maintenance. Therefore Eya1 may regulate Gdf5 directly  by inhibiting Gdf5 expression 
in the chondrocytes of the ossicles, although indirect regulation through an unidentified 
intermediate gene is also plausible. 
It is currently unknown whether the ectopic cartilage and fusion phenotypes of Eya1 -/- 
middle ears are also results of abrogated Gdf5 expression. However, resembling 
conclusions drawn from limb joint studies, stage or concentration dependent roles for 
Gdf5 could be speculated, supporting the idea of ectopic cartilage and joints resulting 
from abrogations of the same developmental pathway. In this hypothesis, connected 
roles for Eya1 and Gdf5 are implicated both in joint and cartilage development, a 
balance of signalling required for appropriate cartilage patterning.
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3.3.2.3   Gdf6 and Six1
Much like Gdf5, Gdf6 has implicated functions in joint development of various 
structures, including the limb, middle ear, and cranial sutures (Settle Jr. et al., 2003; 
Clendenning and Mortlock, 2012). The nature of Gdf6 function however varies 
significantly between regions. Gdf6 is expressed in prospective joint regions of the 
limbs, loss resulting in limb joint fusions. Therefore In the limb, Gdf6 appears to play a 
direct role in joint patterning and development. In addition, double mutants of Gdf6 and 
Gdf5 result  in additional limb joint defects not observed in individual Gdf mutants, 
suggesting partial redundancy of function between these genes in joint development 
(Settle Jr. et al., 2003). This direct role in joint formation however does not  appear 
conserved between the limb and middle ear. In the middle ear, Gdf6 is not expressed in 
prospective joint regions, but only  once the incudo-malleal joint has formed. In 
accordance with this, loss of Gdf6 does not result in ossicle joint fusions but instead 
results in hypoplasia of ossicle articular surfaces (Settle Jr. et al., 2003). Therefore in 
the middle ear, a later role for Gdf6 in joint formation is implicated, and suggests whilst 
Gdf6 does not play a role in joint initiation and specification, it  is important for ossicle 
articular surface growth or maintenance. It has been suggested that Gdf6 may function 
in a paracrine manner from the joint, signalling to the adjacent ossicles to regulate 
chondrogenesis (Settle et al., 2006). In addition, the differential timing of Gdf5 and 
Gdf6 expression does not suggest conserved redundancy of these genes from the limb to 
the middle ear in joint development.
In the Eya1 +/- middle ear, Gdf6 expression is observed in the newly formed ectopic 
joint, but not in the prospective ectopic joint region. Expression following joint 
formation therefore recapitulates the genetics of incudo-malleal joint formation, and 
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supports the idea that Gdf6 plays a secondary role to joint formation, functioning 
downstream of Gdf5. Although synovial joints form differently from suture joints, they 
both share the feature of an undifferentiated mesenchymal joint. In the skull, loss of 
Gdf6 results in premature ossification of the suture joint, suggesting Gdf6 functions to 
maintain the undifferentiated state of the mesenchymal joint. Therefore, Gdf6 does not 
conserve the function of boundary or joint patterning from the limb but rather functions 
in a protective role to prevent the suture joint from developing into bone (Clendenning 
and Mortlock., 2012). In the middle ear, Gdf6 may function in a similar capacity, to 
maintain the mesenchymal joints. A high level of Gdf6 in the newly formed joints may 
maintain an undifferentiated mesenchymal state, and a lower level which diffuses to the 
adjacent ossicles, may function to regulate chondrogenesis. In this way Gdf6 may 
regulate ossicle size and articular surface shape.
Similarly  to Gdf6, Six1 is not expressed in the prospective ectopic joint regions, but is 
expressed in the newly  formed joint at E17.5, again recapitulating the genetics of 
incudo-malleal joint formation. The expression of Six1 in the joint regions following 
joint formation would suggest an indirect role for Six1 in joint formation, most likely 
functioning in a similar role to Gdf6, in joint maintenance of the middle ear.
3.3.2.4    Noggin and Bmps
Loss of Noggin results in joint fusions of the limb in mice (Brunet et al., 1998), and is 
also a genetic cause of multiple synostoses syndrome and proximal symphalangism in 
humans. These syndromes are often accompanied by conductive deafness due to stapes 
ankylosis (Gong et al., 1999), and Noggin mutant mice also exhibit loss of ossicle 
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joints, resulting in fusions (Hwang and Wu., 2008). Therefore, Noggin has implicated 
roles in joint formation, which appear conserved in the limb and middle ear.
Noggin is a classical inhibitor of Bmp signalling (Zimmermann et al., 1996), and is 
often considered when investigating Bmp function. However, whilst  Noggin may inhibit 
various members of the Bmp family, some evidence suggests Noggin may have an 
inductive effect on Gdf5. Loss of Noggin causes loss of Gdf5 expression in the limb, 
and results in interphalangeal joint fusions, suggesting Noggin and Gdf5 may  have 
synergistic functions in joint  formation (Brunet et al,. 1998). In support, mutations in 
Noggin and Gdf5 are both causative of multiple synostoses syndromes in humans 
(Dawson et al., 2006).  Conversely, there is an equal body of evidence to suggest 
Noggin may also function to inhibit  the developmental effects of Gdf5. For example 
incubation of limb cultures with both Gdf5 and Noggin neutralises the loss of joint 
phenotype commonly  caused by incubation with Gdf5 alone (Merino et al., 1999). In 
addition, two Gdf5 point mutations which result in multiple synostoses syndrome, arise 
from an inability of Noggin to bind to and inhibit Gdf5 (Seemann et al., 2009). In vitro 
Noggin and Gdf5 can bind together, and this interaction is inhibited in the presence of 
Bmp7 (Merino et al., 1999). Taken together, it  therefore appears interactions between 
Noggin and Gdf5 may  function to regulate joint patterning and development, although 
the nature of the relationship remains unclear. 
In the middle ear, Noggin expression has previously been observed in chondrocytes of 
the ossicles and the middle ear joint regions (Hwang and Wu., 2008). In this project, 
closer analysis of Noggin in the middle ear has revealed Noggin expression in the 
ossicles, particularly  in the articular surfaces of the malleus and incus, and in the medial 
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borders of both ossicles adjacent to the joint. Contrary to previous investigations, 
Noggin expression is not observed in the incudo-malleal joint. Noggin expression 
appears unaffected between Eya1 +/+ and Eya1 +/- middle ears, although alterations in 
expression levels cannot be ruled out. The expression pattern of Noggin observed in this 
study interestingly purports a role for Noggin in articular surface development, although 
it is unclear if it is working in an inductive, inhibitory, or independent role in relation to 
Gdf5. In addition, exogenous application of Noggin soaked beads in the middle ear, has 
an ability to induce a loss of cartilage. Therefore in vitro Noggin has the potential to 
induce joint formation, in accordance with previous loss of function studies (Hwang and 
Wu., 2008). However, exogenous Noggin more commonly induces ectopic cartilage, 
suggesting a more general role in cartilage development. The variability  of phenotypes 
induced by exogenous Noggin protein may implicate stage, region, or concentration 
specific roles for Noggin.
Bmps are also expressed in the articular surfaces of the limb bones, and are suggested to 
function in a protective capacity to maintain articular cartilage (Fan et al., 2004). 
Specific deletion of Bmpr1 from the limb joint has further implicated a role for Bmps in 
cartilage maintenance of the articular surfaces. Interestingly, these mice exhibit normal 
articular cartilages at birth, however possess degraded surfaces during postnatal stages, 
with signs of osteoarthritis (Rountree et al,. 2004). In addition, down regulation of 
Noggin reduces articular surface degradation, suggesting high Bmp levels may be 
protective of these surfaces (Lories et al., 2006). Therefore Bmps may be required 
throughout life for cartilage maintenance and remodelling of these important functional 
surfaces. Although these studies investigate cartilage loss in pathological circumstances, 
reparative processes often harness the mechanisms of early development (Archer et al., 
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1993). Therefore the Bmps may play similar roles during early embryonic development, 
to protect the newly formed articular surfaces from joint inducing signals.  
pSmads 1,5,8 immunohistochemistry was therefore employed, in order to investigate 
potential Bmp signalling in the middle ear ossicles during embryonic stages. Strikingly, 
pSmads 1,5,8 expression was observed exclusively  in the articular surfaces of both the 
malleus and incus, and was strictly devoid from the incudo-malleal joint region. 
Therefore, Bmp signalling is conserved in the articular surfaces of the middle ear 
ossicles, suggesting a role in articular surface development. Interestingly, the ectopic 
joint in all Eya1 +/- middle ears form in the nearest ossicular region of the incus that is 
devoid of Bmp signalling. This may suggest Bmps function to inhibit Gdf5 expression in 
chondrocytes of the articular regions. In this way  Bmp signalling may protect the 
articular surfaces from joint formation during development, and explain the specific 
positioning of the joint observed in all Eya1 +/- and Eya1 -/- middle ears analysed. As 
Noggin is expressed in overlapping regions to Bmp signalling, Noggin may function to 
regulate Bmp levels.  
Whilst alterations in expression levels remain to be investigated, pSmads 1,5,8 and 
Noggin expression patterns are unaltered in Eya1 +/- middle ear ossicles. Therefore, it 
could be hypothesised that Bmps and Noggin function independently of the Eya1 and 
Gdf5 signalling pathway, suggesting various signalling pathways may function 
independently to pattern the joint. The effects of these pathways may be synergistic and 
influence the position and formation of middle ear joints. Alternatively, in the limb it 
has been proposed that Noggin may function to down regulate Bmps in order to enable 
Gdf5 expression in the joint (Merino et al., 1999). The expression patterns of these three 
160
genes suggest this may also occur in the middle ear, where Bmp levels are down 
regulated in the articular surfaces by Noggin, to produce a gradient which enables Gdf5 
expression in the joint. Therefore, a basic system to regulate joint patterning may exist, 
where Gdf5 induces Noggin, to enable its expression through down regulation of Bmps. 
It is likely a regulatory network exists between Bmps, Noggin, and Gdf5 in the 
regulation of ossicle size, shape, and joint patterning, however further investigation of 
potential epistatic relations of these signals, and their influences on joint patterning in 
the middle ear must be undertaken. 
3.3.3   Mechanism of joint formation; cell fate changes govern joint formation in the 
middle ear
Whilst investigations have revealed several genetic factors with implicated roles in joint 
development (Mallo., 1998), understanding the mechanisms of joint formation has 
proved more elusive. This may  be in part because one discrete mechanism does not 
appear responsible for the whole process, but rather an interplay  of genetics, cellular 
movements intrinsic to the joint region, and extrinsic mechanical forces, influence 
cavitation.
In the limb for example, formation of the interdigital spaces requires cell death, 
accompanied by  migration of cells from the interdigital spaces into the developing digit 
(Kelley et al., 1970; Omi et al., 2000). Through these mechanisms, cells from the 
interdigital spaces are removed in order to create a joint cavity. In the interphalangeal 
joints, cells undergo apoptosis, to give rise to a cavitated joint region (Mori et al., 
1995). In the middle ear, a discrete population of cells undergo cell death in the newly 
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formed joint. However, whether this event contributes to cavitation of the joint remains 
unclear. This is for several reasons; only  a small number of cells undergo cell death in 
the joint and cannot account for the removal of the whole cell population from the joint 
region, and inhibition of cell death using both in vitro culture techniques and transgenic 
knockout mice of pro- apoptotic molecules does not affect  incudo-malleal joint 
formation (Amin et al., 2007). Therefore it appears unlikely middle ear joint  formation 
occurs through a mechanism of cell death, although it  could act as a trigger or 
contribute partially to the process. If cell death is required or contributes to middle ear 
joint formation, then ectopic cell death should be observed in the ectopic joint region of 
Eya1 +/- middle ears. A few apoptotic cells were observed in the ectopic joint region in 
Eya1 +/- middle ears at E17.5, although fewer in number than observed in the incudo-
malleal joint in previous investigations (Amin et al., 2007). In addition, increased 
apoptosis was observed in mesenchyme of the Eya1 +/- middle ears. Therefore whether 
these cells form part of the process of joint formation or are consequences of general 
reduced cell survival in the Eya1 +/- middle ear mesenchyme is unclear. It could be 
speculated that whilst these cells may not contribute to joint formation, they may form 
part of another developmental process that is closely associated with joint formation. 
Eya1 functions to promote cell proliferation in a variety of developmental contexts 
(Schloss et al., 2008; El Hasash et al., 2012). Therefore, to investigate whether ectopic 
joints form due to an abrogated process of cell proliferation, immunohistochemistry of 
the PHH3 marker for cycling cells was undertaken. Differences in the mitotic index 
between Eya1 +/+ and Eya1 +/- incudes however were not observed. Joints have been 
characterised as regions of low proliferation (Mori et al., 1995), and in agreement with 
this cell proliferation was not observed in the newly formed ectopic joint. The lack of 
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proliferative differences in Eya1 +/+ and Eya1 +/- middle ear ossicles and joints 
therefore suggests Eya1 does not function to regulate joint patterning through a 
mitogenic capacity.
In this project, migration of cells in the vicinity of the joint region was not investigated 
as it has already been established that cells of the incudo-malleal joint and ossicles do 
not exhibit migratory  capacity, suggesting cellular movements do not contribute to 
formation of the joints (Amin et al., 2007). 
Taken together, it appears the processes of cell migration, apoptosis, and proliferation 
do not contribute to the formation of middle ear joints, suggesting joints of the middle 
ear and limb form through different mechanisms. Therefore, it is surprising that the 
basic genetics of joint formation are conserved between the two systems; the expression 
of Gdf5 in prospective joint regions, followed by  a down regulation of cartilage genes 
and a corresponding up regulation of ‘joint’ genes. These cell fate changes therefore 
appear integral for the formation of joint regions. Mechanism differences could be 
largely due to developmental differences between the limb and middle ear, specifically 
that all mesenchyme of the middle ear cavity  will eventually be removed during 
postnatal development. Since the ossicles cannot move until this tissue is largely 
removed, cavitation of the joint will not imbue function until these later stages. 
Therefore, a very simple model for joint formation in the middle ear could be proposed, 
which centers largely on cell fate changes of the joint. Indeed, these genetic changes are 
recapitulated in formation of the ectopic joint in the Eya1 +/- middle ear, and may 
function independently of other mechanisms to form the joint region.
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Therefore, Eya1 may regulate joint patterning indirectly through the regulation of 
ossicle cell fate. Several studies to date have shown Eya1 to regulate cell fate either 
directly  through the induction of downstream target  genes, or indirectly  through roles of 
cell survival and proliferation (Zou et al., 2004; Zou et al ., 2006; Schloss et al., 2008; 
El Hashash et al., 2011). In the inner ear Eya1 induces Neurog2 and phox2 expression, 
genes required for neural differentiation. Therefore in the inner ear Eya1 is a direct 
regulator of neural cell fate (Zou et al., 2004). However whilst low levels of Eya1 and 
Six1 promote neuronal differentiation in the inner ear, higher levels promote progenitor 
cell expansion and maintenance, suggesting a concentration dependent mechanism for 
the regulation of inner ear cell fate (Scloss et al., 2008). A similar role for Eya1 can be 
inferred from studies of the lung, where loss of Eya1 results in epithelial progenitor 
cells to erroneously enter terminal differentiation pathways at the expense of the 
progenitor cell population (El Hashash et al., 2012). Therefore in the inner ear and lung, 
Eya1 regulates cell fate indirectly by preventing premature differentiation. 
Similarly  in the middle ear, Eya1 may function to promote a chondrocyte cell fate, loss 
of Eya1 resulting in the formation of ectopic joints. This is marked by transformation of 
cells from a chondrocyte to mesenchymal cell fate. As ossicles of the middle ear 
initially develop from mesenchymal condensations, this aberrant change is more a 
reversal of cell fate, where loss of Eya1 causes loss of cell specification, resulting in 
dedifferentiation. Eya1 may therefore pattern the middle ear through mesenchymal vs 
chondrocyte cell fate regulation, high levels promoting a chondrocyte cell fate and 
lower levels enabling mesenchymal joint formation through expression of Gdf5.
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3.3.4.   Conclusions
Based on the findings from this project and previous investigations, a hypothetical 
model for middle ear joint formation is therefore proposed (Fig. 3.21). This work would 
suggest that the formation and positioning of joints are not a result of any single 
signalling pathway, but rather a result of the integrated function of several signalling 
systems. This also suggests joint synostoses can arise from multiple unrelated causes, 
depending on which signalling system, and in turn which developmental event is 
abrogated. Interestingly, this project has associated Eya1, Noggin, and inferred Gdf5 to 
be the causes of both ectopic joint formation and ectopic cartilage development in the 
middle ear. It therefore seems likely  a balance of these factors in joint formation and 
maintenance is required. This model aims to suggest developmental roles for the genetic 
factors investigated in this project, although further validation of how these signals 
function and integrate in joint patterning will be required.
Figure 3.21.  Eya1 functions to suppress joint formation, through maintenance of 
a chondrocyte cell fate
A) Eya1 is expressed in chondrocytes of the malleus and incus, with strong expression 
in the lateral edges of both ossicles. This creates a gradient, either directly  of Eya1, or 
indirectly of an intermediate signal downstream of Eya1, with strong expression furthest 
from the joint  and lowest expression in chondrocytes adjacent to the joint. As a result, 
Gdf5 expression is inhibited in the chondrocytes of the ossicles, but expression is 
enabled in the joint  region. Gdf5 expression is inhibited in the articular surfaces by  Bmp 
signalling. This Bmp signalling is regulated by Noggin. Other joint genes such as Gdf6 
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and Six1 are also expressed in the joint region, and function to regulate ossicle size and 
shape through paracrine signalling mechanisms. Cartilage genes such as Sox9 are 
suppressed in the joint. 
B) Partial loss of Eya1 expression results in disruption of the gradient and loss of Eya1 
or an intermediate signal, in chondrocytes of the ossicles nearest to the joint. Bmp and 
Noggin signalling remain unaffected, and as a result inhibit  expression of Gdf5 in 
articular surfaces of the ossicles. Partial restriction of Gdf5 by Eya1 is lost, and Gdf5 
expression occurs in the closest region to the joint, which is devoid of Bmp signalling. 
In the incus, these regions occur between the body of the incus and the beginning of the 
articular regions. As a result, these cells enter a joint developmental program, where 
Sox9 is down regulated and cells dedifferentiate to a mesenchymal cell fate, forming an 
ectopic joint. Gdf5 remains expressed in the newly formed joint, and other joint genes 
such as Six1 and Gdf6 also become expressed in the newly formed ectopic joint. 
Together these genes may function to maintain joint cells in a mesenchymal cell fate, 
thus maintaining the ectopic joint region. The increase in expression domains of Gdf5, 
Gdf6, and Six1, may result in lower paracrine signalling of these genes from the incudo-




4.   Development of the stapedio-vestibular joint and annular ligament  
in the Eya1 +/- middle ear
4.1   Introduction
Unlike the malleus and incus, which are mainly first branchial arch derivatives, and 
form from the distal most region of Meckel’s cartilage (Miyake et al., 1996), the stapes 
develops from neural crest of the second branchial arch (Carlson et al., 1994; 
O’Gorman et al., 2005). Defects of the stapes are the most common ossicular deformity 
observed in the middle ear, and are frequently  found in isolation of malleus and incus 
defects (Park and Choung., 2009). As a result, stapes development is often considered 
independently of the malleus and incus. Certain aspects of stapes development remains 
contentious, however in general, the majority of the stapes develops from a communal 
mesenchymal condensation that also gives rise to Reichert’s cartilage, the anlage of the 
styloid process, which in turn forms part of the temporal bone of the skull. Therefore 
much like the malleus and incus, the styloid process and the stapes develop from a 
combined cartilaginous complex and will need to be separated to form two independent 
structures. During development, a region of mesenchyme between the future stapes and 
Reichert’s cartilage (the interhyale), develops into ligamentous tissue, thus functioning 
to separate the cartilaginous condensations of the stapes and styloid process (Anson et 
al., 1944; Anson et al., 1980; Nandapalan et al., 2000). At least  part  of this ligamentous 
tissue forms the stapedial ligament, which anchors the stapes to the wall of the auditory 
bulla and regulates mechanical impedance of the stapes (Rodriguez- Vazquez., 2005).
In addition, the footplate of the stapes arises from two developmental sources; the inner 
half of the footplate develops from the neural crest derived mesenchyme that also gives 
rise to the bulk of the stapes body, whilst the outer half forms from mesoderm of the 
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developing oval window region (Nandapalan et al., 2000; Thompson et al., 2012). 
Therefore the outermost region of the footplate develops as a continuous structure with 
the cartilage of the otic capsule (Whyte et al., 2002). Development of the annular 
ligament between the stapes footplate and otic capsule cartilage therefore serves to 
separate the outer footplate region of the stapes from the inner ear oval window, 
resulting in two independent structures. As a consequence of annular ligament 
differentiation the stapedio-vestibular joint and oval window is formed (Nandapalan et 
al., 2000)(Fig.4.1). During development, the stapes must therefore separate from the 
cartilage of the temporal bone and the inner ear in order to form an independent 
structure. In both regions this occurs through the process of ligament differentiation, 
where  formation of the stapedial ligament separates the stapes from the temporal bone, 
and formation of the annular ligament functions to separate the stapes from the inner ear 
cartilage.
Unlike the fluid filled synovial joint of the incudo-malleal complex, the stapedio-
vestibular joint is a syndesmosis joint and is filled with ligamentous tissue. The annular 
ligament forms a fibrous band that fills the entire gap  between the footplate of the stapes 
and edges of the oval window, and it is for this reason that the stapes is only  a partially 
freely moveable structure (Graham., 1985; Buytaert  et al., 2011). The stapedio-
vestibular joint is therefore a completely ligament filled joint, and anatomically the joint 
and annular ligament are effectively the same structures. For this reason the stapedio-












































































































































































































































Formation of the stapedial muscle and annular ligament therefore serves the same 
purpose as synovial joint formation; to give rise to a mobile ossicle.
Failure of stapedial ligament differentiation results in fixation of the stapes body  to the 
temporal bone, termed stapes suprastructure fixation (Nandapalan et al., 2000), whilst 
failure of annular ligament development results in fixation of the stapes footplate 
(Kelemen et al., 1943; Lindsay  et al., 1960), often termed congenital stapes fixation 
(Fig.4.2). Both of these scenarios lead to conductive hearing loss. For this reason, 
development of the stapes has been of great clinical interest. The causes of stapes 
suprastructure and footplate fixation are of much intrigue, and have been suggested to 
arise from two possible causes; fixation as a result of a failure of ligament 
differentiation as described above, or ectopic ossification of the ligament structures 
following initial development (Nandapalan et al., 2000). The latter scenario may also be 
a consequence of middle ear otosclerosis, resulting in progressively worsened 
conductive hearing loss during later life, as a result of continued ectopic cartilage and 
bone development. It is therefore of clinical importance to distinguish between stapes 
defects that arise from congenital abnormalities and otosclerosis, as resolution of 
conductive deafness in both cases will vary. It  will also be interesting to investigate 
whether genes of embryonic middle ear development play a role in later otosclerosis 
pathophysiology. Many studies of stapes fixation have been heavily reliant on the 
structural and histological analysis of dry skull collections (Bachor et al., 2005; 
Merchant et al., 2001). Whilst these studies are highly  informative of the nature and 
incidence of varying stapes abrogations, information of the developmental abrogation, 
pathophysiological processes, or the genetics involved in these stapes malformations are 
lacking. Further, the syndromic association between stapes abnormalities in specimens 
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Figure 4.2   Stapes fixation can result from the ossification and failure of ligaments to 
develop. (A) The stapes footplate is anchored to the temporal bone by the stapedial 
ligament. The stapes footplate and oval window are separated by the annular ligament (B) 
Ossification or failure of the stapedial ligament to form results in fusion of the stapes body to 
the wall of the middle ear cavity.  This is termed suprastructure fixation.  (C) Ossification, or 
failure of the annular ligament to form results in fusion of the stapes footplate to the inner 
ear oval window. This is termed stapes footplate fixation. mec, middle ear cavity, I,  incus, S, 
stapes, fp,  foot plate, ow, oval window, IE,  inner ear, AL, annular ligament, ost,  ossified 
stapedial tendon, fpf, footplate fixation.
of these studies often remain unidentified or create bias (Bachor et al., 2005), and is 
most likely the reason for the conflicting incidences of fixation drawn from 
comparisons of various investigations. Improved understanding of the genetics and 
mechanisms of stapes patterning defects will enable more accurate classification of 
congenital and pathological stapes malformations.
For this reason mouse models of conductive deafness have proved an invaluable tool, 
providing a system in which the genetic and mechanical causes of stapes defects can be 
extrapolated. The Noggin +/- mouse, for example, provided the first model for 
conductive deafness resulting from stapes fixation. In this model the body of the stapes 
appeared fused with the styloid process, exhibiting classical stapes suprastructure 
fixation (Hwang and Wu., 2008). Stapes malformations are also observed in Eya1 +/- 
mice, with the stapes footplate absent in the vicinity of the oval window (Xu et al., 
1999). In depth description of Eya1 +/- stapes defects however have not been reported, 
therefore whether this is due to complete absence, partial formation, or displacement of 
the stapes is unclear. Both Eya1 +/- and Six1 +/- mice exhibit small lumens of the 
stapes. In addition, the stapes is completely  absent in Eya1 -/- and Six1 -/- middle ears 
(Xu et al., 1999; Zheng et al., 2003). The striking similarity of the phenotypes of Eya1 
and Six1 mutant mice implicate integrated functions for Eya1 and Six1 in stapes 
development. Whilst  middle ear defects have not been reported in the bp mouse, Gdf5 is 
expressed in the annular ligament, which bridges the stapedio-vestibular joint, and may 
implicate a role for Gdf5 in annular ligament development (Hwang and Wu., 2008). In 
addition, Gdf6 is also expressed between the stapes and oval window, and Gdf6 -/- mice 
exhibit reduced annular ligaments and hypoplastic stapes footplates (Settle Jr. et al.,
2003). Therefore roles for Eya1, Six1, Gdf5, Gdf6, and Noggin are implicated in various 
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aspects of stapes development and joint patterning, with expression of Gdf5, Gdf6, and 
Noggin suggesting specific roles in annular ligament development. Whilst Eya1 and 
Six1 expression have not been investigated in the stapes and stapedio-vestibular joint 
region specifically, Eya1 and Six1 are expressed in flexor and extensor ligaments of the 
limb respectively  (Xu et al., 1997; Oliver et al., 1995), implicating potential roles in 
ligament development. 
In addition to ossicle defects previously described, several malformations of the stapes 
and associated ligaments are observed in individuals with BOR syndrome. This includes 
calcification of the oval window, stapes dysplasia, unilateral thickening of the stapes 
footplate, absence of the stapedial ligament, stapes footplate fixation (Ceruti et al., 
2002), and absence of the suprastucture of the stapes (Smith et al., 1984). Therefore 
there is strong suggestion that Eya1 regulates stapes development and stapedio-
vestibular joint patterning.
In the previous chapter, malformations of the stapes through skeletal preparations of 
BL/6 Eya1 +/- middle ears were not visualised, however connective tissue defects 
cannot be ruled out. In this chapter, discrete defects in the anterior and posterior 
stapedio-vestibular joints in Eya1 +/- mice are identified. In chapter three, expression 
pattern analysis for the above mentioned genes in the incudo-malleal and ectopic joints 
were undertaken, the results implicating roles for these genes in joint patterning and 
maintenance. This has also inferred substantial genetic conservation between joint 
patterning in the limb and middle ear. Interestingly, conductive deafness as a result of 
stapes fixation is a diagnostic feature associated with symphalangia, suggesting genes 
which pattern the limb joints may also pattern the stapedio-vestibular joint (Ueda et al., 
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1996; Strasburger et al., 1965). In this chapter the Eya1 +/- mouse is therefore used as a 
tool to investigate potential roles for these genes in stapedio-vestibular joint patterning 
and development, in order to understand how abrogation of the Eya1 gene may result in 
stapes patterning defects in BOR syndrome.
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4.2   Results
4.2.1   Embryonic development of the stapes and annular ligament
Histological analysis was undertaken in order to visualise normal development of the 
stapes and annular ligament, during embryonic stages in the mouse. Cartilaginous 
condensations for the body and footplate of the stapes were visible at  E14.5 (4.3 A and 
F), which by  E15.5 appeared larger and stained strongly with alcian blue. Mesenchyme 
of the otic capsule that surrounds the inner ear, condensed adjacent to the stapes 
footplate. This mesenchyme will form the outer region of the stapes footplate 
(Thompson et al., 2012) (4.3B and G). By E16.5 the stapes footplate acquired an oval 
morphology, resembling morphology of the fully developed stapes footplate. This is 
likely due to fusion of the inner tympanic derived footplate with the outer otic capsule 
derived footplate. Cellular condensations that form the anterior and posterior annular 
ligament were also first visible at this stage (4.3C and H). These condensations 
organised into two linear ligaments by E17.5 (4.3D and I). By E18.5 the anterior and 
posterior annular ligaments appeared adjacent to the stapes footplate and bridged the 
stapedio-vestibular joint between the footplate and oval window (4.3E and J). 
4.2.2   Eya1, Six1, and Noggin are expressed in the stapedio-vestibular joint and 
annular ligament
Although Eya1 and Six1 mouse models exhibit stapes defects, implicating a role for 
these genes in stapes morphogenesis (Xu et al., 1999; Zheng et al., 2003), expression 
patterns of these genes in the vicinity  of the stapes have not been investigated. 
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Therefore in order to understand how Eya1 and Six1 may influence stapes and annular 
ligament development, RNA in situ hybridisation of these genes was undertaken. At 
E18.5, Eya1 was expressed in the stapedio-vestibular joint (the annular ligament). In 
addition, as described in chapter three, Eya1 was also expressed in the mesenchyme 
surrounding the stapes (4.4A and B). Interestingly, differing from the incudo-malleal 
regions, Six1 expression overlapped with Eya1 expression in the stapedio-vestibular 
joint and annular ligament (4.4C and D). Noggin was also observed in the stapedio-
vestibular joint and annular ligament (4.4E and F) as has previously been described 
(Hwang and Wu., 2008). Scleraxis, a gene which is a marker for developing ligaments 
(Cserjesi et al., 1995), was expressed in the annular ligament (4.4G), confirming regions 
of Eya1, Six1, and Noggin expression in 4.4 B,D and F correspond to the annular 
ligament. Six1 and Noggin were also observed in the incudo-stapedial joint (4.4C and 
E).
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4.2.3   Eya1 +/- middle ears exhibit stapes malformations 
Skeletal preparations to visualise the middle ear ossicles did not reveal any  defects of 
the stapes in the BL/6 Eya1 +/- middle ear. However stapes defects have been described 
on the 129/Sv and BALB/c backgrounds. (Xu et al., 1999). Therefore closer analysis 
was undertaken with the use of histological methods, in order to investigate soft tissue 
components of the stapes. 
4.2.4   Break in anterior annular ligament
Comparison of frontal histological sections of Eya1 +/+ and Eya1 +/- stapes at P0 
revealed a break in the anterior annular ligament in Eya1 +/- middle ears. The footplate 
and oval window cartilage adjacent to the break remained present (4.5D and H). At this 
stage the posterior annular ligament resembled Eya1 +/+ morphology (4.5L). The 
defect in the anterior annular ligament was not observed at E18.5 in the Eya1 +/- 
middle ear (4.5B and F), indicating P0 as the stage of anterior annular ligament 
malformation.
4.2.5   Ossification of posterior annular ligament
Analysis of later stages of stapes development revealed a clearly formed anterior and 
posterior annular ligament in the Eya1 +/+ middle ear at P21. The ligament regions 
stained with haematoxylin, and spanned the stapedio-vestibular joint on the anterior and 
posterior sides. In addition, the annular ligament was closely juxtaposed on both sides 
by the cartilaginous otic capsule, which by P21 had not yet ossified (4.6C,G and K). 
180
The break phenotype observed at P0 in the anterior annular ligament of Eya1 +/- middle 
ears was maintained at P21. The footplate and oval window either side of the break 
remain cartilaginous, and in this aspect resembled the Eya1 +/+ morphology (4.6D and 
H). Additionally, ectopic ossification of the posterior annular ligament in Eya1 +/- 
middle ears was observed at P21, marked by continuous staining of this region with 
Alizarin red. Histologically  the posterior annular ligament appeared completely absent 
(4.6D and L). Interestingly, earlier during postnatal development at P5, the posterior 
annular ligament appeared well formed and clearly visible in Eya1 +/- middle ears, as a 
seam of haematoxylin stained tissue, which divided cartilage of the stapes footplate and 
oval window either side (4.6B and J). Therefore at this stage the posterior annular 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































4.2.6   Scleraxis is expressed in the developing annular ligament in Eya1 +/- middle 
ears 
It has been suggested that stapes fixation occurs due to failure of the annular ligament to 
develop (Nandapalan et al., 2000). Therefore to investigate whether the ectopic joint 
phenotype of the anterior annular ligament, and the ectopic ossification of the posterior 
annular ligament arises as a result  of failure of annular ligament differentiation, gene 
expression analysis for Scleraxis was undertaken, a gene that is expressed in developing 
ligaments (Cserjesi et al., 1995), including those of the middle ear (Wang et al., 2011). 
In the Eya1 +/+ middle ear at P0, Scleraxis was expressed in two defined stripes either 
side of the stapes footplate, which corresponded to the annular ligament (4.7A and B). 
As expected, Scleraxis expression was absent from the anterior ligament of the Eya1 +/- 
stapes at  P0, as this region of tissue was absent at this stage. Therefore Scleraxis 
expression was investigated a stage prior at E18.5. At this stage the annular ligament of 
both the anterior and posterior annular ligament expressed Scleraxis (4.7E and F), 
implicating normal development of the annular ligament.
4.2.7   Gdf5 is misexpressed in the prospective break region in the anterior annular 
ligament and absent from the posterior annular ligament
In chapter three I investigated the genetics of the ectopic joint phenotype in the vicinity 
of the incudo-malleal joint, and revealed a direct  role for Gdf5 in patterning of the 
ectopic joint. Gdf5 expression has previously been described in the stapedio-vestibular 
joint (annular ligament) at E16.5 during embryonic development (Hwang and Wu., 






















































































































































































































































































































































middle ears, in order to investigate whether the annular ligament break phenotype was 
also a result of ectopic joint formation. At E18.5, the stage preceding ectopic joint 
formation, Gdf5 expression was not observed in the Eya1 +/+ annular ligament and joint 
(4.8A and B). However in the Eya1 +/- middle ear, Gdf5 expression was observed in 
two parallel stripes, one stripe adjacent to the anterior ridge of the otic capsule (4.8C 
and D) and another stripe adjacent to the anterior edge of the stapes (4.8E and F). 
Therefore in effect two ectopic stripes of Gdf5 expression were observed either side of 
the anterior annular ligament, demarcating the region of the break phenotype at the next 
developmental stage. It would therefore appear the break phenotype observed in the 
anterior annular ligament at P0 is a consequence of ectopic joint formation. Gdf5 
expression was absent in the posterior annular ligament at this stage and resembled the 
Eya1+/+ middle ear (4.8C-F).
4.2.8   Cell death is not observed in the prospective ectopic stapedial joint region
As discussed in chapter three, cell death has been suggested to contribute to the process 
of joint formation in the middle ear (Amin et al., 2007). In order to investigate a 
correlation with the stapedial ectopic joint and apoptosis, TUNEL assay analysis in 
Eya1 +/- middle ears at E18.5 was undertaken. Apoptotic cells were not observed in the 
prospective ectopic joint region at E18.5, implicating cell death does not contribute to 
the formation of this joint  (4.9A and B). As this region of tissue was absent at P0, it was 
not possible to investigate cell death in the ectopic joint at later stages. Cell death was 
observed in the Eya1 +/- external ear at E18.5, resembling normal development of the 
external ear (Nishizaki et al., 1998). This served as a positive control to confirm an 

























































































































































































































































































































Figure 4.9.  Cell death does not occur in the ectopic joint region.  TUNEL 
assay of frontal middle ear sections at E18.5. TUNEL positive cells appear 
black. (A) In the Eya1 +/- middle ear, cell death does not occur in the 
prospective region of the ectopic joint. (B) Higher magnification of the anterior 
annular ligament, boxed region in A. (C) Control to show cell death in the 
developing external ear of the same Eya1 +/- sample (black cells). (n = 3 ears) 
S, stapes. (scale bars, 200um).
4.3   Discussion
4.3.1   Ectopic joint formation results in loss of the anterior annular ligament in Eya1 
+/- middle ears 
In the middle ear, separation of the malleus and incus occurs through the formation of a 
joint (Miyake et al., 1996), whilst separation of the stapes from adjacent cartilage 
occurs through the process of ligament differentiation, which forms the stapedio-
vestibular joint and oval window of the inner ear (Nandapalan et al., 2000). Therefore in 
the middle ear, the effect  of incudo-malleal joint formation and annular ligament 
development is similar; to separate two adjacent cartilages. In this chapter, genes of 
middle ear joint formation are also observed to be expressed in the annular ligament 
(stapedio-vestibular joint), suggesting redeployment of this gene set in stapedio-
vestibular joint patterning. Whilst Noggin and Gdf5 expression have previously been 
reported in the annular ligament at E16.5 (Hwang and Wu.,2008), expression of Eya1 
and Six1 in the annular ligament and stapedio-vestibular joint suggests novel roles for 
these genes in middle ear ligament and joint patterning. Differing from the limb, where 
Eya1 is expressed in the flexor tendons (Xu et al., 1997), and Six1 is expressed in the 
extensor tendons (Oliver et al., 1995), Eya1 and Six1 are co-expressed in the annular 
ligament, suggesting integrated functions of these genes in annular ligament and 
stapedio-vestibular joint development. Intriguingly, much like the ectopic joint 
formation in the incus investigated in chapter three, it appears the break phenotype of 
the anterior annular ligament is also a result of ectopic joint formation, marked by  Gdf5 
misexpression in prospective regions either side of the anterior annular ligament. With 
nothing to hold the anterior ligament in place, this region is most likely lost following 
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ectopic joint formation, resulting in the characteristic gap morphology observed in Eya1 
+/- middle ears. Interestingly, Gdf5 is not  expressed in the Eya1 +/+ annular ligament or 
posterior annular ligament of the Eya1 +/- middle ear at E18.5, suggesting Gdf5 may 
play  a role in annular ligament development during earlier developmental stages. 
Misexpression of Gdf5 in the anterior annular ligament at E18.5, resembles the temporal 
and spatial trend of Gdf5 misexpression in the incudo-malleal joint region; in both 
regions misexpression occurs during late embryonic development, in regions which are 
usually devoid of Gdf5 expression.  
In the limb bud, Bmps function to restrict spatial expression of Scleraxis through 
inhibition, whilst Noggin functions to promote Scleraxis expression through inhibition 
of Bmps. Therefore Bmp and Noggin interactions are implicated in the regulation of 
ligament patterning in the limb. Importantly, whilst this system functions to regulate 
expression levels of Scleraxis, it is not capable of inducing de novo Scleraxis expression 
or ligaments, emphasising a role in patterning rather than induction (Schweitzer et al., 
2001). A hypothetical model for stapedio-vestibular joint and annular ligament 
patterning is therefore proposed: Eya1 and Six1 are expressed in the annular ligament, 
with expression spanning the stapedio-vestibular joint region. During normal 
development, Eya1 and Six1 may function together to maintain a ligament cell fate. This 
is achieved through inhibition of Gdf5, most likely indirectly through a paracrine factor. 
As a result, Gdf5 is not normally  expressed in the annular ligament at E18.5. Loss of 
Eya1 in the Eya1 +/- middle ear, results in partial loss of a paracrine gradient, and in 
turn loss of Gdf5 inhibition. Due to this, Gdf5 is expressed ectopically  in the vicinity  of 
the joint, specifically in the outermost regions of the anterior stapedio-vestibular joint, 
either side of the annular ligament. It cannot be expressed in the annular ligament itself 
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as some Eya1 expression or paracrine mediator is retained. Ectopic expression of Gdf5 
results in ectopic joint development, which in turn results in excision of this region 
containing the anterior annular ligament. During development in the Eya1 +/+ middle 
ear, this signalling pathway may function to maintain the annular ligament structures 
once formed. In support of this, Scleraxis expression in Eya1 +/- annular ligament 
remains unaffected, suggesting defects are not a result of abrogated ligament initiation. 
The role of Noggin in this hypothetical theory is unclear, as both Noggin and Gdf5 are 
expressed in the annular ligament during earlier stages of embryonic development 
(Hwang and Wu., 2008). Due to this, it is unlikely Noggin functions to inhibit Gdf5 
expression. It will therefore be interesting to investigate Noggin expression in the 
annular ligament region of the Eya1+/- middle ear. Resembling conclusions drawn in 
chapter three, Eya1 may function to maintain ligaments in the middle ear through the 
regulation of cell fate (Fig 4.10). Further investigations will be required to either assert 
or disprove this theory. It will be particularly interesting to investigate Eya1 expression 
at earlier stages of development, to see if Eya1 is expressed in the newly formed annular 
ligament. The Eya1 +/- mouse may therefore be used as a tool to dissect the genetics of 
annular ligament and stapedio-vestibular joint patterning. A further consideration is the 
possibility that the break in the anterior annular ligament is a histological artefact, 
which occurs consistently  in all samples during tissue processing. However the lack of 
this lesion in the Eya1 +/+ anterior annular ligament would suggest that the anterior 
annular ligament is either weaker in the Eya1 +/- middle ears or that the break occurs in 
vivo. In vivo damage to the oval window would also compromise the integrity of the 
inner ear, resulting in perilymph loss from the inner ear with possible leakage into the 
middle ear space. This would cause considerable, if not complete hearing loss, resulting 
in a ‘dead ear.’
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Whilst stapes fixation has often been correlated with the cause of conductive deafness, 
ectopic breaks or joints in the annular ligament have not previously been described. It is 
difficult to speculate how this phenotype would affect hearing, although loss of 
anchorage on one side of the stapes could result  in displacement of the stapes, or may 

































































































































































































































































































































































4.3.2   Ossification of the posterior annular ligament results in stapes footplate fixation 
in Eya1 +/- middle ears 
Stapes fixation due to congenital abnormalities and disease (otosclerosis) both result  in 
conductive deafness, and for this reason has been a subject of great clinical interest. 
Previous investigations suggest stapes fixation can arise from the abrogations of several 
developmental processes, namely the failure of ligaments to form and separate the 
stapes from the adjacent cartilages, or ectopic ossification of the ligaments (Nandapalan 
et al., 2000). Although these are both possibilities, developmental studies investigating 
the mechanisms and genetics of stapes fixation have been limited, therefore what causes 
stapes fixation to occur in vivo is not fully understood. Stapes suprastructure fixation in 
the Noggin +/- mouse arises due to failure of the body of the stapes to separate from the 
styloid process (Hwang and Wu., 2008), however it is not known if this occurs due to 
failure of stapedial ligament differentiation, or ossification of the ligament once it has 
formed. Similarly  in humans, fixation of the footplate has been proposed to arise from a 
failure of the annular ligament to differentiate, ectopic calcification of the annular 
ligament once formed, or fusion of cartilage of the oval window and footplate due to 
cartilage hyperplasia (Ueda et al., 1996; Cremers et al., 1985). Without knowledge of 
how these fixations occur, differentiation between congenital stapes fixation and 
otosclerosis is difficult. The stage at which fixation occurs is a principle factor in 
diagnosis of congenital stapes fixation and otosclerosis. For example, conductive 
deafness before the age of six is considered congenital, whilst following six years is 
considered otosclerosis. Fixation observed in newborns is therefore assumed a result of 
erroneous embryonic development and considered congenital stapes fixation, whilst 
ossification during later life, marked by progressive worsening of conductive hearing is 
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considered otosclerosis (Bachor et al., 2005). Hearing amelioration following surgery of 
congenital stapes fixation is usually very  successful, resulting in permanent hearing 
improvement. However benefits following surgery of otosclerosis driven footplate 
fixation in some cases gradually diminishes with the reoccurrence of new ectopic bone 
(Usami et al., 2012). Therefore for treatment options, distinction between the two are 
clinically important. 
In this study, stapes fixation of the posterior annular ligament is observed in the Eya1 
+/- middle ear. Interestingly  Scleraxis expression in the Eya1 +/- annular ligament at 
E18.5 resembles Eya1 +/+ Scleraxis expression, suggesting early annular ligament 
development in the Eya1 +/- mouse occurs normally. However whilst Scleraxis is 
considered a marker for developing ligaments (Cserjesi et al., 1995), middle ear 
ligament defects are not observed in the Scleraxis null mouse (Wang et al., 2011), 
suggesting genetic redundancy and the requirement of other genes in middle ear 
ligament development. Therefore further investigation of genetic factors during annular 
ligament development at earlier stages in the Eya1 +/- middle ear will be required to 
rule out developmental defects. However histologically the Eya1 +/- posterior annular 
ligament appears well developed at  P5 and resembles the morphology of the Eya1 +/+ 
annular ligament, suggesting a failure or abrogation of posterior annular ligament 
development is not the cause of stapes fixation in the Eya1 +/- middle ear. In further 
support, whilst the annular ligament develops during early embryonic stages, ectopic 
ossification of the annular ligament occurs between one week and three weeks of age in 
the Eya1 +/- mouse, suggesting that fixation may arise from an inability to maintain the 
annular ligament. This also suggests ligament tissue retains competence to differentiate 
into hard tissue. As this tissue is thought to originate from cartilage of the otic capsule, 
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this could be considered a dedifferentiation back to a cartilaginous cell fate, and these 
chondrocytes then form into bone through the process of endochondral ossification. 
Additionally, whilst the ectopic joint phenotype of the anterior annular ligament is 
observed consistently in all Eya1 +/- middle ears analysed, ossification of the posterior 
annular ligament is not, which may suggest fixation arises due to pathology, and 
therefore manifests with greater variability. As Eya1 is expressed in the annular 
ligament, a direct role for Eya1 could be implicated in the maintenance of a ligament 
cell fate. It has been suggested that congenital stapes fixation and otosclerosis may not 
derive from common genetic abrogations (Usami et al., 2012). However ossicular 
patterning defects of the malleus and incus during embryonic development, followed by 
later ossification of the formed annular ligament in Eya1 +/- mice during postnatal 
development, would suggest that congenital defects and later ossifications can arise 
from a common genetic etiology. Therefore the Eya1 mouse could be proposed as a 
model for otosclerosis. Whilst  otosclerosis has not been described as a feature of BOR 
syndrome, otosclerosis during early postnatal life in children with BOR may go 
unnoticed or be misdiagnosed as congenital stapes fixation if observed before the age of 
six. In this study the exact stage of stapes fixation was not identified, therefore the 
genetics of annular ligament ossification were not investigated. A few mouse models 
with otosclerosis type phenotypes have been characterised, however whether the ectopic 
bony lesions observed in these mice form through the same mechanism of otosclerosis 
observed in humans will require further investigation. For example, ectopic bone 
growth is observed in the LP/J mouse strain, although does not histologically resemble 
bony lesions of otosclerosis in humans. In addition, the distribution of otosclerotic type 
lesions differs from human otosclerosis, with the incus primarily  affected in these mice 
as opposed to the stapes (Chole and Henry., 1985; Steel et al., 1987). More recently, the 
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Tail short mouse, which has a mutation in the Rpl38 gene, exhibits ectopic bony  growth 
at the round window ridge that projects into the middle ear cavity, resembling 
otosclerotic lesions. Interestingly these lesions histologically appear as endochondral 
bone (Noben-Trauth and latoche., 2011). In humans, the most common types of 
otosclerosis are associated with over 1500 mutations in the COL1 and COL2 genes 
(Forlino et al., 2011), and otosclerosis manifests as either delayed endochondral 
ossification in neonatal stages, that results in neonatal lethality, or increased bone 
turnover in the adult, which results in otosclerosis (Santos et al., 2012). Therefore the 
process of endochondral ossification appears to underly the pathology  of otosclerosis. 
As discussed in chapter three, the Eya1 +/- mice exhibit ossicle patterning defects, most 
likely due to abrogated cartilage development. Therefore it is likely otosclerotic type 
lesions observed at later developmental stages in these mice form through ectopic 
endochondral ossification. In addition, the isolated fusion of the posterior annular 
ligament in the Eya1 +/- mouse reflects the otosclerotic distribution of lesions observed 
in  humans.  Another consideration, however, is the possibility of multiple mechanisms 
creating an otosclerotic type lesion, and syndromic and non syndromic otosclerosis may 
form through differing mechanisms. This is an important question, and with a greater 
understanding of how human otosclerotic lesions form, the usefulness of mouse models 
with otosclerotic type phenotypes can now be assessed. The Eya1 +/- mouse will 
therefore provide a valuable tool for future studies to investigate early embryonic 
annular ligament development and the later genetics and mechanisms of annular 
ligament ossification, which may in turn elucidate the causes of stapes fixation in 
individuals with BOR. 
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Previous studies of human skulls have found ankylosis of the posterior annular ligament 
to be relatively  uncommon in comparison to anterior ligament ankylosis. In addition 
Posterior annular ligament ankylosis has also been suggested to have a greater impact 
on movement of the stapes than the anterior annular ligament, due to its narrower 
morphology  (Merchant et al., 2001). This morphological asymmetry of the annular 
ligament is also matched by genetic asymmetry. For example in the Eya1 +/- middle 
ear, Gdf5 is misexpressed in the anterior stapedial ligament, resulting in ectopic joint 
formation but appears unaffected in the posterior annular ligament. Eya1, Six1 and 
Noggin are expressed in both the anterior and posterior annular ligament, suggesting 
this asymmetry  may be attributed to another as yet unidentified autocrine or paracrine 
factor. However ectopic Gdf5 expression corresponding with ectopic joint formation, 
further supports the idea of Gdf5 as a regulator of joint patterning in the middle ear.
Gdf5 expression in the annular ligament (stapedio-vestibular joint) suggests a role in 
ligament development, and in this way may be responsible for the initial separation of 
the stapes footplate from the oval window. A role for Gdf5 in ligament development has 
been investigated in several regions, and much like joint formation, has yielded 
conflicting results. For example a gain of CDMP-1 (Gdf5) in the spine is associated 
with ectopic ossification of the spinal ligamentum flavum (Nakase et al., 2001), and 
implantation of ectopic Gdf5 in vitro induces osteogenic differentiation in human 
ligamentum flavum cells (Zhong et al.,2010), suggesting Gdf5 functions in an 
osteogenic capacity. In the rat however, human Gdf5 has shown a capacity to induce 
neoligament differentiation and repair when implanted at ectopic sites in vivo (Wolfman 
et al., 1997; Tashiro et al., 2006). In addition, bp mice lack intra-articular ligaments of 
the knee joint, suggesting Gdf5 is required for the development or maintenance of 
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ligaments (Harada et al., 2007). Therefore conflicting results may demonstrate a 
concentration or region dependent role of Gdf5 that is able to induce both ligament and 
cartilage differentiation.
As discussed in chapter three, Gdf5 and Noggin mutations both result in several 
syndromes characterised by defects of the limb joints, such as symphalangia (Dawson et 
al., 2006). Interestingly  conductive deafness due to stapes footplate fixation is a 
diagnostic feature which also correlates with symphalangia (Ueda et al., 1996). 
Symphalangisms have not been reported in Eya1 mouse models or in patients with BOR 
syndrome to date, which may reflect genetic redundancy or unconserved roles of Eya1 
in the limb and middle ear. However clinodactyly, resulting in the slight bending of the 
digits, has been observed in individuals with BOR (Melnick et al., 1978; Weber et al., 
1999), suggesting Eya1 may play a role in development of the interphalangeal cartilage. 
The idea of limb joint defects and conductive deafness arising from a common genetic 
etiology is not a novel idea and was first proposed by Schwartzbart and collegues in 
1963. However in recent years, investigation of this concept with the use of transgenic 
approaches in animal models has not been extensively studied. The Eya1 mouse 
therefore provides a tractable genetic tool for future studies, which investigate the 
genetics and mechanisms of stapes development, annular ligament development, 
congenital stapes fixation and fixation due to otosclerosis.
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5.   The postnatal development of Meckel’s cartilage
5.1   Introduction
Meckel’s cartilage appears as two rods of hyaline cartilage that traverse the lateral 
aspect of the mandible. It is a transient structure present throughout embryonic 
development in mammals, with the mid region disappearing before birth in humans and 
during neonatal stages in mice (Sperber., 1992; Bhaskar et al., 1953; Richany et al., 
1956). Despite not functioning as an adult structure, Meckel’s cartilage is an integral 
supporting scaffold of the mandible throughout embryonic development, functioning to 
hold the two sides of the jaw in place through its symphysis, and forming a temporary 
connection between the mandible and middle ear (Bhaskar et al., 1953). In humans, 
Meckel’s cartilage is an initial attachment site for muscles of the mandible, and once 
these muscles reach the developing mandible, Meckel’s cartilage commences regression 
(Wyganowska-S !wia "tkowska and Przystan !ska., 2011). In addition, defects in Meckel’s 
cartilage also cause malformations of the developing mandible, suggesting it’s 
importance for mandibular morphology and ossification (Ivkovik et al., 2003). 
Therefore Meckel’s cartilage provides support to peripheral structures during 
development.
In addition to these secondary functions, studies in the field of developmental biology 
have revealed the dynamic nature of the seemingly  homogenous chondrocytes of 
Meckel’s cartilage, which function as potent cellular source for the development of 
several adult structures. Therefore although not present in its initial form during adult 
stages, Meckel’s cartilage integrates into several structures in order to give rise to their 
adult form. Through various investigations, it has become apparent that chondrocytes of 
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Meckel’s cartilage are differentially  specified, and to date the length of Meckel’s 
cartilage has been divided into four discrete regions, each with a distinct fate (Bhaskar 
et al., 1953; Richman and Diewert., 1988; Harada and Ishizeki., 1998; Tsuzurahara et 
al., 2011) (Fig. 5.1). 
For example, chondrocytes of the distal intramandibular region of Meckel’s cartilage 
exhibit osteogenic phenotypes following in vitro culture (Ishizeki et al., 1996), and 
matrix in this region is resorbed, calcified and replaced with bone in vivo (Ishizeki et 
al., 1999). Therefore the distal most region of Meckel’s cartilage contributes to bone of 
the mandible through an endochondral type process of ossification (Richman and 
Diewert.,1988; Harada and Ishizeki.,1998). In contrast, the midsection of Meckel’s 
cartilage exhibits two distinct fates. Whilst the more distal region is removed, most 
likely through resorption by  alkaline phosphatase positive cells such as macrophages 
and osteoclasts, the more proximal midsection gives rise to the sphenomandibular 
ligament (Ishizeki et al., 2001; Richman and Diewert., 1988). Resorption in the distal 
mid region commences with a break down of the perichondrium, followed by invasion 
of vasculature and an infiltrate of TRAP positive functional osteoclasts. These TRAP 
positive cells engulf chondrocytes, are restricted to the distal mid portion and are not 
observed in the fibroblastic mid region that remains intact  with the ossicles of the 
middle ear. (Harada and Ishizeki., 1998). In the more proximal mid region, 
chondrocytes differentiate into cells of fibroblast morphology, which turn down 
cartilage specific genes and do not express cartilage specific proteoglycans typical of 
chondrocytes (Richman and Diewert., 1988; Harada and Ishizeki.,1998; Ishizeki 2001; 
Tsuzurahara et al., 2011). Chondrocytes in this region do not exhibit proliferative 
behaviour and transform directly into fibroblasts of the sphenomandibular ligament, 
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which stretches from the mandible to the malleus of the middle ear (Richman and 
Diewert., 1988). The ability of chondrocytes of Meckel’s cartilage to transform into 
various cell types has been attributed to their neural crest origin (Tsuzurahara and 
Nakamura., 2010). 
Cartilage matrix remodelling is thought to play an influencial role in the determination 
of cell fate throughout Meckel’s cartilage. Cellular matrix contains growth factors, 
cytokines, and various proteins that influence the development of the cell. Cell fate 
changes can therefore be initiated through resorption of this matrix by TRAP positive 
cells such as osteoclasts and macrophages, which for example remove uncalcified 
cartilaginous matrix during the process of endochondral ossification (Ishizeki et al., 
2001; Tsuzurahara and Nakamura., 2010; Tsuzurahara et al., 2011). In addition, 
matrixmetalloproteinases (MMPs) are a family of enzymes that degrade protein 
components of the extracellular matrix, in this way influencing cellular development 
(Sakakura et al., 2007). Chondrocytes of Meckel’s cartilage have been postulated to 
regulate their own cell fate through matrix remodelling, through the chemoattraction of 
macrophages (Tsuzurahara et al., 2011) and expression of MMPs and their inhibitors, 
TIMPs (tissue inhibitors of metalloproteinases) (Ishizeki and Nawa., 2000; Sakakura et 
al., 2007). The mechanism of cell death, however, does not contribute to the resorption 
or transdifferentiation of the mid region in the mouse (Harada and Ishizeki., 1998; 
Trichilis and Wroblewshi., 1997), although cell death of the chondrocytes has been 
suggested to occur in humans (Richany., 1956). Finally, the proximal most region of 
Meckel’s cartilage provides the cartilage of the first two ossicles of the middle ear, the 
malleus and incus, which are eventually  transformed into bone through the process of 
endochondral ossification (Bhaskar et al., 1953; Miyake et al., 1996). Therefore despite 
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appearing as a united cartilaginous structure, development of Meckel’s cartilage occurs 
in region specific domains, each of which contributes to independent structures. 
The sphenomandibular ligament attaches indirectly  to the malleus of the middle ear 
through the anterior malleolar ligament. (Rodriguez-Vazquez et al., 1992; Ogutcen-
Toller.,1995). Therefore both the sphenomandibular ligament and the anterior malleolar 
ligament derive from Meckel’s cartilage. In humans this attachment occurs at five and a 
half months of development (Rodriguez-Vazquez et al., 1992), and by 8 months the 
ligament is additionally observed to attach to the sphenoid bone. As the 
sphenomandibular ligament functions primarily in jaw movements of mastication, the 
timing of this attachment is thought to correlate with the first mandibular movements in 
utero (Ouchi et al., 1998).
The development of part of the mandible and middle ear from a common chondrogenic 
source therefore results in a temporary connection during embryonic development 
between the ear and jaw, through Meckel’s cartilage. Correct transformation of the 
proximal mid region is therefore required to separate the jaw from the middle ear, 
creating the ligaments and establishing a flexible connection between the two structures. 
From the perspective of middle ear development, the consequence of postnatal Meckel’s 
cartilage maturation is therefore to free the malleus of the middle ear from the rest of 
the cartilage, in this way  removing the connection between the jaw and middle ear. This 
separation of our feeding and hearing apparatuses is an adaptation observed in all living 
mammals today  and is an integral feature that characterises the definitive mammalian 
middle ear (DMME). Erroneous ossification of Meckel’s cartilage is a rare defect 
observed in isolated cases of prenatal death (Keith., 1910; Herring., 1993), and may 
203
arise due to defects in postnatal differentiation of Meckel’s cartilage. Ossification of 
Meckel’s cartilage will result in permanent fixation of the mandible to the middle ear 
malleus, which fixes the ossicular chain to the jaw and results in conductive deafness. 
Therefore correct development of the discrete domains of Meckel’s cartilage is integral 
for middle ear function.  
 
The genetics of embryonic Meckel’s cartilage development has also been investigated, 
and has implicated roles for several growth factors in the development of this cartilage 
(Terao et al., 2011; Shum et al., 1993; Havens et al., 2008). However, these studies have 
primarily  focused on embryonic development of Meckel’s cartilage, often with a focus 
on mandibular development. Therefore whilst the mechanisms of transformation of 
Meckel’s cartilage have been investigated, less is known of the genetics of this process. 
In addition, whilst much information has been derived from histological and 
immunology based studies in wild type mice, in vivo analysis with the use of mouse 
models is the next integral step to further correlate mechanisms of various regions of 
postnatal Meckel’s cartilage development with genetic regulators of this process.
In this chapter, a delay in postnatal development of Meckel’s cartilage in Eya1 +/- 
middle ears is identified, establishing these mice as tools for integrated studies of the 
mechanics and genetics of postnatal Meckel’s cartilage transformation. Here I 






















































































































































































































































































































































5.2   Results
As previously described, several studies have investigated the fate of Meckel’s cartilage 
chondrocytes in the intramandibular portion, the mid portion, and the proximal most 
region which gives rise to the ossicles themselves. However most  of these 
investigations have been in relation to mandibular development. Due to this, analysis of 
the cartilage directly adjacent to the middle ear region has been neglected, and is 
assumed to transform into the ligamentous tissue with the rest of the midregion (Harada 
and Ishizeki., 1998). Meckel’s cartilage gives rise to the sphenomandibular ligament 
and the anterior malleolar ligament. Therefore the sphenomandibular ligament connects 
to the malleus through the anterior malleolar ligament (Ogutcen-Toller., 1995). 
However the mechanisms of transformation in this region have not been investigated. 
Therefore skeletal, histological, and tartrate resistant  acid phosphatase (TRAP) analysis 
was employed, in order to determine if this small region directly adjacent to the 
ossicles, forms the anterior malleolar ligament. From the perspective of middle ear 
development, the correct transformation of this region into ligamentous tissue is of 
pivotal importance in comparison to the rest of Meckel’s cartilage, as it will give rise to 
a freely moveable ossicular chain that is required for conductive hearing.  
5.2.1   Skeletal analysis
Transformation of Meckel’s cartilage is preceded by  a loss of staining for cartilage dyes 
such as Alcian blue, and is indication of a loss of cartilage cell matrix (Tsuzurahara et 
al., 2011). Therefore a skeletal preparation series for cartilage and bone was undertaken 
on postnatal middle ears from birth onwards, in order to investigate chondrocyte cell 
fate in this region. At P0, chondrocytes of Meckel’s cartilage from the distal most region 
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to the region adjacent to the middle ear stained homogeneously  with Alcian blue (5.2A). 
However during the next developmental stages, whilst  the distal most regions retained 
staining for Alcian blue, the region adjacent to the malleus exhibited a loss of staining. 
Whilst this was observed at P1 and P2, tissue in this region was still visible and 
composed of rounded cells, suggesting cells in this region had not yet altered their fate 
(5.2B and C). By P4, in addition to loss of Alcian blue staining, this region of tissue was 
no longer visible, forming a gap  between Meckel’s cartilage and the malleus (5.2D). 
This is most likely a result of the method of skeletal preparation, which preserves hard 
tissues but macerates soft tissue. Therefore it would appear by  P4, the proximal most 
region of Meckel’s cartilage adjacent to the middle ear has transformed.
5.2.2   Histological analysis
During transformation, cells in the midportion of Meckel’s cartilage alter from a 
rounded chondrocyte cell morphology  to flattened ligamentous cells (Richman and 
Diewert., 1988). Therefore trichrome histological analysis was subsequently  employed 
in order to investigate cell morphology  in this region of Meckel’s cartilage adjacent to 
the malleus. At P0, a slight loss of Alcian blue staining was observed in the proximal 
most region of Meckel’s cartilage, although the bulk of this region stained 
homogeneously with Alcian blue as observed in skeletal preparations at this stage (5.3A 
and E). The variation between trichrome staining and skeletal preparation observations 
at P0 may reflect slight differences in developmental ages or even the natural variability 
of the process of transformation between individuals. In addition staining on sections is 


































































































































































































































































































































































Figure 5.3. Histological analysis and Tartrate resistant acid phosphatase staining 
(TRAP) of postnatal Meckel’s cartilages. (A- H) Trichrome staining on parasagittal middle ear 
sections. E- H are higher magnifications of A-D respectively. (A and E) At P0 a slight loss of 
Alcian blue staining is observed in the region adjacent to the malleus (arrow). The majority of this 
region stains homogeneously with Alcian blue. (B and F) By P1, Alcian blue staining is lost in the 
proximal region of Meckel’s cartilage adjacent to the malleus (arrow). At this stage cells appear 
rounded and chondrogenic. (C and G) At P2, Alcian blue staining is lost in the proximal region of 
Meckel’s cartilage adjacent to the malleus (arrow). At this stage cells still appear rounded and 
chondrogenic. (D and H) At P3, the proximal region adjacent to the malleus is no longer visible. 
Tissue of fibrous histology resides in its place (arrow).  Cells in the distal region of Meckel’s 
cartilage stain strongly with Alcian blue and appear chondrogenic. (I-P) TRAP staining on 
parasagittal middle ear sections.TRAP positive regions stain red. M-P are higher magnifications of 
I-P respectively. TRAP positive cells appear red. (I and M) TRAP positive cells are not observed in 
or surrounding Meckel’s cartilage at P0. (J and N) TRAP positive cells are not observed in or 
surrounding Meckel’s cartilage at P1.  (K) TRAP positive cells are observed in the tissues 
surrounding  Meckel’s cartilage (arrow). (O) TRAP positive cells are observed in the 
perichondrium and cartilage of Meckel’s cartilage (arrowheads).  (L) By P3 a gap exists between 
the malleus and the ligamentous tissue (arrow) (P) TRAP positive cells are observed in the border 
of the malleus which was adjacent to Meckel’s cartilage. TRAP positive cells are also observed 
surrounding the distal most region of Meckel’s cartilage (D).  mc, Meckel’s cartilage, M, Malleus,  I, 
Incus, D,  distal region of Meckel’s cartilage. (Scale bars A-D and I- L, 200um, E-H and M-P 
100um)
At P2 and P3, loss of Alcian blue staining was observed in the region of Meckel’s 
cartilage adjacent  to the malleus, resembling observations of skeletal preparations 
(5.3B, C, F and G). At P2, cells in this region appeared rounded, suggesting cells at this 
stage remained chondrogenic (5.3G). At P3, the region of Meckel’s cartilage adjacent to 
the malleus was not apparent in histological sections, and instead flattened ligament like 
cells were observed in a path stretching from the vicinity of the malleus to the distal 
most tip  of Meckel’s cartilage. At this stage the distal most region was composed of 
cells with distinct chondrogenic morphology that stained strongly with Alcian blue 
(5.3D and H). Histological observations therefore suggest P3 as the stage of 
chondrocyte to ligament transformation in this region of Meckel’s cartilage. 
5.2.3   Tartrate resistant acid phosphatase (TRAP) analysis
TRAP staining is a method for the detection of cells that synthesise tartrate resistant 
acid phosphatase, such as macrophages and osteoclasts (Janckila et al., 2007; Palle et 
al., 1989). TRAP positive cells have previously  been reported as absent from the region 
of Meckel’s cartilage, which transforms into ligamentous tissue (Harada and Ishizeki., 
1998). Therefore, in order to investigate the presence of TRAP positive cells in the 
region of Meckel’s cartilage adjacent to the malleus, analysis was undertaken on the 
same sections observed histologically, in order to investigate the involvement of 
resorptive cells such as macrophages or osteoclasts. Whilst TRAP positive cells were 
not observed at P0 (5.3I and M) or P1 (5.3J and N), a distinct infiltrate was observed at 
P2, the stage prior to ligament transformation. These cells were typically observed in 
the tissue surrounding Meckel’s cartilage in addition to the perichondrium and in 
cartilage directly adjacent to the malleus (5.3K and O). By P3 TRAP positive cells were 
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observed in the outer edge of the malleus, however at  this stage the proximal most 
region of Meckel’s cartilage appeared absent. TRAP positive cells were also observed 
surrounding the distal most region of Meckel’s cartilage at this stage (5.3L and P).
5.2.4   Eya1 is expressed in Meckel’s cartilage
Investigations in chapters three and four implicated roles for Eya1 in cartilage 
development, with Eya1 expression observed in the lateral regions of the malleus and 
incus in relation to the joint. Therefore in order to investigate a potential role for Eya1 
in Meckel’s cartilage development, RNA in situ hybridisation of Eya1 on parasagittal 
middle ear sections was undertaken. Following birth at P0, Eya1 was expressed in the 
chondrocytes of Meckel’s cartilage, including the proximal most region, which at this 
stage appeared continuous with the first ossicle of the middle ear, the malleus (5.4A and 
B). 
5.2.5   Eya1 +/- middle ears exhibit a delay in regression of Meckel’s cartilage
The expression of Eya1 in Meckel’s cartilage following birth, suggests a role for Eya1 
in the postnatal development of Meckel’s cartilage. Skeletal preparation analysis of 
postnatal middle ears of Eya1 +/+ and Eya1 +/- middle ears was 
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Figure 5.4.  Eya1 is expressed in Meckel’s cartilage following birth.  
RNA in situ hybridisation of Eya1 on parasagittal middle ear sections at P0. 
Regions of gene expression appear purple. B is a higher magnification of A. (A 
and B). At P0, Eya1 is expressed in chondrocytes of Meckel’s cartilage and the 
malleus (arrows). MC,  Meckel’s cartilage, M, malleus, I,  incus. (Scale bars A 
and B, 200um).
therefore undertaken in order to identify  developmental abnormalities of Meckel’s 
cartilage during these stages. At E18.5, Meckel’s cartilages of both Eya1 +/+ and Eya1 
+/- middle ears stained homogeneously with Alcian blue, indicating cells throughout 
Meckel’s cartilage to be of a chondrogenic cell fate at  this stage (5.5A and B). At P3, as 
observed previously, Meckel’s cartilages of Eya1 +/+ middle ears did not stain with 
Alcian blue in the proximal region adjacent to the malleus, and this region of tissue 
appeared absent, implicating transformation of Meckel’s cartilage (5.5C). In contrast 
however, chondrocytes throughout Meckel’s cartilage of Eya1 +/- middle ears at P3 
stained homogeneously with Alcian blue, and resembled Meckel’s cartilages of Eya1 +/
+ middle ears at E18.5 (5.5D). By one week following birth (P7) however, Meckel’s 
cartilages of the Eya1 +/- middle ears had lost Alcian blue staining in the region 
adjacent to the malleus, implicating a developmental delay rather than complete failure 
of Meckel’s cartilage to transform (5.5F). However at this stage, a larger distal region of 
Meckel’s cartilage was present in Eya1 +/- middle ears in comparison to Eya1 +/+ 
middle ears (5.5E).
5.2.6   A TRAP positive infiltrate is observed at P3 in Eya1 +/- middle ears
In order to investigate potential correlation of a delayed transformation of Meckel’s 
cartilage with delayed TRAP cellular infiltrate, TRAP analysis was undertaken in Eya1 
+/- middle ears. Analysis was undertaken at E18.5, as several studies have shown the 
presence of TRAP positive cells in the vicinity  of Meckel’s cartilage at this stage 
(Harada and Ishizeki., 1998; Sakakura et al., 2007; Tsuzurahara et al., 2011). However 
TRAP positive cells were not observed at this stage, in or surrounding Meckel’s 
cartilages of both Eya1 +/+ and Eya1 +/- middle ears, and cells of Meckel’s cartilage 
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stained homogeneously  with Alcian blue (5.6A-F). This implicates comparable 
development between Eya1 +/+ and Eya1 +/- Meckel’s cartilages during the last stage 
of embryonic development. At P3, as observed previously, TRAP positive cells were not 
observed in the proximal most region of Meckel’s cartilage adjacent to the malleus in 
Eya1 +/+ mice, as this region of Meckel’s cartilage was no longer present (5.6A and 
C). Corresponding histological analysis revealed tissue composed of thin, ligamentous 
cells in the vicinity of the malleus (5.6E). In contrast, a large TRAP cellular infiltrate 
was observed amongst the chondrocytes of Meckel’s cartilage in Eya1 +/- middle ears 
at P3. Interestingly, these cells appeared confined to the proximal most  region of 
Meckel’s cartilage adjacent to the malleus and were not observed in the more distal 
region (5.6B and D). Corresponding histology at this stage revealed a loss of Alcian 
Blue staining in this region, although tissue of Meckel’s cartilage was still clearly 
present. The more distal regions of Meckel’s cartilage however still stained 





































































































































































































































































































































































































































































































































































































































Figure 5.6 Comparison of TRAP staining and histology of Eya1 +/+ and 
Eya1 +/- Meckel’s cartilages at E18.5. A,B, D and E, TRAP staining on parasagittal 
middle ear sections. TRAP positive regions stain red.  B and E are higher 
magnifications of A and D respectively. (A and B) TRAP positive cells are not present 
in the proximal region of Meckel’s cartilage adjacent to the malleus in Eya1 +/+ 
middle ears at E18.5.  (D and E). TRAP positive cells are not present in the proximal 
region of Meckel’s cartilage adjacent to the malleus in Eya1 +/- middle ears at E18.5. 
C and F, trichrome histology of Meckel’s cartilage at E18.5. (C) At E18.5 Meckel’s 
cartilage stains homogeneously with Alcian blue and appears continuous with the 
malleus in Eya1 +/+ middle ears (arrow). (F) At E18.5 Meckel’s cartilage stains 
homogeneously with Alcian blue and also appears continuous with the malleus in Eya1 
+/- middle ears (arrow).  M, malleus. (Scale bars, A and D, 200um, B, C, E and F,
100um)
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Figure 5.7. Comparison of  TRAP staining and histology of Eya1 +/+ and Eya1 
+/- Meckel’s cartilages at P3. (A-D) TRAP staining on parasagittal middle ear sections. 
TRAP positive regions appear red. C and D are higher magnifications of A and B 
respectively. (A and C). By P3, TRAP positive cells are observed around the distal most 
region of Meckel’s cartilage in Eya1 +/+ middle ears (arrowheads). They are not 
observed in the region adjacent to the malleus. (B and D) A Large TRAP cellular 
infiltrate is observed in the proximal most region adjacent to the malleus in Eya1 +/- 
middle ears (arrowheads). E and F, trichrome histology of corresponding sections in A-
D).  (E) At P3, the proximal length of Meckel’s cartilage does not stain with Alcian blue 
and appears ligamentous.  The distal most region remains chondrogenic and stains 
strongly with Alcian blue (Arrow). (F) The length of Meckel’s cartilage remains visible 
in Eya1 +/- middle ears, although a loss of Alcian blue staining is observed in the 
proximal most region (arrow).M,  Malleus, D, distal region. (Scale bars, A-B,200um, C-
F, 100um).  
5.3   Discussion
5.3.1   The proximal region of Meckel’s cartilage transforms into the anterior malleolar 
ligament
This study focused on the mechanisms of Meckel’s cartilage transformation in the 
proximal most region immediately adjacent to the malleus, in order to investigate the 
process of separation of the middle ear and mandible. This region has often been 
excluded (Ishizeki et al., 2001), or not investigated explicitly  (Harada and Ishizeki., 
1998; Tsuzurahara et al., 2011), and it is therefore assumed that  this region transforms 
into the ligamentous tissue, along with the rest of the mid region. 
In this study transformation of Meckel’s cartilage is preceded by a loss of Alcian blue 
staining, followed by  a subsequent loss of cartilaginous tissue. This agrees with 
previous studies, which observe a down regulation of collagen !! (Col !!) expression and 
cartilage specific proteoglycan (CSPG), genes associated with differentiated cartilage 
(Harada and Ishizeki.,1998; Richman and Diewert.,1988). The down regulation of 
cartilage specific genes is considered the first sign of cartilage degradation (Tsuzurahara 
et al., 2011). Therefore a loss of cartilage cell fate is the first step  in the transformation 
of this region of Meckel’s cartilage. Histological analysis further revealed ligamentous 
tissue to stretch from the mandible to the vicinity  of the middle ear, suggesting loss of 
cartilage may be due to transformation of chondrocytes into ligamentous tissue in this 
region. Lineage tracing studies, that labelled chondrocytes of Meckel’s cartilage, found 
fibroblasts and osteoblasts to be labelled following culture. Therefore chondrocytes of 
Meckel’s cartilage are considered to modulate to these cell types directly (Richman and 
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Diewert.,1988). Development of the proximal most region may  therefore conform with 
the more distal ligamentous regions (Bhaskar et al., 1953; Richman and Diewert., 1988; 
Harada and ishizeki et al., 1998), and transform directly  into the anterior malleolar 
ligament.
TRAP positive cells such as macrophages and osteoclasts have been highly implicated 
in the transformation of the distal regions of Meckel’s cartilage. Specifically, they are 
thought to function in the formation of bone through an endochondral type mechanism 
and resorption of uncalcified matrix (Richman and Diewert.,1988; Harada and Ishizeki.,
1998; Chung et al.,1995). In this study, a role for TRAP positive cells was investigated 
in the proximal region of Meckel’s cartilage, at stages preceding transformation of this 
region. TRAP positive cells were observed in the cartilage immediately  adjacent to the 
malleus only  at P2, the stage preceding transformation of Meckel’s cartilage. TRAP 
positive cells were not observed, however, in earlier postnatal stages or during the late 
stages of embryonic development at E18.5. This result contrasts with the study of 
Harada and Ishizeki (1998), which does not observe TRAP positive cells in the 
proximal transforming region of Meckel’s cartilage. In their study however, TRAP cells 
are only investigated at E18.5, the stage at which the distal end commences 
transformation. From the work done in this present study, the proximal most region 
remains intact at E18.5, therefore this discrepancy  appears a result of different 
developmental stages investigated. Instead, the proximal most region transforms later 
during postnatal development at P3, and is marked by  a TRAP cell infiltrate preceding 
transformation at P2. Taken together, the transformation of Meckel’s cartilage correlates 
strongly with TRAP positive cells, which only appear at  the stages preceding regional 
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transformation. This further emphasises the temporal dynamics of the transformation of 
Meckel’s cartilage. 
Extra cellular matrix remodelling has been proposed to play  influencial roles in cell fate 
progression (Streuli.,1999). Therefore TRAP positive cells may function to remove 
growth factor and protein laden extracellular matrix in this region, facilitating change 
from a chondrogenic to ligamentous cell fate. For example, chondrocytes of Meckel’s 
cartilage have been suggested to mediate their transformation autonomously in two 
possible ways. Firstly, chondrocytes may recruit macrophages through the expression of 
chemoattractant cytokines, and macrophages may subsequently remodel the 
extracellular matrix. Chondrocytes express interleukin receptors during early embryonic 
development, and in turn during later stages express interleukins. Through this 
mechanism they  can autocrinally induce themselves to synthesise MMPs. MMPs can in 
turn cause degradation of the extracellular matrix (Tsuzurahara and Nakamura., 2010; 
Tsuzurahara et al., 2011). Timps are also implicated in the process of chondrocyte 
matrix remodeling, and a balance of MMPs and their TIMPs may be required to 
regulate postnatal transformation (Ishizeki and Nawa., 2000).
Postnatal development of the proximal most region could therefore be subdivided into a 
series of events; the loss of cartilage matrix and reduction in the expression of cartilage 
specific genes, followed by transformation of the cartilage into ligamentous tissue. 
TRAP positive cells may facilitate this transformation through removal of matrix, or a 
modest removal of chondrogenic cells. Further investigations will be required to 
determine the exact contribution of TRAP positive cells to the transformation of 
Meckel’s cartilage in this region. Identification of these cell types and analysis of the 
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matrix surrounding these cells may provide further insight into how these cells function 
in this process. In addition, comparison of chemokines and MMPs in tissues 
surrounding the Eya1 +/+ and Eya1 +/- Meckel’s cartilage, may  also reveal mechanisms 
associated with the postnatal transformation.
5.3.2   Anatomical considerations
Formation of the anterior malleolar ligament from this region of Meckel’s cartilage also 
complies with anatomical observations. These results introduce important 
considerations for malleal fixation due to abnormal sphenomandibular ligament 
development. For example, fixation due to ossification of Meckel’s cartilage is 
extremely rare (Keith.,1910). As has been discussed, the transformation of Meckel’s 
cartilage is a dynamic process, with each region exhibiting unique cell fates through 
region specific mechanisms. Therefore abnormal development and fixation of the entire 
length of Meckel’s cartilage would require several developmental events to be 
abrogated. It is unlikely  one gene solely regulates the cell fates in all regions, therefore 
fixation of the whole of Meckel’s cartilage most likely occurs due to abrogation of an 
earlier developmental event preceding regional specification. It would appear more 
likely that  malleal fixation, which is observed more commonly than ossification of 
Meckel’s cartilage, occurs as a result of later erroneous regional specifications. One 
such abrogation could be abnormal development of the anterior malleolar ligament.
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5.3.3   Meckel’s cartilage transforms during postnatal stages in the mouse
Another comparison between this study and previous investigations concerns the 
developmental timing of the transformation of Meckel’s cartilage. Most previous 
investigations have focused on the transformation of Meckel’s cartilage in the distal 
most region near the mandible, during embryonic development. In this region TRAP 
positive cellular infiltrates are observed as early  as E17.5 (Harada and Ishizeki.,1998; 
Sakakura et al., 2007; Tsuzurahara et al., 2011). In the present study, the appearance of 
TRAP positive cells are first observed only during postnatal developmental stages at P2, 
a stage just prior to the loss of Meckel’s cartilage in the proximal region. 
Transformation of the mid region into a ligamentous cell fate is subsequently observed 
at P3. The discrepancy of these observations may again be due to region specific cell 
fates, with the distal most region commencing transformation earlier during 
development than the more proximal regions. Indeed, transformation of Meckel’s 
cartilage has previously been described to progress in a distal to proximal direction, 
starting at the mandible and finishing at the middle ear (Bhaskar et al., 1953), although 
this study largely  focused on the distal mandibular region of the cartilage. Taken with 
observations in this study, Meckel’s cartilage could be suggested to develop 
bidirectionally, with the distal and proximal most regions undergoing transformation 
first, and progressing towards the center. Whilst this idea seems plausible, in this 
present study, the distal most region is present and composed of distinctly rounded 
chondrogenic cells that stain strongly with Alcian blue up until the first week following 
birth (P7). Therefore based on these observations alone, it appears Meckel’s cartilage 
transforms in a proximal to distal direction, with resorption in the proximal most region 
observed first during postnatal stages, typically  at P3. In order to investigate intrinsic 
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development of Meckel’s cartilage, several studies have used in vitro culture methods to 
study the development of Meckel’s cartilage (Richman and Diewert., 1988; Tsuzurahara 
and Nakamura., 2010). However development in vitro does not always reflect 
developmental timing in vivo accurately, and may account for the temporal variabilities 
observed between studies.
5.3.4   Eya1 may influence transformation of Meckel’s cartilage
Whilst several growth factors have been implicated in the embryonic development of 
Meckel’s cartilage, less attention has been paid to genes which may regulate the 
transformation of Meckel’s cartilage. Two growth factors, epidermal growth factor (Egf) 
and transforming growth factor beta (Tgfb), however have been implicated specifically 
in the transformation of Meckel’s cartilage. 
Exogenous application of Egf in vitro induces chondrogenic cell cultures to transform 
into fibroblastic morphologies. These cells expressed type ! collagen, and have reduced 
alkaline phosphatase staining, further confirming their departure from a chondrogenic 
cell fate. Quite strikingly, injection of Egf into newborn mice accelerated the loss of 
Alcian blue staining in the proximal region of Meckel’s cartilage, further implicating 
Egf as an inducer of sphenomandibular ligament formation. Interestingly, these 
alterations in response to Egf were uniform throughout Meckel’s cartilage (Ishizeki et 
al., 2001), suggesting chondrocytes of Meckel’s cartilage to have homogenous potential 
to respond to Egf, despite their domain specific cell fates. This is unique, as 
chondrocytes of Meckel’s cartilage are differentially responsive to Fgf10 from as early 
as E12.5 (Terao et al., 2007). Expression of Egf in or surrounding Meckel’s cartilage 
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remains to be determined, however from these studies Egf is strongly implicated in the 
transformation of chondrocytes of Meckel’s cartilage into ligamentous tissue, and may 
function to control the boundaries and formation of the sphenomandibular ligament in 
vivo (Ishizeki et al., 2001).
Another important  growth factor that is implicated in the correct differentiation of 
Meckel’s cartilage is Tgfb. Interestingly, Tgfb receptor 2 knockout mice (Tgfbr2 KO) 
are born with ossified Meckel’s cartilages, in the region which would usually  transform 
into the sphenomandibular ligament. This has been attributed to erroneous 
differentiation of Meckel’s cartilage, with a larger proportion of chondrocytes 
expressing Indian hedgehog (Ihh), a gene expressed in mature chondrocytes. It is 
therefore suggested that  cells in Meckel’s cartilage of the Tgfbr2 KO mouse are unable 
to maintain an immature cartilaginous cell fate, and chondrocytes erroneously form into 
bone through an expanded process of endochondral ossification (Oka et al., 2007). 
Intriguingly, these cell specification alterations are observed during embryonic stages of 
development, supporting the idea that ossification of the entire length of Meckel’s 
cartilage is likely due to early embryological defects.This study  in particular is 
exemplary  of the concept of developmental timing, where loss of Tgfb effectively 
causes accelerated differentiation of chondrocytes in the mid region of Meckel’s 
cartilage. As a result, cells in this region follow a bone differentiation pathway, and 
through endochondral ossification, lose responsiveness to ligament inductive signalling. 
Therefore Tgfb may  indirectly control the fate of the mid region by regulating 
chondrocyte differentiation to maintain responsiveness (Oka et al., 2007). It is likely 
several growth factors such as Tgfb and Egf may act in concert to control developmental 
224
timing of proliferation, differentiation, and therefore the fate of chondrocytes in 
Meckel’s cartilage. 
In this study, Eya1 expression was observed in the chondrocytes of Meckel’s cartilage at 
birth (P0), suggesting a direct role in postnatal differentiation of Meckel’s cartilage. In 
support of this, whilst Eya1 +/- mice did not exhibit retention of Meckel’s cartilages 
into adulthood, a delay in transformation was observed during early postnatal stages, 
with the length of Meckel’s cartilage staining strongly with Alcian blue at  P3. 
Interestingly  by P7, development of Meckel’s cartilage in Eya1 +/- middle ears closely 
matched Meckel’s cartilages in the Eya1 +/+ middle ear, indicating a quick recovery in 
postnatal transformation. Correspondingly, a strong TRAP positive infiltrate was 
observed amongst the chondrocytes at P3 in Eya1 +/- middle ears, further associating 
these cells with the transformation of Meckel’s cartilage. At this stage, a loss of Alcian 
blue staining was also observed in the regions of TRAP cell infiltrate. Therefore 
recovery of postnatal differentiation of Meckel’s cartilage correlates with a TRAP 
positive infiltrate in the Eya1 +/- middle ear, providing further evidence that resorptive 
cells play a direct role in the transformation or resorption of this region. 
It is tempting to speculate that Eya1 may promote the transformation and resorption of 
Meckel’s cartilage through the recruitment of TRAP positive cells. This is most likely 
indirect, perhaps through the induction of chemoattractants such as interleukins, which 
have been proposed to recruit TRAP positive cells to the vicinity of Meckel’s cartilage 
(Tsuzurahara and Nakamura., 2010). Additionally, Eya1 may exert  its function through 
the regulation of other genes that are influential in this process. In this mouse model, the 
delay in Meckel’s cartilage regression does not appear to result in morphological 
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abnormalities in the adult. However speculatively, if this delay did not recover, it could 
have resulted in ectopic ossification. It will therefore be interesting to observe postnatal 
Meckel’s cartilage development of Eya1 mutant mice on other backgrounds that 
typically exhibit more severe phenotypes. The Eya1 +/- mouse therefore provides a 
model system for future studies of the mechanisms and genetics of the postnatal 
differentiation of Meckel’s cartilage. 
It has been suggested that extrinsic signals are required to induce transformation, and 
temporally regulate postnatal Meckel’s cartilage development. For example, in vitro 
culture of E14 Meckel’s cartilage does not emulate in vivo development, whilst  culture 
of E17 Meckel’s cartilage resembles in vivo development (Tsuzurahara et al., 2011). 
Different culture conditions also affect the development of Meckel’s cartilage in vitro, 
implicating responsiveness to extrinsic factors and their possible roles in guiding 
Meckel’s cartilage development (Chung et al., 1999). It will therefore be interesting to 
investigate expression of Tgfb and Egf in the Eya1 +/- middle ear, in order to identify 
genetic abrogations associated with the Meckel’s cartilage phenotype.  
Interestingly, the perichondrium surrounding Meckel’s cartilage has been identified as 
an important signalling source of Tgfb, Egf, and also has high immunoreactivity for 
MMPs (Oka et al.,2007; Shum et al., 1993; Sakakura et al., 2007). The differential 
expression of Collagen X (CollX) throughout the cartilage is also a suggested 
determinant for the regions that form endochondral bone and ligament (Chung et al.,
1995). The delay in Eya1 +/- middle ears can therefore be used to provide further 
correlation of the presence of these factors with the transformation and resorption of 
Meckel’s cartilage.  
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5.3.5   Evolutionary considerations for the transformation of Meckel’s cartilage
Fossils from ancestral mammals have shown Meckel’s cartilage to have once been a 
permanent ossified structure retained in the adult, creating a bony connection between 
mandible and middle ear. The benefit of this extra ossified cartilage is unclear, although 
it may  have functioned as a point of insertion for the pterygoid muscle, facilitating 
lower jaw movement in mastication (Wang et al., 2001). In marsupials, Meckel’s 
cartilage is retained into postnatal development, functioning as a temporary jaw joint  for 
suckling (Maier.,1987). Marsupials are born prematurely and complete development in 
an extra uterine environment, which could be a possible explanation for the necessity  of 
such a temporary load bearing structure. The transient presence of Meckel’s cartilage in 
living mammals may implicate the ossified Meckel’s cartilage (OMC) in ancestral 
mammals as an example of paedomorphosis, which is the retention of an embryonic 
structure in the mature adult  (Ji et al., 2009; Luo et al., 2011). Why some ancestral 
mammals re evolved the OMC is unclear, although paedomorphosis could have 
reversed the DMME specialisation and may suggest preference for a strengthened 
feeding apparatus over a separated middle ear (Gould.,1977).
Paedomorphosis is a result of developmental heterochrony, which is the shift in timing 
of a particular genetic pathway. Therefore the timing of growth factor expression which 
influences Meckel’s cartilage differentiation such as Tgfb, Egf, and potentially Eya1 
signalling, may  influence chondrocyte differentiation, and could perhaps have been a 
determining factor for the fate of the mid portion of Meckel’s cartilage. In this way, 
these genes may have played a role in determining whether Meckel’s cartilage was 
retained as an ossified adult structure or a resorbed remnant. Therefore correlation of 
227
developmental biology in combination with analysis of fossils has been an additional 
avenue to understand the influence of genes in the postnatal development of Meckel’s 
cartilage, and formation of the DMME. Genetic investigations with the use of mouse 
models such as the Eya1 +/- mouse, will aid the identification of key genetic influences 
in the process of disconnection of the jaw and middle ear. Temporal shifts in these 
integral genetic developmental pathways may therefore have influenced the 
evolutionary  variation of Meckel’s cartilages and the middle ear in ancestral mammals, 
driving the eventual disconnection of the feeding and hearing apparatuses seen in living 
mammals today.
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6   The Eya1 +/- mouse model for otitis media
6.1 Introduction
Otitis media can cause considerable conductive hearing loss (Chan et al., 1967), and 
those exposed to chronic recurring otitis media may in addition endure long term 
hearing complications as a result of permanent structural alterations of the middle ear 
(Deka., 1998). Due to these clinical implications, studies in the field of epidemiology, 
pathology, and much more recently developmental biology, have been dedicated to 
understanding the predisposition of otitis media. The latter field in particular has arisen 
due to the emerging idea of a genetic predisposition to the development of otitis media. 
Whilst earlier epidemiological studies first alluded to this concept (Casselbrant et al., 
1999), the field of developmental biology has greatly extrapolated this idea, and 
unveiled several genetic predisposing factors to the development of otitis media. This 
has been achieved greatly  with the use of mouse models. From these studies, various 
factors that contribute to the development of otitis media have been identified and 
include developmental malformations of the middle ear and associated structures, which 
are often observed in syndromes of craniofacial development, immunodeficiencies, and 
ciliopathies. These are all considered factors which contribute to syndromic otitis 
media. The following discussion will center on the main ideas that  have evolved from 
this field of study with emphasis on mouse models of the RDGN.
Mouse models of the RDGN, namely  Eya4, Eya1, and Six1, exhibit postnatal middle ear 
defects and pathology, which likely  contribute to the deafness phenotypes of these mice. 
Eya1 +/- and Six1 +/- mice exhibit signs of inflammation in the middle ear cavity, and 
Eya4 -/- mice exhibit early onset otitis media, with effusions evidenced in mice from 
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just two weeks of age (Xu et al., 1999; Zheng et al., 2003; Depreux et al., 2008). 
Interestingly, the middle ear cavities of Eya1 +/- and Six1 +/- mice appear filled with 
loose connective tissue during adult stages (Xu et al., 1999; Zheng et al., 2003), and the 
middle ear cavities of Eya4 -/- mice also appear full of middle ear mesenchyme at a 
stage prior to signs of otitis media, when the cavity should be predominantly air filled 
(Depreux et al., 2008). These genes of the RDGN may therefore influence postnatal 
middle ear development and maturation, in this way influencing the development of 
middle ear infections during these stages. The presence of mesenchyme in the middle 
ear cavity during adult  stages is a suggested predisposing factor in the development of 
otitis media (Jaisinghani et al., 1999). As mesenchyme has been proposed to disperse 
around the edges of the growing middle ear cavity during postnatal development (Piza 
et al., 1998), smaller middle ear cavity sizes have been correlated with the retention of 
embryonic middle ear mesenchyme. This retention of mesenchyme is referred to as a 
cavitation defect, due to the failure to form a middle ear cavity during these stages 
(Richter et al., 2010). Indeed middle ear cavities of the Eya4 -/- and Six1 +/- mice are 
smaller than cavities of corresponding wild type mice, implicating middle ear cavity 
size as a contributing factor to the pathologies observed in these mice (Depreux et al., 
2008; Zheng et al., 2003). Therefore smaller middle ear cavities may be at greater risk 
of developing otitis media. The occurrence of otitis media and related middle ear 
cavitation defects have not been investigated in the Eya1 mouse model in depth. 
Whether tissue in the adult middle ear cavity is always evidence of a cavitation defect 
and a predisposing factor to later inflammation and disease of the cavity however, are 
currently unsolved questions in the field of middle ear pathology. Nevertheless these 
cavity defects implicate important roles for the Eya4, Eya1, and Six1 genes, and 
potentially the RDGN in postnatal middle ear cavity development.
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The eustachian tube, a structure closely associated with middle ear function, is also 
implicated in the development of otitis media. As this structure functions to drain 
effusions from the middle ear cavity, obstructions of the eustachian tube are strongly 
implicated as a cause of otitis media with effusion. Eya4 -/- mice, for example, exhibit 
narrower more restricted eustachian tubes which open into the middle ear cavity  at an 
abnormal position (Depreux et al., 2008). Similarly the Jeff mouse, which harbours a 
mutation in the Fbxo11 gene (Hardisty-Hughes et al., 2006), exhibits a fully penetrant 
otitis media phenotype, with all mice showing signs of infection following weaning. 
These mice on a C3H/HeH background exhibit  eustachian tubes with narrowed lumens, 
in addition to smaller middle ear cavities (Hardisty et al., 2002). The width and 
positioning of the eustachian tube in the middle ear cavity is of critical importance for 
effective drainage of middle ear fluids, therefore these mice may have compromised 
drainage. Indeed children are considered more susceptible to middle ear infections due 
to the horizontal positioning of their eustachian tubes (Daniel et al., 1982). Concurrent 
with growth of the cranial structures, the eustachian tube is pulled into an oblique 
position by adulthood, which is more effective for middle ear drainage (Bosma.,1986). 
Interestingly  gerbils and chinchillas have a very low predisposition to developing OM 
due to their almost vertically  orientated eustachian tubes. The rat on the other hand is 
much more prone due to the horizontal positioning of the eustachian tube (Daniel et al,. 
1982). Intriguingly, widened eustachian tubes also impede effective drainage, causing a 
build up of effusions in the middle ear cavity  (Noben-Trauth and Latoche., 2010). 
Patent eustachian tubes may enable pathogens form the nasopharynx to enter the middle 
ear cavity, in this way causing infection (Bluestone., 2005). The positioning and 
structure of the eustachian tube in relation to the middle ear cavity is therefore thought 
to play  a highly influencial role in the development of otitis media with effusions. It is 
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likely  several genetic factors and pathways that are integral for craniofacial 
development, including the RDGN, may  cause structural alterations that predispose 
sufferers of such syndromes to otitis media. 
 
Cilia of the middle ear and eustachian tube are also important structures for the removal 
of mucus and debris from the cavity. Several mouse models exhibit altered distribution 
and structure of cilia, however these may  also be secondary consequences of otitis 
media with effusion. For example the Phex hyp-duk/y mutant mouse exhibits thinner 
and irregularly  distributed cilia (Han et al., 2012). Paucity, abnormal morphology, or 
immotility  of cilia are also associated with rhinitis- a build up of mucus in the 
respiratory airways (Voronina et al,. 2009; Ibanez-Tallon et al.,2002 ). These mice are 
additionally predisposed to developing otitis media. Whilst it is likely predisposition to 
otitis media is also a result of ciliary defects, in depth studies of the contribution of 
middle ear and eustachian tube cilia to otitis media in these mice are lacking. In 
addition, cilia defects can be consequences of otitis media and accumulated effusions in 
the middle ear cavity. Therefore a mouse model with ciliary defects overtly preceding 
the development of middle ear infection remains to be characterised. 
In addition to structural malformations, immune system function is a further 
determining factor for the predisposition and severity of otitis media. The C3H/HeJ 
mouse strain, for example, is predisposed to developing bacterial related otitis media. 
This is due to a mutation in the Toll like receptor 4 gene (Tlr4), which encodes an 
integral receptor for innate immune responses (Macarthur et al., 2007). Tlr2 -/- mice are 
also predisposed to developing otitis media following bacterial innoculation of the 
middle ear cavity. Unlike wild type mice, Tlr2 -/- mice are unable to clear infection and 
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exhibit high mortality rates due to bacteremia (Han et al., 2009). MyD88 is an adaptor 
protein required for Tlr mediated signalling and MyD88 -/- mice also exhibit delayed 
immune responses and prolonged infection (Hernandez et al., 2005). Therefore 
increased severity  of otitis media due to an inability to resolve infection, is a general 
trend observed in mouse models of the immune system, and demonstrates the 
importance of the immune response for the resolution of otitis media. Interestingly, 
Eya4 alongside Eya1, Eya2, and Eya3 are able to enhance innate immune responses of 
mouse embryonic fibroblasts in vitro. This implicates additional functions for Eya genes 
in immune signalling pathways and suggests Eya4 -/- mice may additionally develop 
otitis media as a result of immunodeficiency (Okabe et al., 2009; Rye et al., 2011). 
Additionally, Eya1 -/- mice lack the thymus and parathyroid glands, organs integral for 
immune system development. They also exhibit hypoplasia of the thyroid gland (Xu et 
al.,2002). Similarly Six1 -/- mice also lack the thymus and parathyroid glands (Zou et 
al., 2006), suggesting these mice may  both develop middle ear infections due to 
immune deficiencies, which may be a result of integrated Eya1 and Six1 function in the 
development of these organs. Jeff mice bred on a C57/BL/6 background do not exhibit 
the mild craniofacial and eustachian tube defects which they  do on the C3H/HeH 
background, yet are still predisposed to developing otitis media. This has been 
suggested to implicate an additional immune related susceptibility to development of 
middle ear infections (Rye et al., 2011). Therefore immune system deficiencies may be 
the primary, or a contributory factor to the predisposition and development of otitis 
media. 
It therefore appears that several factors may contribute to the otitis media phenotype of 
mouse models of the RDGN, such as middle ear cavity size, postnatal cavitation, and 
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eustachian tube structure. In addition, cilia and immune system functions are also 
important considerations when assessing disease pathology. These factors are affected 
in several syndromes, including those of craniofacial development, and may underlie 
predisposition to middle ear infections in such syndromes. In this chapter, a 
predisposition to otitis media in Eya1 +/- mice has been observed. Here I characterise 
the Eya1 mouse as a model of otitis media, and commence preliminary investigations 
into factors which may influence development of middle ear infections in these mice. 
As otitis media is often observed in patients of BOR syndrome (Worley et al., 1999), 
the Eya1 +/- mouse will provide a valuable tool to investigate the likely causes of 
middle ear infections in sufferers of this syndrome.
234
6.2 Results
6.2.1   Eya1 is expressed in the middle ear epithelium
Eya1 is expressed in the middle ear mesenchyme during embryonic development 
(Kalatzis et al, 1998), however expression of Eya1 during postnatal stages when the 
middle ear mesenchyme has resolved, has not been previously investigated. Eya4 is 
expressed in the middle ear epithelium during adult stages, and these mice also develop 
otitis media (Depreux et al.,2008), suggesting the RDGN may play a role in cavity 
development and function. Therefore in order to investigate a potential role for Eya1 in 
postnatal middle ear development, gene expression analysis was undertaken at  P21, 
once the middle ear cavity is fully aerated. At P21, Eya1 expression was observed in the 
middle ear epithelium (6.1A and B). This expression appeared continuous throughout 
the epithelium of the cavity. 
6.2.2    Eya1 +/- middle ear cavities exhibit reduced aeration
Eya4 -/- mice exhibit cavitation defects during postnatal development, followed by the 
development of otitis media (Depreux et al., 2008). As Eya1 is expressed in the middle 
ear epithelium during these stages, and is closely  related to Eya4, Eya1 may play a role 
in postnatal development and related middle ear disease. Sagittal planes of Micro-CT 
scans of the Eya1 +/+ and Eya1 +/- middle ear cavities were examined, in order to 
investigate potential cavitation defects or otitis media in these mice. This method is 
sufficient for the preliminary  assessment of middle ear cavity  aeration. In Micro-CT 
scans, hard tissue appears white, soft tissue appears grey, and an absence of tissue 
appears black. At P21, the malleus and incus were suspended in a predominantly  air 
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filled middle ear cavity, with the last remnants of mesenchyme observed near the 
articular regions of the ossicles (6.2A). In contrast, the middle ear cavity of the Eya1 +/- 
middle ear lacked aeration, and appeared completely tissue filled. This tissue 
surrounded and embedded the ossicles (6.2B). These observations were taken as a 
preliminary indication of a cavitation defect or otitis media in the Eya1 +/- middle ear. 
6.2.3    Dissection confirmed the presence of mesenchyme and otitis media in the Eya1 
+/- middle ear 
In order to investigate the cause of reduced aeration in the Eya1+/- middle ear, middle 
ears from Eya1 +/+ and Eya1 +/- mice were dissected and compared. The middle ear of 
the Eya1 +/+ mouse was fully  cavitated, and the malleus and incus were suspended in 
an air filled middle ear cavity. Tissue was not observed surrounding the ossicles (6.3A). 
In contrast, the Eya1 +/- middle ear cavity appeared filled with effusions. In addition, 
tissue adhered to the malleus and incus, obscuring their morphology (6.3B). Therefore 
the presence of both tissue and effusions in the Eya1 +/- middle ear, implicated the 
possibility of otitis media with effusions in association with middle ear mesenchyme.
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Figure 6.1. Eya1 is expressed in the middle ear mucosa. RNA in 
situ hybridisation of Eya1 on a P21 middle ear sagittal section.  Regions 
of gene expression appear purple. B is a higher magnification of the 
boxed region in A. (A and B) Eya1 is expressed in the middle ear 
epithelium (arrow).  mec middle ear cavity. (Scale bars in A, 200um, 
scale bars in B, 100um).
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Figure 6.2. Aeration is reduced in the Eya1 +/- middle ear cavity. 
Micro-CT analysis of P21 sagittal planes of sections. Black spaces indicate air 
filled regions whilst grey spaces indicate tissue filled regions.  (A) By P21 the 
middle ear cavity is mostly aerated in the Eya1 +/+ mouse. (B) The middle ear 
cavity of the Eya1 +/- mouse at the same stage has reduced aeration, and appears 
filled with soft tissue (*). M malleus, I incus, O,  extra ossicle, mec middle ear 





























































































































































































   
6.2.4   Eya1 +/- middle ears exhibit mucosal hyperplasia and secretory dysplasia, 
characteristics of middle ear inflammation
In order to investigate the possibility of otitis media in more detail, histological analysis 
of Eya1 +/+ and Eya1 +/- middle ears was undertaken. The Eya1 +/+ middle ear cavity 
exhibited a thin epithelium, of only a few cell layers thick. The epithelium was 
continuous and adhered closely to the bone of the middle ear cavity. Slight separation of 
the epithelium from the bone of the middle ear cavity was observed in some regions, 
although this was considered a histological artifact (6.4A and B). In contrast, the Eya1 
+/- middle ear exhibited severe mucosal hyperplasia. Here the middle ear epithelium 
appeared thickened and was composed of several layers. In addition, polyps of 
mesenchymal tissue protruded into the middle ear cavity. Hypervascularisation of the 
mesenchymal layers closer to the bone of the middle ear cavity  was observed. This was 
evidenced by the appearance of gaps in the mesenchymal tissue, which marked the 
regions of perforating blood vessels (6.4C and D). In addition, secretory dysplasia was 
observed in the Eya1 +/- middle ear epithelium, with mucinous cells staining with 
Alcian blue, a dye that stains heavily glycosylated proteins (Wardi et al., 1972). These 
cells appeared dispersed amongst the cilia of the epithelium in this region (6.4E). 
Hyperplasia of the middle ear epithelium, hypervascularisation, and secretory  dysplasia 
were most prominent in the anterior regions of the middle ear cavity, furthest from the 
inner ear. The mucosa adjacent to the inner ear appeared slightly thickened but not to 
the extent of the rest of the middle ear epithelium. These described features are all 
characteristics of middle ear inflammation, further confirming the presence of otitis 
media in the Eya1 +/- middle ear.
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Figure 6.4. Mucosal hyperplasia and secretory dysplasia is observed in the Eya1 +/- middle ear 
epithelium. Trichrome histology of adult (P21 and older) sagittal middle ear sections. (A) The middle ear 
cavity of the Eya1 +/+ is air filled and free from tissue and effusion. The middle ear epithelium appears 
thin and composed of a few layers of cells. (B) magnification of the boxed region in A to show the thin 
middle ear mucosa of Eya1 +/+ middle ears. Evidence of blood vessels and secretory cells are not 
observed in this region. (C) The middle ear cavity of the Eya1 +/- middle ear is filled with cellular debris. 
(D) Magnification of the larger boxed region in C. The mucosa of the Eya1 +/- middle ear is hyperplastic 
and composed of several layers of dense tissue which forms polyps (arrow). In addition, the mucosa of 
the Eya1 +/- middle ear is hypervascularised. (E) Magnification of smaller boxed region in C and boxed 
region in D. Secretory dysplasia is observed in the Eya1 +/- middle ear mucosa, and mucins stain with 
Alcian blue (arrow). (Scale bars = 200um) mec, middle ear cavity, tm,  tympanic membrane,  bv, blood 
vessel, lv, lymphatic vessels.   
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6.2.5   Eya1 +/- mice exhibit otitis media of varying severity
Through histological analysis, the Eya1 +/- middle ears were observed to exhibit 
varying severities of inflammation. To further assess the incidence and severity of otitis 
media in this mouse line, grading criteria were established (Table 6.1). This was based 
on the histological analysis of fourteen Eya1 +/- middle ears of stages P21 or older. 
According to this criteria, 36% (n = 5/14 ears) of Eya1 +/- middle ears did not exhibit 
otitis media, and this was evidenced by an air filled middle ear cavity with a thin 
epithelial lining (6.5A and B). 7% (n = 1/14 ears) of Eya1 +/- middle ears exhibited 
mild otitis media, which was denoted as grade 1 otitis media. The main sign of 
inflammation in these middle ears was a substantial immune cell infiltrate. Often this 
infiltrate was observed in the vicinity of cellular debris. Other extrovert signs of 
inflammation such as mucosal hyperplasia and dysplasia were not evidenced (6.5 C and 
D). The majority  of Eya1 +/- middle ears (43%) (n = 6/14 ears) exhibited grade 2 otitis 
media; otitis media with effusion. Effusion presented as either serous or cellular. Serous 
effusions appeared as an acellular substance in the middle ear cavity and sparse immune 
cell infiltrates were often present. Signs of inflammation such as hypervascularisation 
and mucosal hyperplasia were also present (6.5 E and F). Cellular otitis media was 
typically evidenced as a dense cellular infiltrate that filled the entire middle ear cavity. 
These cells appeared histologically as mononuclear immune cells. Cellular debris and 
serous effusions may also be present in these middle ears, but identification was 
difficult due to the large immune cell infiltrate. In these middle ears, mucosal 
hyperplasia, hypervascularisation, and secretory dysplasia were evidenced. Secretory 
dysplasia was implicated by a continuous Alcian blue staining of regions of the middle 
ear epithelia (6.5 G and H). Cellular effusions are most likely  evidence of more 
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progressed pathology of otitis media with serous effusion. The final category, grade 3 
otitis media, was the most severe category, and evidenced in 14% (n = 2/14 ears) of 
middle ears. These middle ears were distinctive due to the presence of cholesterol clefts. 
Cholesterol clefts are an artifact of tissue processing. If cholesterol crystals are present 
in the middle ear effusion, they will be removed from the tissue by fat  dissolving agents, 
which are routinely incorporated in the processing of histological sections. As a result, 
clefts will be left behind, and are taken as evidence of the presence of cholesterol 
crystals in the tissue. Cholesterol crystals usually form under severely under aerated 
conditions and are commonly associated with secretory and purulent forms of otitis 
media (Biller and Linthicum., 2001). Under these conditions, cholesterol granulomas 
may also form. These are characterised by the presence of cholesterol clefts surrounded 
by immune cell infiltrates. Tissue of the middle ear effusion in these circumstances 
often appears brown (Akylidiz and Kemaloglu., 2004). This appears to be the case in 
grade 3 effusions, which are marked by the presence of cholesterol clefts, immune cells, 
and a brown appearance even before staining. This grade is therefore considered 
purulent. In these middle ears, the effusion and cholesterol granuloma typically filled 
the whole middle ear cavity, embedding the ossicles completely (6.5 I and J) 
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Grade Otitis media Characteristics
0 No otitis media
Air filled middle ear cavity with thin mucosa. 
Mesenchyme, effusions, and immense cellular 
infiltrates are absent. 
1 Mild
otitis media
The middle ear cavity is mostly  air filled. Discrete 
domains of mucosal hyperplasia may be present. An 
immune cell infiltrate is often visible in the vicinity  of 
cellular debris. Mesenchyme and effusions are not 
evidenced
2
Otitis media with 
effusion
Effusion is present in the middle ear cavity. Effusions 
can be serous or cellular. In middle ears with serous 
effusion, scattered immune cells are often observed. 
Mucosal hyperplasia may  be wide spread or evidenced 
in discrete domains. Specific domains of cholesterol 
clefts may  also be observed. These appear in the 
vicinity  of immune cell infiltrates. In middle ears with 
cellular effusion, immune cells surround the middle 
ear ossicles. This is often accompanied by gross 
mucosal hyperplasia, which can be evidenced as 
polyps. Hypervascularisation and secretory dysplasia 
are often apparent.
3
Otitis media with 
purulent effusion
The middle ear cavity  is filled with a thick purulent 
effusion. Cholesterol clefts and immune cells, forming 
cholesterol granulomas, are present. Signs of 
i n f l a m m a t i o n s u c h a s h y p e r p l a s i a , 
hypervascularisation, and secretory dysplasia are also 
present.
Table 6.1.  Grading criteria of  otitis media in Eya1 +/- middle ears. Characterisation based on 
trichrome histology of 14 Eya1 +/- middle ears (Fig.  6.5). All ears were of stage P21 or older. 36% of 
Eya1 +/- mice did not exhibit OM, grade 0 (n = 5 ears). 7% of Eya1 +/- mice exhibited grade 1 OM (n = 1 
ear).  43% of Eya1 +/- mice exhibited grade 2 OM (n = 6 ears). 14% of Eya1 +/- mice exhibited grade 3 







































































































































































































































































































































































































































































































































































































































































6.2.6   Otitis media in Eya1 +/- middle ears correlated with the presence of middle ear 
mesenchyme
The presence of mesenchyme in the postnatal middle ear has been a suggested 
predisposing factor in the development of otitis media (Takahara and Sando., 1987). 
Therefore histological analysis of P21 middle ears was undertaken, in order to 
investigate a potential correlation of the presence of otitis media with mesenchyme. 
Eya1 +/+ middle ears without otitis media (92%, n = 11/12 ears) were characterised by 
an air filled middle ear cavity, as previously described (6.6 A,D,G and H). At this stage, 
whilst the majority  of middle ear mesenchyme had resolved, the last remaining layers of 
mesenchyme were observed in the edges of the attic of the middle ear cavity 
surrounding the articular regions of the malleus and incus (6.6 A and D). Otitis media in 
Eya1 +/+ middle ears was a rare occurrence (8%, n = 1/12 ears), but exhibited similar 
features to Eya1 +/- middle ears with otitis media, such as the presence of effusions and 
mucosal hyperplasia (6.6 H and K). This mouse however did not present mesenchyme 
in or around the ossicles, and in this respect resembled Eya1 +/+ middle ears without 
otitis media. All Eya1 +/- middle ears of the same age that developed otitis media (6.6 I 
and L), also exhibited mesenchyme in the regions surrounding the articular surfaces of 
the ossicles (100%, n = 9/9 ears). These regions of the ossicles were completely 
embedded in mesenchyme (6.6 C and F). Therefore whilst otitis media in P21 Eya1 +/+ 
middle ears did not  correlate with the presence of excess mesenchymal tissue in the 
middle ear cavity, otitis media in the Eya1 +/- middle ears did correlate with the 
presence of mesenchyme. 
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Figure 6.6.   Otitis media in the Eya1 +/- middle ear is associated with the retention 
of mesenchyme. Trichrome histology of P21 middle ears.  A-F, sections to show regions 
of articulation between the malleus and incus. G-L, more medial sections to show the 
malleus. D,E,F,J,K,L are higher magnifications of A,B,C,G,H and I respectively. (A,D,G 
and J) show histology of an Eya1 +/+ middle ear without otitis media. The ossicles of the 
middle ear are surrounded by air (n = 11/12 ears). (B,H and K) Otitis media is observed 
in an Eya1 +/+ middle ear (n = 1/12 ears) (E) Mesenchyme is not observed around the 
ossicles of the middle ear. (I and L) Otitis media is observed in the Eya1 +/- middle ear 
cavity at P21 (n=9/9 ears, 100%) (C and F) Mesenchyme is observed surrounding the 
articular surface of the incus in the attic (n=9/9 ears, 100%). M, malleus,  I,  incus,OM, 
otitis media, mes,  mesenchyme. Scale bars,  A,B,C,G,H,I, 200um. D,E,F, J, K and L, 
100um. 
6.2.7   Eya1 +/- middle ears exhibit cavitation defects 
Cavitation in the middle ear is complete by two weeks postnatally  in the mouse (Richter 
et al., 2010). Therefore in order to assess if mesenchyme present in the middle ear 
cavity of Eya1 +/- mice is a result  of a cavitation defect, histological analysis of Eya1 +/
+ and Eya1 +/- middle ears was undertaken at P14. At this stage, cavitation in the Eya1 
+/+ middle ear was almost complete, with only a few remnants of mesenchyme present 
by the edges of the middle ear cavity. The majority of the middle ear cavity was 
therefore air filled (6.7A and B). In contrast, at this stage the middle ear cavity of the 
Eya1 +/- middle ear was filled with a loose mesenchymal tissue, which surrounded the 
malleus (6.7C and D). This was taken as indication of a cavitation defect.
6.2.8   Differences in the size of the auditory bullae were not observed between Eya1 +/
+ and Eya1 +/- middle ears
Several mouse models which develop otitis media also possess smaller middle ear 
cavities (Depreux et al., 2008; Zheng et al., 2003; Hardisty et al., 2002). In addition, the 
process of cavitation has been correlated with growth of the middle ear cavity (Palva 
and Ramsay; Richter et al., 2010). Therefore in order to investigate any differences in 
the size of the auditory bullae between Eya1 +/+ and Eya1 +/- mice that may influence 
the cavitation defects and in turn development of  otitis media in the Eya1 +/- middle 
ear, the length and width of the auditory  bullae were measured (Eya1 +/+, n=13) (Eya1 
+/-, n = 18). However, significant differences in these measurements of auditory bullae 
were not observed between Eya1 +/+ and Eya1 +/- mice, suggesting reduction in middle 
ear cavity  size in the Eya1 +/- middle ear does not  account for cavitation defects in 
these mice (6.8A and B) (Fig. 6.9).
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Figure 6.7. Eya1 +/- mice exhibit cavitation defects of  the middle ear.  
Trichrome histology of P14 middle ears. (A) The middle ear cavity of the Eya1 +/
+ mouse is aerated ( n = 1 ear) (B) Magnified image of the boxed region in A. The 
malleus sits in a predominantly aerated cavity (*). (C) The Eya1 +/- middle ear 
exhibits mesenchyme in the hypotympanum near the malleus (n = 1 ear). (D) 
Mesenchyme surrounds the malleus and fills the middle ear cavity in the Eya1 +/- 

























































































































































































































































































































Fig 6.9.    Size of  Eya1 +/+ and Eya1 +/- auditory bullae at stage 
P21. Statistically significant differences between the length and 
width of auditory bullae of Eya1 +/+ and Eya1 +/- mice are not 
present. (Eya1 +/+ n = 13 auditory bullae,  Eya1 +/- n = 18 auditory 
bullae).
The middle ears from both auditory bullae were subsequently dissected to confirm the 
presence of otitis media in the Eya1 +/- middle ears. All Eya1 +/- middle ears included 
in the assessment of auditory bulla size exhibited otitis media, often evidenced as signs 
of hypervascularisation. The visibility of the ossicles was often shrouded in tissue and 
effusion (6.8D and F). Middle ears of Eya1 +/+  mice appeared aerated, and the malleus 
was clearly visible (6.8C and E) .
6.2.9   Bacterial infection may contribute to the development of otitis media of Eya1 +/- 
mice
Bacteria of the middle ear can cause or exacerbate the presence of otitis media 
(Murphy., 2000; Parkinson et al., 2006; Han et al., 2012). In addition, bacterial 
innoculation of the middle ear often induces a middle ear inflammatory  reaction 
(Leichtle et al., 2011). In order to identify whether otitis media in the Eya1 +/- middle 
ear may be caused or influenced by the presence of bacteria, swabs of Eya1 +/+ and 
Eya1 +/- middle ears were plated and cultured on FAA plates. Bacteria was evidenced in 
the middle ears of all Eya1 +/- middle ears swabbed (n= 4), which exhibited effusions in 
the middle ear cavity (6.10 B-E). Bacterial growth was not observed in swabs taken of 
Eya1 +/+ middle ears (6.10 A)(n = 4), which correspondingly  did not exhibit  signs of 
otitis media. These preliminary results may therefore suggest a pathogenic factor may 























































































































































































   
 
6.3   Discussion
6.3.1   The Eya1 +/- mouse model for otitis media
In this chapter, the Eya1 +/- mice are discovered to exhibit postnatal middle ear defects, 
characterised by reduced aeration of the middle ear cavity, which is caused by  the 
presence of soft mesenchymal tissue and effusion. These mice displayed several 
features associated with the inflammatory reaction, including mucosal hyperplasia, 
hypervascularisation, and secretory  dysplasia, strongly  implicating a predisposition of 
the Eya1 +/- mice to developing otitis media. Here the possible influences of the Eya1 
gene in the disease etiology of otitis media will be discussed.
6.3.2   Eya1 +/- middle ears exhibit signs of inflammation 
6.3.2.1   Mucosal hyperplasia
A striking feature of otitis media in the Eya1 +/- mouse was hyperplasia of the middle 
ear epithelia, which appeared pseudostratified, and in the most severe cases formed 
polyps that protruded into the middle ear cavity. Mucosal thickening during otitis media 
has been associated with increased proliferation of the middle ear epithelia, and for this 
reason is referred to as chronic proliferative otitis media (Han et al., 2012). Growth 
factors are thought to be largely responsible for hyperplasia of the middle ear mucosa 
during disease progression (Palacios et al., 2002). For example Fgf23 is upregulated in 
the BALB/c-Phex hyp-Duk/Y mice, a mitogen which may  account for the increased 
proliferation in the middle ear mucosae of these mice (Han et al., 2012). Therefore Eya1 
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may function to regulate mucosal cell proliferation indirectly through the regulation of 
growth factor signalling.
Cell death may also play an integral role in the remodelling of hyperplastic middle ear 
mucosa following otitis media. For example, Lpr/lpr -/- mice fail to produce functional 
fas proteins, which are transmembrane receptors that mediate apoptotic signalling. 
These mice exhibit a greater middle ear mucosal thickness than wild type mice during 
episodes of otitis media, and experience prolonged episodes of infection following 
bacterial inoculation. Cell death may therefore be a mechanism triggered to resolve 
pathology of OM, through removal of increased mucosa and cellular debris present  after 
infection (Rivkin et al., 2005). Regulation of the middle ear mucosa through a balance 
of proliferation and apoptosis, may therefore play a role in the pathogenesis of otitis 
media.
Interestingly, the Eya1 +/- middle ears exhibited significant hyperplasia in the mucosa 
furthest from the inner ear, and very mild or an absence of increased mucosal thickness 
observed in the epithelium closest to the inner ear. Recently, mucosa of the middle ear 
has been found to be of dual origin, with mucosa in the attic region deriving from the 
neural crest, and the rest  of the mucosa forming from endoderm of the branchial arch. 
Neural crest derived epithelium is unciliated, whilst endodermally  derived epithelia is 
ciliated (Thompson and Tucker., 2013). Mucosa in these regions may  therefore be 
differentially responsive to infections of the middle ear. It  will be interesting to compare 
the cellular mechanisms of otitis media in neural crest and mesoderm derived middle 
ear epithelia, in order to investigate potential differences in disease response. 
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6.3.2.2   Secretory metaplasia and dysplasia
Secretory metaplasia, evidenced as the presence of ectopic mucin producing cells, was 
also observed in the Eya1 +/- middle ear. These cells stained with Alcian blue, a dye 
which  stains heavily glycosylated mucins (Wardi et al., 1972). They appeared ciliated, 
and were present in several regions of the mucosal epithelium. In contrast, mucin 
producing cells were rarely  observed in the Eya1 +/+ middle ear. In a healthy middle 
ear, mucous secreting cells are usually  restricted to the middle ear epithelium in the 
vicinity  of the eustachian tube. However under pathological conditions, cells of the 
middle ear epithelia may transdifferentiate into mucous producing cells. An increase in 
mucous secreting cells is a common feature of otitis media and is considered an innate 
immune response that  occurs during disease progression. This provides mucous to flush 
out excess cells and bacteria from the middle ear cavity. However in effect, an increase 
in mucous secreting cells can result in exacerbation of otitis media, with the increased 
effusions accumulating in the middle ear cavity  (Lin et al., 2012). An increase in goblet 
cells are observed in several mouse models of otitis media (Yang et al., 2000; Depreux 
et al., 2008; Han et al., 2012; Tian et al., 2012). In the BALB/c-Phex hyp-Duk/Y mice, 
secretory metaplasia is considered the cause of excess secretions during infections in 
these mice (Han et al., 2012). The presence of mucin producing cells in ciliated regions 
of the Eya1 +/- middle ear epithelium may be an indication of abnormal 
transdifferentiation of cilia into secretory cells, in this way resulting in increased 
numbers of mucin producing cells. Alternatively, ciliated cells of the middle ear 
epithelium are capable of producing limited amounts of secreted and membrane bound 
mucins (Lin et al., 2012). Therefore histological observation through staining with the 
Mayer’s mucicarmine method will confirm if these mucous producing cells are 
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evidence of goblet cell metaplasia or dysplasia. Interestingly, increases in mucous 
secreting cells are considered irreversible, and these cells remain in the epithelium even 
after resolution of infection has occurred. This increase in mucous secreting cells may 
predispose those individuals to recurring episodes of otitis media with effusion (Tos and 
Caye-Thomasen., 2002). Increased effusions through secretory metaplasia and dysplasia 
may therefore arise due to erroneous cell fate specification in the middle ear epithelia.
Interestingly, several gene mutations that result in an increased prevalence to 
developing otitis media, are expressed in the middle ear epithelium, including Eya4, 
Evi1, P73, Tgif, and Fbxo11 (Depreux et al., 2008; Parkinson et al., 2006; Yang et al., 
2000; Tateossian et al., 2013; Hardisty-Hughes et al., 2006), suggesting otitis media in 
these mice may result from cellular dysfunction of the middle ear epithelium. For 
example, Fbxo11 is expressed in the wild type  middle ear epithelia from birth until just 
prior to stages when otitis media develops in the Jeff mouse. Interestingly expression 
appears confined to mucin secreting cells, suggesting Fbxo11 may play a specific role in 
the development or regulation of these cell types (Hardisty-Hughes et al., 2006). In 
addition to expression in the epithelium of inflamed middle ears, Evi1 is additionally 
expressed in neutrophils and leukocytes in the middle ear cavity. Therefore Evi1 may 
also regulate immune cell responses following infection (Parkinson et al ., 2006). The 
middle ear epithelium functions as a pathogenic barrier, often through the secretion of 
mucins, induction of cytokines, and the mechanical clearance by cilia, and is therefore 
composed of a variety of specialised cell types (Kubba et al., 2000). Correct cellular 
homeostasis of the middle ear epithelium is therefore vital for middle ear function. 
Several genes may function to maintain the regulation of this dynamic epithelia through 
the mechanisms of proliferation, apoptosis, and cell fate. In this chapter, Eya1 
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expression was observed in the middle ear epithelia of three week old mice. As Eya1 
functions in an autocrine manner to regulate several cellular processes such as 
proliferation, cell fate, cell survival, cell death, and cell polarity (Bonini et al., 1993; 
Hirose et al., 2010; Schlosser et al., 2008; El-Hashash et al., 2011), Eya1 may function 
in the postnatal middle ear, to regulate the middle ear epithelia through cell intrinsic 
mechanisms. Further investigations will be required to identify cellular abrogations of 
the middle ear epithelia, such as changes in proliferation, cell death, and cell fate, prior 
to or during disease progression. In addition, it will be interesting to observe Eya1 
expression in the inflamed middle ear.  
6.3.3   Cavitation defects may predispose the Eya1 +/- mice to developing otitis media
Mucosal hyperplasia and the presence of mesenchyme in the middle ear cavity during 
adulthood could be results of unregulated mesenchymal proliferation. Alternatively, 
mesenchyme present in the middle ear cavity during postnatal stages could be evidence 
of unresorbed embryonic mesenchyme of the middle ear. Retention of mesenchyme in 
the middle ear cavity after birth is frequently  observed in syndromes of craniofacial 
development (Jaisinghani et al., 1999), in particular in syndromes that present with 
malformations of the ear (Kasemsuwah et al., 1996). This persistence of mesenchyme in 
the middle ear strongly correlates with the development of otitis media (Takahara and 
Sando., 1987), with an increased amount of mesenchyme correlating with a more severe 
pathology of otitis media (Kasemsuwah et al., 1996). Several mouse models of otitis 
media also exhibit mesenchyme in the middle ear cavity (Xu et al., 1999; Zheng et al., 
2003; Depreux et al., 2008), further suggesting a role for mesenchyme in the pathology 
of otitis media. The Eya4 -/- mouse in particular exhibits a middle ear cavity full of 
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mesenchyme at P11, a stage when the cavity should be largely aerated. At this stage, 
otitis media has not yet developed, suggesting retained mesenchyme may be a cause of 
otitis media (Depreux et al,. 2008). Interestingly, the genes abrogated in these mouse 
models are all members of the RDGN, suggesting they may play a common 
developmental role in disease development. However, with exception of the Eya4 -/- 
mouse, whether mesenchyme observed in these mouse models is a cause or 
consequence of otitis media remains unclear. For example, retained embryonic 
mesenchyme may obstruct clearance of effusions from the middle ear cavity, in this way 
causing otitis media. Alternatively mucosal hyperplasia, which is a common sign of 
otitis media, may result  from excess proliferation of the middle ear mucosa. This 
mucosal hyperplasia may also be the source of an excess of mesenchymal tissue in the 
middle ear cavity. In this latter scenario, excess tissue is therefore a consequence of 
otitis media.
In this chapter, mesenchyme is observed in the Eya1 +/- middle ears that also develop 
otitis media. Cavitation of the middle ear has been proposed to occur in an inferior to 
superior direction, so that mesenchyme in the attic where the malleus and incus 
articulate, is usually  the last to resolve (Thompson and Tucker,  2013). During adult 
stages ( P21), mesenchyme in the Eya1 +/- middle ear is observed specifically in those 
regions where the malleus and incus articulate. As mesenchyme does not appear 
prominent in other regions of the cavity, mesenchyme in the Eya1 +/- middle ear may 
be a result of a delay  in cavitation. Further, whilst otitis media in the Eya1 +/- middle 
ear correlates with the presence of mesenchyme, mesenchyme was not observed in the 
middle ear cavity of the Eya1 +/+ middle ear that  did develop otitis media. This may 
suggest the disease etiology for otitis media to vary  in part between Eya1 +/+ and Eya1 
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+/- middle ears, most likely with environmental factors such as the presence of 
pathogens predominantly contributing to development of otitis media in the Eya1 +/+ 
middle ears. In order to confirm cavitation defects in the middle ear, earlier histological 
analysis at two weeks following birth was undertaken, a stage when the process of 
cavitation is usually complete. At this stage, the Eya1 +/- middle ear was full of 
mesenchyme, whilst the Eya1 +/+ middle ear cavity was predominantly aerated. The 
presence of mesenchyme in the most inferior regions (the hypotympanum) of the Eya1 
+/- middle ear cavity, in particular implicates a cavitation defect, as these regions are 
usually  the first  to resolve (Thompson and Tucker., 2013). Therefore from these results 
there is a strong implication that Eya1 +/- mice may be predisposed to developing otitis 
media due to a cavitation defect. The presence of mesenchyme in the functional middle 
ear may impair effusion clearance, and encourage infection of the middle ear cavity, in 
this way predisposing the middle ear to otitis media. However, further analysis of a 
larger cohort of Eya1 +/- mice will be required, in order to determine if cavitation 
defects are present in the majority  of Eya1 +/- mice, and therefore if it is likely to be the 
main cause of later otitis media development. Interestingly, the presence of 
mesenchyme and otitis media in the Eya4 mouse model (Depreux et al., 2008), may 
suggest Eya1 and Eya4 play similar roles during postnatal middle ear development.
Middle ear cavitation has been associated with growth of the auditory  bulla (Piza et al., 
1998), defects in size resulting in retention of mesenchyme in the middle ear (Richter et 
al., 2010). Indeed retained mesenchyme has been observed in several mouse models 
that exhibit smaller middle ear cavity sizes (Depreux et al., 2008; Zheng et al., 2003; 
Hardisty et al., 2002). Whilst Eya1 +/- mice exhibit mesenchyme in the middle ear 
cavity, differences in the length and width between the auditory bullae of Eya1 +/+ and 
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Eya1 +/- middle ears were not observed. Therefore it appears unlikely that mesenchyme 
in the Eya1 +/- middle ear cavity is a result  of middle ear growth defects. However as 
several processes may  contribute to removal of middle ear mesenchyme during 
postnatal development (Richter et al., 2010), cavitation defects in the Eya1 +/- middle 
ear is still a possibility.  Defects in other structures of the Eya1 +/- mouse that may 
contribute to the otitis media phenotype, such as the eustachian tube, paratubal muscles, 
and cilia of the middle ear, remain to be investigated. Eya4 is expressed in the 
epithelium of the middle ear and eustachian tube, and Eya4-/- mice exhibit eustachian 
tube and cilia defects, although the latter may be a secondary consequence of infection 
(Depreux et al., 2008). Therefore it will be interesting to observe these structures in the 
Eya1 +/- mouse, in order to investigate potential influences of these structures in the 
development of otitis media in this model.
6.3.4   Pathogenic environmental factors may contribute to the disease etiology of otitis 
media 
Otitis media can arise from bacterial infections, and is the suspected cause of several 
epidemiological factors that increase the prevalence to developing otitis media, such as 
the attendance of day care for children (Paradise et al., 1997; Kubba et al., 2000). 
Bacteria can gain entrance to the middle ear cavity through the eustachian tube, and 
several respiratory pathogens found in the oro nasal pharynx are often identified in 
middle ear effusions (Murphy  et al., 1987). Therefore pathogenic factors often play a 
significant role in the initiation or contribution to otitis media pathology.
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The presence of bacteria is suggested to contribute to the development of otitis media in 
several mouse models, although other structural or immunological factors are often 
additionally present. For example, large numbers of gram negative bacteria are present 
in the majority of middle ears of the Junbo mouse, suggesting bacteria may contribute 
to the initiation or disease progression of otitis media in these mice (Parkinson et al., 
2006). In addition to Fgf23 misregulation, greater colony forming units of bacteria are 
present in the BALB/c-Phex hyp-Duk/Y. Treatment of these mice with antibiotic 
prophylaxis however does not eliminate the incidence of otitis media, suggesting 
bacterial infections are secondary consequences to the initial disease development. 
Nevertheless in these mice, bacteria may  contribute to the severity of otitis media (Han 
et al., 2012). 
Bacterial growth occurred following the culture of middle ear swabs from the Eya1 +/- 
middle ear, suggesting the contribution of a pathogenic factor in the development of 
otitis media in these mice. Swabs from all Eya1 +/+ middle ears did not result in the 
growth of bacteria. The FAA medium encourages the growth of anaerobic bacteria 
(Heginbothom et al., 1989), therefore the growth of bacteria may be encouraged due to 
reduced aeration in the Eya1 +/- middle ear cavity. Anerobic conditions may 
additionally suggest bacteria as a secondary factor in the development of otitis media, 
which may  exacerbate otitis media already  present in the cavity. In addition, bacteria 
may underly  the rare instances of otitis media in Eya1 +/+ mice. However, whilst the 
culture of middle ear swabs is a cheap  and time efficient method for a preliminary 
assessment of a pathogenic contribution to the development of otitis media, further 
investigations  will be required to ascertain a pathogenic factor. This will include 
investigation of a larger cohort of Eya1 +/+ and Eya1 +/- middle ears, in order to 
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correlate the presence of bacteria with the severity of otitis media. In addition, the re-
assessment of the incidence and severity  of otitis media following antibiotic prophylaxis 
or housing of these mice in specific pathogen free conditions will provide an indication 
of the true influence of pathogenicity. Further identification of the species of bacteria 
present in the Eya1 +/- middle ear will also enable comparison to the common strains 
involved in the development of otitis media in humans. 
As would be expected, bacteria plays a particularly  influencial role in mouse models 
that possess defects in immune system components, and bacteria is considered a 
predisposing factor to the development of otitis media in the C3H/HEJ mouse (Tlr4 
deficient) (Macarthur et al., 2008). Delayed resolution of otitis media following 
bacterial innoculation is also observed in the  Myd88 -/- and Tlr2 -/- mice (Hernandez et 
al., 2008; Han et al., 2009). Another related possibility may therefore be an increased 
susceptibility of Eya1 +/- mice to the development of otitis media due to immune 
system defects. Eya1 is required for the development of the thymus, thyroid, and 
parathyroid (Xu et al., 2002), glands of the endocrine system with implicated roles in 
immune system function. In addition, in vitro, all members of the Eya family  (Eya1, 
Eya2, Eya3, and Eya4) can enhance the innate immune response to polyinosinic- 
polycytidylic acid (poly I:C), a double stranded RNA that provokes similar immune 
responses to viruses. This function is mediated through the Eya threonine- phosphatase 
domain of cytoplasmic Eya proteins (Okabe et al., 2009). It  would therefore be 
interesting to investigate the immunity  of these mice, in order to assess an 
immunocompromisation factor in the development of otitis media in these mice. 
Investigation of the morphology  of the thymus, thyroid, and parathyroid glands may 
reveal structural defects of these organs in Eya1 +/- mice of a BL/6 background. In 
addition an immunisation assay, for example antigenic innoculation of Eya1 +/+ and 
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Eya1 +/- mice, followed by FACS analysis of granulocyte cells, will enable a 
comparison of the immune response between these mice.
Eya1 may therefore contribute to the disease etiology of these mice as a result of 
developmental roles such as the regulation of the middle ear epithelia through cell 
intrinsic mechanisms, or the process of mesenchymal cavitation during early  postnatal 
development. Eya1 may additionally influence susceptibility to otitis media through 
immunogenic roles, and it will be interesting to reassess the otitis media status once the 
pathogenic factor has been eliminated. Eya1 +/- mice exhibit characteristic signs of 
middle ear inflammation and will prove useful as a model for future investigations of 
the mechanisms and genetics of otitis media, which may in turn elucidate the disease 
etiology of otitis media in individuals with BOR syndrome.
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7.3   Discussion
The aim of this thesis was to investigate the genetics of middle ear development and 
disease, with the use of the Eya1 mouse model. This is a particularly interesting model 
to use, as several embryological and pathological abrogations observed in BOR 
syndrome are phenocopied in the Eya1 +/- mouse. The middle ear is a developmentally 
intricate organ, with the correct formation, and maintenance of several bone and soft 
tissue structures required for middle ear function. With the use of this mouse model, I 
have investigated the genetics and mechanisms of several of these processes, and have 
implicated the importance of the Eya1 gene in both middle ear development and 
disease. Here I will draw on some of the conclusions from these chapters and discuss 
these ideas in a greater context of middle ear development and disease.
7.3.1   Eya1 is a genetic regulator of embryonic and postnatal middle ear development
In this project, novel middle ear defects in the Eya1+/- mouse have been identified 
during both embryonic and postnatal development. These include ectopic joint 
formation in the incus and anterior annular ligament of the stapes, stapes fixation 
through ossification of the posterior annular ligament, and a delay in the transformation 
of Meckel’s cartilage. Roles for Eya1 are therefore suggested in ossicle joint patterning, 
joint maintenance, and Meckel’s cartilage development, implicating Eya1 as a regulator 
of both embryonic and postnatal middle ear development. These abrogations may 
impact on hearing and are often associated with syndromic conductive deafness. From 
this study  it appears that Eya1 may regulate the development of several middle ear 
structures, therefore mutations in EYA1 may manifest as widespread middle ear defects. 
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Indeed, BOR syndrome is characterised by  a variety of middle ear malformations 
(Konig et al., 1994), which may reflect the loss of function of EYA1 or EYA1 related 
signalling.
7.3.2   Eya1 and middle ear disease
In this project I have characterised the Eya1 +/- mouse as a model for both otosclerosis 
and otitis media, diseases of the middle ear that cause conductive hearing loss. In this 
model, otosclerosis is evidenced as fixation of the stapes. Fixation in the Eya1 +/- 
mouse occurs between one week and three weeks of postnatal development, with the 
posterior annular ligament histologically appearing normal during embryonic and early 
postnatal stages. Unlike the Noggin +/- mouse, which exhibits stapes fixation during 
late embryonic stages and arises as a result of initial developmental defects (Hwang and 
Wu ., 2008), fixation in the Eya1 +/- mouse arises due to abnormal ossification of the 
already formed ligament. This may be considered as syndromic associated otosclerosis. 
Whilst the mechanisms of syndromic and non syndromic otosclerosis may differ and are 
often considered independently (Hirshoren et al., 2008), the Eya1 +/- mouse could be 
used to elucidate common pathological mechanisms. Several factors are considered 
influential in the development of otosclerosis, including the immune system, viruses, 
endocrine hormones, and genetics (Stankovic et al., 2006). For example mutations in 
the type 1 collagen gene (COL1), a developmental regulator of cartilage development, 
predisposes individuals to the development of otosclerosis (McKenna et al., 1998), and 
over 1500 mutations in the COL1 and COL2 genes underly  the etiology of otosclerosis 
(Forlino et al., 2011). Interestingly, Eya1 may  play roles in the immune and endocrine 
system (Xu et al., 2002; Okabe et al., 2009; Weber et al., 1999), and in this project has 
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been implicated in cartilage development. Therefore regulators of middle ear 
development may also underly the genetics of otosclerosis. Otosclerosis is the most 
common cause of conductive deafness in adults (Moumoulidis et al., 2007), therefore 
the Eya1 +/- mouse may provide a valuable tool for the future investigation of factors 
that contribute to this pathology.
Just over half of Eya1 +/- mice analysed also developed otitis media, therefore Eya1 
may  play  a role in the disease etiology of syndrome associated middle ear infections. 
Indeed, recurrent otitis media is a common observation in individuals with BOR 
(Legius et al., 1990; Weber and Kousseff., 1999; Johnston et al., 2011). However, 
further investigations will be required to understand how Eya1 may predispose the 
middle ear to infection when mutated. Eya1 may  influence otitis media through a 
developmental role, and mutations may result in structural defects. In this project  I have 
ruled out the possibility of auditory  bullae size influencing middle ear inflammation in 
these mice, although retention of mesenchyme is clearly  observed in the Eya1 +/- 
middle ear. Cavitation defects are strongly  associated with middle ear cavity size, 
however several factors are implicated in the process of cavitation (Richter et al., 2010). 
The Eya1 +/- mouse therefore presents as an interesting model of otitis media with 
associated cavitation defects, and can be used to reveal other highly influencial factors 
in the process of cavitation. It will be interesting to investigate these other factors in the 
Eya1 +/- middle ear, namely  cell death and the presence of macrophages in the middle 
ear. Retained tissue may encourage the development of middle ear infections through 
physical obstruction, or perhaps the initiation of middle ear inflammation in an attempt 
to resolve the tissue.  
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Other structural defects, for example of the eustachian tube, have not been investigated. 
The eustachian tube is a highly influential structure in the development of otitis media, 
and Eya4 -/- mice develop otitis media in association with eustachian tube defects. 
Therefore, Eya1 may play a role in eustachian tube development also, and abrogated 
eustachian tube development may further predispose these mice to otitis media. 
Interestingly, widening of the eustachian tube has been observed in an individual with 
BOR syndrome (Johnston et al., 2011), therefore future investigation of eustachian tube 
structure will be clinically relevant. In addition to developmental roles, loss of Eya1 
may  result in the development of otitis media due to immune system related roles. Eya1 
is required for development of the thymus, parathyroid, and thyroid glands in the 
mouse, organs which play  roles related to the immune system (Xu et al., 2002). In vitro, 
the Eya genes are implicated in cellular immune responses (Okabe et al., 2009). 
However defects in these organs have not been reported in BOR syndrome, and whether 
Eya genes play a role in immune system responses in vivo is undetermined. Eya1 +/- 
mice have good survival rates and are viable beyond a year; therefore it  is unlikely they 
have major defects in immune system responses. They do however develop infections 
of the eyes, which may suggest a slight immunodeficiency. Further analysis of immune 
system components may reveal a mild underlying immune defect, which may further 
enhance the otitis media phenotype or impair resolution. Further analysis of these mice 
may therefore reveal important factors in the disease etiology of otitis media. 
7.3.3  Otitis media: future perspectives
A focus in the field of otitis media research is to understand the signalling pathways that 
may underlie genetic susceptibilty and disease progression of otitis media. Several 
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growth factors are implicated in the pathogenesis of otitis media, including Bmps and 
Fgfs. Interestingly  whilst  Bmp6 and Bmp7 are increased during acute episodes of otitis 
media, they  are down regulated during chronic otitis media. These Bmps are associated 
with tissue remodeling, which may only occur during the early events of otitis media 
(MacArthur et al., 2011). Several Fgfs are also associated with the angiogenic responses 
during otitis media (Husseman et al., 2012). Additionally  increased levels of the Tlr2, 
Tlr4, and pro-inflammatory cytokines have been observed during the pathology of otitis 
media (MacArthur et al., 2011; Han et al., 2012).
Tgfb is an integral growth factor during development, which additionally functions as a 
cytokine in the immune response. Several studies associate the Tgfb signalling pathway 
with the presence of otitis media in the middle ear, implicating this pathway  in the 
pathology of middle ear infections. Smad proteins are the downstream effectors of the 
Tgfb signalling pathway. In the cytoplasm, Smads interact together to form transcription 
factor complexes, which then translocate to the nucleus and regulate gene expression 
(Kitisin et al., 2007). Recently, abrogations in Tgfb signalling have been implicated in 
several mouse models of otitis media. For example, Tgif mutant mice (transforming 
growth interacting factor 1), exhibit chronic otitis media with effusion, with resulting 
conductive deafness. Tgif is expressed in the middle ear epithelia with Smad 2, and 
decreased levels of phosphorylated Smad 2 are observed in Tgif -/- mice. Therefore, 
alterations in Tgfb signalling may predispose the Tgif mutant mice to developing otitis 
media (Tateossian et al., 2013). Similarly, the Jeff mouse, which has a mutation in the 
Fbxo11 gene (Hardisty-Hughes et al, 2006), exhibits fully penetrant otitis media with 
effusion (Hardisty et al., 2003). Fbxo11 -/- mice possess increases in pSmad2 in the 
palate, eyelids, and lungs, tissues which are developmentally  regulated by Tgfb 
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signalling. In addition, increased nuclear localisation of Psmad2 is observed in all three 
organs in comparison to Fbxo11 +/+ mice, suggesting alterations in Tgfb signalling in 
Fbxo11 mutants. Therefore Fbxo11 may  regulate Tgfb signalling in various epithelia 
through the regulation of Smad2 (Tateossian et al., 2009), and dysregulation of the Tgfb 
signalling pathway may also play a role in development of otitis media in these mice. 
Similarly, a mutation in Evi1 underlies otitis media in the Junbo mouse (Parkinson et 
al., 2006). Evi1 is a transcription factor that binds Smad 3 in the nucleus and represses 
the antagonistic effects of Tgfb on cellular growth, resulting in increased proliferation 
(Kurokawa et al., 2008). Although these experiments examine the role of Evi1 in the 
context of oncogenesis, Evi1 interactions with downstream effectors of the Tgfb 
pathway may  also play a role in the pathogenesis of otitis media (Parkinson et al., 
2006). Therefore it is also likely, dysregulation of the Tgfb signalling pathway underlies 
otitis media in the Junbo mice also. In addition, being integral to the innate immune 
response, Tgfb functions to down regulate the transcription of mucins, proteins which 
are key components of protective mucous secretions in the middle ear and respiratory 
airways. This is achieved through the Smad3- Smad4 complex, which functions to down 
regulate transcription of the Muc5a gene (Jono et al., 2003). Therefore the Tgfb 
signalling pathway  may underlie the mechanisms of effusion, both under normal and 
pathological middle ear conditions.
Severe inflammatory reactions, such as those of OM, can cause a build up of hypoxic 
conditions. Indeed, hypoxic conditions are present in the middle ears of both the Junbo 
and Jeff mice. Under these conditions, vascular endothelial growth factor (Vegf) 
promotes angiogenesis and recruitment of lymphocytes to the site of infection, in order 
to provide an oxygen supply  and promote resolution of OM. In addition, Vegf signalling 
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lies downstream of hypoxia inducible factor Hif1, a transcription factor that promotes 
restoration of oxygen to the tissues. In the Junbo mouse model of OM, inhibition of 
both Vegf and Hif1! results in improvement of hearing due to reduction of fluids and 
blood vessels in the middle ear cavity. The Vegf pathway under chronic conditions of 
inflammation, may provide a therapeutic target for the resolution of OM  (Cheeseman et 
al., 2011). Therefore Junbo (Evi1), Jeff (Fbxo11), and Tgif1 mice may develop otitis 
media due to abrogations in the Tgfb signalling pathway, due to an inability to resolve 
hypoxic conditions of the inflamed middle ear. This may  occur through Hif1! mediated 
Vegf signalling. 
Through these studies, the first evidence of signalling pathways that may  underlie 
genetic predisposition to otitis media have been identified. Investigation of these 
pathways will reveal a greater understanding of the disease mechanisms of otitis media, 
and in turn therapeutic targets for disease resolution. The Eya1 +/- mouse model may 
prove useful for understanding the signalling pathways that underlie syndromic 
associated otitis media.
7.3.4   Cellular function of Eya1 in middle ear development; cell fate regulation
Eya1 is a transcription factor, therefore most likely mediates its function through 
cellular intrinsic mechanisms. In this project, several roles for Eya1 in middle ear 
development and disease have been implicated, and further investigation into how Eya1 
may mediate these roles will be an interesting focus of future research.  
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Eya1 has been shown to regulate several mechanisms, including cell survival, cell 
death, cell fate, and cell proliferation (Bonini et al., 1993; Hirose et al., 2010; Schlosser 
et al., 2008; El-Hashash et al., 2011). In this project I have proposed Eya1 to play a 
general role in cartilage development. For example, Eya1 may  regulate joint patterning 
through the maintenance of a cartilage cell fate, loss of Eya1 resulting in a loss of 
chondrocyte specification. In turn, this may  result in dedifferentiation of these cells into 
mesenchymal joint cells. Eya1 may also function to maintain cell fates of the stapedial 
anterior and posterior annular ligament, loss of Eya1 resulting in the formation of an 
ectopic joint in the region of the anterior ligament, and ossification in the posterior 
annular ligament, resulting in stapes fixation. As cells of the annular ligament develop 
initially from cartilage of the inner ear otic capsule, the cells of the posterior annular 
ligament could also be considered to lose ligament specification, and dedifferentiate 
back to their original cartilaginous cell fate. These cells may then ossify  through the 
process of endochondral ossification. Therefore in this region, Eya1 may function to 
maintain cells of the annular ligament by inhibiting a cartilage cell fate, and maintaining 
a ligament cell fate. During postnatal development, a loss of Eya1 results in a delay in 
the transformation of Meckel’s cartilage, a process that relies predominantly on regional 
cell fate specifications of chondrocytes of this cartilage. This delay correlates with a 
delay in the recruitment of TRAP positive cells, suggesting Eya1 may regulate this 
process through recruitment of these resorptive cells. This is most  likely an indirect role, 
perhaps through the regulation of chemoattractant factors such as cytokines, which are 
believed to play  a role in the recruitment of these cells types (Tsuzurahara et al., 2010). 
Although an extremely speculative idea, it is further tempting to consider an 
evolutionary  role for Eya1 in the determination of a connected or separated jaw and 
middle anatomy, which may  have influenced the eventual formation of the DMME. In 
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the Eya1 +/- mouse, abrogations in middle ear joint patterning, ligament maintenance, 
and transformation of Meckel’s cartilage, appear to arise due to an inability  to maintain 
or lose cell fate specifications. Significant differences in proliferation and cell death 
were not observed in the vicinity  of ectopic joint phenotypes, although more thorough 
investigation of stages preceding and following these developmental abrogations may 
reveal a narrow time window in which these processes may  be altered. Therefore, 
results from this project suggest a role for Eya1 in middle ear cell fate specification, 
which may influence developmental abrogations in this mouse model. However, future 
studies of the genetics and the mechanisms of these developmental events will be 
required to further investigate this idea, and elucidate how Eya1 may mediate these cell 
fate decisions.
In this project, the cellular role for Eya1 in otitis media was not investigated, therefore 
future studies will be required to understand the influence of Eya1 in middle ear 
inflammation. Eya1 is expressed in cells of the middle ear epithelium and may therefore 
influence disease onset or progression through regulation of proliferation, cell death, or 
cell fate in the epithelium. Through these roles Eya1 may  also influence the process of 
cavitation. It also appears likely that  Eya1 plays a role in immune system function 
through several independent influences, perhaps through cellular induction of the innate 
immune response (Okabe et al.,2009). Evi1, a gene which when mutated, predisposes 
the middle ear to otitis media, is expressed in both the middle ear epithelium, 
fibroblasts, and neutrophil leukocytes, suggesting Evi1 may  influence otitis media 
development through several mechanisms (Parkinson et al., 2006). It will therefore be 
interesting to investigate Eya1 expression in wild type middle ears that exhibit signs of 
otitis media, to look for expression in components of the inflammatory reaction such as 
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immune cell infiltrates. Similarly, Fbxo11 expression appears restricted to secretory 
middle ear epithelial cells, and may function to regulate this particular cell type. 
Therefore more in depth expression analysis of Eya1 during early postnatal stages, and 
stages preceding and following disease onset, may  further specify a role for Eya1 in 
otitis media    
7.3.5   Clinical implications; The role of Eya1 in middle ear defects of BOR syndrome
Individuals with BOR syndrome exhibit middle ear ossicle defects, often evidenced by 
ossicle hypoplasias, malformations, and ankylosis (Ceruti et al.,2002; Worley et al.
1999; Motta et al., 1996). Whilst otosclerosis is not explicitly associated with BOR 
syndrome, individuals do exhibit ankylosis of the ossicles (Ceruti et al.,2002), which 
may occur through ossification of the ligaments (Weber and Kousseff .,1999). In 
addition, these individuals are often predisposed to developing otitis media (Legius et 
al., 1990; Weber and Kousseff., 1999; Johnston et al., 2011). As individuals with BOR 
syndrome exhibit a myriad of the phenotypes, common genetic regulation of several of 
these developmental processes is suspected. As summarised above, the Eya1 +/- mouse 
exhibits developmental defects of ossicle patterning, Meckel’s cartilage transformation, 
and Eya1 +/- mice are also predisposed to developing otitis media and otosclerosis. 
Therefore, Eya1 appears to be a regulator of several of these processes, and in these 
functions may  contribute to the various features of BOR syndrome. The variability  of 
disease phenotypes and their widespread manifestations further highlight the 
complicated nature of treatment  and diagnosis of these individuals in the clinic. 
Currently there are not many treatment options for BOR syndrome, and a quick 
diagnosis can be the most beneficial result for individuals with BOR. For example, 
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based on middle ear phenotypes, BOR syndrome may  appear as one of several 
craniofacial syndromes. However, defects of the ureters and kidney may also be present, 
and may  be the cause of considerable health impairment. In these circumstances, quick 
diagnosis will enable early  treatment for kidney failure, such as dialysis, or kidney 
transplantation, before further damage occurs (Smith., 2009). In addition, speech 
therapy can reduce learning delays that can occur as a result of deafness 
(Stelmachowicz et al., 2004). Interestingly, joint defects in the Eya1 +/- mouse of both 
the incus and stapes are associated with the misexpression of Gdf5, and may arise from 
the abrogation of a common genetic pathway. This result is interesting as CDMP1 
(Gdf5) mutations are associated with syndromes of limb joint  defects (Seemann et al., 
2009), and stapes fixation is often observed in syndromes of multiple synostoses and 
brachydactyly (Cremers et al., 1985; Ueda et al., 2012). It has been proposed previously 
that genes which regulate limb development and patterning, may also function in middle 
ear development (Ueda et al., 1996; Strasburger et al., 1965). Whilst mutations in the 
Eya1 gene account for 40% of individuals with BOR syndrome, and the Six1 and Six5 
gene accounting for approximately 5% of cases (Abdelhak et al., 1997; Ruf et al., 2004; 
Hoskins et al., 2007), the genetic etiology of 60% of cases of BOR syndrome remains 
unaccounted for. Therefore future investigations with the use of this mouse model may 
enable further elucidation of the genetics and mechanisms that regulate these 
developmental processes, and may  suggest additional candidates for the genetic etiology 
of BOR syndrome. This may enable wider genetic screening for BOR syndrome, and 
possibly identify overlapping genetic etiologies for closely related syndromes.
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7.3.6   Ossicular joint synostoses may arise from a failure to maintain joint patterning
Ossicular synostoses resulting in the loss of middle ear joints, are observed in several 
syndromes of craniofacial development, including BOR. As these defects are usually 
evident by  birth, it has naturally  been assumed that ossicular fusions, such as incudo-
malleal synostoses, are a result of the failure of the joint to initiate during embryonic 
development (Phelps et al., 1981; Visosky et al., 2003; Ceruti et al., 2002). In this 
project, investigation of the incudo-malleal joint in both Eya1 +/+ and Eya1 +/- middle 
ears reveals normal joint morphology at E14.5, the stage following joint  initiation. 
Further, ectopic joints in the Eya1 +/- mouse and ectopic fusions in the Eya1 -/- mouse 
are only evidenced during later stages of embryonic development following initial joint 
formation. This therefore suggests the idea that ossicle synostoses can occur through an 
inability to maintain joints following formation, most likely due to re-patterning of the 
joint regions through the formation of ectopic cartilage. In support  of this, stapes 
fixation in the Eya1 +/- mouse is only evidenced during postnatal developmental stages, 
with the posterior annular ligament exhibiting normal morphology during embryonic 
and early  postnatal stages. Interestingly, incudo-malleal joint initiation has not  been 
specifically investigated in several mouse models that exhibit incudo-malleal fusions 
during later embryonic development (Hwang and Wu., 2008; Zheng et al., 2003; Xu et 
al., 1999), and has resulted in the presumption that these synostoses may arise through 
the failure of these joints to be patterned, initiated or cavitated. As the malleus and incus 
originate from a common cartilage anlage of Meckel’s cartilage, a failure of joint 
formation would cause these ossicles to morphologically resemble their embryonic 
form. However, in several syndromes of craniofacial development, such as cleidocranial 
dysplasia and BOR syndrome, the middle ear ossicles can appeared ‘clustered’ or 
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‘plump,’ and morphologically  indiscernible (Visosky et al., 2000; Ceruti et al., 2002; 
Motta et al.,1996). A similar phenotype is also observed in the Eya1 +/- mouse of 129/
Sv and BALB/c backgrounds. In these mice the ossicles appear fused and incorporated 
into a mass bony complex (Xu et al., 1999). It therefore seems plausible, that these joint 
defects are not the cause of a failure of the joint to initiate, but are results of later 
ectopic cartilage development. As the main option for resolution of middle ear defects is 
surgery, understanding how these fusions form is of clinical value (Motta et al., 1996), 
as procedures to correct a failure of initial joint formation, and a later fixation of the 
joint by an otosclerotic type mechanism may  differ (Tos., 2000). This additionally 
widens the field of potential genetic regulators of joint patterning in the middle ear, 
increasing the inclusions of genes such as Eya1, Bmps, and Noggin, which are not 
expressed directly in the joint region and may play a more general role in cartilage 
development, in addition to genes such as Gdf5 which play  direct roles in patterning and 
joint formation.
In this project, close expression analysis of Eya1 in the middle ear was undertaken, 
revealing previously uncharacterised expression of Eya1 in the ossicles themselves. 
Whilst the joint phenotype of the incus suggests an indirect role for Eya1 in joint 
patterning, I was unable to identify the genetic mediator of this function. In this project, 
the main technique employed was expression pattern analysis with the use of RNA in 
situ hybridisation, however this technique cannot identify possible changes in the 
expression levels of the genes investigated. Quantitative analysis may therefore reveal 
differences in levels of Noggin and Bmps in the Eya1 +/- middle ear. Therefore there is 
potential that Eya1 mediates joint patterning through the Bmp signalling pathway. 
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Future studies will therefore be required in order to investigate a potential link between 
the RDGN and BMP in ossicle patterning.
7.3.7  Future research 
In this project, characterisation of the Eya1 +/- mouse has revealed a use for this model 
in several avenues of research, namely: ossicle joint patterning, articular surface 
development, annular ligament development, transformation of Meckel’s cartilage, 
postnatal middle ear cavitation, and the pathologies of syndromic associated otitis 
media and otosclerosis. Abrogations of several of these developmental events and 
pathologies are observed in BOR syndrome, therefore the Eya1 +/- mouse can be used 
to investigate the genetics and mechanisms which could cause these defects in humans. 
Eya1 +/- mice on a BL/6 background exhibit mild, relatively  isolated phenotypes, and 
will facilitate future studies that aim to focus on these discrete developmental events 
which are integral for middle ear function.
278
8. References
Abdelhak, S., Kalatzis, V., Heilig, R., Compain, S., Samson, D., Vincent, C., et al. 
(1997). A human homologue of the Drosophila eyes absent gene underlies 
branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat 
Genet, 15(2), 157-164.
Acampora, D., Merlo, G. R., Paleari, L., Zerega, B., Postiglione, M. P., Mantero, S., et 
al. (1999). Craniofacial, vestibular and bone defects in mice lacking the Distal-
less-related gene Dlx5. Development, 126(17), 3795-3809.
Ahituv, N., Erven, A., Fuchs, H., Guy, K., Ashery-Padan, R., Williams, T., et al. (2004). 
An ENU-induced mutation in AP-2alpha leads to middle ear and ocular defects 
in Doarad mice. Mamm Genome, 15(6), 424-432.
Ahmed, M., Wong, E. Y., Sun, J., Xu, J., Wang, F., & Xu, P. X. (2012)a. Eya1-Six1 
interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 
expression in cooperation with Sox2. Dev Cell, 22(2), 377-390.
Ahmed, M., Xu, J., & Xu, P. X. (2012)b. EYA1 and SIX1 drive the neuronal 
developmental program in cooperation with the SWI/SNF chromatin-remodeling 
complex and SOX2 in the mammalian inner ear. Development, 139(11), 
1965-1977.
Ahnfelt-Ronne, J., Ravassard, P, Pardanaud- Glaviux, C, Scharfmann, R, Serup, P. 
(2010). Mesenchymal Bmp signalling is required for normal pancreas 
development. Diabetes, 59, 1948-1956.
Aimi, K. (1983). Role of the tympanic ring in the pathogenesis of congenital 
cholesteatoma. Laryngoscope, 93(9), 1140-1146.
Albrecht, W. (1922). Uber der verenbung der hereditaren labyrinth-schwerkorigkeit und 
der otosclerose. Arch. ohrenheilk. Nas. Kehlkopfheilk, 110, 15-48.
Altmann F, G. A., Macduff JP. (1967). The incidence of otosclerosis as related to race 
and sex. Ann Otol Rhinol Laryngol 22, 249-257.
Amin, S., Matalova, E., Simpson, C., Yoshida, H., & Tucker, A. S. (2007). 
Incudomalleal joint formation: the roles of apoptosis, migration and 
downregulation. BMC Dev Biol, 7, 134.
Amin, S., & Tucker, A. S. (2006). Joint formation in the middle ear: lessons from the 
mouse and guinea pig. Dev Dyn, 235(5), 1326-1333.
Ando, W., Hashimoto, J., & Yoshikawa, H. (2005). [Osteosclerosis related with bone 
morphogenetic protein (BMP)]. Nihon Rinsho, 63 Suppl 10, 444-449.
279
Anson. (1944). Terminal stages in the development of the stapes. Ann Otol Rhinol 
Laryngol, 53, 42-53.
Anson. (1980). Otolaryngology Vol 1. Philadelphia: WB Saunders.
Anthwal, N., Joshi, L., & Tucker, A. S. (2013). Evolution of the mammalian middle ear 
and jaw: adaptations and novel structures. J Anat, 222(1), 147-160.
Archer, C. W., Morrison, H., & Pitsillides, A. A. (1994). Cellular aspects of the 
development of diarthrodial joints and articular cartilage. J Anat, 184 ( Pt 3), 
447-456.
Azuma, N., Hirakiyama, A., Inoue, T., Asaka, A., & Yamada, M. (2000). Mutations of a 
human homologue of the Drosophila eyes absent gene (EYA1) detected in 
patients with congenital cataracts and ocular anterior segment anomalies. Hum 
Mol Genet, 9(3), 363-366.
Bachor, E., Just, T., Wright, C. G., Pau, H. W., & Karmody, C. S. (2005). Fixation of the 
stapes footplate in children: a clinical and temporal bone histopathologic study. 
Otol Neurotol, 26(5), 866-873.
Bancroft, J. D. (2008). Theory and practive of histological techniques. China: Churchill 
Livingstone Elsevier.
Bandyopadhyay, A., Yadav, P. S., & Prashar, P. (2013). BMP signaling in development 
and diseases: A pharmacological perspective. Biochem Pharmacol, 85(7), 
857-864.
Bezold, F. (1891). Ueber das cholesteatoma des Mittelohres. Zeitsch fuer Ohrenheilk, 
21, 252- 271.
Bhaskar, S. N., Weinmann, J. P., & Schour, I. (1953). Role of Meckel's cartilage in the 
development and growth of the rat mandible. J Dent Res, 32(3), 398-410.
Bluestone, S., Alper, Arjmand, Casselbrant, Dohar, Yellon. (1983). Pediatric 
otolaryngology. Philadelphia: Saunders.
Bluestone, C. (2005). Eustachian Tube. Structure, Function, Role in Otitis Media. USA: 
BC Decker Inc.
Bolande, R. P. (1974). The Neurocristopathy. A unifying concept of disease arising in 
neural crest maldevelopment Human Pathol, 5, 409- 429.
Bonini, N. M., Leiserson, W. M., & Benzer, S. (1993). The eyes absent gene: genetic 
control of cell survival and differentiation in the developing Drosophila eye. 
Cell, 72(3), 379-395.
280
Bonini, N. M., Bui, Q. T., Gray-Board, G. L., & Warrick, J. M. (1997). The Drosophila 
eyes absent gene directs ectopic eye formation in a pathway conserved between 
flies and vertebrates. Development, 124(23), 4819-4826.
Borsani, G., DeGrandi, A., Ballabio, A., Bulfone, A., Bernard, L., Banfi, S., et al. 
(1999). EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum 
Mol Genet, 8(1), 11-23.
Bosma, J. F. (1986). Anatomy of the infant head: University press Baltimore.
Bronner-Fraser, M. (1994). Neural crest  cell formation and migration in the developing 
embryo. FASEB J, 8(10), 699-706.
Brunet, L. J., McMahon, J. A., McMahon, A. P., & Harland, R. M. (1998). Noggin, 
cartilage morphogenesis, and joint formation in the mammalian skeleton. 
Science, 280(5368), 1455-1457.
Bui, Q. T., Zimmerman, J. E., Liu, H., & Bonini, N. M. (2000). Molecular analysis of 
Drosophila eyes absent  mutants reveals features of the conserved Eya domain. 
Genetics, 155(2), 709-720.
Bujia, J., Alsalameh, S., Jerez, R., Sittinger, M., Wilmes, E., & Burmester, G. (1994). 
Antibodies to the minor cartilage collagen type IX in otosclerosis. Am J Otol, 15
(2), 222-224.
Buytaert, J. A., Salih, W. H., Dierick, M., Jacobs, P., & Dirckx, J. J. (2011). Realistic 3D 
computer model of the gerbil middle ear, featuring accurate morphology of bone 
and soft tissue structures. J Assoc Res Otolaryngol, 12(6), 681-696.
Byrnes, A. M., Racacho, L., Nikkel, S. M., Xiao, F., MacDonald, H., Underhill, T. M., 
et al. (2010). Mutations in GDF5 presenting as semidominant brachydactyly  A1. 
Hum Mutat, 31(10), 1155-1162.
Carlson. (1994). Human embryology and developmental biology. St. Louis: Mosby Year 
Book Inc.
Carpinelli, M. R., Wise, A. K., Arhatari, B. D., Bouillet, P., Manji, S. S., Manning, M. 
G., et  al. (2012). Anti-apoptotic gene Bcl2 is required for stapes development 
and hearing. Cell Death Dis, 3, e362.
Casselbrant, M. L., Mandel, E. M., Fall, P. A., Rockette, H. E., Kurs-Lasky, M., 
Bluestone, C. D., et al. (1999). The heritability of otitis media: a twin and triplet 
study. JAMA, 282(22), 2125-2130.
Cate, T. (2008). Oral histology, development, structure, function. St. Louis, Missosouri: 
Mosby Elsevier.
281
Ceruti, S., Stinckens, C., Cremers, C. W., & Casselman, J. W. (2002). Temporal bone 
anomalies in the branchio-oto-renal syndrome: detailed computed tomographic 
and magnetic resonance imaging findings. Otol Neurotol, 23(2), 200-207.
Chadee, D. N., Hendzel, M. J., Tylipski, C. P., Allis, C. D., Bazett-Jones, D. P., Wright, 
J. A., et al. (1999). Increased Ser-10 phosphorylation of histone H3 in mitogen-
stimulated and oncogene-transformed mouse fibroblasts. J Biol Chem, 274(35), 
24914-24920.
Chan, J. C., Logan, G. B., & McBean, J. B. (1967). Serous otitis media and allergy. 
Relation to allergy and other causes. Am J Dis Child, 114(6), 684-692.
Cheeseman, M. T., Tyrer, H. E., Williams, D., Hough, T. A., Pathak, P., Romero, M. R., 
et al. (2011). HIF-VEGF pathways are critical for chronic otitis media in Junbo 
and Jeff mouse mutants. PLoS Genet, 7(10), e1002336.
Chen, A., Francis, M., Ni, L., Cremers, C. W., Kimberling, W. J., Sato, Y., et al. (1995). 
Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet, 58
(4), 365-370.
Chimal-Monroy, J., Rodriguez-Leon, J., Montero, J. A., Ganan, Y., Macias, D., Merino, 
R., et al. (2003). Analysis of the molecular cascade responsible for mesodermal 
limb chondrogenesis: Sox genes and BMP signaling. Dev Biol, 257(2), 292-301.
Chisaka, O., Musci, T. S., & Capecchi, M. R. (1992). Developmental defects of the ear, 
cranial nerves and hindbrain resulting from targeted disruption of the mouse 
homeobox gene Hox-1.6. Nature, 355(6360), 516-520.
Chole, R. A., & Henry, K. R. (1985). Ossicular and otic capsular lesions in LP/J mice. 
[Research Support, Non-U.S. Gov't]. Ann Otol Rhinol Laryngol, 94(4 Pt 1), 
366-372.
Chung, K. S., Park, H. H., Ting, K., Takita, H., Apte, S. S., Kuboki, Y., et al. (1995). 
Modulated expression of type X collagen in Meckel's cartilage with different 
developmental fates. [Research Support, U.S. Gov't, P.H.S.]. Dev Biol, 170(2), 
387-396.
Chung, K. S., & Nishimura, I. (1999). Maintenance of regional histodifferentiation 
patterns and a spatially restricted expression of type X collagen in rat Meckel's 
cartilage explants in vitro. Arch Oral Biol, 44(6), 489-497. 
Cisneros Gimeno, A. I., Whyte Orozco, J. R., Obon Nogues, J. A., Yus Gotor, C., 
Crovetto De La Torre, M. A., & Whyte Orozco, A. (2009). Contribution to 
morphological knowledge of the development of the human incudo-mallear 
joint. Acta Otolaryngol, 129(12), 1380-1387.
Clendenning, D. E., & Mortlock, D. P. (2012). The BMP ligand Gdf6 prevents 
differentiation of coronal suture mesenchyme in early cranial development. 
PLoS One, 7(5), e36789.
282
Core, N., Caubit, X., Metchat, A., Boned, A., Djabali, M., & Fasano, L. (2007). Tshz1 is 
required for axial skeleton, soft palate and middle ear development in mice. Dev 
Biol, 308(2), 407-420.
Cremers, C., Theunissen, E., & Kuijpers, W. (1985). Proximal symphalangia and stapes 
ankylosis. Arch Otolaryngol, 111(11), 765-767.
Cserjesi, P., Brown, D., Ligon, K. L., Lyons, G. E., Copeland, N. G., Gilbert, D. J., et al. 
(1995). Scleraxis: a basic helix-loop-helix protein that prefigures skeletal 
formation during mouse embryogenesis.Development, 121(4), 1099-1110.
Cui, Y., Jean, F., Thomas, G., & Christian, J. L. (1998). BMP-4 is proteolytically 
activated by  furin and/or PC6 during vertebrate embryonic development. EMBO 
J, 17(16), 4735-4743.
Daluiski, A., Engstrand, T., Bahamonde, M. E., Gamer, L. W., Agius, E., Stevenson, S. 
L., et al. (2001). Bone morphogenetic protein-3 is a negative regulator of bone 
density. Nat Genet, 27(1), 84-88.
Daniel, H. J., 3rd, Fulghum, R. S., Brinn, J. E., & Barrett, K. A. (1982). Comparative 
anatomy of eustachian tube and middle ear cavity  in animal models for otitis 
media. [Comparative Study], Ann Otol Rhinol Laryngol, 91(1 Pt 1), 82-89.
Davis, R. J., Shen, W., Sandler, Y. I., Heanue, T. A., & Mardon, G. (2001). 
Characterization of mouse Dach2, a homologue of Drosophila dachshund. Mech 
Dev, 102(1-2), 169-179.
Dawson, K., Seeman, P., Sebald, E., King, L., Edwards, M., Williams, J., 3rd, et al. 
(2006). GDF5 is a second locus for multiple-synostosis syndrome. Am J Hum 
Genet, 78(4), 708-712.
Depew, M. J., Liu, J. K., Long, J. E., Presley, R., Meneses, J. J., Pedersen, R. A., et al. 
(1999). Dlx5 regulates regional development of the branchial arches and sensory 
capsules. Development, 126(17), 3831-3846.
Depreux, F. F., Darrow, K., Conner, D. A., Eavey, R. D., Liberman, M. C., Seidman, C. 
E., et al. (2008). Eya4-deficient mice are a model for heritable otitis media. J 
Clin Invest, 118(2), 651-658.
Di Francesco, R., Paulucci, B., Nery, C., & Bento, R. F. (2008). Craniofacial 
morphology and otitis media with effusion in children. Int J Pediatr 
Otorhinolaryngol, 72(8), 1151-1158.
Dixon, J., Brakebusch, C., Fassler, R., & Dixon, M. J. (2000). Increased levels of 
apoptosis in the prefusion neural folds underlie the craniofacial disorder, 
Treacher Collins syndrome. Hum Mol Genet, 9(10), 1473-1480.
283
Dreyer, S. D., Naruse, T., Morello, R., Zabel, B., Winterpacht, A., Johnson, R. L., et al. 
(2004). Lmx1b expression during joint and tendon formation: localization and 
evaluation of potential downstream targets. Gene Expr Patterns, 4(4), 397-405.
Ducy, P., & Karsenty, G. (2000). The family of bone morphogenetic proteins. [Review]. 
Kidney Int, 57(6), 2207-2214.
Duprez, D. M., Coltey, M., Amthor, H., Brickell, P. M., & Tickle, C. (1996). Bone 
morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes 
cartilage formation in chick limb bud cultures. Dev Biol, 174(2), 448-452.
Ealy, M., Chen, W., Ryu, G. Y., Yoon, J. G., Welling, D. B., Hansen, M., et al. (2008). 
Gene expression analysis of human otosclerotic stapedial footplates. Hear Res, 
240(1-2), 80-86.
Ealy, M., & Smith, R. J. (2010). The genetics of otosclerosis. Hear Res, 266(1-2), 
70-74.
El-Hashash, A. H., Al Alam, D., Turcatel, G., Bellusci, S., & Warburton, D. (2011a). 
Eyes absent  1 (Eya1) is a critical coordinator of epithelial, mesenchymal and 
vascular morphogenesis in the mammalian lung. Dev Biol, 350(1), 112-126.
El-Hashash, A. H., Turcatel, G., Al Alam, D., Buckley, S., Tokumitsu, H., Bellusci, S., 
et al. (2011b). Eya1 controls cell polarity, spindle orientation, cell fate and Notch 
signaling in distal embryonic lung epithelium. Development, 138(7), 1395-1407.
Emonts, M., Veenhoven, R. H., Wiertsema, S. P., Houwing-Duistermaat, J. J., Walraven, 
V., de Groot, R., et al. (2007). Genetic polymorphisms in immunoresponse genes 
TNFA, IL6, IL10, and TLR4 are associated with recurrent  acute otitis media. 
Pediatrics, 120(4), 814-823.
Fan, Z., Chubinskaya, S., Rueger, D. C., Bau, B., Haag, J., & Aigner, T. (2004). 
Regulation of anabolic and catabolic gene expression in normal and 
osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin 
Exp Rheumatol, 22(1), 103-106.
Forlino, A., Cabral, W. A., Barnes, A. M., & Marini, J. C. (2011). New perspectives on 
osteogenesis imperfecta. [Review]. Nat Rev Endocrinol, 7(9), 540-557.
Fougerousse, F., Durand, M., Lopez, S., Suel, L., Demignon, J., Thornton, C., et al. 
(2002). Six and Eya expression during human somitogenesis and MyoD gene 
family activation. J Muscle Res Cell Motil, 23(3), 255-264.
Francis-West, P. H., Abdelfattah, A., Chen, P., Allen, C., Parish, J., Ladher, R., et al. 
(1999). Mechanisms of GDF-5 action during skeletal development. 
Development, 126(6), 1305-1315.
284
Fraser, F. C., Sproule, J. R., & Halal, F. (1980). Frequency of the branchio-oto-renal 
(BOR) syndrome in children with profound hearing loss. Am J Med Genet, 7(3), 
341-349.
Freijd, A., Hammarstrom, L., Persson, M. A., & Smith, C. I. (1984). Plasma anti-
pneumococcal antibody  activity of the IgG class and subclasses in otitis prone 
children. Clin Exp Immunol, 56(2), 233-238.
Frisch, T., Sorensen, M. S., Overgaard, S., & Bretlau, P. (2000). Predilection of 
otosclerotic foci related to the bone turnover in the otic capsule. Acta 
Otolaryngol Suppl, 543, 111-113.
Ganbo, T., Sando, I., Balaban, C. D., Suzuki, C., & Kitagawa, M. (1999). Inflammatory 
response to chronic otitis media in DiGeorge syndrome: a case study using 
immunohistochemistry  on archival temporal bone sections. Ann Otol Rhinol 
Laryngol, 108(8), 756-761.
Gaupp, E. (1911). Beiträge zur Kenntnis des Unterkiefers der Wirbeltiere I; der Proc. 
Anterior (Folii) des Hammers Nichtsäuger. Anat. Anz, 39, 97- 135.
Gendron-Maguire M, M. M., Zhang M, Gridley T. (1993). Hoxa-2 mutant mice exhibit 
homeotic transformation of skeletal elements derived from cranial neu- ral crest. 
Cell, 75, 1317- 1331.
Gong, Y., Krakow, D., Marcelino, J., Wilkin, D., Chitayat, D., Babul-Hirji, R., et al. 
(1999). Heterozygous mutations in the gene encoding noggin affect human joint 
morphogenesis. Nat Genet, 21(3), 302-304.
Gong, K. Q., Yallowitz, A. R., Sun, H., Dressler, G. R., & Wellik, D. M. (2007). A Hox-
Eya-Pax complex regulates early kidney developmental gene expression. Mol 
Cell Biol, 27(21), 7661-7668.
Goodrick, E. S. (1914). The Chorda Tympani and Middle Ear in Reptiles, Birds, and 
Mammals. Quarterly Journal of Microscopical Science, s2-61, 137-160.
Gorlin, R. J., Cohen, M. M., Levin. L.S (1990). Syndrome of the head and neck. UK: 
Oxford University Press.
Graboyes, E. M., Chole, R. A., & Hullar, T. E. (2011). The ossicle of Paaw. Otol 
Neurotol, 32(7), 1185-1188.
Graham, M. D. (1985). The annular ligament attachment to the normal human stapes 
footplate. A scanning electron microscopic study. [Research Support, U.S. Gov't, 
P.H.S.]. Ann Otol Rhinol Laryngol, 94(2 Pt 1), 171-175.
Granato, L., Silva, C. J., & Yoo, H. J. (2012). Isolated congenital cholesteatoma of the 
mastoid process: a case report. Braz J Otorhinolaryngol, 78(4), 133.
285
Grayeli, A. B., Sterkers, O., Roulleau, P., Elbaz, P., Ferrary, E., & Silve, C. (1999). 
Parathyroid hormone-parathyroid hormone-related peptide receptor expression 
and function in otosclerosis. Am J Physiol, 277(6 Pt 1), E1005-1012.
Graziussi, D. F., Suga, H., Schmid, V., & Gehring, W. J. (2012). The "eyes absent" (eya) 
gene in the eye-bearing hydrozoan jellyfish Cladonema radiatum: conservation 
of the retinal determination network. J Exp Zool B Mol Dev Evol, 318(4), 
257-267.
Green, E. L., & Green, M. C. (1946). Effect of the short  ear gene on number of ribs and 
presacral vertebrae in the house mouse. Am Nat, 80(795), 619-625.
Grifone, R., Demignon, J., Giordani, J., Niro, C., Souil, E., Bertin, F., et al. (2007). 
Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the 
mouse embryo. Dev Biol, 302(2), 602-616.
Groppe, J., Greenwald, J., Wiater, E., Rodriguez-Leon, J., Economides, A. N., 
Kwiatkowski, W., et al. (2002). Structural basis of BMP signalling inhibition by 
the cystine knot protein Noggin. Nature, 420(6916), 636-642.
Gruneberg, H., & Lee, A. J. (1973). The anatomy and development of brachypodism in 
the mouse. J Embryol Exp Morphol, 30(1), 119-141.
Guggenheim, P., Clements, L., & Schlesinger, A. (1956). The significance and fate of 
the mesenchyme of the middle ear. Laryngoscope, 66(10), 1303-1326.
Guo, C., Sun, Y., Zhou, B., Adam, R. M., Li, X., Pu, W. T., et al. (2011). A Tbx1-Six1/
Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial 
morphogenesis. J Clin Invest, 121(4), 1585-1595.
Guzinska-Ustymowicz, K., Kurzyna, A., Trzpis, K., Kemona, A., & Hassmann-
Poznanska, E. (2013). Keratinocyte growth factor and its receptor in middle-ear 
cholesteatoma. Otolaryngol Pol, 67(2), 67-71.
Hagr, A. (2007). BAHA: Bone-Anchored Hearing Aid. Int J Health Sci (Qassim), 1(2), 
265-276.
Hall, B. K. (1988). The neural crest. Oxford: Oxford University Press.
Han, F., Yu, H., Li, P., Zhang, J., Tian, C., Li, H., et al. (2012). Mutation in Phex gene 
predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media. PLoS One, 7(9), 
e43010.
Han, F., Yu, H., Tian, C., Li, S., Jacobs, M. R., Benedict-Alderfer, C., et al. (2009). Role 
for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae 
infection in mouse otitis media. Infect Immun, 77(7), 3100-3108.
Hanken, J., Hall, B.K. (1993). The Skull (Vol. 2). Chicago: University of Chigago Press.
286
Harada, M., Takahara, M., Zhe, P., Otsuji, M., Iuchi, Y., Takagi, M., et al. (2007). 
Developmental failure of the intra-articular ligaments in mice with absence of 
growth differentiation factor 5. Osteoarthritis Cartilage, 15(4), 468-474.
Harada, Y., & Ishizeki, K. (1998). Evidence for transformation of chondrocytes and site-
specific resorption during the degradation of Meckel's cartilage. Anat Embryol 
(Berl), 197(6), 439-450.
Hardisty, R. E., Erven, A., Logan, K., Morse, S., Guionaud, S., Sancho-Oliver, S., et al. 
(2003). The deaf mouse mutant Jeff (Jf) is a single gene model of otitis media. J 
Assoc Res Otolaryngol, 4(2), 130-138.
Hardisty-Hughes, R. E., Tateossian, H., Morse, S. A., Romero, M. R., Middleton, A., 
Tymowska-Lalanne, Z., et al. (2006). A mutation in the F-box gene, Fbxo11, 
causes otitis media in the Jeff mouse. Hum Mol Genet, 15(22), 3273-3279.
Hattori, A., Katayama, M., Iwasaki, S., Ishii, K., Tsujimoto, M., & Kohno, M. (1999). 
Bone morphogenetic protein-2 promotes survival and differentiation of striatal 
GABAergic neurons in the absence of glial cell proliferation. J Neurochem, 72
(6), 2264-2271.
Havens, B. A., Velonis, D., Kronenberg, M. S., Lichtler, A. C., Oliver, B., & Mina, M. 
(2008). Roles of FGFR3 during morphogenesis of Meckel's cartilage and 
mandibular bones. [Research Support, N.I.H., Extramural]. Dev Biol, 316(2), 
336-349.
He, G., Tavella, S., Hanley, K. P., Self, M., Oliver, G., Grifone, R., et al. (2010). 
Inactivation of Six2 in mouse identifies a novel genetic mechanism controlling 
development and growth of the cranial base. Dev Biol, 344(2), 720-730.
NICE REPORT: (2008).Surgical management of otitis media with effusion in children.
Heginbothom, M., Fitzgerald, T. C., & Wade, W. G. (1990). Comparison of solid media 
for cultivation of anaerobes. [Comparative Study]. J Clin Pathol, 43(3), 
253-256.
Heimler, A., & Lieber, E. (1986). Branchio-oto-renal syndrome: reduced penetrance and 
variable expressivity in four generations of a large kindred. Am J Med Genet, 25
(1), 15-27.
Hernandez, M., Leichtle, A., Pak, K., Ebmeyer, J., Euteneuer, S., Obonyo, M., et al. 
(2008). Myeloid differentiation primary response gene 88 is required for the 
resolution of otitis media. J Infect Dis, 198(12), 1862-1869.
Hernandez Orozco, F., & Torrescourtney, G. (1965). Otosclerosis in Identical Twins; a 
Genetic and Clinical Study. Ann Otol Rhinol Laryngol, 74, 252-259.
287
Herring, S. W. (1993). Formation of the vertebrate face: Epigenetic and functional 
influences. Am Zool, 33, 472- 483.
Hilton, J. M., Lewis, M. A., Grati, M., Ingham, N., Pearson, S., Laskowski, R. A., et  al. 
(2011). Exome sequencing identifies a missense mutation in Isl1 associated with 
low penetrance otitis media in dearisch mice. Genome Biol, 12(9), R90.
Hirose, T., Galvin, B. D., & Horvitz, H. R. (2010). Six and Eya promote apoptosis 
through direct transcriptional activation of the proapoptotic BH3-only  gene egl-1 
in Caenorhabditis elegans. [Research Support, Non-U.S. Gov't]. Proc Natl Acad 
Sci U S A, 107(35), 15479-15484.
Hirshoren, N., Gross, M., Banin, E., Sosna, J., Bargal, R., & Raas-Rothschild, A. 
(2008). P35S mutation in the NOG gene associated with Teunissen-Cremers 
syndrome and features of multiple NOG joint-fusion syndromes. Eur J Med 
Genet, 51(4), 351-357.
Hoeffner, E. G., and Suresh, K. M. (2008). Temporal Bone Imaging. New York: Thieme 
Medical Publishers Inc.
Holm, V. A., & Kunze, L. H. (1969). Effect of chronic otitis media on language and 
speech development. Pediatrics, 43(5), 833-839.
Holt, J. J. (2003). Cholesteatoma and Otosclerosis: Two slowly progressive causes of 
hearing loss treatable through corrective surgery. Clinical Medicine & Research, 
1, 151-154.
Hopson, J. A. (1966). The origin of the mammalian middle ear. Am Zool, 6(3), 437-450.
Hoskins, B. E., Cramer, C. H., Silvius, D., Zou, D., Raymond, R. M., Orten, D. J., et al. 
(2007). Transcription factor SIX5 is mutated in patients with branchio-oto-renal 
syndrome. Am J Hum Genet, 80(4), 800-804.
Hu, D., Colnot, C, Marcucio, R. (2008). The effect of BMP signaling on development of 
the jaw skeleton. Dev Dyn, 237, 3727- 3737.
Huang, M. H., Lee, S. T., & Rajendran, K. (1997). A fresh cadaveric study of the 
paratubal muscles: implications for eustachian tube function in cleft palate. Plast 
Reconstr Surg, 100(4), 833-842.
Husseman, J., Palacios, S. D., Rivkin, A. Z., Oehl, H., & Ryan, A. F. (2012). The role of 
vascular endothelial growth factors and fibroblast growth factors in angiogenesis 
during otitis media. [Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.]. Audiol Neurootol, 17(3), 148-154.
Hwang, C. H., & Wu, D. K. (2008). Noggin heterozygous mice: an animal model for 
congenital conductive hearing loss in humans. Hum Mol Genet, 17(6), 844-853.
288
Ibanez-Tallon, I., Gorokhova, S., & Heintz, N. (2002). Loss of function of axonemal 
dynein Mdnah5 causes primary ciliary dyskinesia and hydrocephalus. Hum Mol 
Genet, 11(6), 715-721.
Ikeda, K., Watanabe, Y., Ohto, H., & Kawakami, K. (2002). Molecular interaction and 
synergistic activation of a promoter by Six, Eya, and Dach proteins mediated 
through CREB binding protein. Mol Cell Biol, 22(19), 6759-6766.
Ishizeki, K., Takigawa, M., Harada, Y., Suzuki, F., & Nawa, T. (1996). Meckel's 
cartilage chondrocytes in organ culture synthesize bone-type proteins 
accompanying osteocytic phenotype expression. [Research Support, Non-U.S. 
Gov't]. Anat Embryol (Berl), 193(1), 61-71.
Ishizeki, K., Saito, H., Shinagawa, T., Fujiwara, N., & Nawa, T. (1999). Histochemical 
and immunohistochemical analysis of the mechanism of calcification of 
Meckel's cartilage during mandible development in rodents. [Research Support, 
Non-U.S. Gov't]. J Anat, 194 ( Pt 2), 265-277.
Ishizeki, K., & Nawa, T. (2000). Further evidence for secretion of matrix 
metalloproteinase-1 by Meckel's chondrocytes during degradation of the 
extracellular matrix. [Research Support, Non-U.S. Gov't]. Tissue Cell, 32(3), 
207-215.
Ishizeki, K., Takahashi, N., & Nawa, T. (2001). Formation of the sphenomandibular 
ligament by Meckel's cartilage in the mouse: possible involvement of epidermal 
growth factor as revealed by studies in vivo and in vitro. Cell Tissue Res, 304(1), 
67-80.
Ishizeki, K., Fujiwara, N, Otsu, K, Harada, H. (2010). Biological Significance of Site-
specific Transformation of Chondrocytes in Mouse Meckel’s Cartilage. J. Oral 
Biosci, 52(2), 136-142.
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., et 
al. (2003). Connective tissue growth factor coordinates chondrogenesis and 
angiogenesis during skeletal development. Development, 130(12), 2779-2791. 
Jaisinghani, V. J., Paparella, M. M., Schachern, P. A., Schneider, D. S., & Le, C. T. 
(1999). Residual mesenchyme persisting into adulthood. Am J Otolaryngol, 20
(6), 363-370.
Janckila, A. J., Slone, S. P., Lear, S. C., Martin, A., & Yam, L. T. (2007). Tartrate-
resistant acid phosphatase as an immunohistochemical marker for inflammatory 
macrophages. Am J Clin Pathol, 127(4), 556-566.
Jaskoll, T. F., & Maderson, P. F. (1978). A histological study of the development of the 
avian middle ear and tympanum. Anat Rec, 190(2), 177-199.
289
Ji, Q., Luo, Z. X., Zhang, X., Yuan, C. X., & Xu, L. (2009). Evolutionary development 
of the middle ear in Mesozoic therian mammals. Science, 326(5950), 278-281.
Johnston, D. R., Whittemore, K., Poe, D., Robson, C. D., & Perez-Atayde, A. R. (2011). 
Diagnostic and surgical challenge: middle ear dermoid cyst in 12 month old with 
branchio-oto-renal syndrome and multiple middle-ear congenital anomalies. Int 
J Pediatr Otorhinolaryngol, 75(10), 1341-1345.
Jones, N. C., & Trainor, P. A. (2004). The therapeutic potential of stem cells in the 
treatment of craniofacial abnormalities. Expert Opin Biol Ther, 4(5), 645-657.
Jono, H., Xu, H., Kai, H., Lim, D. J., Kim, Y. S., Feng, X. H., et al. (2003). 
Transforming growth factor-beta-Smad signaling pathway negatively regulates 
nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via 
mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition 
of p38 MAPK. J Biol Chem, 278(30), 27811-27819.
Kalatzis, V., Sahly, I., El-Amraoui, A., & Petit, C. (1998). Eya1 expression in the 
developing ear and kidney: towards the understanding of the pathogenesis of 
Branchio-Oto-Renal (BOR) syndrome. Dev Dyn, 213(4), 486-499.
Kanzler B, F. R., Labosky PA, Mallo M. (2000). BMP signaling is essential for 
development of skeletogenic and neurogenic cranial neural crest. Development, 
127, 1095- 1104.
Karmody, C. S., & Northrop, C. (2012). The pathogenesis of acquired cholesteatoma of 
the human middle ear: support for the migration hypothesis. Otol Neurotol, 33
(1), 42-47.
Kasemsuwan, L., Schachern, P., Paparella, M. M., & Le, C. T. (1996). Residual 
mesenchyme in temporal bones of children. Laryngoscope, 106(8), 1040-1043.
Kawakami, K., Ohto, H., Takizawa, T., & Saito, T. (1996). Identification and expression 
of six family genes in mouse retina. FEBS Lett, 393(2-3), 259-263.
Keith, A. (1910). Abnormal Ossification of Meckel's Cartilage. J Anat Physiol, 44(Pt 2), 
151-152.
Kelemen. (1943). Malformation involving external, middle and internal ear with 
otosclerotic focus. Arch Otolaryngol, 70, 1587-1602.
Kelley, R. O. (1970). An electron microscopic study of mesenchyme during 
development of interdigital spaces in man. Anat Rec, 168(1), 43-53.
King, J. A., Marker, P. C., Seung, K. J., & Kingsley, D. M. (1994). BMP5 and the 
molecular, skeletal, and soft-tissue alterations in short ear mice. Dev Biol, 166
(1), 112-122.
290
Kirikae, I. (1959). Relation between the structure of the skull including the middle and 
inner ear of vertebrates and the bone conduction. Acta oto-laryngologica, 50, 
145.
Kitisin, K., Saha, T., Blake, T., Golestaneh, N., Deng, M., Kim, C., et al. (2007). Tgf-
Beta signaling in development. [Review]. Sci STKE, 2007(399).
Klein, B. a. (2007). Otitis media in infants and children. Italy: BC Decker Inc.
Kochhar, A., Fischer, S. M., Kimberling, W. J., & Smith, R. J. (2007). Branchio-oto-
renal syndrome. [Research Support, N.I.H., Extramural Review]. Am J Med 
Genet A, 143A(14), 1671-1678.
Konig, R., Fuchs, S., & Dukiet, C. (1994). Branchio-oto-renal (BOR) syndrome: 
variable expressivity  in a five-generation pedigree. Eur J Pediatr, 153(6), 
446-450.
Kontages, G., Lumsden, A. (1996). Rhombencephalic neural crest segmentation is 
preserved throughout craniofacial ontogeny. Development, 122, 3229- 3242.
Kozmik, Z., Pfeffer, P., Kralova, J., Paces, J., Paces, V., Kalousova, A., et al. (1999). 
Molecular cloning and expression of the human and mouse homologues of the 
Drosophila dachshund gene. Dev Genes Evol, 209(9), 537-545.
Kriebel, M., Muller, F., & Hollemann, T. (2007). Xeya3 regulates survival and 
proliferation of neural progenitor cells within the anterior neural plate of 
Xenopus embryos. Dev Dyn, 236(6), 1526-1534.
Kubba, H., Pearson, J. P., & Birchall, J. P. (2000). The aetiology of otitis media with 
effusion: a review. [Review]. Clin Otolaryngol Allied Sci, 25(3), 181-194.
Lamb, K. J., Lewthwaite, J. C., Bastow, E. R., & Pitsillides, A. A. (2003). Defining 
boundaries during joint cavity formation: going out on a limb. [Review]. Int J 
Exp Pathol, 84(2), 55-67.
Landauer, W. (1952). BRACHYPODISM: A Recessive Mutation of House-Mice The 
Journal of Heredity, 43(6), 293-298.
Larsson, A. (1960). Otosclerosis. A genetic and clinical study. Acta Otolaryngol Suppl, 
154, 1-86.
Le Dourain, N. (1982). The Neural Crest. New York: Cambridge University Press.
Le Page, C., Puiffe, M. L., Meunier, L., Zietarska, M., de Ladurantaye, M., Tonin, P. N., 
et al. (2009). BMP-2 signaling in ovarian cancer and its association with poor 
prognosis. J Ovarian Res, 2, 4.
291
Legius, E., Fryns, J.P, Van Den Berghe, H. (1990). Dominant branchial cleft syndrome 
with characteristics of both branchio-oto-renal and branchio-oculo-
facialsyndrome. Clinical Genetics, 37, 347-350.
Leichtle, A., Hernandez, M., Lee, J., Pak, K., Webster, N. J., Wollenberg, B., et al. 
(2012). The role of DNA sensing and innate immune receptor TLR9 in otitis 
media. Innate Immun, 18(1), 3-13.
Lemmerling, M. M., Stambuk, H. E., Mancuso, A. A., Antonelli, P. J., & Kubilis, P. S. 
(1997). CT of the normal suspensory ligaments of the ossicles in the middle ear. 
AJNR Am J Neuroradiol, 18(3), 471-477.
Li, X., Oghi, K. A., Zhang, J., Krones, A., Bush, K. T., Glass, C. K., et al. (2003). Eya 
protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in 
mammalian organogenesis. Nature, 426(6964), 247-254.
Lim, D. J., & Birck, H. (1971). Ultrastructural pathology of the middle ear mucosa in 
serous otitis media. Ann Otol Rhinol Laryngol, 80(6), 838-853.
Lin, J., Caye-Thomasen, P., Tono, T., Zhang, Q. A., Nakamura, Y., Feng, L., et al. 
(2012). Mucin production and mucous cell metaplasia in otitis media. Int J 
Otolaryngol, 2012, 745325.
Lindsay, J. R., Sanders, S. H., & Nager, G. T. (1960). Histopathologic observations in 
so-called congenital fixation of the stapedial footplate. Laryngoscope, 70, 
1587-1602.
Little, S. C., & Mullins, M. C. (2006). Extracellular modulation of BMP activity  in 
patterning the dorsoventral axis. Birth Defects Res C Embryo Today, 78(3), 
224-242.
Liu, W., Yin, T., Ren, J., Li, L., Xiao, Z., Chen, X., et al. (2013). Activation of the 
EGFR/Akt/NF-kappaB/cyclinD1 survival signaling pathway in human 
cholesteatoma epithelium. Eur Arch Otorhinolaryngol.
Lories, R. J., Daans, M., Derese, I., Matthys, P., Kasran, A., Tylzanowski, P., et al. 
(2006). Noggin haploinsufficiency differentially  affects tissue responses in 
destructive and remodeling arthritis. Arthritis Rheum, 54(6), 1736-1746.
Lucas, J. S., Adam, E. C., Goggin, P. M., Jackson, C. L., Powles-Glover, N., Patel, S. 
H., et al. (2012). Static respiratory cilia associated with mutations in Dnahc11/
DNAH11: a mouse model of PCD. Hum Mutat, 33(3), 495-503.
Lumsden, A., Sprawson, N., & Graham, A. (1991). Segmental origin and migration of 
neural crest cells in the hindbrain region of the chick embryo. Development, 113
(4), 1281-1291.
292
Luo, G., Hofmann, C., Bronckers, A. L., Sohocki, M., Bradley, A., & Karsenty, G. 
(1995). BMP-7 is an inducer of nephrogenesis, and is also required for eye 
development and skeletal patterning. Genes Dev, 9(22), 2808-2820.
Luo, Z. (2007). Tranformation and Diversification in Early Mammal Evolution. Nature, 
450, 1011- 1019.
Luo, Z.-X. (2011). Developmental Patterns in Mesozoic Evolution of Mammal Ears. 
Annu Rev Ecol Evol Syst, 42, 355-380.
MacArthur, C. J., Pillers, D. A., Pang, J., Degagne, J. M., Kempton, J. B., & Trune, D. 
R. (2008). Gram-negative pathogen Klebsiella oxytoca is associated with 
spontaneous chronic otitis media in Toll-like receptor 4-deficient C3H/HeJ mice. 
Acta Otolaryngol, 128(2), 132-138.
Macias, D., Ganan, Y., Sampath, T. K., Piedra, M. E., Ros, M. A., & Hurle, J. M. 
(1997). Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and 
skeletogenesis during chick limb development. [Research Support, Non-U.S. 
Gov't]. Development, 124(6), 1109-1117.
Maier. (1987). Der Processus angularis bei Monodelphis domestica und seine 
Beziehungen zum Mittelohr. Eine ontogenetische und evolutionsmorphologische 
Untersuchung. Gegenbaurs Morphol Jahrb Leipzig, 133, 121-161.
Mallo, M., & Gridley, T. (1996). Development of the mammalian ear: coordinate 
regulation of formation of the tympanic ring and the external acoustic meatus. 
Development, 122(1), 173-179.
Mallo, M. (1997). Retinoic acid disturbs mouse middle ear development in a stage-
dependent fashion. Dev Biol, 184(1), 175-186.
Mallo, M. (1998). Embryological and genetic aspects of middle ear development. Int J 
Dev Biol, 42(1), 11-22.
Mallo, M., Schrewe, H., Martin, J. F., Olson, E. N., & Ohnemus, S. (2000). Assembling 
a functional tympanic membrane: signals from the external acoustic meatus 
coordinate development of the malleal manubrium. Development, 127(19), 
4127-4136.
Martin, J. F., Bradley, A., & Olson, E. N. (1995). The paired-like homeo box gene 
MHox is required for early events of skeletogenesis in multiple lineages. Genes 
Dev, 9(10), 1237-1249.
Mason, M. J. (2012). Of mice, moles and guinea pigs: Functional morphology of the 
middle ear in living mammals. Hear Res.1-15
Massa, H. M., Cripps, A. W., & Lehmann, D. (2009). Otitis media: viruses, bacteria, 
biofilms and vaccines. Med J Aust, 191(9 Suppl), S44-49.
293
McKenna, M. J., Kristiansen, A. G., Bartley, M. L., Rogus, J. J., & Haines, J. L. (1998). 
Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology 
with mild osteogenesis imperfecta. Am J Otol, 19(5), 604-610.
McLeod, M. J. (1980). Differential staining of cartilage and bone in whole mouse 
fetuses by alcian blue and alizarin red S. Teratology, 22(3), 299-301.
McPherron, A. C., Lawler, A. M., & Lee, S. J. (1999). Regulation of anterior/posterior 
patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet, 
22(3), 260-264.
Melnick, M., Bixler, D., Nance, W. E., Silk, K., & Yune, H. (1976). Familial branchio-
oto-renal dysplasia: a new addition to the branchial arch syndromes. Clin Genet, 
9(1), 25-34.
Melnick, M., Hodes, M. E., Nance, W. E., Yune, H., & Sweeney, A. (1978). Branchio-
oto-renal dysplasia and branchio-oto dysplasia: two distinct autosomal dominant 
disorders. Clin Genet, 13(5), 425-442.
Merchant, S. N., Incesulu, A., Glynn, R. J., & Nadol, J. B., Jr. (2001). Histologic studies 
of the posterior stapediovestibular joint  in otosclerosis. Otol Neurotol, 22(3), 
305-310.
Merino, R., Macias, D., Ganan, Y., Economides, A. N., Wang, X., Wu, Q., et al. (1999). 
Expression and function of Gdf-5 during digit skeletogenesis in the embryonic 
chick leg bud. Dev Biol, 206(1), 33-45.
Michaels L, P. R., Liang J, Soucek S, Wright A. (1986). Epidermal hyperplasia on the 
tympanic membrane and deep external canal:. Assoc Res Otolaryngol Abs, 486.
Mikic, B., Rossmeier, K., & Bierwert, L. (2009). Identification of a tendon phenotype in 
GDF6 deficient mice. Anat Rec (Hoboken), 292(3), 396-400.
Millman, B., Gibson, W. S., & Foster, W. P. (1995). Branchio-oto-renal syndrome. Arch 
Otolaryngol Head Neck Surg, 121(8), 922-925.
Miyake, T., Cameron, A. M., & Hall, B. K. (1996). Stage-specific onset of condensation 
and matrix deposition for Meckel's and other first arch cartilages in inbred 
C57BL/6 mice. J Craniofac Genet Dev Biol, 16(1), 32-47.
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002). Two major 
Smad pathways in TGF-beta superfamily signalling. Genes Cells, 7(12), 
1191-1204.
Moller, A. R. (2006). Hearing: Anatomy, Physiology, and Disorders of the Auditory 
System. USA: Academic Press, Elsevier.
294
Moraes, F., Novoa, A., Jerome-Majewska, L.A., Papaioannou, V.E. and, & Mallo, M. 
(2005). Tbx1 is required for proper neural crest migration and to stabilize spatial 
patterns during middle and inner ear development. Mech. Dev, 122, 199-212.
Mori, C., Nakamura, N., Kimura, S., Irie, H., Takigawa, T., & Shiota, K. (1995). 
Programmed cell death in the interdigital tissue of the fetal mouse limb is 
apoptosis with DNA fragmentation. Anat Rec, 242(1), 103-110.
Motta, G., Mesolella, M., & Salafia, M. (1996). [Malformation processes in the middle 
ear. Branchio-oto-renal syndrome (BOR)]. Acta Otorhinolaryngol Ital, 16(2 
Suppl 53), 42-46.
Moumoulidis, I., Axon, P., Baguley, D., & Reid, E. (2007). A review on the genetics of 
otosclerosis. [Review]. Clin Otolaryngol, 32(4), 239-247.
Murphy, T. F. (2000). Bacterial otitis media: pathogenetic considerations. Review. 
Pediatr Infect Dis J, 19(5 Suppl), S9-15; discussion S15-16.
Nakase, T., Ariga, K., Yonenobu, K., Tsumaki, N., Luyten, F. P., Mukai, Y., et al. (2001). 
Activation and localization of cartilage-derived morphogenetic protein-1 at the 
site of ossification of the ligamentum flavum. Eur Spine J, 10(4), 289-294.
Nandapalan, V., & Tos, M. (2000). Isolated congenital stapes ankylosis: an embryologic 
survey and literature review. Am J Otol, 21(1), 71-80.
Niedermeyer, H. P., & Arnold, W. (1995). Otosclerosis: a measles virus associated 
inflammatory disease. Acta Otolaryngol, 115(2), 300-303.
Nishizaki, K., Anniko, M., Orita, Y., Masuda, Y., Yoshino, T., Kanda, S., et al. (1998). 
Programmed cell death in the development of the mouse external auditory canal. 
Anat Rec, 252(3), 378-382.
Noben-Trauth, K., & Latoche, J. R. (2011). Ectopic mineralization in the middle ear and 
chronic otitis media with effusion caused by RPL38 deficiency  in the Tail-short 
(Ts) mouse. J Biol Chem, 286(4), 3079-3093.
Nonomura, K., Takahashi, M., Wakamatsu, Y., Takano-Yamamoto, T., & Osumi, N. 
(2010). Dynamic expression of Six family genes in the dental mesenchyme and 
the epithelial ameloblast stem/progenitor cells during murine tooth development. 
J Anat, 216(1), 80-91.
Northrop, C., Piza, J., & Eavey, R. D. (1986). Histological observations of amniotic 
fluid cellular content in the ear of neonates and infants. Int J Pediatr 
Otorhinolaryngol, 11(2), 113-127.
NOVACEK, M. J. (1993). The Skull. Chicago: University of Chicago Press.
295
O'Gorman, S. (2005). Second branchial arch lineages of the middle ear of wild-type and 
Hoxa2 mutant mice. Dev Dyn, 234(1), 124-131.
Ogutcen-Toller, M. (1995). The morphogenesis of the human discomalleolar and 
sphenomandibular ligaments. J Craniomaxillofac Surg, 23(1), 42-46.
Ohtani, I., & Schuknecht, H. F. (1984). Temporal bone pathology in DiGeorge's 
syndrome. Ann Otol Rhinol Laryngol, 93(3 Pt 1), 220-224.
Ohto, H., Kamada, S., Tago, K., Tominaga, S. I., Ozaki, H., Sato, S., et  al. (1999). 
Cooperation of six and eya in activation of their target genes through nuclear 
translocation of Eya. Mol Cell Biol, 19(10), 6815-6824.
Oka, K., Oka, S., Sasaki, T., Ito, Y., Bringas, P., Jr., Nonaka, K., et al. (2007). The role 
of TGF-beta signaling in regulating chondrogenesis and osteogenesis during 
mandibular development. Dev Biol, 303(1), 391-404.
Okabe, Y., Sano, T., & Nagata, S. (2009). Regulation of the innate immune response by 
threonine-phosphatase of Eyes absent. [Research Support, Non-U.S. Gov't]. 
Nature, 460(7254), 520-524.
Oliver, G., Wehr, R., Jenkins, N. A., Copeland, N. G., Cheyette, B. N., Hartenstein, V., 
et al. (1995). Homeobox genes and connective tissue patterning. Development, 
121(3), 693-705.
Omi, M., Sato-Maeda, M., & Ide, H. (2000). Role of chondrogenic tissue in 
programmed cell death and BMP expression in chick limb buds. Int J Dev Biol, 
44(4), 381-388.
Orvidas, L. J., Fabry, L. B., Diacova, S., & McDonald, T. J. (1999). Hearing and 
otopathology in Crouzon syndrome. Laryngoscope, 109(9), 1372-1375.
Ouchi, Y., Abe, S., Sun-Ki, R., Agematsu, H., Watanabe, H., & Ide, Y. (1998). 
Attachment of the sphenomandibular ligament to bone during intrauterine 
embryo development for the control of mandibular movement. Bull Tokyo Dent 
Coll, 39(2), 91-94.
Padget, D. H. (1948). The development of the cranial arteries in the human embryo. 
Contrib. Embyol., 32, 205- 261.
Palacios, S. D., Pak, K., Rivkin, A. Z., Bennett, T., & Ryan, A. F. (2002). Growth factors 
and their receptors in the middle ear mucosa during otitis media. 
Laryngoscope, 112 (3), 420-423.
Palle, S., Chappard, D., Vico, L., Riffat, G., & Alexandre, C. (1989). Evaluation of the 
osteoclastic population in iliac crest biopsies from 36 normal subjects: a 
histoenzymologic and histomorphometric study. J Bone Miner Res, 4(4), 
501-506.
296
Palva, T., & Ramsay, H. (2002). Fate of the mesenchyme in the process of 
pneumatization. Otol Neurotol, 23(2), 192-199.
Paparella, M. M., Shea, D., Meyerhoff, W. L., & Goycoolea, M. V. (1980). Silent otitis 
media. Laryngoscope, 90(7 Pt 1), 1089-1098.
Paradise, J. L., Bluestone, C. D., & Felder, H. (1969). The universality  of otitis media in 
50 infants with cleft palate. Pediatrics, 44(1), 35-42.
Park, K., & Choung, Y. H. (2009). Isolated congenital ossicular anomalies. Acta 
Otolaryngol, 129(4), 419-422.
Park, K., & Lim, D. J. (1992). Luminal development of the eustachian tube and middle 
ear: murine model. Yonsei Med J, 33(2), 159-167.
Parkinson, N., Hardisty-Hughes, R. E., Tateossian, H., Tsai, H. T., Brooker, D., Morse, 
S., et al. (2006). Mutation at the Evi1 locus in Junbo mice causes susceptibility 
to otitis media. PLoS Genet, 2(10), e149.
Pau, H., Fuchs, H., de Angelis, M. H., & Steel, K. P. (2005). Hush puppy: a new mouse 
mutant with pinna, ossicle, and inner ear defects. Laryngoscope, 115(1), 
116-124.
Persaud, R., Hajioff, D., Trinidade, A., Khemani, S., Bhattacharyya, M. N., 
Papadimitriou, N., et al. (2007). Evidence-based review of aetiopathogenic 
theories of congenital and acquired cholesteatoma. J Laryngol Otol, 121(11), 
1013-1019.
Phelps, P. D., Poswillo, D., & Lloyd, G. A. (1981). The ear deformities in 
mandibulofacial dysostosis (Treacher Collins syndrome). Clin Otolaryngol 
Allied Sci, 6(1), 15-28.
Piza, J., Northrop, C., & Eavey, R. D. (1998). Embryonic middle ear mesenchyme 
disappears by redistribution. Laryngoscope, 108(9), 1378-1381.
Pizette, S., & Niswander, L. (1999). BMPs negatively  regulate structure and function of 
the limb apical ectodermal ridge. Development, 126(5), 883-894.
Platt, J. (1893). Ectodermic Origin of the Cartilages of the Head: Mass.
Polinkovsky, A., Robin, N. H., Thomas, J. T., Irons, M., Lynn, A., Goodman, F. R., et al. 
(1997). Mutations in CDMP1 cause autosomal dominant brachydactyly type C. 
Nat Genet, 17(1), 18-19.
Portman, M. (1998). The invagination theory for the pathogenesis of cholesteatoma. In 
Sade ! J, ed. Cholesteatoma and Mastoid Surgery. Amsterdam: Kugler.
297
Pron, G., Galloway, C., Armstrong, D., & Posnick, J. (1993). Ear malformation and 
hearing loss in patients with Treacher Collins syndrome. Cleft Palate Craniofac 
J, 30(1), 97-103.
Qiu, M., Bulfone, A., Ghattas, I., Meneses, J. J., Christensen, L., Sharpe, P. T., et al. 
(1997). Role of the Dlx homeobox genes in proximodistal patterning of the 
branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter 
morphogenesis of proximal skeletal and soft tissue structures derived from the 
first and second arches. Dev Biol, 185(2), 165-184.
Qiu, M., Bulfone, A., Martinez, S., Meneses, J. J., Shimamura, K., Pedersen, R. A., et 
al. (1995). Null mutation of Dlx-2 results in abnormal morphogenesis of 
proximal first and second branchial arch derivatives and abnormal 
differentiation in the forebrain. Genes Dev, 9(20), 2523-2538.
Ramakrishnan, K., Sparks, R. A., & Berryhill, W. E. (2007). Diagnosis and treatment of 
otitis media. Am Fam Physician, 76(11), 1650-1658.
Deka, R.C. (1998). Newer concepts of pathogenesis of middle ear
        cholesteatoma. Indian J Otol, 4, 55-57.
Reddi, A. H. (1992). Regulation of cartilage and bone differentiation by  bone 
morphogenetic proteins. Curr Opin Cell Biol, 4(5), 850-855.
Rhodes, C. R., Parkinson, N., Tsai, H., Brooker, D., Mansell, S., Spurr, N., et  al. (2003). 
The homeobox gene Emx2 underlies middle ear and inner ear defects in the deaf 
mouse mutant pardon. J Neurocytol, 32(9), 1143-1154.
Rich, T. H., Hopson, J. A., Musser, A. M., Flannery, T. F., & Vickers-Rich, P. (2005). 
Independent origins of middle ear bones in monotremes and therians. Science, 
307(5711), 910-914.
Richany, S. F., Bast, T. H., & Anson, B. J. (1956). The development of the first 
branchial arch in man and the fate of Meckel's cartilage. Q Bull Northwest Univ 
Med Sch, 30(4), 331-355.
Richman, J. M., & Diewert, V. M. (1988). The fate of Meckel's cartilage chondrocytes 
in ocular culture. Dev Biol, 129(1), 48-60.
Richter, C. A., Amin, S., Linden, J., Dixon, J., Dixon, M. J., & Tucker, A. S. (2010). 
Defects in middle ear cavitation cause conductive hearing loss in the Tcof1 
mutant mouse. Hum Mol Genet, 19(8), 1551-1560.
Rider, C. C., & Mulloy, B. (2010). Bone morphogenetic protein and growth 
differentiation factor cytokine families and their protein antagonists. Biochem J, 
429(1), 1-12.
298
Rivkin, A. Z., Palacios, S. D., Pak, K., Bennett, T., & Ryan, A. F. (2005). The role of 
Fas-mediated apoptosis in otitis media: observations in the lpr/lpr mouse. Hear 
Res, 207(1-2), 110-116.
Roberts, D. S., & Miller, S. A. (1998). Apoptosis in cavitation of middle ear space. Anat 
Rec, 251(3), 286-289.
Rodriguez Vazquez, J. F., Merida Velasco, J. R., & Jimenez Collado, J. (1992). 
Development of the human sphenomandibular ligament. Anat Rec, 233(3), 
453-460.
Rodriguez-Vazquez, J. F. (2005). Development of the stapes and associated structures in 
human embryos. J Anat, 207(2), 165-173.
Rosen, V. (2006). BMP and BMP inhibitors in bone. Ann N Y Acad Sci, 1068, 19-25.
Rountree, R. B., Schoor, M., Chen, H., Marks, M. E., Harley, V., Mishina, Y., et al. 
(2004). BMP receptor signaling is required for postnatal maintenance of 
articular cartilage. PLoS Biol, 2(11), 355.
Rowe, T. (1996). Coevolution of the mammalian middle ear and neocortex. Science, 
273(5275), 651-654.
Ruf, R. G., Xu, P. X., Silvius, D., Otto, E. A., Beekmann, F., Muerb, U. T., et  al. (2004). 
SIX1 mutations cause branchio-oto-renal syndrome by  disruption of EYA1-
SIX1-DNA complexes. Proc Natl Acad Sci U S A, 101(21), 8090-8095.
Rye, M. S., Bhutta, M. F., Cheeseman, M. T., Burgner, D., Blackwell, J. M., Brown, S. 
D., et al. (2011). Unraveling the genetics of otitis media: from mouse to human 
and back again. Mamm Genome, 22(1-2), 66-82.
S.J, G. (1977). Ontogeny and Phylogeny. Belknap, Cambridge, MA.
Sade, J., Babiacki, A., & Pinkus, G. (1983). The metaplastic and congenital origin of 
cholesteatoma. Acta Otolaryngol, 96(1-2), 119-129.
Sajithlal, G., Zou, D., Silvius, D., & Xu, P. X. (2005). Eya 1 acts as a critical regulator 
for specifying the metanephric mesenchyme. Dev Biol, 284(2), 323-336.
Sakakura, Y., Hosokawa, Y., Tsuruga, E., Irie, K., & Yajima, T. (2007). In situ 
localization of gelatinolytic activity  during development and resorption of 
Meckel's cartilage in mice. Eur J Oral Sci, 115(3), 212-223.
Santos, F., McCall, A. A., Chien, W., & Merchant, S. (2012). Otopathology in 
Osteogenesis Imperfecta. [Research Support, N.I.H., Extramural]. Otol 
Neurotol, 33(9), 1562-1566.
299
Schlosser, G., Awtry, T., Brugmann, S. A., Jensen, E. D., Neilson, K., Ruan, G., et al. 
(2008). Eya1 and Six1 promote neurogenesis in the cranial placodes in a SoxB1-
dependent fashion. Dev Biol, 320(1), 199-214.
Schmidt, M., Schler, G., Gruensfelder, P., & Hoppe, F. (2002). Expression of bone 
morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma 
fibroblasts. Otol Neurotol, 23(3), 267-270.
Schweitzer, R., Chyung, J. H., Murtaugh, L. C., Brent, A. E., Rosen, V., Olson, E. N., et 
al. (2001). Analysis of the tendon cell fate using Scleraxis, a specific marker for 
tendons and ligaments. Development, 128(19), 3855-3866.
Seemann, P., Brehm, A., Konig, J., Reissner, C., Stricker, S., Kuss, P., et al. (2009). 
Mutations in GDF5 reveal a key residue mediating BMP inhibition by 
NOGGIN. PLoS Genet, 5(11), e1000747.
Settle, S. H., Jr., Rountree, R. B., Sinha, A., Thacker, A., Higgins, K., & Kingsley, D. M. 
(2003). Multiple joint and skeletal patterning defects caused by single and 
double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol, 254(1), 116-130.
Shibahara, Y., & Sando, I. (1988). Histopathologic study of eustachian tube in cleft 
palate patients. Ann Otol Rhinol Laryngol, 97(4 Pt 1), 403-408.
Shum, L., Sakakura, Y., Bringas, P., Jr., Luo, W., Snead, M. L., Mayo, M., et al. (1993). 
EGF abrogation-induced fusilli-form dysmorphogenesis of Meckel's cartilage 
during embryonic mouse mandibular morphogenesis in vitro. Development, 118
(3), 903-917.
Silver, S. J., Davies, E. L., Doyon, L., & Rebay, I. (2003). Functional dissection of eyes 
absent reveals new modes of regulation within the retinal determination gene 
network. Mol Cell Biol, 23(17), 5989-5999.
Smith, P. G., Dyches, T. J., & Loomis, R. A. (1984). Clinical aspects of the branchio-
oto-renal syndrome. Otolaryngol Head Neck Surg, 92(4), 468-475.
Soker, T., Dalke, C., Puk, O., Floss, T., Becker, L., Bolle, I., et al. (2008). Pleiotropic 
effects in Eya3 knockout mice. BMC Dev Biol, 8, 118.
Sperber, G. H. (1992). First year of life: prenatal craniofacial development. [Review]. 
Cleft Palate Craniofac J, 29(2), 109-111.
Stankovic, K. M., & McKenna, M. J. (2006). Current research in otosclerosis. Curr 
Opin Otolaryngol Head Neck Surg, 14(5), 347-351.
Steel, K. P., Moorjani, P., & Bock, G. R. (1987). Mixed conductive and sensorineural 
hearing loss in LP/J mice. Hear Res, 28(2-3), 227-236.
300
Stelmachowicz, P. G., Pittman, A. L., Hoover, B. M., Lewis, D. E., & Moeller, M. P. 
(2004). The importance of high-frequency  audibility in the speech and language 
development of children with hearing loss. Arch Otolaryngol Head Neck Surg, 
130(5), 556-562.
Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., & Lee, S. 
J. (1994). Limb alterations in brachypodism mice due to mutations in a new 
member of the TGF beta-superfamily. Nature, 368(6472), 639-643.
Storm, E. E., & Kingsley, D. M. (1996). Joint patterning defects caused by single and 
double mutations in members of the bone morphogenetic protein (BMP) family. 
Development, 122(12), 3969-3979.
Storm, E. E., & Kingsley, D. M. (1999). GDF5 coordinates bone and joint formation 
during digit development. Dev Biol, 209(1), 11-27.
Strasburger. (1965). Symphalangism: genetic and clinical aspects. Bull Johns Hopkins 
Hosp., 117, 108-127.
Streuli, C. (1999). Extracellular matrix remodelling and cellular differentiation. 
[Review]. Curr Opin Cell Biol, 11(5), 634-640.
Takahara, T., & Sando, I. (1987). Mesenchyme remaining in temporal bones from 
patients with congenital anomalies. A quantitative histopathologic study. 
[Comparative Study]. Ann Otol Rhinol Laryngol, 96(3 Pt 1), 333-339.
Takahashi, H., Fujita, A., & Honjo, I. (1989). Effect of adenoidectomy on otitis media 
with effusion, tubal function, and sinusitis. Am J Otolaryngol, 10(3), 208-213.
Tashiro, T., Hiraoka, H., Ikeda, Y., Ohnuki, T., Suzuki, R., Ochi, T., et al. (2006). Effect 
of GDF-5 on ligament healing. J Orthop Res, 24(1), 71-79.
Tassabehji, M., Fang, Z. M., Hilton, E. N., McGaughran, J., Zhao, Z., de Bock, C. E., et 
al. (2008). Mutations in GDF6 are associated with vertebral segmentation 
defects in Klippel-Feil syndrome. Hum Mutat, 29(8), 1017-1027.
Tateossian, H., Hardisty-Hughes, R. E., Morse, S., Romero, M. R., Hilton, H., Dean, C., 
et al. (2009). Regulation of TGF-beta signalling by Fbxo11, the gene mutated in 
the Jeff otitis media mouse mutant. Pathogenetics, 2(1), 5.
Tateossian, H., Morse, S., Parker, A., Mburu, P., Warr, N., Acevedo-Arozena, A., et al. 
(2013). Otitis media in the Tgif knockout mouse implicates TGFbeta signalling 
in chronic middle ear inflammatory disease. Hum Mol Genet,  (ahead of print).
Terao, F., Takahashi, I., Mitani, H., Haruyama, N., Sasano, Y., Suzuki, O., et al. (2011). 
Fibroblast growth factor 10 regulates Meckel's cartilage formation during early 
mandibular morphogenesis in rats. Dev Biol, 350(2), 337-347.
301
Thies, R. S., Bauduy, M., Ashton, B. A., Kurtzberg, L., Wozney, J. M., & Rosen, V. 
(1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic 
differentiation in W-20-17 stromal cells. Endocrinology, 130(3), 1318-1324.
Thompson, H., Ohazama, A., Sharpe, P. T., & Tucker, A. S. (2012). The origin of the 
stapes and relationship to the otic capsule and oval window. Dev Dyn, 241(9), 
1396-1404.
Thompson, H., & Tucker, A. S. (2013). Dual origin of the epithelium of the mammalian 
middle ear. Science, 339(6126), 1453-1456.
Tian, C., Yu, H., Yang, B., Han, F., Zheng, Y., Bartels, C. F., et al. (2012). Otitis media 
in a new mouse model for CHARGE syndrome with a deletion in the Chd7 
gene. PLoS One, 7(4), e34944.
Tos, M. (2000). Surgical Solutions for Conductive Hearing Loss. Stuttgart, Germany: 
Gerog Thieme Verlag.
Tos, M., & Caye-Thomasen, P. (2002). Mucous glands in the middle ear - what is 
known and what is not. ORL J Otorhinolaryngol Relat Spec, 64(2), 86-94.
Trichilis, A., & Wroblewski, J. (1997). Expression of p53 and hsp70 in relation to 
apoptosis during Meckel's cartilage development in the mouse. [Research 
Support, Non-U.S. Gov't]. Anat Embryol (Berl), 196(2), 107-113.
Trojanowska, A., Drop, A., Trojanowski, P., Rosinska-Bogusiewicz, K., Klatka, J., & 
Bobek-Billewicz, B. (2012). External and middle ear diseases: radiological 
diagnosis based on clinical signs and symptoms. Insights Imaging, 3(1), 33-48.
Trokovic, N., Trokovic, R., Mai, P., & Partanen, J. (2003). Fgfr1 regulates patterning of 
the pharyngeal region. Genes Dev, 17(1), 141-153.
Tsumaki, N., Nakase, T., Miyaji, T., Kakiuchi, M., Kimura, T., Ochi, T., et  al. (2002). 
Bone morphogenetic protein signals are required for cartilage formation and 
differently regulate joint development during skeletogenesis. J Bone Miner Res, 
17(5), 898-906.
Tsumaki, N., Tanaka, K., Arikawa-Hirasawa, E., Nakase, T., Kimura, T., Thomas, J. T., 
et al. (1999). Role of CDMP-1 in skeletal morphogenesis: promotion of 
mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol, 144
(1), 161-173.
Tsuzurahara, F., Nakamura, M. (2010). Macrophages Are Key  Cells for the Initiation of 
Meckel’s Cartilage Disappearance. J. Oral Biosci, 52(2), 150-154.
Tsuzurahara, F., Soeta, S., Kawawa, T., Baba, K., & Nakamura, M. (2011). The role of 
macrophages in the disappearance of Meckel's cartilage during mandibular 
development in mice. Acta Histochem, 113(2), 194-200.
302
Tucker, A. S., Watson, R. P., Lettice, L. A., Yamada, G., & Hill, R. E. (2004). Bapx1 
regulates patterning in the middle ear: altered regulatory role in the transition 
from the proximal jaw during vertebrate evolution. Development, 131(6), 
1235-1245.
Ueda, H., Miyazawa, T., Fujimoto, T., & Yanagita, N. (1996). Stapes fixation associated 
with symphalangia. Arch Otolaryngol Head Neck Surg, 122(10), 1124-1128.
Uppal, S., Bajaj, Y., Rustom, I., & Coatesworth, A. P. (2009). Otosclerosis 1: the 
aetiopathogenesis of otosclerosis. Int J Clin Pract, 63(10), 1526-1530.
Urist, M. R. (1965). Bone: formation by autoinduction. Science, 150(3698), 893-899.
Usami, S., Abe, S., Nishio, S., Sakurai, Y., Kojima, H., Tono, T., et al. (2012). Mutations 
in the NOG gene are commonly found in congenital stapes ankylosis with 
symphalangism, but not in otosclerosis. Clin Genet, 82(6), 514-520.
Van De Water, T. R., Noden DM, Maderson PFA. (1988). Embryology of the ear, outer, 
middle, and inner ear. In Otologic Medicine and Surgery. New York: Churchill 
Livingstone.
Visosky, A. M., Johnson, J., Bingea, B., Gurney, T., & Lalwani, A. K. (2003). 
Otolaryngological manifestations of cleidocranial dysplasia, concentrating on 
audiological findings. Laryngoscope, 113(9), 1508-1514.
Voronina, V. A., Takemaru, K., Treuting, P., Love, D., Grubb, B. R., Hajjar, A. M., et al. 
(2009). Inactivation of Chibby affects function of motile airway cilia. J Cell 
Biol, 185(2), 225-233.
Wang, L., Bresee, C. S., Jiang, H., He, W., Ren, T., Schweitzer, R., et al. (2011). 
Scleraxis is required for differentiation of the stapedius and tensor tympani 
tendons of the middle ear. J Assoc Res Otolaryngol, 12(4), 407-421.
Wang, Y., Hu, Y., Meng, J., & Li, C. (2001). An ossified Meckel's cartilage in two 
Cretaceous mammals and origin of the mammalian middle ear. Science, 294
(5541), 357-361.
Wang, Y., Hu, Y., Meng, J., & Li, C. (2001). An ossified Meckel's cartilage in two 
Cretaceous mammals and origin of the mammalian middle ear. [Research 
Support, Non-U.S. Gov't]. Science, 294(5541), 357-361.
Wardi, A. H., & Michos, G. A. (1972). Alcian blue staining of glycoproteins in 
acrylamide disc electrophoresis. Anal Biochem, 49(2), 607-609.
Weaver, M., Yingling, J. M., Dunn, N. R., Bellusci, S., & Hogan, B. L. (1999). Bmp 
signaling regulates proximal-distal differentiation of endoderm in mouse lung 
development. Development, 126(18), 4005-4015.
303
Weber, K. M., & Kousseff, B. G. (1999). New' manifestations of BOR syndrome. Clin 
Genet, 56(4), 306-312.
W. H. O. (2004). Chronic suppurative otitis media. Burden of Illness and Management 
Options. 3.
Whyte, J. R., Gonzalez, L., Cisneros, A. I., Yus, C., Torres, A., & Sarrat, R. (2002). 
Fetal development of the human tympanic ossicular chain articulations. Cells 
Tissues Organs, 171(4), 241-249.
Williamson, I., Benge, S, Mullee, M, Little, P. (2006). Consultations for middle ear 
disease, antibiotic prescribing and risk factors for reattendance:
 a case-linked cohort study. British Journal of General Practice, 56, 170-175.
Wilson, J., & Tucker, A. S. (2004). Fgf and Bmp signals repress the expression of 
Bapx1 in the mandibular mesenchyme and control the position of the developing 
jaw joint. Dev Biol, 266(1), 138-150.
Winkler, D. G., Yu, C., Geoghegan, J. C., Ojala, E. W., Skonier, J. E., Shpektor, D., et al. 
(2004). Noggin and sclerostin bone morphogenetic protein antagonists form a 
mutually inhibitory complex. J Biol Chem, 279(35), 36293-36298.
Wolfman, N. M., Hattersley, G., Cox, K., Celeste, A. J., Nelson, R., Yamaji, N., et al. 
(1997). Ectopic induction of tendon and ligament in rats by growth and 
differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin 
Invest, 100(2), 321-330.
Worley, G. A., Vats, A., Harcourt, J., & Albert, D. M. (1999). Bilateral congenital 
cholesteatoma in branchio-oto-renal syndrome. J Laryngol Otol, 113(9), 
841-843.
Wrana, J. L. (2000). Crossing Smads. Sci STKE, 2000(23), re1.
Wyganowska-Swiatkowska, M., & Przystanska, A. (2011). The Meckel's cartilage in 
human embryonic and early fetal periods. Anat Sci Int, 86(2), 98-107.
Xu, P. X., Cheng, J., Epstein, J. A., & Maas, R. L. (1997). Mouse Eya genes are 
expressed during limb tendon development and encode a transcriptional 
activation function. Proc Natl Acad Sci U S A, 94(22), 11974-11979.
Xu, P. X., Woo, I., Her, H., Beier, D. R., & Maas, R. L. (1997). Mouse Eya homologues 
of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal 
placode. Development, 124(1), 219-231.
Xu, P. X., Adams, J., Peters, H., Brown, M. C., Heaney, S., & Maas, R. (1999). Eya1-
deficient mice lack ears and kidneys and show abnormal apoptosis of organ 
primordia. Nat Genet, 23(1), 113-117.
304
Xu, P. X., Zheng, W., Laclef, C., Maire, P., Maas, R. L., Peters, H., et al. (2002). Eya1 is 
required for the morphogenesis of mammalian thymus, parathyroid and thyroid. 
Development, 129(13), 3033-3044.
Xu, P. X., Zheng, W., Huang, L., Maire, P., Laclef, C., & Silvius, D. (2003). Six1 is 
required for the early  organogenesis of mammalian kidney. Development, 130
(14), 3085-3094.
Yamada, G., Mansouri, A., Torres, M., Stuart, E. T., Blum, M., Schultz, M., et al. 
(1995). Targeted mutation of the murine goosecoid gene results in craniofacial 
defects and neonatal death. Development, 121(9), 2917-2922.
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., et al. 
(2000). p73-deficient mice have neurological, pheromonal and inflammatory 
defects but lack spontaneous tumours. Nature, 404(6773), 99-103.
Yang, B., Tian, C., Zhang, Z. G., Han, F. C., Azem, R., Yu, H., et al. (2011). Sh3pxd2b 
mice are a model for craniofacial dysmorphology and otitis media. PLoS One, 6
(7), e22622.
Yi, S. E., Daluiski, A., Pederson, R., Rosen, V., & Lyons, K. M. (2000). The type I 
BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. 
Development, 127(3), 621-630.
Youngs, R., & Rowles, P. (1990). The spatial organisation of keratinocytes in acquired 
middle ear cholesteatoma resembles that of external auditory  canal skin and pars 
flaccida. Acta Otolaryngol, 110(1-2), 115-119.
Yu, L., Han, M., Yan, M., Lee, J., & Muneoka, K. (2012). BMP2 induces segment-
specific skeletal regeneration from digit and limb amputations by establishing a 
new endochondral ossification center. Dev Biol, 372(2), 263-273.
Zehnder, A. F., Kristiansen, A. G., Adams, J. C., Kujawa, S. G., Merchant, S. N., & 
McKenna, M. J. (2006). Osteoprotegrin knockout mice demonstrate abnormal 
remodeling of the otic capsule and progressive hearing loss. Laryngoscope, 116
(2), 201-206.
Zeifer, B., Sabini, P., & Sonne, J. (2000). Congenital absence of the oval window: 
radiologic diagnosis and associated anomalies. AJNR Am J Neuroradiol, 21(2), 
322-327.
Zhang, Z., Zhang, X., Avniel, W. A., Song, Y., Jones, S. M., Jones, T. A., et al. (2003). 
Malleal processus brevis is dispensable for normal hearing in mice. Dev Dyn, 
227(1), 69-77.
305
Zheng, W., Huang, L., Wei, Z. B., Silvius, D., Tang, B., & Xu, P. X. (2003). The role of 
Six1 in mammalian auditory  system development. Development, 130(17), 
3989-4000.
Zhong, Z. M., Chen, J. T., Zhang, Y., Zha, D. S., Lin, Z. S., Zhao, C. Y., et al. (2010). 
Growth/differentiation factor-5 induces osteogenic differentiation of human 
ligamentum flavum cells through activation of ERK1/2 and p38 MAPK. Cell 
Physiol Biochem, 26(2), 179-186.
Zimmerman, J. E., Bui, Q. T., Steingrimsson, E., Nagle, D. L., Fu, W., Genin, A., et al. 
(1997). Cloning and characterization of two vertebrate homologs of the 
Drosophila eyes absent gene. Genome Res, 7(2), 128-141.
Zimmerman, L. B., De Jesus-Escobar, J. M., & Harland, R. M. (1996). The Spemann 
organizer signal noggin binds and inactivates bone morphogenetic protein 4. 
Cell, 86(4), 599-606.
Zou, D., Silvius, D., Fritzsch, B., & Xu, P. X. (2004). Eya1 and Six1 are essential for 
early steps of sensory  neurogenesis in mammalian cranial placodes. 
Development, 131(22), 5561-5572.
Zou, D., Silvius, D., Davenport, J., Grifone, R., Maire, P., & Xu, P. X. (2006). 
Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and 
Eya1. Dev Biol, 293(2), 499-512.
Zou, D., Silvius, D., Rodrigo-Blomqvist, S., Enerback, S., & Xu, P. X. (2006). Eya1 
regulates the growth of otic epithelium and interacts with Pax2 during the 
development of all sensory areas in the inner ear. Dev Biol, 298(2), 430-441.
Zou, D., Erickson, C., Kim, E. H., Jin, D., Fritzsch, B., & Xu, P. X. (2008). Eya1 gene 
dosage critically  affects the development of sensory  epithelia in the mammalian 
inner ear. Hum Mol Genet, 17(21), 3340-3356.
Zou, Y., Mak, S. S., Liu, H. Z., Han, D. Y., Zhuang, H. X., Yang, S. M., et al. (2012). 
Induction of the chick columella and its integration with the inner ear. Dev Dyn, 
241(6), 1104-1110.
Zuzarte-Luis, V., Montero, J. A., Rodriguez-Leon, J., Merino, R., Rodriguez-Rey, J. C., 
& Hurle, J. M. (2004). A new role for BMP5 during limb development acting 
through the synergic activation of Smad and MAPK pathways. Dev Biol, 272(1), 
39-52.
306
